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ABSTRACT 
This dissertation addressed the hypothesis that macrophages have an alternative killing 
mechanism that is independent of superoxide and nitric oxide but dependent on IFN-y, TNF 
and C/EBP[3. Since the mechanism and the gcnes involved in this alternative pathway are 
1110stly unknown, the aim ofthis dissertation was to identify these macrophage effector genes 
and to functionally eharacterize their role during inl'ection uti I izing gene deficient mouse 
models. Since mice defieient for C/E1Wr) (C/E1Wrr/-) expressed normal levels of IFN-y and 
T'NF during Listeria l1lonocy/ogenes infection, the macrophage effector genes involwd in 
conlinement and killing of L. Inonocy/ogencs were postulated to be dowllstream ofC/EBPp. 
Furthermore, CIEBPrr/- miee arc highly susceptible L. I1lOrlocylogenes due to impaired 
listericidal activity. Comparison of the gene expression profiles of W'[' and C/r~Bprr/­
Illal'rophages inCected with L. lI1onoc}'/ogenes was postulated to increase the probability of 
identifying these effector genes, which would be differentially expresscd between the two 
groups. COIll parative gene expression pro Ii ling by DNA m icroarrays between L. 
Ir/orloc)'togenes in Iccted WT and C/lm Pf3-1- Illacrophages, successfully identi lied 1268 genes 
to be differentially expressed between the two groups. A focussed functional elustering 
strategy redueed the number of candidate genes to 220. PKC8 was selected for l'lIIiher study 
since it was involved in humoral defense, immune signalling, production of superoxide, 
regulation 01' transcription and Illay be putatively transcriptionally regulated by C/EBP[I. 
Furthermore, PKCo was indirectly shown to promote L. rnonocytogcJ/es escape fi'om the 
phagosome and to negatively regulate transcription activity of C/EI3P[3. In addition, since 
PKC8 was up-regulated, as shown by microarray and confirmed by RT-PCR, in L. 
mOllocy/ogcnc.l' infected C/rmrrri - Illacrophages, it was therefore thought to play a 
detrimental ro Ie d uri ng L. l1Iollocy/ogenes. However, since this prem ise has never been 
investigated directly, the role PKCo during innate immunity against L 1I/0J1ocy/ogenes was 
examined Llsing the PKC8 deficient (PKCo-I-) mouse model. Data in this dissertation provides 
new insight into the role of PKCo during innate immunity to L. mOllocytogelles. PK('O-I- mice 
were highly susceptible to L. monocytogenes due to enhanced listerial escape and impaired 
listericidal activity. Despite full macrophage activation and production of nitric oxide, PKCSI -
mice displayed uncontrolled bacterial growth and disseminatiun of L. II/onocy/ogenes, which 
led to early death of lhe miee. In contrast, PKC8-1- mice were able to control Mvcohaclerillnl 
in/ceLion as well as WT mice, suggesting thal the activity of PKC8 may be negatively 
XXI 
regulated by L. 111Ol1ocytogenes. A systems biology approach generated the hypothcsis that 
PKC'i) may promote Rab5a activation, which together with localized release of superoxide 
into the phagosome and activation of C/EBPP by PKC8, resulted in the confincment of thc L. 
1I10l1ocvtogenes within the phagosome. Alternatively, PKC8 mny act in a separate pathway 
thal confines L mOl1ocytogenes within thc phagosome, by activating and/or syncrgizing with 
unidcntilied proteins to neutralize that activity of listerial LLO and PI-PLC. Data in this 
dissertation clcarly demollstrates that PKC8 is critical for conlinement of L mOl1ocytogcne.l' 
within phagosomes and may be part 01' a listericidal mechanism that is independent or nitric 
oxide, slIperoxide and pro-inflammatory cytokines. 
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') he aim or the current study was identify genes involved in macrophage effector functions 
against intracellular pathogens. In this stuuy, Listeria monocylogenes was used as a model 
illtracdlular pathogen to study host macrophage-mediated immunity and to identify 
macrophage effector genes against intracellular pathogens. L monocylogenes is widely used 
as a model organism to study bacterial pathogenesis and pathophysiology due to its ability to 
invade non-phagocytic cells and to survive and multiply within phagocytic cells. In addition, 
L fnonocylogenes crosses several host de1ense harriers such as the intestinal. the blood~brain 
and the placental barriers and can therefore infect a wide variety of organs (1). Furthermore, 
L nlonocylogenes is easily manipulated and grows well in vitro and in tissue cultured cells. 
This literature review comprises three parts, the Ilrst part will review the pathogenesis and 
survival strategy of L. monocylogenes, the second part the will review the host's innate 
immune response and the third part will discuss the research aims and strategy undertaken in 
this study. 
A. THE PATHOGENESIS OF' L MONOCYTOGENES lNFECTlONS 
L mOl1ocylogenes is a Gram-positive, facultative intracellular bacterium that is found in soil, 
water, eflluenls, human and animal faeces and a large variety of foods. L monoLy/ogenes is 
pathogenic and causes the infectious disease termed listeriosis in humans and domesticated 
animals. In domesticated livestock, L mono()!logenes iniection is transmitted hy the ingestion 
of contaminated silage, resulting in herd outbreaks (2). Similarly, in humans infection occurs 
through ingestion of contaminated ibods, such as industrially produced, n:frigcrated ready-to-
eat products that do not require cooking or reheating e.g. soft cheeses, dairy products, pates, 
sausages, smoked fish and salads (2). Since 1.. nlonocytogenes can tolerate high 
concentrations of salt, relatively low pHs and can multiply at refrigeration temperatures, it can 
survive most food processing technologies and therefore is a threat to ilJod safety (2). The 
clinical manilestations of listeriosis include encephalitis, gastroenteritis, meningitis, mother-
to-fbetus infections and septicaemia. Although listeriosis is a rare disease, when infection 
docs occur it is usually a very severe and has a mean mortality rate in humans of 30% or 
higher despite early antihiotic treatment (2, 3). The clinical outcome of L fnonocylogenes 
infection depends on three major variahles: (i) the number of bacteria ingested with food, (ii) 
the virulence properties of the strain and (iii) the health status of the host. Individuals most at 
risk include pregnant females, unborn foetuses, the elderly (55 years and older), and 
immunocompromised or debilitated adults with underlying diseases sueh as HlV/AIDS, 
lupus, leukaemia, lymphoma, sarcoma, chronic liver disease, kidney disease and diabetes (2). 
[n addition adults undergoing anti-cancer chemotherapy or immunosuppressant therapy (for 
organ transplantation) are also at risk (2). The immune systems of immunocompromised and 
debilitated individuals are unable to mount a strong enough response even at low dose 
infections. As a consequence, they are unable to control bacterial proliferation resulting in 
invasive disease. Uncontrolled bacterial growth in the liver, the primary target organ of L. 
mono"ytogenes, results in the release of bacteria into the bloodstream and subsequent 
infection and septicaemia in secondary Larget organs such as the hrain and placenta. 
Furthermore, L monocyloRenes also has the potential 10 intect immunocompetent individuals 
(4). In immunocompetent individuals, ingestion of low doses of L. monocyloRelws usually has 
no clinical manifestations other than boosting protective anti-listerial immunity. However, 
ingestion of large doses may result in gastroenteritis and fever, and in rare cases, invasive 
disease depending on the virulence of the strain. These diverse clinical manifestation of 
listeriosis highlights its ability to cross three wry important host barriers: (i) the intestinal 
barrier via invasion of the intestinal epithet ium and thereby gaining access to the bloodstream 
and organs, (ii) the blood -brain barrier resulting in meningitis and (iii) the foetal-placental 
barrier in pregnant women resulting in foetal infection and/or abortion. 
1. 1nternalization into target host cells by molecular mimicry 
Entry of L rnonocyloRenes into mammalian cells is a dynamic process whereby L 
f}]onocytogenes manipulates host-cell signaling and endocytic pathways to induce remodelling 
of the actin cytoskeleton and plasma memhrane facilitating its uptake into target cells. L 
/11onocytoR(mes is able to induce its own internalization into professional phagocytes (e.g. 
macrophages and dendritic cells) and non-prokssional phagocytes (e.g. epithelial cells, 
fibroblasts, enterocytes, hepatocytes, endothelial cells and neurons) (2). The invasion of 
prolessional phagocytes is a passive process, whereas entry into l1on-proJessional phagocytes 
is induced by a "zipper mechanism" involving direct interactions between bacterial surface 
proteins and host cdl surface receptors, resulting in the engulfment of the bacterium by the 
plasma membrane (5). Regardless of the mechanism used by the bacterium ror invasion, the 
interactions between the bacteria and the host cell result in re-organization of the cell's actin 
cytoskeleton induced by cellular signaling cascades, culminating in bacterial uptake (5, 6). 
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The ability of L monocylogenes to infect such as wide varicty of cell types is bcilitated by 
interactions of its surlace proteins, internalin (inl) A [n18 and p60 with several host cell 
surface receptors including E-cadherin, the Met receptor f(H hepatocyte growth factor (HOF), 
the C 1 q complement fraction receptor, macrophage scavenger receptor and components of the 
extracellular matrix (ECM) such as heparan sulillte proteoglycans (HSPG) and fibronectin (2). 
More recently, several other L monoc-:ylogenes proteins have been implicated in the adhesion 
and invasion process. For example, L monocytogenes expresses lectin-like ligands that are 
involved in adherence to eukaryotic cells (7, 8). Bacterial surface protein, Lap is involved in 
attachment to Caco-2 cells and the autolysin Ami has a cell wall-anchoring domain similar to 
Inln at its C-terminal (9, 10). Expression of an adhesin protein containing aD-galactose 
moiety induces L mot1()(:yfogenes uptake into mouse dendritic cells (ii). More recently, 
genetic studies utilizing the genome sequence of L mot1ocytogenes has enabled the 
identilication of other listerial proteins involved invasion of eukaryotic cells. With respect to 
virulence, the L. mOt1ocytogenes genome contains a significantly large percentage (4.7% of all 
predicted genes) (12) of genes encoding surface proteins, which may potentially interact with 
host cells and may thererore be virulence factors. Similarly, global interference RNA studies 
in Drosophila S2 macrophage-like cells, have identified several new host genes involved 
during the invasion (13, 14). The natural route of infection tt)r L. monocylogenes is through 
the gastrointestinal tract, where the bacterium inCects the intestinal epithelial cells via the 
interaction between InlA and epithelial cadherin (E-cadherin) (15). L monoc-ylogenes then 
crosses the epithelial-ceil layer and disseminates into the bloodstream and lymph to 
mesenteric lymph nodes and other organs such as the liver and spleen, where they arc 
internal ized by hcpatocytes and resident macrophages. 
1.1. Invasion of phagocytic cells 
1.. monocylogenes internalization into phagocytic cells such as macrophages and dendritic 
cells occurs either via the opsonin-dependenl pathway mediated by Fc gamma receptor (FcyR) 
and C3bi and Clq complement receptors (Io-It») and/or via the opsonin-independent pathway 
mediated macrophage scavenger receptors (20, 21) (Fig. 1). In the opsonin-dependent 
pathway, dissemination or L. monocytogene,." in the blood stream results in the bacilli 
becoming coated (opsonized) with host opsonins sLlch as [gG antibodies and complement 
fragments C3bi and e1q. The IgG molecules recognize and attach to specific bacterial surface 
proteins, whereas the complement fragments bind non-speci Ii cally to the bacterium's cell wall 
(22). I gG-opsonized L. monocyfogenes are recognized and engaged by the Fe gamma 
rl'ceptor (FcyR). The C3bi-opsonized bacteria arc recognized and engaged by complement 
') ., 
receptor 3 (CR3; also known as CDllb, CD18 or Mac-I) or complement receptor of the 
immunoglobulin superfamily (CRlg) (23). ('1 q-opsonized bacteria art~ bound by the elq 
complement receptor (ClqR; also known as Ly68). In the non-opsonic pathway, L 
trlonocy/ogenes surface proteins bind to host receptors that then trigger the engul fment of the 
bacterium into the cell. For example, the invasion of dendritic cells by L 17100UJLy/o?:cnes into 
dendritic cells involves a bacterial adhesion protein containing a-D-galactose (II) and non-
opsonic uptake by maerophages is mediated by the macrophage scavenger receptor and 
components of the extracellular matrix (ECM) such as heparan sulfate proteoglycans (HSPG) 
(2). In addition, L fIlono<.:ylogenes binds to the globular ClqR (gClqR), the receptor itw the 
globular part of complement component elq, via its surface protein Internalin R (In18) (24). 
The crosslinking of these receptors upon binding L. Inono(ytogenes initiates waves of signal 
transduction events that require kinase activation, alterations in phospholipid metabolism, 
remodelling of the actin cytoskeleton and acceleration of membrane tramc (25) leading to the 
internalization or the bacteria into a primary phagosome (26, 27). Several proteins are 
implicated in the phagocytosis process, and the list is continually growing longer, and at 
present includes protein kinases, phosphatases, GTPases, lipid-modifying enzymes, adaptor 
complexes, actin-binding proteins and membrane fusion and scission mediators (22). 
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Figure 1. Internalization of L. monocytogenes into antigen presenting cells. (A) L. 
monocytogenes opsonized with IgG antibodies and/or complement proteins such as C3bi and 
Clq are recognized by the FcyR, CR3, CRlg and ClqR and internalized by receptor-mediated 
phagocytosis. (B) L. monocytogenes surface molecules such as ActA, InlB and lipoteichoic 
acid are recognized by macrophage HSPG receptors, gC 1 qR and macrophage scavenger 
receptors I and II. On dendritic celis, InlB is recognized by glycolyslated receptors containing 
a-O galactose moieties. Attachment of L. monocytogenes to its target celis by either pathway 
results in receptor-mediated phagocytosis involving kinase activation, alterations In 
phospholipid metabolism, remodelling of the actin cytoskeleton and acceleration of 
membrane traffic. 
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1.2. Invasion of non-phagocytic cells 
I nvasion of non-phagocytic cells by L. mono(ylogenes occurs "zipper" mechanism, where 
listerial surface proteins Internalin A ([nIA) and InlB interact with E-cadherin and the Met 
r(:ceptors on the host cell respectively, resulting in the localized remodeling of the actin 
cytoskeleton that culminates in the engulfment and internalization of the bacterium in a 
zipper-like manner by the plasma membrane (5). Internalization into non-phagocytic cell also 
involves kinase activation, alterations in phospholipid metabolism, remodeling of the actin 
cytoskeleton and acceleration of membrane tratlic (25). 
InlA exploits intercellular atlherens junction complexes to cross host defense barriers. 
InlA is anchored covalently to the cell wall of L. monocylogenes by an LPTTG (L for leucine, 
P for proline, T for threonine and G for glycine) motif in its C-terminal domain. The binding 
of InlA to E-cadherin induces local cytoskeletal rearrangements in host epithelial cells to 
induce the internalization of L. monocytogenes (28) (Fig. 2). J nlA docs not share any 
structural homology to E-cadherin and binds to a different E-cadherin domain other than that 
involved in homophilic interactions (29). E-cadherin is a transmembrane glycoprotein that 
belongs to a large family of cell--cell adhesion molecules that are required for the calcium 
dcpendent stabilization of adherens junctions between host epithelial cells. F-cadherin is 
localized at these cellular junctions, where its intracellular domain forms a complex with the 
cytoskeleton through protein-protein interactions with (X-catenin and r~-eatenin, whereas its 
extra-cellular domain is involved in homophilic interactions with other E-cadherin molecules 
on adjacent cells (30). [niA binds to the extracellular domain of E-cadherin and triggers the 
recruitment of several molecules that estahlish a functional link between the InlNE-cadherin 
complex and the actin cytoskeleton (31) (Fig. 2). For example, once InlA has bound to E-
cadherin, i~-catenin bound at the distal domain of the intracytoplasmic tail of E-cadherin 
recruits (X-catenin which in turn binds to actin. Since both (X-catenin and p-catenin arc usually 
present in adherence junctions, this suggests that L. mono(~vtogenes exploits the molecular 
machinery involved in the formation of adherens junctions to induce its entry into target cells. 
The exact mechanism of how the cytoskeleton is remodeled is not yet fully understood. 
1 Jowever, several proteins involved adherens junction complexes have been shown to be 
important for L monocylogenes invasion into non-phagocytic cells. For example, Rho 
GTPase activating (GAP) protein, ARHGAPIO, binds to (X-catenin and is essential for 
recruitment of (X-catenin to cellular junctions (32). ADP-ribosylation factor 6 (I\r1'6) tethers 
I\RIIGAPIO to Vezatin, another ubiquitous cell junction protein, anchors the motor myosin 
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V IIA to the l'>cadherin/catenin complex, thereby creating a tension t(wce between cell 
junctions and the actin cytoskeleton. The tension generated beneath the plasma membrane by 
the E-cadherill-catenin-actin complex in adherence junctions is counteracted by an opposite 
equal j()rce exerted by neighbouring cells and ti1eref()[c strengthens the cell-cell adhesion. 
Both myosin VilA and Vezatin were f()Und to be important f()[ cell invasion by L 
tnonocyloxmes and most likely also creates a tension f()[ce that is used by the bacterium to 
propel itself forward into its target cell membrant~ to trigger its internalization en). The 
interaction between E-cadherin and Inl/\ results in phagocytosis and not to adherence. 
because the L. fl/onocy/ogenes bac i IIi is not attached to a substratum and there1(yrc docs not 
counteract the link of a-eaten in to the cytoskeleton. In addition the shape of the bacterium 
itself induces a "zippering" of the plasma membrane around the bacterial body due to the 
interaction of InlA with E-cadherin. Once L tnOf7ocy/oxcncs has penetrated the epithelial-cell 
layer and crossed the intestinal barrier, it travels via the bloodstream and lymph to mesenteric 
lymph nodes and other organs such as the liver and spleen, where they arc internalized by 
hepatocytes and resident macrophages. Since E-eadherin is present on the surface of 
hcpatocytes, dendritic cells, brain microvascular endothelial cells and the epithelial cells 
lining the choroid plexus and placental chorionic villi, L tnonocytogenc.\· is able to cross host 
physiological barriers such as the intestinal barrier, blood-brain barrier and placental barrier 
by exploiting the molecular machincry or the intercellular adherens junctions. 
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Figure 2. Invasion by InlA exploits intercellular adherens junction complexes to cross 
host barriers_ (A) Adherens junctions hold neighbouring together via homophilic interactions 
between epithelial E-cadherin, which is anchored to the actin cytoskeleton via its interaction 
with a-catenin. Fonnins interact directly with a-catenin and fonn actin filaments that connect 
the adherens junction machinery to the cytoskeleton. (B) L. monocytogenes InlA binds to E-
cadherin and recruits proteins involved in adherens junctions assembly and actin cytoskeletal 
remodeling to induce its internalization. Figure modified and redrawn from reference (3). 
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InlB subverts host cellular-signaling anti endoqtic pathways to invade hepato(vtes 
InlB is a listerial surface protein that is loosely attached to the lipoteichoic acids of the 
bacteria's cell wall via its glycine (G)-tryptophan(W) rich domains (9) InIB contains leucine 
rich repeats (34, 35) which induces the internalization of L. monocytogenes into a much 
broader range of target cells than InlA (15, 36). The main signaling receptor for InlR is the 
hepatocyte growth factor (HGF) receptor, Met, (37) which is a tyrosine kinase receptor 
present on many cell types. The activation of Met by HGF, its natural ligand, activates 
cellular survival and proliferation signals and cytoskeletal rearrangements that functionally 
conlribute to cellular motility and differentiation. The binding of InlB to Met activates the 
n~ceptor's protein-tyrosine-kinase activity and the phosphatidylinositol 3-kinase (PI3K) and 
Ras---mitogen-activated protein kinase (MAPK) pathways which synergize to internalize L. 
monocylogenes into the host cell (37-39) (Fig. 3). Since InIB does not share any structural 
similarity to IIGF (40, 41), it does not compete with HGF for binding with Met suggesting 
that these molecules bind to different sites on the receptor (37). Although In1l3 and HGF both 
bind and activate Met, InlB does not strictly mimic signaling induced by HGF since the 
kinetics of InlB-induced signaling are difCerent from those induced by HGF (37). In addition 
equal concentration of InlB induces more potent activation of the Ras-MAPK pathway than 
does HGF (42). These differences in signaling may be due to the ability of InIB to also bind to 
gC1qR, the receptor for the globular part of complement component Cl q (24). The gCI qR 
may therefore act as a co-receptor tor InlB and thereby enhance Ras-MAPK pathway 
signaling in addition to signaling induced by activated Met. However, there are some 
similarities in signaling mediated by InlB and HGF that induces parallel morphological 
changes in target cells (43). For example IlGF requires interactions with extracellular 
oligosaccharide glucosaminoglyeans (GAGs) in order to activate Met (44, 45). Similarly, L. 
monocylogenes interacts with GAGs via the GW domains of InlB resulting in strong 
activation of Met. Similar 10 HGF, [nIB is also able to induce tyrosine auto-phosphorylation 
of Met and the recruitment of several adaptor molecules such as farp2f( 46). The signaling 
pathways activated by InlB ultimately result in cytoskeletal rearrangements downstream of 
Met that facilitate entry of L. mon()(ylogenes into its target cells. The remodelling of actin at 
the I nIB attachment site requires the recruitment and activation of the Actin related protein 
2/3 (Arp2/3) actin-nucleation complex, which promotes actin nucleation and polymerization 
(discussed later). The activation of Arp2/3 involves a combination of proteins such Racl, Cell 
division cycle 42 homolog (CDC42) and Wiskott-Aldrich syndrome protein (WASP) family 
proteins such as neural WASP (N-WASP) and WASP verprolin homologue (WAVE (47). 
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In addition, Ena/VASP (enabled homologue/vasodilator-stimulated phosphoprotein) proteins 
promote actin-filament elongation, whereas cotilifl depolymerizes actin 1ilaments and 
functions as both a stimulator and a repressor of actin rearrangements that occur during the 
internalization process (46, 47). More recently, L monocytogenes has been shown to invade 
epithelial cells by exploiting clathrin-mediated endocytosis (48) (Fig. 3). Both HGF and 1111B 
induce the ubiquination and internalization of Met by a clathrin-mediated endocytosis 
mechanism (49) leading to degradation of the receptor and internalization of the bacterium 
that is bound to Met. In addition to taking advantage of the host's endocytic machinery, L. 
IJlOl1oLytogenes may exploit other mechanisms for cellular invasion, since inhibitors of 
endocytosis reduced bacterial entry but did not completely abolish it (48). For example, 
plasma-membrane microdomains known as lipid rafts have also been shown to be important 
for the entry of L monocytogenes (50). Furthermore, Recent studies in Drosophila S2 cells, 
which arc macropbage-like, revealed that about 295 host proteins arc important 1<)f bacterial 
invasion and survival and many or these still need to be characterized (14). T'herefore by 
mimicking the activity or host molecules, L. mOl1ocylogenes is able to exploit several host 
cellular-signaling and endocytic pathways to induce its cntry into target cells. 
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Figure 3. InlB subverts host cellular-signaling and endocytic pathways to invade 
hepatocytes. (A) HGF activates Met by inducing its tyrosine auto-phosphorylation. Activated 
Met recruits signal transducing adaptor proteins and cytosolic signaling proteins, which 
activate survival and proliferation signals and induces cytoskeletal rearrangements needed for 
cellular motility and differentiation. Regulation of HGF. signaling is mediated by clathrin-
mediated endocytosis of activated Met. (B) rolB bound to Met activates the receptor by 
inducing its tyrosine auto-phosphorylation. In addition, interaction of InlB with GAGs results 
in strong activation of Met. Activated Met recruits adaptor molecules Shc, Cbl and Gab 1 
which activate PI3K, MAPK and Rac 1, which mediate actin remodeling via Arp2/3, Rac, 
COC42, N-WASP, WAVE, EnaIV ASP and cofilin, which together facilitate internalization of 
L. monocytogenes into its target cells. InlB also induces the ubiquination and internalization 
of Met by a c1athrin-mediated endocytosis mechanism. In addition to signaling induced by 
activated Met, 1nIB interaction with gC 1 qR enhances Ras-MAPK pathway signaling. Figure 
modified and redrawn from reference (3). 
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2. Escape from the phagosome 
After invasion and internalization into its target cells, 1,. monocytogenes escapes into the 
cytoplasm from the phagosome by secreting the pore-forming toxin listeriolysin 0 (LIi)) and 
two phospholipases (PLC), phosphatidylinositol (PI) specific PLC (PI-PLC) and broad range 
PLC (HR.-PLC). Escape from the primary vacuole (phagosome) formed upon invasion is 
dependent on LLO and PI-PLC, whereas escape from the secondary vacuole formed upon 
cell-to cell spread, requires LLO, PI -PLC and 13R-PLC (1, 6, 51). The essential role of these 
proteins in bacterial escape was demonstrated by the failed or defective phagosomal escape of 
L. 11100WC)i{ogenes mutants lacking LLO or both PLCs. PI-PLC is encoded by the bacterium's 
pIcA gene and IS a highly specific bacterial PLC that hydrolyzes PI- and 
glycosylphosphatidylinositol (GPI)- anchored phosphoglyerolipids, by cleaving the PI and 
GPI anchors. Purified PI-PLC from L. lI1onocy/ogenes is highly active on PI, but not on GPI-
anchored proteins (52). BR-PLC is encoded by the plcH gene and is a broad range PLe that 
that hydrolyzes phosphoglyerolipids as well as sphingomyelin (53). LLO is encoded by the 
hly gene and is a member of a large family of cholesterol-dependent cytolysins that are 
secreted by numerous Gram-positive bacteria. Once LLO has bound cholesterol, LLO 
monomers insert into the phagosome membrane and polymerize to 1'i.')rm pores of varying 
sizes depending on the concentration of the monomers. During the invasion of host cells, LLO 
synthesis is increased in the phagosome (54, 55) and is further increased in the cytoplasm 
aJ1er bacterial escape from the phagosome (55). Since LLO secreted into the host cytoplasm is 
free to interact with the host ccll membrane, I J,O activity is theref(we tightly regulated in 
order to balance eiTicient bacterial escape from the phagosome, while preventing host-cell 
damage and thereby ensuring the bacterium's intracellular survival. 'fhe compartmentalization 
or LLO activity is achieved through its optimal activity at acidic pII «6), where it is ClIlIy 
active in the acidic environment of the phagosome but is inactive at the neutral pH of the host-
cell cytoplusm. At acidic pH, LLO monomers oligomerize into large complexes that form 
pores in the phagosome membrane by extending transmembrane p-hairpins (56). At neutral 
pfL the acidic amino-acid residues in the transmembrane domain initiate irreversible 
denaturation of the r.~-hairpins, resulting in permanent inactivation of the pore-fc)[lning activity 
of LLO (57). The complex structure of LLO therct(xe enables it to sense and respond to its 
environment. Indeed, L. monocy/ogenes containing phagosomes gradually acidify to an 
average pH of 5.9 during the maturation process (58) and inhibition 01' acidification, by 
batilomyein, resulted in inhibition of vacuolar perforation and bacterial escape (59-6 I). 
Another mechanism regulating the activity of LLO is the presence of a PEST-like sequence (P 
f<)r proline, E for glutamic acid, S for serine and T for threonine) near its N-terminal that is 
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rich in proline, glutamic acid, serine and threonine (62, 63) residues, which promotes LLO 
degradation in the cytoplasm in a proteasoml~-dependent manner (64). Removal of the PEST-
like sequence from LLO resulted in a listerial strain that was extremely toxic to infected host 
cells, since the mutant LLO accumulated in the host cytosol and subsequently permeabilized 
and killed the host cell (62). [n addition, L. monocy/ogencs expressing LLO mutants lacking 
the PEST-like sequence was strongly impaired in its ability to escape 11'0111 the phagosomal 
vacuole, suggesting that the PEST-like sequence may playa role in phagosomal escape (63). 
Indeed. LID's PEST-like sequence has recently been reported to control LLO production in 
the cytosol (M). In addition to its pore-forming ability, LLO is also a potent signaling 
molecule in the host cell and has been shown to activate nuclear factor kappa B (NF-KB) (65), 
MAPK (66), phosphatidylinositol (67, 68)' calcium (69-71) and protein kinase C (72) 
signaling pathways (discussed later). 
The precise mechanism hy which L. lI1onocytogencs outwits the host's immune defenses and 
escapes II'om the phagosome is not clear. The primary defense strategy l~mployed by the host 
is to restrict the L mono(ytogl!nes bacilli within phagosomes and promote fusion with 
Iysosomes. The lysosome is highly bactericidal and contains many hydrolytic enzymes which 
damage and digest the bacilli (25, 26). The process of phagosome maturation, phago-
lysosome fusion and subsequent bacterial killing is regulated by the Ras related protein 5a 
(Rab5a) in an lFN-y dependent manner (73, 74). Active RabSa causes remodeling of the 
phagosomal environment, facilitating localized production of superoxide and nitric oxide into 
the phagosome which has been shown to decrease listcrial phagosomal escape (75). L. 
lnonocylO,\!,enes counteracts these host defense responses by delaying phagosome maturation 
in order 10 "'buy time" for itself so that it can escape from the phagosome via the activity or 
1.1,0, PI-PLC and BR-PLC. L. 1I10110C)i/ogenes has been shown to delay phagosomal 
maturation by inhibiting the activity or RabSa by preventing the exchange of inactive GDP-
hound Rah5a for active CiTP-hound Rab5a (76). This manipulation of Rah5a activity occurs 
possihly via modulation or Rah5a regulating proteins such as guanine nucleotide exchange 
factors (GEFs). GTPase activating proteins (GAPs) and guanine diphosphate (GDP) 
dissociation inhibitors (GDls). However, the mechanism of how U D, PI-PLe and BR-PLC 
activity enahles phagosomal escape still remains elusive. Studies by Wadsworth and Goldfine 
addressed this issue using in vitro infection of the .1774 macrophage ceU line with various L. 
I1wnocytogencs mutants deficient for LLU, PI-PLC, BR-PLC and/or both Pl-PLC and BR-
PLe (51, 71, 72, 77, 78). Data from their studies suggests that L. mOl70lytogcncs manipulates 
the macrophage's calcium and protein kinase C (PKC) signaling cascades via its virulencc 
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proteins LLO, PI-PLC and BR-PLC (51, 71, 72, 77, 78), Infection of J774 macrophages with 
L tnOllocy/ogcnes was shown to induce three calcium intluxes (71), Using calcium channel 
blockers SK&F96365 and thaspigargin, it was shown that the first calcium elevation resulted 
It'om an influx of extracellular calcium through an unidentified channel in the cell membrane, 
whereas the second and third intracellular calcium elevations resulted from release of calcium 
from intracellular stores. lnhibition of both extracellular and intracellular calcium 
mobilization resulted in increased phagocytosis of L tnom)c}'togcnes into the cells and greatly 
decreased escape of WT L. tnOllocy/ogcnes from the primary phagocytic vacuole (71). 
Concurrent wi 1h these three calcium influxes, was the activation of host phospholipases C and 
]) which together with the activity of PI-PLC and BR-PLC activated the host's PKC 
signalling pathway (72, 78). Activation of host PKC in turn modulated the uptake and escape 
of L monoc)'/ogenes from the phagosome (72). LLO, PI-[1LC and BR-PLC were shown to 
activate host polyphosphoinosilide-speciiic phospholipase C (PLC) (78), which hydrolyzes 
host Pl-4,5-P2 (PIP:» in a calcium dependent manner into diacylglycerol (DAG) and inositol-
1,4,5-P1 (l P3) (79), which in turn activated PKC and calcium release /1'0111 the endoplasmic 
reticulum respectively (51, 80). In addition, inl'ection of macrophages with L. f/10llocytogenes 
also resulted in the activation of host phospholipase 0 (PLD) in a LLO dependent manner 
(PloD) (78) and coincided with the internalization ofWT L. tnOnoLytogenes into host cells and 
the beginning of phagosome maturation (71). Moreover. inhibition or PLD hy 2,3-
diphosphoglycerate decreased the eiliciency L. monocytogellcs of escape from the primary 
vacuole (78) indicating that PLD plays a role in phagosomal escape. However. the mechanism 
by which PLD achieves this is unknown, although phosphatidic acid, a product of PLD 
activity, has been implicated in regulating intracellular vesicle trafficking (79, 81). 
Furthermore, the combined activity of listerial 1,LO and PI-PLC hydrolyzed host phosphatidyl 
inositol (PI) into DAG and inositol-phosphate (lP) (78). whereas the activity of listerial BR-
PLC hydrolyzed host sphingomyelin, resulting in the release of ceramide and sphingosine-
phosphate, the latter of which has been shown to release intracellular calcium stores (82. 83). 
The elevated levels of DAG generated by the combined activities of bacterial and host PLCs. 
resulted in the activation PKC signalling within the cells (72). Using a combination or 
pharmacological inhihitors speciiic for different PKC isoforms, it was shown that the first 
calcium influx upon L tnOl1ocylogenes infection was mediated by PKC8 in a calcium 
independent manner (72), Since PKC& been has been implicated in phosphorylation and 
opelling of L-type calcium channel calci lim channe Is (84, 85) and large conductance, calci um-
and voltage-activated potassium ([3K(Ca» channels (86, 87), the calcium channel activated by 
PKC8 in macrophages infected with L monocytogenes may belong to either one of these 
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calcium channel nlmilies. In addition, DAG also activated calcium-dependent PKCBI and 
PKCf311 isoforms, which upon the first calcium inllux translocated to the early endosome. 
Blocking the activity of PKC6 by rottlerin, a putative specific inhibitor of PKC6, prevented 
the first calcium inllux. The consequent lack of calcium prevented full activation of PKqm, 
even though DAG was present, resulting in t~lilure to translocate to early endosomes. 
Surprisingly, PKC[3f was able to translocate to the endosomes. In separate experiments, 
blocking the activity of PKCj3lI by hispidin, prevented PKC[m translocation to endosomes 
and resulted in decreased escape of [,. l11onocylogenes from the phagosome. Taken together, 
these experiments suggested that L. tnoJ10cyfogencs manipulates the activity of PKC6 to 
induce elevated intracellular calcium levels, in order to facilitate its escape from the 
phagosome via an unknown mechanism that requircs elevated calcium levels, PKQ3IL LLO, 
PI-PLC, BR-PLC and PLD (72). In addition, the tirst calcium influx mediated by PKC6 and 
tnmslocation of PKC[31 and PKCBll occurred prior to L. tnoflocyfogenes adherenee and/or 
internalization into the eells. 
Based on their lindings Wadsworth and Goldfine proposed a model (Fig. 4) in which PI-PLC 
initially enters the macrophage's cytosol from outside the cell (68) via pores formed by LLO 
in the macrophage cell membrane (72). PI-PLC generates DAG through hydrolysis of PI in 
1 he macrophage membranes in an LLO dependent manner. The induction of DAG leads to the 
calcium independent activation of PKC6 which then translocates to the macrophage cell 
membrane where it activates an unknown calcium channel(s) resulting in the tirst calcium 
int1ux into the cell. PKCBI and PKCf111 become activated by DAG and the elevated 
intracellular calcium levels and translocate to early endosomes. Once internalized into the 
phagosome, the expression of LLO, pl-PLe and BR-PLe is increased. In the acidic pH o/'the 
phagosome Ll J) monomers integrate into the phagosome membrane and t()rm pores that 
allow the passage of PI-PI ,C and possibly other phagosomal proteins into the host cytoplasm. 
In the cytoplasm PI-PLC continues to hydrolyze PI in host membranes, generating DAG 
which sLlstains activation of PKC6, PKCf31 and PKCPII from the time of entry until the escape 
or L. monocylogenes from the vacuole (72, 88). In addition, sustained activation of PKC6 in 
turn activates the host's PLD (78), which together with PKCf31, PKCPIl, LLO and PI-PLe 
orchestrate the permeablization of the primary phagosome membrane and escape of L. 
JJlOflO(yfogcnes into the cytoplasm. Similarly escape from the secondary phagosome formed 
upon cell to cell spread is also mediated by a the proposed sequence of events, except that 
Im.-PLC is secreted together with 1,1,0 and PI-PLe from the secondary phagosome into the 
host cytoplasm, where it also hydrulyzes PI in host membranes to generate DAG. In addition, 
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the hydrolysis of sphingomyelin by BR-PLC generates sphingosine-phosphate which 
mediates the release of intracellular cakium stores form the endoplasmic reticulum, thereby 
mediating the second and third (prolonged) intracellular calcium levels (51, 72), which 
sustains activation of PKCo, PKCf)i and PKCf:HI (72, 88). The mechanism oC how the 
membrane permeabilization and escape is still unknown. However, PLD activity is induced in 
L monocylogenes infected macrophages (78) and a by-product of its activity, phosphatidic 
acid, has been implicated in regulating intracellular vesicle traflicking. Moreover, PKCpr and 
PKq:Hf mobilize to early endosomes during L monocylogenes infection (72) and early 
cndosomcs have been shown to traflic through sorting endosomes with other organelles 
including lysosomes and phagosomes (26, 89). 'Therefore phosphorylation of proteins on early 
cndosomes by PKCPI and PKqHI, together with increased PLD activity and phosphatidic 
acid levels, may therefore "buy time" lew LLO and Pi-PLe to permeabilize the phagosomal 
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Figure 4. Proposed signaling pathway mediating escape of L. monocytogenes from J774 
macro phages. Upon infection, L. monocytogenes secretes LLO and PI-PLC, which enters the 
macrophage cytosol via pores formed in the macrophage cell membrane by LLO. PI-PLC 
hydrolyzes PI in host cell membranes to generate DAG which activates PKC8. Activated 
PKC8 translocates to the cell membrane where it activates an Wlknown calcium channel(s) 
resulting in a calcium influx into the cell. Elevated levels of DAG and calcium activate 
PKCPI and PKCPII which translocated to early endosomes (EE), which then fuse with 
pathogen containing phagosomes. In the acidic phagosome, LLO monomers form pores in the 
phagosome membrane that allow transport of LLO, PI-PLC and other phagosomal proteins 
into the cytoplasm. In the cytoplasm, LLO activates host PLC, which together with PI-PLC 
generate DAG by hydrolysis of PI in host membranes. Host PLC also generates IP3 which 
stimulates calcium release from the endoplasmic reticulum. The consequent elevated levels of 
DAG and calcium sustains activation of PKC8, PKCpr, PKCprr and activates host PLD, 
which together orchestrate the permeabilization of the primary phagosome membrane and 
escape of L. monocytogenes in to the cytoplasm. Escape from the secondary phagosome 
involves the same proposed pathway and requires BR-PLC in addition to LLO and PI-PLC. 
Figure modified and redrawn from reference (51). 
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3. Cytosolic growth and replication 
Optimal cytosolic growth of L. monocytogenes within the cytoplasm of many types of host 
cells is a unique characteristic of L. monocytogenes. Other intracellular pathogens, such as M 
tuherculosis normally reside inside the phagosome and are unable to replicate in the cytosol 
of the host cell (90), highlighting that L. monocytogenes has evolved specific mechanisms to 
grow in the host-cell cytosol. The ability of L. monocytogenes to thrive inside the cytosol is 
ref1ected in its genome, which contains a large number or regulatory and transport proteins 
(11.6%) of all predicted genes) (91). For example, 25% of the transport proteins encoded by 
the L. monocytogenes genome are dedicated to carbohydrate transport as compared to only 
2.4% of the M tuherculosis genome (92). In addition, the L. monocytogenetl' genome contains 
16 putative two-component regulatory systems, which is is two fold greater than i()Und in the 
M tuherculosis genome(92). Inactivation of several of these two-component regulatory 
systems revealed their importance fix the resistance of L. monocytogenes to various stresses 
and for survival in the host. Although the intracytosolic survival of L. monocytogcnes is not 
well understood, two key proteins fhr intracellular growth have been identified: the sugar-
uptake system (IIpt) and lipoate protein ligase Al (LpIAl). The listerial lIpt protein is a 
homologue of the mammalian glucose-6-phosphate translocase and it is essential for optimal 
intracellular bacterial replication. Expression of Bpt allows the bacterium to use glucose-l-
phosphate in the host cytoplasm as a carbon source for growth (93). LplA I catalyses the 
lipoylation of the bacteria's pyruvate-dehydrogenase enzyme (PDH) complex which is 
required t()r full PDH activity. Since the host cytosol lacks lipoic acid, LplA 1 scavenges 
lipoyl groups Irom host molecules which is then used to activate the bacteria's pyruvate-
dehydrogenase. A mutant lacking LplA 1 was unable to replicate in the cytoplasm of 
macrophages and displayed 300-fold decrease in virulence, due to loss of pyruvate-
dehydrogenase activity (94). Recently, two studies using whole genome DNA arrays, has 
revealed that L. monocytogenes activates approximately 500 genes for its survival within the 
host cytoplasm (95, 96) and further investigation of these genes may provide new insight into 
the mechanism employed by L. mOYlocytogenes to adapt and survive within the host cell 
cytoplasm. 
18 
4. Actin-based motility and cell to cell spread 
Shortly after entry into the mammalian cytosol, L. monocytogenes polymerizes actin 
asymmetrically along its surface, producing an actin tail that propels the bacterium through 
the cytoplasm and then into neighbouring cells (97, 98). 
1. Internalization 
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Figure 5. Pathogenesis of cellular L. monocytogenes infection. L. monocytogenes induces 
its internalization into phagocytic cells and non-phagocytic cells and is engulfed by receptor-
mediated phagocytosis into a primary vacuole (phagosome). Escape from the primary 
phagosome is facilitated by lysis of the phagosome membrane mediated by the combined 
activities of LLO and PI -PLC. In the cytoplasm, L. monocytogenes is able to survive, replicate 
and move by polymerizing actin as observed by the formation of actin tails. Actin-based 
motility is mediated by the bacterial ActA protein and allows the bacterium to invade 
neighbouring cells, where they are confined within a double membrane secondary 
phagosome. Escape from the secondary phagosome is mediated by the combined actions of 
LLO, PI-PLC and BR-PLC. The ability to spread from cell to cell allows L. monocytogenes to 
avoid contact with circulating antibodies or other extracellular bactericidal compounds. Figure 
modified and redrawn from reference (3). 
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The listerial surface protein ActA is responsible for inducing actin polymerization, actin-
based motility and pathogenicity (99, 100). L. monocytogenes mutants deficient in ActA 
efficiently escaped from the primary phagosome, but were unable to spread from cell to cell 
and grew as micro-colonies in the host cytosol (101-103). The amino terminal end of ActA 
binds to monomeric actin and acts as a constitutively active nucleation promoting factor by 
stimulating the intrinsic actin nucleation activity of the Arp2/3 complex by a mechanism 
similar to that proposed for host neural Wiskott-Aldrich syndrome protein (N-WASP) and 
WASP verprolin homologue (WAVE) proteins (104-108). By mimicking the activity of N-
W ASP and WAVE, L. monocytogenes has therefore successfully been able to harness the 
actin polymerization machinery in the host cytoplasm to facilitate its intracellular and 
intercellular movement. (104-108). 
movement 
Cofil 
Figure 6. Model of L. monocytogenes actin-based motility. ActA mediates actin-based 
motility of L. monocytogenes by mimicking the eukaryotic N-WASP and WAVE actin 
nucleating proteins. The polar distribution of ActA is represented as a hatched area and its N-
terminal activates the Arp2/3 complex. Profilin and EnaIV ASP bound at the N-terminal tail 
deliver actin monomers to Arp2/3' complex which nucleates actin monomer into filaments. 
Profilin increases the elongation rate of nucleated actin filaments and EnaIV ASP proteins 
interact with the barbed ends of growing filaments, preventing the binding of capping 
proteins. The growth of actin filaments is stopped by the Arp2/3 complex which caps the 
pointed ends of filaments. The rapidly growing barbed ends (protected from capping protein 
by EnaIV ASP) are concentrated at the site necessary for force generation, thereby propelling 
the bacterium forward. The bacterium is moving from left to right as indicated by the arrow. 
Figure adapted and redrawn from (109). 
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B. HOST IMMUNE REPSONSES TO L. MONOCYTOGENES INFECTION 
1. The Murine Listeriosis Infection Model 
For many years, the murine model of listeriosis has been used to study basic aspects of innate 
and acquired ceiJuiar immunity due to the similarity of the pathogenesis between humans and 
rodents (110, III). Although natural infections with L. monocytogenes are acquired through 
the gastrointestinal tract, most experimental studies use either intravenous or intraperitoneal 
inoculation to initiate infection. The reason for this "unnatural" route of infection was that 
mice are relatively resistant to oral inoculation due to a single amino-acid difference between 
human and mouse E-cadherin, which prevented listerial InlA binding and consequent 
inefficient invasion of epithelial cells (112) (Fig. 7). Most studies over the past four decades 
have therefore focused on immune responses to systemic L. monocytogenes infection. 
However, a transgenic mouse model expressing human E-cadherin on the surface of 
enterocytes, has been recently developed enabling investigation of process involved III 
crossing the intestinal barrier (113). 








Figure 7. Host specificity for entry of L. monocytogenes into non-phagocytic cells. 
L. monocytogenes induces it own internalization into non- 'phagocytic cells cell via the 
interaction of its surface proteins InlA and InlB with the host receptors E-cadherin and Met 
respectively. However, L. monocytogenes is unable to invade mouse epithelial cells due to a 
single amino acid change in the mouse E-cadherin receptor, which prevents InlA from 
binding. Figure adapted and redrawn from (3). 
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2. Cellular Immune Responses to L. monocy/ogenes Infection 
Early control of' L. monocy{()genes infection requires the non-specific, innate Immune 
response which plays a crucial role in controlJ ing the initial bacterial burden, thereby allowing 
time for the adaptive cellular immune response to develop which eliminates the bacteria and 
confers sterilizing immunity. The innate immune response to L. monocylogenes occurs 
independently of T cells and IS dominated by resident macrophages (Kupffcr cells), 
nClItrophils, natural killcr (NK) cells and activated macro phages. The effectiveness of the 
innatc immune response to L. monocylogenes was demonstrated in Severe Combined 
Immunodc!icient (SCID) mice and Nude mice (114), which lack T-, B-cells and humoral 
immunity. At early time points these mutant mice were resistant to L. monocylogeY/(!s 
infection, but were unable to clear bacteria in the long term. The adaptive immune response is 
entirely cell mediated and largely dependent on cytotoxic C08+ T-cells that recognize and 
lyse L. monoc),/()genes infected cells (l11, 114). 
The first step in the innate immune response is to control the growth of L. monolytogenes in 
tile liver, which is lhe primary target organ I(H L. monocylogenes, in order to prevent 
dissemination to other organs and overwhelming sepsis. Upon infection, most L. 
monoc),logenes bacilli are rapidly cleared from the bloodstream by resident macro phages in 
the spleen and liver (115-117). In the liver, resident macrophages called KuptTer cells, line the 
liver sinusoids and arc most dense at the periportal region, the area where the portal vein from 
the gut enters the liver. The Kupffer cells are therefore optimally located for response [0 
systemic bacteria and bacterial products transported from gut via the portal vein. Mice 
depleted of Kupffer cells and infected with L. monocylo;:;cnes had increased numbers of 
bacilli in the blood and decreased bacterial load in the liver at 10 minutes after infection as 
compared to controls (118). [n addition, Kupffer cells are also important for the secretion of 
cytokines and chemokines such as interleukin (l L)-l, granulocyte-macrophage colony 
stimulating factor 2 (GM-CSF), lL-6, interferon (IFN)-y, macrophage inf1ammatory protein 
(M1P)-la, M1P-lr~ and MIP-2 early during infection and f()r inducing antigen-dependent 
proliferation of T cells (119). However, not all L. mon()(~vfogenes bacilli that are engulfed by 
KuptTer cells are destroyed by phago-lysosome fusion, anel the surviving bacteria are able to 
replicate in the liver t()r 2 to 5 days after infection (115, 120-125). Contrary to the long-held 
idea that macrophages arc the major niche for L monocyfogenes in the liver, the principal site 
or bacterial multiplication is the hepatocyte (116, 126-130). L. mOf1ocylogenes therefore gains 
access to the liver parenchyma via two routes: the first is via uptake by KuptTcr cells and 
suhsequent cell to cell spread, and the second route is by direct invasion ofhepatocytes via the 
interaction of InlB with the Met receptor present on hepatocytes (36.37). The consequent cell 
to cell spread of L n1onocylo?,enes in the liver (127, 131) results in the formation of infectious 
Cod wilhout the bactcrium coming into contact with the humoral effectors of the immune 
system. This Illay explain why antihodies generated by the adaptive immune response play no 
Illajor role in anti-Listeria immunity (132). However, a protective role for Listeria-specil1c 
natural antibodies and anti-fLO monoclonal antibodies (mAb) has heen demonstrated, where 
they wen~ shown to reduce the dissemination of the bacilli into organs and to enhance antigen-
trapping in secondary lymphoid organs (133). In addition, mice treated passively with an anti-
I J,O mAb had significantly lower bacterial burdcn in the spleen and liver and increased 
survival time after a cha Ilenge with a lethal dose of L. mon(}cylogencs (134). 
During the lirst 48 hours after infection neutrophils playa critical role in resolving early L. 
monoc),lo?,enes infection, especially in the liver (135-139). Hepatocytes respond to L. 
mOI1(}(ylogenes infection hy undergoing apoptosis, thereby releasing neutrophil 
chemoattractants. I n addition, hepatocytes up-regulate expression of adhesion molecules 
rcsuiting in increased adhesion to neutrophils (135). The recruited neutrophils appear at the 
sites or infection within 24 hours, forming discrete microahscesses where they destroy L. 
l11ol1ocylogenes infected hepatocytes and released bacteria (140). The importance of 
neutrophils was demonstrated in neutrophil-depleted mice which died early in infection and 
had large bacteria laden foci in the liver parenchyma (135-140). Two to four days after 
infection, neutrophils are gradually replaced by monocytes and lymphocytes that infiltrate the 
sites of infection and contrihute to the {'ormation of early granulomatous lesions that arc 
composed of granulocytes and activated macrophages (122). These granulomatous lesions act 
as physical baJTiers to confine the infectious t(xi, and therefore prevent further hacterial 
dissemination by direct cell to cell spread (141). NK cells arc activated during this phase and 
become the major source of interferon-gamma (IFNy) (142, 143), which is essential for full 
macrophage activation and anti-listerial immunity (discussed later) (141). Moreover, IFN-y 
activation of hcpatocytes also impairs the replication of L. monocylogenes within these cells, 
especially if co-stimulated with 1L-6 and tumor necrosis factor (TNF) (144, 145). Thereafter, 
between days 5 and 7 post inlection, IFN-y activated macrophages in the granulomatous 
lesions destroy the haeteria and present the hacterial peptides (antigens) on their sur1;lce 
together with either major histocompatihility complex (MCH) class I or MHC class II 
molecules to CD8+ or CD4+ T cells respectively (2,114,129,132,146-148). The activation 
and recruitment of macrophages is essential f()r bacterial clearance and listericidal activity as 
shown by experiments where depiction or inhibition of either CR3 or CC-chemokine receptor 
23 
2 (CCR2) in mice resulted in dramatically enhanccd susceptibility to L. monocytogenes 
infection (130, 149). CR3 is the major receptor on the surf~lce of macrophages that mediates 
phagocytosis of I. monocytogenes into the cell (17) and is important tor listericidal activity 
(\8). Activated macrophages express CCR2 which binds monocyte chemoattractant protein-I 
(MCP-l; also known as CC-chemokine ligand 2 (CCL2)), which is secreted L. 
fJ70JIO(v/ogene.'i intected macrophages. Mice that lack C'CR2 were extremely susceptible to L. 
Jrlonocy/ogenes, since they hlilcd to recruit activated macrophagcs resulting in markedly 
decreased levels of inducible nitric oxide synthase (iNOS) and 'fNF in the splees during the 
first 2 days after infection (149). IFN-y activated macrophages become a rich source of 
cytokincs and chemokines, resulting in a transition of the macrophage being a habitat 
supporting bacterial growth, into an eHector-cel1, terminating or restricting microbial survival 
(116, ]]2). In addition, pro-inflammatory cytokines and chemokines also trigger the 
maturation of immature dendritic cells (DC's) that were recruited to the microabscesses. For 
example, a novel DC population which produced high levels of TNF and iNOS, termed TNF-
and iNOS-producing DCs (TipDCs), were shown to be critical to control L. fl/onocytogenes 
growth during the early stages of infection (150). 
The primary function of activated macrophages and dendritic cells is to engulf: destroy and 
present listerial antigenic peptides Lo T cells, thereby initiating the adaptive immune response. 
L. monocy/ogenes is intcrnalized into macrophages and dendritic ceUs via opsonic dependent 
or independent receptor mediated phagocytosis (2, 11, 16-24). During phagocytosis, the 
endoplasmic reticulum (ER) and not the plasma membrane, is the major reservoir of 
membrane [cx primary phagosomc formation (26, 151, 152). Since the newly fixmed 
phagosome is relatively inert and are unable to kill and digest the L. mono(ylogenes bacilli, its 
has to undergo a transformation process in which it acquircs proteins that mediatc its fusion 
with the Iysosomc. The lysosome is highly bactericidal and contains many hydrolytic 
cnzymes which fatally damage and digcst the bacilli (25, 26). After its scission fron1 the 
plasmalemma, the phagosome fuses sequentially with early endosomes, late endosomes and 
finally with lysosomes, by a maturation process which is regulated by Rab and soluble N-
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Figure 8. Schematic outJine of phagosome matu ration and phago-lysosome fusion. 
The newly fonned phagosome containing the L. monocytogenes bacilli acquires Rab5a from 
the plasmalemma or cytosol. Rab5 recruits p 150NPS34 to generate PI(3)P and attracts EEAl, 
which in turn facilitates tethering and fusion to early endosomes. During the transient fusion, 
the early phagosome acquires early endosomal marker proteins such as Vamp3. Subsequently, 
the intennediate phagosome fuses with late endosomes and acquires Rab7, Rab9, MPR, Stx7, 
LAMP l, LAMP2 and LBPA either from the cytosol and/or along with late endosomes. Rab7 
on the late phagosome promotes fusion with lysosomes, leading to the killing and enzymatic 
digestion of the bacilli by proteases such as cathespin O. The resulting listerial peptides are 
then processed via the MHC class II antigen presentation pathway and presented to CD4+ T 
cells. 
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The fusion between phagosomes and endo/ lysosomes does not result in amalgamation of the 
organelles, but rather forms transient hybrid organelles connected by fusion pores that allow 
selective exchange of some membranes and luminal components, followed by scission. The 
age of the phagosome (i.e. the time elapsed after scission of the phagosome from the 
plasmalemma) dictates which individual sub-compartments of the endocytic pathway it will 
fuse with. Generally, early phagosomes selectively fuse with early endosomes (also termed 
sorting or recycling endosomes), intermediate phagosomes with late endosomes and late 
pbagosomes with lysosomes (26, 153-158). At each fusion step, the phagosome acqUIres 
particular proteins which are characteristic oj" the age of the phagosome Crable 1). For 
example, early endosomes contain early endosome antigen (EEA 1), Rab5a, 
phosphatidylinositol 3-phosphate (PJ(3)p), syntaxin-13 (Stx 13), transferrin receptor (TF) and 
vesicle-associated membrane protein 3 (V AMP3). 
Table 1. Molecular markers of endomembrane organelles that interact with L. 
lIlonocytogelles containing phagosomes 
organelle markers 
early endosome; early EEA-l, Rab5a, PI(3)P, Stx]3, TF, Vamp3 
_phag()so_lne ____________________________________________________________________________ _ 
Late endosome; late Rab7, Rab9, MPR, Stx7, LAMP], LAMP2, LBPA 
_~~g~~ol~1~L________________ _ _________________________________________________________________ _ 
Lysosome; phago- LAMPs, mature cathepsin 0; .i1uid-phase markers chased for +/- 2 
?~~~~-G-~~nic-- --- -- -- -1~~~~;Zi~-:c~l~ticulin~-(iRP78, LJDPGT, VAP33------- ----------
reticulum 
-- ~--- - ---------~-- - ---~------~ - ~ - --~ --- ---- ------ ------
early endosome antigen I, Er:A 1; RAS oncogene 1~lInily JIlelllha Sa. RabSa; rhosrhatidylinositol-3-kin<lse. PI(3 )1'; syntaxin 
11, Stx 13; transferrin recertof. TF; vesicle-associated Illeilibralll' protein 3. Vamr3; RAS oncogene CUllily member 7, Rab7: 
RAS oncogene Camily member 9. Rab9; m<lIlIHlse-(,-pllOsphale receptor. MPR; syntaxin 7, Sh 7: lysosomal membrane: 
gl)Cllprotcin 1. LAMP 1; Iysosomalmcrnbrane glycoprotein 2, LAMP2; Iysobisrhosphalidic acid (UWA); glucose-regulated 
protein 7X kDa, (,RI'78: I JlW-glucuronosyltr;lllslCrase_ I J 1»,( iT: vascular adhcsion rrolein 33, v /\1'33_ 
As a result of these fusion events the phagosomal lumen becomes a highly acidic and 
oxidizing environment, and contains a variety of hydrolytic enzymes that fatally damage and 
digest the L. monocytogenes bacilli (25, 26, 153, 155, 159-161). After degradation within the 
phagosome, listerial peptides are processed via the MHC class II antigen presentation 
pathway and are presented to C04+ T celis, which primes the development of T Helper 1 
(TH 1) C04+ T cells which produce IFN-y (162) and protective type 1 immune responses 
(163, 1(4) that activates macrophages to become more bactericidal (165) (Fig. 9). In addition, 
listerial proteins in the cytosol such as LLO (166-l71), the metalloprotease Mpl (172) and the 
listerial surJace protein p60 (163,173-]75) are degraded by the proteosome and presenled via 
the M IIC class I antigen processing pathway to CD8+ T cells. 
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Figure 9. Schematic outline of antigen processing. Proteins secreted by cytosolic L. 
monocytogenes are degraded by the proteosome into peptides, which are transported 
across the endoplasmic reticulum (ER) membrane by transporter I ATP-binding cassette 
sub-family B member 1 (TAP 1) and T AP2. Synthesis and assembly of MHC class I heavy 
chain (a) and ~-2-microglobulin (~) occurs in the ER, where the listerial peptides form a 
stable complex that is transported through the Golgi and trans-Golgi apparatus to the cell 
surface. Similarly, L. monocytogenes containing phago-Iysosomes kill and enzymatically 
digest the bacilli into peptides. In the ER, the invariant chain (Ii) associates with newly 
synthesized MHC class II a and ~ chains via its CLIP domain. The newly assembled 
MHC class II complex is then transported through the Golgi and trans-Golgi apparatus to 
reach the phago-lysosome, where the invariant chain is digested and the listerial peptide 
fragments are able to bind to the MHC class II molecules. The antigen bound MHC class 
II complex is transported to the cell surface by transport vesicles. At the cell surface, 
listerial peptides bound to MHC class I and MHC class II molecuJes are presented to 
CD8+ T cells and CD4+ T cells respectively. Antigen stimulation of CD8+ T cells leads 
to killing of cells infected with L. monocytogenes, whereas activated CD4+ T cells secrete 
pro-inflammatory cytokines and IFN-y thereby augmenting the listercidal activity of 
macrophages, neutrophils and IKDCs. Figure modified and redrawn from reference (176). 
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The end of the innate phase is marked by an in11ux of T cells to the sites of infection on 
days 4 to 5 (177), where clearance of L. monocylogcnes is mediated primarily by 
cytotoxic CD8+ T cells which destroy L. monocytogenes-infected cells (114, 147, 167). 
Iluwever, interferon producing killer Des (IKDCs ) have also been recently shown to kill 
L monocytogenes infected cells by utilizing NK-activating receptors (178). In summary, 
the above course of events in the immunocompetent host results in the rapid elimination 
of L. m()n()cylo~('nes from the liver and acquired anti-listeria] immunity. However, if the 
infection is not controlled in the liver due to an inadequate immune response, as with 
iml1lunocompromised hosts, unlimited listeria] growth in the liver results in the 
dissemination of the bacteria via the bloodstream and systemic infection of other organs, 
the central nervous system and/or placenta. 
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3. Recognition of L. mOflocytogenes and signaling by TLRs and NLRs 
Activated lllacrophages, dendritic cclls, ncutrophils and NK arc major cell types of the innate 
immune system that act immediatcly to control I"" 171onotytOf,;enes gro\\-1h upon infcction. 
These different cell types communicate with each other by producing and/or rcsponding to 
pro-inflammatory cytokines and chemokines, which in turn activate and mobilize effector cell 
populations to the site of infection. At the cellular level, neutrophils and macrophages are 
considered the major effector cells important for mediating listericidal activity. Depletion of 
neutrophils in mice using antibodies specific ror GRI (136, 138, 140) markedly enhanced 
their susceptibility to inCection with L tnono(~v/ogl'nes. Similarly, blocking CR3 or CCR2 
with neutralizing antibodies or by gene targeting also dramatically enhanced susceptibility to 
L tnOt1ocy/ogenes (130. 149). During the early stage of infection, macrophages arc recruited 
to the site of infection (microabscesses) where they encounter baci Ili released by infected 
hcpatocytes and Kupfter cells that were lysed by neutrophils or underwent apoptosis. 
Mucrophages recogmze the L. tnOl1ocy/of,;enes bacilli Via pattern recognition receptors 
(PRRs), sllch as Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain 
(NOD)-like receptors (NLRs), which sense conserved pathogen associated molecular patterns 
(PAMPs) via a leucine rich domain (LRR) (179-182). TLRs are transmembrane proteins 
whose LLR I igand-binding domains extend towards the extracellular milieu or to a 
topologically equivalent lumen of mcmbrane-enclosed intracellular compartments (182) (Fig. 
10). TLRs therefore recognize either extracellular or phagosome restricted L. t1lonocytogenes. 
In contrast, NLRs arc soluble proteins that recognize microbial components in the cytosol, 
rather than at the cell surl~lce or in vesicles (183,184) (Fig. ]0). Upon ligand binding, TLRs 
and NLRs dimerize with adaptor proteins and recruit additional signaling proteins and triggers 
the activation of NF-KB, which results in the induction of antimicrobial peptides, pro-
ini1ammatory chemokines, and cytokines, adhesion molecules and enzymes that catalyze 














Figure 10. The structure and cellular location of TLRs and NLRs involved in 
recognition of L. monocytogenes. TLRs contains an intracellular TolllIL-1 receptor (TIR) 
domain and an extracellular leucine rich repeat (LRR) domain. At the macrophage cell 
surface TLR2, TLR4 and TLR5 recognize L. monocytogenes via their LRR domains. TLR2 
recognizes peptidoglycan, lipoteichoic acid and lipoproteins and TLR5 recognizes listerial 
flagellin. TLR2 forms a heterodimer with either TLRI or TLR6 depending on the identity of 
the ligand, and CD 14 acts in synergy with TLR4 to bind LPS. NLRs are cytosolic proteins 
that recognize listerial proteins in the cytosol. NLRs contain a caspase-recruitment domain 
(CARD) or a pyrin (PYR) effector domain, a nucleotide-binding and oligomerization domain 
(NOD) and a LRR domain that detects degradation production of listerial peptidoglycan. 
NODI and NOD2 detect dipeptide or tripeptide motifs (iE-DAP) while NOD2 detects 
muramyl dipeptide (MOP). Cold autoinflammatory syndrome I (CIAS I) is structurally 
similar to NOD2 except that it contains a PYR domain instead of a CARD domain, and also 
recognizes listerial MOP. Upon ligand binding, the TLRs and NLRs initiate downstream 
signalling events that activate NF -ill leading to the production of pro-inflammatory 
cytokines, chemokines and antimicrobial peptides. Figure modified and redrawn from 
reference (185). 
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TLRs contain two distinct domains, a leucine rich repeal (LRR) domain in their extracellular 
region, which recognize and bind specific PArvJPs, and a Toll/IL-l receptor CrJR) domain in 
their intracellular region (Fig 10). To date, 11 different TLRs have been identified and each 
TLR recognizes different PAMPs and mediate distinctive pathways by associating with 
different combinations of adaptor proteins such as Myeloid differentiation primary response 
gene 88 (MyD88), TIR domain-containing adaptor protein (Tirap), Toll-like receptor adaptor 
molecule 1 (TRIF, also known as T'icaml) and Toll-like receptor adaptor molecule 2 (TRAM, 
also known as Ticam2) (182). Macrophages express most TLRs except 'IT,R3 (186) and the 
expression of TLRs is highly up-regulated in these cells (187). In contrast. the expression of 
TLRs in Des is difTerentially expressed depending on the DC subset and maturation stage 
(186, 188-198). TLR2 and TLRS have been implicated in recognition of L. monocylogenes 
(199-202). Generally, TLR2 is a receptor 1(J)' bacterial peptidoglycan, lipoteichoic acid and 
lipoproteins, whereas TLRS recognizes bacterial f1agellins (182). L.monocytogenes of mice 
deficient for TLR2 CfRLTI-) revealed that TLR2 was important for macrophage production of 
TNF, IL-12, [L-18, IFN-y and nitric oxide (NO). In addition, IL-12 and IL-18 synergistically 
induced IFN-y production, leading to normal clearance of L. monocytogenes (200). Although 
in vivo data about the role ofTLRS has not yet been investigated in TLRy/- mice, in vitro data 
has shown that intravenous or oral infection of mice with a L. monocytoJ!,enes strain lacking 
flagellins resulted in impaired macrophage activation as shown by a SO% reduction in TNF 
production by of macrophages (202). In addition MyD88, the intracellular adaptor protein that 
transmits many, but not all, TLR-mediated signals, was shown to be critical for innate 
immunity against L monocytogenes (200, 203). Mice that lack MyD88 (Myd88-1-) were more 
susceptible to infection with L. monocytogenes than mice that lack either IFN-y or both lL-12 
and 11,-18 (200). fJowever macrophage-mediated killing of bacteria did not require MyD88 
(203 ). 
'fhe binding of L fI1ol1oqtogcnes to 'rRL2, TRlA and TLRS stimulates the receptors to 
dimerize Myd88 and to recruit interleukin-l receptor OL-l R)-associated kinase (lI{j\K) 4 and 
lRAKl. (Fig. 11) TNF receptor associated factor 6 (TRAF6) binds to [RAKI and then 
dissociates to form a complex with transforming-growth-factor-p activated kinase I (T AK 1), 
TAK I-binding protein 1 (TAB 1) and TAB2. This complex is required for the ubiquitylation 
of'TRAF6 and for the activation of the kinase activity of TAKl, which then leads to the 
phosphorylation of components of the inhibitor of NF-KB (l KB)-kinase (IKK) complex which 
results in the activation of NF-KB. In addition, TAK 1 activates MAP kinase kinase (MKK)-
3/6 and MKK4 which in turn activate p38 kinase and c-Jun N-terminal kinase (JNK) 
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n:spec1ively, which in turn activate the transcription factor API. Activation of NF-KB and 
AP-l results in the up-regulation of genes encoding pro-intlammatory cytokines such as TNF, 
IL-Ir3, IL-6, IL-12 and chemokines MIP-la, MIP-lf3 and RANTES (regulated on activation 
normal T cell expressed and secreted) (Fig. I I). Myd88-independent signaling by TLR4 
through the adaptor proteins TRAM and TRI F to activate NF-KB to up-regulate expression of 
co-stimulatory molecules (,D40, CD80 and CD86 at the macrophage cell surface which 
initiates T cell activation. L. mOl1ocyfogel1es has been shown to induce up-regulation of type I 
interferons such as r FN-a and IFN-~ via a TLR4-Myd88-indepcndent pathway that is 
mediated by lRF3. Type I IFNs have been shown to sensitize lymphocy1es to LLO-media1ed 
apoptosis, thereby disrupting the innate immune response and reducing resistance 10 1,. 
mOl1ocylogenes (204-208). In addition, cytosolic invasion of L. mOl1ocylogenes and membrane 
permcabilization by LLO has been shown to activate NF-KB in a MyD88- and IRAK-



































Figure 11 . TLR signalling in macrophages in response to L. monocytogenes infection. 
Solid black lines with plus signs represent activation; blunt-ended solid lines with minus signs 
represent inhibition. Figure modified and redrawn from reference( 185). 
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The NLR family arc soluble proteins that survey the cytosoI1()r microhial PAMPs which they 
recognize via a LRR domain. T'he NLR family includes the NOD proteins and NACHT 
(domain present in NAIP, CHTA, IIET-E and TPl)-LRR - and pyrin-domain-containing 
(NALP) proteins (183, 184). NLRs contain three distinct domains: (i) an amino-terminal 
easpase-recruitment domain (CARD) or pyrin effector domain, (ii) a nucleotide-hinding and 
oligomerization domain ('NACHT' domain) and (iii) a variable number of LRRs at the 
carhoxy-terminal (Fig. 10). To date, 22 NLRs have been identifIed (179, 185) however, only 
NOD] (<llso knO\,vn as CARD4), NOD2 (also known as CARD15) and CIASl (also known as 
cryopyrin or NAL(3) have heen found to recognize L monocytogenes (211-217). NODI and 
NOD2 detect peptides derived from the degradation of L. monocytogenes peptidoglycan 
(PGN) released by the listerial hydro lases during cell-wall biosynthesis and remodeling, 
and/or after phago-lysosome degradation. NODl recognizes diaminopimelic acid-containing 
dipeptide or tripeptide motifs (iE-DAP) while NOD2 detects muramyl dipeptide (MDP), 
which is a common component or bacterial cell walls (214, 218-220), Both NODI and NOD2 
are mainly expressed in epithelial celis, macrophages and Des (184, 221. 222), NODI 
expression is up-regulated by IFN-y only (223), whereas NOD2 is up-regUlated hy TNF 
which is further augmented by IFN-y (224). Upon ligand binding NOD] and NOD2 recruit 
downstream adaptor protein, receptor-interacting protein 2 (RIP2; also known as RICK and 
CARDlAK), that drives the activation of mitogen-activated protein kinases (MAPKs) and 
NF-KB (218, 225, 226) (Fig. 12). Activated NOD2 recruits RIP2 which mediates 
polyuhiquitylation of an inhihitor ofNF-KB (IKB)-kinase-y (IKKy; also known as NEMO) at 
the lysine residue at position 285 (227). This is followed hy the phosphorylation of IKKf1 and 
IKl3 resulting in the release NF-KB for translocation 10 the nucleus where it transcribes its 
target genes (228). In the case of NOD I, uhiquitylation of IKKy by RIP2 has not heen 
investigated and the mechanism or NOD I mediated activation of NF-KB is not clear. 
Furthermore, NODI and NOD2 signaling activate MAPKs such as .INK, extracellular-signal-
regulated kinase (ERK) and p38 MAPK by an, as yet, unidentified mechanism (211, 216). In 
addition, NOD2 has been shown to bind to procaspase-l, and induces IL-l ~ secretion (229). 
Since caspase-I is required fiJI' processing pro- I L-I ~ into mature fL-I [3 (230), the binding of 
NOD2 to pro-caspase I via CARD-CARD interactions, may convert the pro-caspase into a 
caspase. However, this putative NOD2 function still needs to be investigated in vivo, Both 
NOD I and NOD2 have been shown to be important is defense against L. mono(ytogencs. 
(211, 231). I nhibitiol1 of NOD I hy interlcrence RNA .. revealed that NOD 1 is critical far the L. 
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Figure 12. NODI and NOD2 signalling in macrophages in response to L. monocytogenes 
infection. Solid black lines with plus signs represent activation; blunt-ended solid lines with 
minus signs represent inhibition, dashed lines represent activation by unknown mechanisms. 
Figure modified and redrawn from reference (185). 
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NOD2 is involved in mucosal defense against L. monocytogenes and is required for the 
cxpression intestinal antimicrobial peptides. known as cryptdins. NOD2 deficient mice were 
susceptible to L. 1I70II()cJ'(ogenes infection due to impaired expression cryptdins (211). 
Moreover, mouse deficient for the adaptor molecule Rl P2, has profoundly increased 
susceptibility to L. mOl1oc),/ogenes and RIP2 deficient (RJPT
I
-) mice succumb to infection 
within 8 days of inoculation (232). RIP2-!- macrophages infected with L. mono(.y/ogenes or 
treated with LPS had decreased activation of NF-KB and impaired production of [L-12, fL-6 
and IFN-y production. Although RJP2 is a component of the NOD 1 and TLR4 signalling 
pathways, RIPTI- mice seem to be less immunocompromised than MyD88-deficient mice 
with respect to infection with L. monocylogenes (233). In addition to NODI and NOD2, the 
NLR protein e[AS 1 (also known as cryopyrin and NALP3) detects L. monocy/ogenes and 
induces production of L-Ifi and IL-I8. CIAS1 is structurally similar to NOD2 except that it 
contains a pyrin domain in place of a CARD at its amino-terminal domain and is also 
activated by MDP (234). Upon ligand binding, CIAS 1 together with apoptosis-associated 
speck-like protein containing a C-terminal caspase recruitment domain protein (ASC) 
activates pro-caspase-I and assembles with together with CARDINAL and mature caspase 1 
to form a multi-protein complex termed the NALP3 inllammasome, which controls the 
processing and activation of pro-inflammatory cytokines IL-lf3 and IL-18 (179,212,213) 
(Fig. 13). Consequently, mice deficient for elAS 1 (CIAS-I-) had increased susceptibility to L 
monOl.ylogenes due to impaired production 0 r mature I L l-r~ and IL-18. 
The TloR and NLR pathways in l11acrophagcs theref(He co-operate during L. monocytogenes 
infection to activate the transcription factors NF-KB and AP-l which induce the expression of 
pro-inllammatory chemokines sllch as M1P-1n, MIP-113 and RANTES and cytokines such as, 
lL-l, IL-6, TNF and JL-12, which is pivotal in controlling innate immune responses to L 











...... "",y ASC 
pro IL-1 P 
or 
pro IL-18 
1 + active I L-1 P 
~....±..-.  or 
 active IL-18 
Figure 13. ClASt signalling in macrophages in response to L. monocytogenes infection. 
Solid black lines with plus signs represent activation; blunt-ended solid lines with minus signs 
represent inhibition. Figure modified and redrawn from reference (179). 
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4. Role of Chemokincs and Cytokines during L. monocytogefles infection 
Chemokines are low molecular weight cytokines whose chemoattractant activities are critical 
during innate immunity to L. monocylof.;enes: Chemokines are essential for trafficking and 
recruiting eilector cells such as neutrophils, macrophages, DCS and N K cells to the site of 
infection, which confine the infection within microabscesses and destroy the bacteria, Within 
3 hOllrs after infection with L monocylogcnes, Kuptler ceUs, hepatocytes, macrophages and 
neutrophils up-regulate expression of MIP-I (1, MIP-If), MIP-1, RANTES, KC and IFN-y 
inducible protein-lO (IP-I0) in the liver, which is the primary target organ of L 
monocylogenes (236-240), The initial secretion of MIP-1 by infected Kupfter cells and 
hepatocytes recruit neutrophils, which become activated and secrete MIP-I a and MIP-lf3 
which in turn recruits and co-localizes macrophages, NK cells and T cells at the site of 
infection (241), However, MCP-J is the most important chemokine that is critical for delense 
against L monocy/ogenes, MCP-l in induced by LLO secreted by cytosolic L mono(ylogenes 
(65) and is indispensable for the recruitment of macrophages (l49), Mice lacking CCR2, 
receptor tCl[ MCP-\, are highly sLlsceptible to L monocYlOgenes due to impaired emigration 
of monocytes from bone marrow, resulting in accumulation of activated macrophages in the 
bone marrow rather than at the site of in1ection (242, 243). In addition to recruiting effector 
cells, chemokines also playa role in macrophage activation and have direct antimicrobial 
activity, For example, iVUP-la, MlfJ-lp, RANTES, and ATAC/lymphotactin secreted by NK 
cells were shown to act in synergy with IFN-y as "type 1 eytokines" to activate maerophages 
(241). Moreover, cnemokines such as monokine induced by IFN-y (MIG or CXCL9), IFN-y 
inducible protein of 10 kDa (lP-l0 or CXCLIO) and IFN-y inducible T cell alpha 
chemoattractant (I-TAC or CXCL 11) share structural homology with antimicrobial peptides 
called defensins, and posses antimicrobial activity against Escherichia coli and L. 
fl/OnocylOgenes which is augmented by fFN-y (244), 
B\.)th lL-6 and IL-l are required for resistance to L. l1lonocylogenes early during infection and 
are important f()r regulating the neutrophil responses at the sites of infection (245-148), 
KupfJer and macrophages are the primary souree oflL-6 produced in the livers of mice during 
I", mOf1oLY/oxenes infection, and the production of IL-6 by is independent on fFN-y and TNF 
and correlates with disease severity (249), Mice deficient for fL-6 (lL-6-1-) arc highly 
susceptihle to L. monocylogenes and have increased bacterial load in the liver and spleen that 
correlates with inctlicient peripheral blood neutrophilia (246), However, at low doses IL-6'·/-
mice are able to clear L. monocytoxene5' infection (250), The protective function of lL-6 
during L. mOf1ocylogenes intection is not completely understood, probably due to pleiotropic 
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eJkcts on diverse systemic and tissue specific biological responses (251). I L-I a ane! 11,-1 ~ 
belong 10 the lL-1 family of potent inllammatory cytokines that contribute to a number 01' 
normal physiologic processes and (0 the development of a number of inflammatory diseases. 
IL-I is essential for the activation of and neutrophils during L monocy/ogenes infection (245, 
247) and primes ncutrophils to produce bactericidal molecules such as reactive oxygen 
intermediates (ROI) (252). In addition, although TL-l is not chemotactic, it up-regulates thc 
expression or chemokines and adhesion molecules (253, 254) thereby promoting thc 
recruitment of effector cells to infectiolls fixi (245, 247). Although, lL-l B deficicnt (IL-l rr'-) 
mice showed equivalent resistance to L 1110l1lJcy/ogenes as WT controls, complete inhibition 
or 11,-1 signaling via blockade of the type I IL-IR by mAb or by gene targeting greatly 
increased the susceptibility of the mice injected with a sub-lethal dose or r. mOlwL'J'/ogenes, 
and was accompanied with enhanced bacterial growth in the livers and spleens (248, 255). 
TNF, lL-12 and IL-18 produced via the TLR and NLR pathways, synergize to stimulate the 
production or IFN-y by NK cells (256-259), CD8+ T cells (260-263), dcndritic cells (264), 
Th I cells (265) and I KDCs (178). TNF is critical I'(H innate antibacterial defenses and 
macrophage activation during L moyu)(:ytogenes infection (266, 2(7). Blockade of TNF 
signaling by the genetic deletion of the TNF receptor 1 or by the depletion of TNF USl11g 
monoclonal antihodies (268) rendered mice highly susceptible to sub-lethal doses of L. 
fI1ol1ocy/ogenes (266-270). Induction of TNF during L. monocytogenes infection is dependent 
on TLR2 and Myd88 signaling pathway (200), and together with IL-12 activates NK cells to 
produce IFN-y (259). Moreover, TNF has phagocytic and bactericidal/bacteriostatic functions 
(271) and synergizes with I FN-y 10 activate the listericidal activity or macrophages (272). 
Recently, the soluble f(xl1l ofTNF was shown to he required for the control ol'listerial growth 
and cellular inflammation during primary high-dose infections, whereas the membrane bound 
form of TNF was required for resolution or a secondary high-dose infection and for T eell 
memory (273, 274). IL-12 is also critical for innate immune responses against L 
fI1onocy/ogenes (275) and is produced by Kupffer cells, macrophages, neutrophils and 
dendritic cells (276-280). Neutralization of lL-12 in mice decreased macrophage activation 
resulting in enhanced susceptibility, bacterial overgrowth and early death (275, 281). 
Administration or recombinant IFN-y was ahle to restore the deleterious effect of anti-IL-12 
treatment, thereby demonstrating a role for 11,-12 in the production of IF"N-y early during L. 
mon()(ylogenes infection (275). Moreover, mice deIicient f()r IFN-yR (IFN-yR-1-) expressed 
llormal levels of IL-12 as compared to controls, conlinning the that thc initial production of 




) showed that IL-12 was only crucial for elTcctive innate immune responses at higher 
infective doses of L. monocytogenes, but not at low infective doses when residual activity or 
IL-18 could compensate for IL-12 (283). In addition to TNF, 11,-12 can also synergize with 
[L-18 to stimulate the production of IFN-y in NK cells (256-258), CD8+ T cells (261), Thl 
cells (265) and dendritic cells (264). JL-18 is a pro-intlammatory cytokine that belongs to the 
I L-I cytokine family and is a pleiotropic factor involved in the regulation of both innate and 
acquired immune responses. IL-18 is expressed via a Myd88-dependent pathway in antigen-
presenting cells and is produced as a precursor requiring caspase-l for cleavage into an active 
IL-18 molecule (284). Indeed mice deficient Cor IL-18 (lL-18
ol
-) or caspase 1 (Caspl-IO) were 
mildly susceptible to L tnonocy/ogenes, since they were able to produce TL-12 and TNF (200, 
285). Ilowever, mice doubly deficient fiJr 12 and lL-18 were highly sllsceptible to L. 
tnonocytogenes, but not to the same extent as Myd88-10 or IFN-y 01- mice (200). In addition, the 
activation of IL-18 is also dependent on the NALP3 inflammasome proteins NALP3 and 
ASC, which activate caspase 1 in response to cytosolic invasion by r. IJlOnOC}'/ogenes (286). 
Besides its IFN-y enhancing capacity, IL-18 also augments the cytotoxic activity of both NK 
and T cells (257, 287-290) and can enhance production of other pro-inflammatory mediators 
in these cells (257, 291-2(4). Moreover, IL-18 plays an important in both innate and adaptive 
immune responses to L. tnonocytogenes involving the production of TNF and nitric oxide 
(NO) as well as IFN-y (295). During r. tnonocytogenes infection, the pro-inflammatory 
responses are themselves regulated by anti-inflammatory cytokine IL-lO, which is also 
produced by activated macrophages with kinetics similar to those fiJr the pro-inflammatory 
mediators (259, 296). The suppressive role of IL-l 0 early in L. tnonocy/ogenes infections was 
demonstrated by in vivo neutralization (297), administration of recombinant IL-I0 
administration (298) or by 1 L-l 0 deficient (fL-l (
010
) mice (299). 
5. Role of IFN-y during L. monocytogenes Infection 
The production of IFN-y is crucial for full macrophage activation, which produce pro-
inflammatory cytokines and chcmokines which in turn further induce further production of 
IFN-y and enhanced macrophage activation in a positive feedback loop (114). During the 
innate immune response to L. tnonocy/ogene.'l', 1 FN-y is crucial for controlling bacterial 
growth by activating the antimicrobial and antigen-presenting properties or macrophages 
(142, 143,300-3(5). lFN-y is produced by multiple cclltypes upon synergistic activation by a 
combination ofTNF, 11,-12 and/or 11,-18 (142,143,178,257-259,261,264,270,301,306-
310). More recently, other TFN-y inducing cytokines such as IL-21, 11,-23, and IL-27 have 
been described and may play overlapping and/or redundant roles in the innate Immune 
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response against L. monocytogenes (311-313). Evidence that IFN-y is critically important in 
the inllate immune responses to L. monocylogenes comes from experiments using mice 
deficient for either TFN-y (I FN-y-I-) (277, 314), or the IFN-y receptor (fFN-y R-1-) (277, 282) or 
cell specific deletion or fFN-yRu in recelllly activated rnacrophages (315). These mice have 
multiple defecls and do not survive the first 5 Jays of L. monocylogenes infection, even when 
injected with a very low dose or 70 L. monoc.ylogenes baci Iii (282). I:arly in vitro studies by 
Portnoy indicated that TNF acted synergistically with IFN-y to promote the listericidal 
activity of macrophages, and that the primary role of IFN-y was to prevent access of L. 
ll1onocylogenes to the macrophage cytoplasm and to enhance phago-Iysosome digestion of the 
bacilli (165). Indeed, electron microscopy of macrophages from L. monocytogenes infected 
IFN-y-l- or IFN-yR-1-mice showed that these mice were unable to restrict L. ll1onocylogenes 
bacilli to the phagosomes resulting in increased escape into the cytoplasm leading to 
uncontrolled bacterial growth and early death (277, 282, 314). However, the mechanism 
whereby IFN-y mediates confinement and bacterial killing is only partially understood. Two 
general antimicrobial mechanisms implemented by activated macrophages include (i) the 
production ofreactive oxygen intermediates (RO!) by the phagocyte NADPH oxidase (phox) 
and reactive nitrogen intermediates (RNI) by inducible nitric oxide synthase (iNOS) and (ii) 
enzymatic degradation of the pathogen mediated by phago-Iysosome fusion. Both these 
pathways synergize to rapidly contine and restrict/tenninate listerial growth within the liver. 
;\t the phagosome level, listericidal activity of f1"N-y is mediated by the small GTPaseRab5a, 
which co-ordinates confinement of the L. monocylogenes bacilli within the phagosome, 
phagosome maturation, phago-Iysosome fusion and subsequent killing hy lysosomal enzymes 
(73, 316). ConFinement of L. Jnof1ocylogenes within the phagosome is dependent on active 
(iTP-bound Rab5a (76) and the localized release of nitric oxide and superoxide into the 
phagosomal space (73, 75). However the actual mechanisms of how this is achieved are not 
fully elucidated. IFN-y up-regulates the expression and activation of Rab5a into its active 
GTP-bound from (316), which directly accelerates maturation of L monocylogenes-
containing phagosomcs, phago-lysosome fusion and consequent bacterial killing (316). The 
rei case of nitric oxide and superoxide into the small space of the phagosome is generally 
considered to cause fatal oxidative damage to the bacilli (132, 317, 318). However, recent 
studies have indicated that phagocyte NADPII oxidase, is involved in an additional pathway 
that promotes bacterial killing via potassium ion in11ux. High concentrations of superoxide in 
the phagosome was shown to result in the accumulation of anionic charge, which was 
compensated for by an inf1ux of' potassium ions across the phagosome membrane in a pH-
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dependent mClnner. The cOllsequent rise in ionic strength and alkalinity Cacilitated the release 
or cationic granule proteins elastase and cathepsin G from the anionic sulphated proteoglycan 
matrix, which resulted in hacterial destruction. (319-322). Furthermore, the alkaline 
conditions within the phagosome would most likely neutralize the activity of LtO by 
preventing its integration into the phagosome membrane and therehy contine L 
lI1ono(y/ogenes within the phagosome (56). 1.. mOl1ocy/ogelles competes with the above 
defense pathway by delaying of phagosome maturation, thereby "buying time" for its escape 
from the phagosome and consequently avoiding phago-Iysosome fusion and digestion hy lytic 
enzymes (3, 6). L ntonocy/ogcnes achieves this by preventing the exchange of inactive GDP-
bound Rah5a for active GTP-bound Rah5a (76) via modulation of Rab5a regulating proteins 
sLich as guanine nucleotide exchange factors (GEFs), GTPase Activating proteins (GAPs) and 
guanine diphosphate (GDP) dissociation inhibitors (GDls) (76). 
ll. Role of RNI and ROI during L. monocytogenes infection 
Although, several studies using gene deficient mice have shown that nitric oxide and 
superoxide are important for pathogen killing, these rnoleeules are not essential (75, 323-325). 
Mice de1icient je)f inducible nitric oxide genes (iNOS-1-) had significantly increased 
susceptihility to pathogens such as Mycohacteriwn {uherculosis (326), Leishmania major 
(327) and ectromelia virus (328), but were able to adequately clear and recover 1i-om 1.. 
mOflocy/o}{cfles (110, 27&, 324) and Toxoplas/Illl gOl1dii (329,330) infections. Similarly, mice 
deficient for the p47phox (p47pbox·I-) (323) and gp91 phox (gp91 phox-I-) (325) components of 
the phagocyte NADP[ I phagocyte oxidase, efliciently cleared and recovered from L 
monocy/ogcnes infections. Furthermore, studies using gp91 ph ox I INOS2 douhle gene 
delicient mice, indicated that phagocyte NADPH oxidase and iNOS could substantially 
compensate Jar each other's deficicncy (324). 
Taken together, these studies demonstrated that although nitric oxide and superoxide were are 
important t()r pathogen killing, they werc not essential. Moreover, studies using mice 
deficient 10r specific innate immulle receptors or components of innate immune signaling 
pathways have underscored the hypothesis that macrophages have an alternative listericidal 
pathway that is independent of nitric oxide (I 10,27&,324), superoxide (323-325) TLR2 (203) 
and MyD88 (203) Crable 2). Mice deficient for TNF Receptor p55 (TNFRp55-1-) (266. 2(7), 
I FN-y (1 FN-y-l-) (277, 314), IFN-y-Receptor (lFN-yR-1-) (277, 282), Intederon Consensus 
Sequence L3inding Protein (1CSl3p-I-) (331), Interferon Regulatory Factor 2 (lRF2-1-) (331), 
RelB (332) and CCAAT/enhancer hinding protein beta (C/EBPW I-) (333) are all severely 
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susceptible to 1" Inonocylogenes, even when infected with very low doses. Since IFN-y 
activates the cytocidal or cytostatic potential of macrophages (271, 282) and TNF has 
phagocytic and bactericidal/bacteriostatic Cunctions (271), this hypothetical killing pathway is 
most likely activated by these cytokines. I FN-y would be the lirst component in the pathway, 
since the lFN-l- (277,314) and lFN-yR-/- (277, 282) mice had impaired induction ofTNF. 
Similarly RelB would be downstream of IFN-y, since mice dcticient in this transcription 
factor eniciently produced IFN-y but have impaired macrophage activation due to dcJcctive 
induction of TNF (334). Consequently TNF would be downstream of IFN-y and RelB. The 
most downstream molecule in this hypothetical pathway would be C/EBPfi, since the 
C/EBPrr/- mice expressed normal levels of IFN-y and TNF (333). Moreover, experiments by 
Pizarro-Cerda et al (335) using C/EBPW/- mice infected with Brucella aborlus, indicated that 
C/EBP~ promoted endocytosis and membrane fusion between endosomes and pathogen-
containing phagosomes in a G-CSF-dependent manner (335). Since IFN-y stimulation results 
ill the enhanced expression (336, 337) and activation of C/EBPI\ (338, 339), and TNF 
promotes the translocation of C/EBPP to the nucleus in response to pro-innammatory 
cytokille signalling (340), it can therefore be envisaged that IFN-y and TNF signalling 
converge on C/EBPP to transcribe genes required for confinement of 1.. monocyto~enes 
within the phagosome, leading to phago-Iysosome fusion and consequent bacterial killing 
(Fig. 14). Alternatively, a third pa1hway mediated by IFN-y and/or TNF activation and 
independent of iNOS , superoxide and C/EBP~ may be possible. 
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Table 2. Gene deficient mouse strain responses to L. monocytogel1es infection 
Mouse strain R(~sponse to L. mOl1ocytogenes infection Reference 
ICSBP Very susceptible, early lethality (331 ) 
I----.--.-~---·-·--·-··---r__--·----·-··--·--·-~-·---··-.. ---.. _ .. _-... - .. - ... --.. --.-..... - ... -.-.-.... ---------.---
Very susceptible, early lethality (314) 
IFN-yR Very susceptible, early lethality (277,282) 
IRF2 Very susceptib1e, early lethality (331 ) 
_ .. _ ... _---,._._._._._--_._-+------_._._ ... _ ... _-_ .. _--_.-... __ ..... _ .. _ .... -..... _ .._-_. __ .. _- _ ... __ .. _---_._. ----.--.------.-.-------
Myd Very susceptible, early lethality (200,203,243) 
·--·--T·-·~---···-·-·-- ------------.. -- - .. -.-.... .-.. ----.-.- .. -------------- --------.. - .. - .. ---.. _-.. -
RdW· Very susceptible, early lethality (334) 
TNI::I{l;55:'r:------V~;:y s usccrti b I~: ~;~'I y·l~th~Tity---~------~ -(2-66:26~i)----·--- -.... -.. 
-C ,c:R2:r---···--·· -- ... -f1i-g-hl-y-s~L~,,~~ptTbl~:~;-~lyl·~th-ality -.-.... -------- (149~1-5() )-------. 
J 1~=II{=-r--·-·- -- -fiTghiY-~~~ce-p-tibl~:~;;~iyl~·th;lit y-----.------- (248)----- .----.... -.----
llAJ Highly susceptible, early lethality (246) 
Moderately increased susceptibility (212) 
c·-·---·--· .... ---.-.... ---. ---.------.-.--.---.----... -. -........... -..... ----------.----. -.. - .. -----.--.--.--.--
I L-12 Moderately increased susceptibil ity (283) 
.-.-..... -.-.--.r----.-.--.-.-- ~---.-----.--.--- ... -.-.-....... --.- .... -.--.. --.--.-.. - ----... -- --.-.---.--... ---.----. 
iNOS- - Moderately increased susceptibility (150, 278, 324) 
-MC-;-p::-j-:7--~.--.. ~1oder~t~yi;;~~~~~~d-~;;;Z;pti b i lity---·----·~----- - --(2-43-j----·----·--
--- .--.. --:r:-.------.-.--- -.. -.. -.---- -----.------........ ---.-.... --. -.-... --.... ---.. -.-.. ------ ---.--.--.-.-------.--.-.--.-
CASP r - Mildly increascd susceptibility (203,285) 
.--.. ----.----:r- ... ---.--.-.- .-.-.-.. - ... -.---.------.. ---... ---.----------------.-----.-.--.---.-.-.. -----------.. --.---.-.. -
p47phox- - Mildly increased susceptibility (323) 
---.----7-----.-.--... --- .----.-.-.-.--.---.. -.. --.---------.---.. ----.-.-...... ---.-.. --.. - .. --------- .---.. ---.---------.---------. 
RIPT - Mildly increased susceptibility, delayed lethality (232) 
JRFI Normal resistance (331 ) 
-.... -- -.. -----.r------.------- -.. ----------.-----------.---------~--.-.---.-.----- .------.------.---
TLR2 -- Normal resistance (200, 203, 243) 
.. - .. ·-·····-··-7-··---·---·--···-----· ---.---.. ---------.-------.-.-.• -.---.--.------------.---- --.-.-.. ----.--~.-- -.-----
TLR4- - Normal resistance (200,243) 
-·ij;N·=~R-/-::--------- -l~~reased resi ~t~;~~·c~·-----·-··----··--------·- (i04=2()6-)-------
J 1.-1 0 Increased resistance (299) 
.... -... --~----.-... -... -.. ---------- -_ .. __ ._--_. __ ._---_._--_.-
I RF3 - - I ncreased resistance (206) 























Figure 14. Hypotheticallistericidal pathway independent of nitric oxide and superoxide. 
Mice deficient for IFN-y, IFN-y-R, ICSBP, IRF2 and CIEBPP have underscored the 
hypothesis that macrophages have an alternative listericidal pathway that is independent of 
nitric oxide, superoxide, TLR2 and MyD88. In this hypothetical pathway, IFN-y and TNF 
signalling via their receptors converge on the transcription factor CfEBPP, resulting in its 
activation and translocation to the nucleus respectively. In response to IFN-y and TNF 
stimulation, activated CIEBPP transcribes granulocyte colony stimulating factor (G-SCF) and 
other, as yet, unknown (designated as 7) genes required for confinement of L. monocytogenes 
within the phagosome leading to phago-lysosome fusion and consequent bacterial killing and 
enzymatic digestion. 
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6. Role of C/EBP~ in IFN -"( signal transduction 
C/EBP~ is a transcription factor that is also known as Nuclear Factor IL-6 (NF-IL-6), IL-6 
induced DNA binding protein (IL-6- DBP) and C-reactive protein 2 (CRP2). In this 
dissertation, the current gene name, CIEBP~, as stipulated by Mouse Genomic Nomenclature 
Committee (MGNC) (342), will be used. CIEBP~ belongs to the bZIP transcription factor 
family which includes CIEBPu, CIEBPy, CIEBPo, CIEBPE, and is involved in many 
physiologic processes such as carbohydrate metabolism, lipid storage, differentiation, cellular, 
Th 1 immune responses, macrophage-mediated antibacterial, anti-tumour defenses and female 
fertility (339). CIEBP~ contains a bZIP domain at its C-terminal end which is comprised of a 
leucine zipper and a basic region (217, 343) (Fig. 15). The bZIP domain is essential for DNA 
binding and for mediating homodimeric and heterodimeric interactions with other CIEBP 
isoforms. The dimerization domain, also known as the leucine zipper, contains seven leucine 
repeats that interca1ate with the leucine repeats of the dimerizing partner (344). In the centre 
of the protein are two regulatory domains (RD), RDI and RD2, which contain sites that can 
be phosphorylated by protein kinases. At the N-terminal end of the protein is the transcription 
activation domain. Dimerization between CIEBP~ and different CIEBP isoforms allows the 
expression of CIEBP~ target genes to be finely regulated in particular tissues and in response 








RD1 c- terminal 
'"'---.... ---~/,---- ----~ V V 
Regulatory domain DNA binding and 
dimerization domain 
Figure 15. Schematic diagram showing structure of C/EBP~. CIEBP~ contains three 
structural modules, the N-terrninal transcriptional activation domain (AD), the intracellular 
regulatory domains (RD) and the bZIP domain that consists of a leucine zipper and a basic 
region. Activation of C/EBP~ requires dephosphorylation at serine 64 in the AD and 
phosphorylation at the GTPS consensus site in RD2. The leucine zipper mediates 
dimerization with other transcription factors while the basic domain, which rich in basic 
amino acids, dictates DNA-binding specificity. The amino acid sequence phosphorylated by 
ERK 1 12 is indicated in red. Figure modified and redrawn from reference (339). 
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cmBP~ is expressed as two isoforms, which arc generated from a single mRNA by a leaky 
ribosomal scanning mechanism. The IIrst isoform encodes the full-length C/E13Pl3 protein 
(346) and Lhe second isoform a truncaled prokin termed liver inhibitory proLein (LIP), which 
contains only the DNA-binding and leucinc zipper domains (347, 348). Hcterodimerization 
hetween LIP and full-length C/EI3P~i inhibits transcriptional activity in sub-stoichiometric 
amounts, suggesting a naturally occurring dominant negative mechanism of transcriptional 
regulation (349). C/EBP~ (also known as CflOP or GADDI53) is cxprcssed only under 
conditions of stress (349, 350) and its dimerization with C/EBPl3 also inhibits transcription 
(349). The expression of C/EllPB is strongly up-regulated by LPS, IFN-y, 11.-6, lL-I, 
dexamethasone and glucagon (336, 337). Moreover, TNF promotes nuclear localization of 
C/EBPf3 in response to inl1ammatory stress (340). Cytokine treatment further increases 
C/EBPr3 transcriptional activity via enhanced DNA binding (348). The activation of (,IEB]>[3 
at the post-transcriptional level involves phosphorylation by protein kinases such as PKA, 
PKC, ribosomal 86 kinase (RSK), and extracellular signal-related kinase (ERK) at conserved 
serine and threonine residues (338, 351-356). Once activated, C/EBPf3 «wms hetcrodimeric 
complexes with other transcription factors, such as Retinoblastoma 1 (pRS), NF-KB, trans-
acting transcription factor 1 (Sp I) and myeloblastosis oncogene (Myb) and binds to a variety 
or response elements (339). For example the C/EBPrlNF-Kf3 heterodimer synergizes to 
transcribe genes encoding thc acute-phase response proteins such as serum amyloid (SA)A I, 
SAA2, 8AA3 and u1-acid glycoprotein, as well as cytokines JL-6, IL-12, grnaulocyte colony 
stimulating f~lctor (G-CSF) and MIP2 (357-363). In some instanccs, other C/EBP isofonns are 
able to compensate for C/EBP[~, thereby preventing impaired transcription of CIEBpr~ target 
genes in absence of c/Lmpf3. For example, the promoter for iNOS contains a C/EBpr~ binding 
site, yet C/EBPWI- mice efficiently produce nitric oxide in response to infection by L. 
111onocyloKcnes (333). On the other hand, C/EBP~ is indispensable for the transcription of 
genes slIch as C-type lectin domain family 4 member e (CLECSF9), IFN-sti11lulaLed gene 
factor 3 gamma (lSGF3y), G-CSF and IL-12p35 in response LPS stimulation (364-366). 
Moreover, studies using C/EBPWI- mice have shown that C/EBPl3 is critical for killing 
intracellular pathogens such as Listeria (333), 5,'abnonella (333), Brucella (335), 
Myco/Jaclerium (367) and Candida (36X). Tbe mortality kinetics of C/EBPrr/- mice inlected 
with a low dose or L. monoc:ytof;Cllcs infcction is comparable to that of TNFRp5y/- (266, 
267), (IFN-y-I- (277, 314), IFN-yR+ (277, 282), ICSBP'/- (331), lRF2-1- (331) and RelB (332) 
mice suggesting that C/EBPlr'- is a downstream eftecLor molecule of IFN-y signalling. 
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Moreover, C/EBP[3 is also involved in regulating transcription of genes stimulated by 1 FN-Il 
and IFN-f3. Generally, IFN-y stimulated genes contain a IFN-y-activatcd site (GAS) in their 
promoters, whereas 1 FN-Il/r~ stimulated genes contain IFN-stimulated response element I SRE. 
MOI"I:.' recently. a novel fFN-y-response element termed IFN-y-activated transcriptional 
clement (GATE) \vas discovered (369). through which C/EBPf1 links the IFN-y and IFN-n/f3 
signalling pathways (339, 352, 369-371). In the IFN-n/f1 induced signalling pathway, Janus 
kinase 1 (JAK 1) and Tyrosine kinase 2 (TYK2) induces tyrosine phosphorylation of Signal 
transducer and activator of transcription (STAT) 1 and STAT2 respectively, which in 
association with I SGF3y (also known as I FN gene regulatory factor-9; f RF-9) /()f]ns the 
multimeric transcription nlctor termed IFN-stimulated gem.' factor 3 (lSOF3). The ISGF3 
transcription f~tctor complex initiates transcription of genes containing an the IFN-stimulatcd 
response element (ISRE) in their promoters e.g. MHC class I genes. ISOF3y is critical for 
driving antiviral dc1enses and ads in synergy with lRF-1 to drive transcription in response to 
both IFN-y and IFN-Il/[1 signalling (372). The transcription oflSGF3y is mediated by C/EBPP 
though the GATI: in the ISGF3y promoter (373-376). Both IL-6 and IFN-y augment IFN-u/[) 
signalling by inducing the expression of C/EHPf3 (336, 337) and consequently that of ISGF3y 
(370, 373-376)s. 
Recent studies have shovv'l1 that at least two IFN-y-induced MAPK signals converge on to 
C/EIW!1 for inducing transcription of IFN-y responsive genes (338, 339) (Fig. 16). The {irst 
pathway is driven by extracellular signal-regulated kinases (ERKs), which phosphorylates 
(,/1~Bpr) in its RD2 and the second pathway is driven by the mixed-·lineage kinascs (MLKs), 
which induces a dephosphorylation leading to the recruitment or transcriptional co-activators. 
Both these pathways act in concert to mediate transcription of genes in response to IFN-y 
signalling. In the first pathway, IFN-y binding to its receptor IFN-yR results in the 
phosphorylation of S'rAT1, which in turn activates an unknown t~lctor that phosphorylates 
and activates MAP kinase kinase 1 (M[·:KKl) (352). Activated MEKK 1 recruits MAP kinase 
kinase I (MEKl) and ERK1/2 to its N-terminal domain (377). Activated MEKK1 
phosphorylates MEK 1 un the same residue as docs Rat' (]78). Activated MEK 1 in turn 
activates FRK 112 (379), which phnsphorylates CIEBPB at threonine residue 189 in the ERK 
consensus GlPS phosphorylation site located in the RD2 domain (380). Phosphorylation at 
the O'l'PS site induces a conformational change that allows C/EBPl3 to dimerize with otiler 
transcription lactors (381). In the second pathway, lFN-y signals through the IFN-yR to 
activate an unknown tactor whieh in turn activates MLK3. Activated MLK3 indirectly 
mediates the dephosphorylation or C/EBP[-I at a cnnserved serine residue at position 64 (338), 
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which results in recruitment or transcriptional co-activators such as p300 (338). The 
convergence of till' ERK 1 12 and MLK3 pathways on C/EBPI} and the recruitment or 
tnmscripLional co-activators thercCore sets the stage f(w activation orthc IFN-stimulated genes 
containing ISRE, (lAS and GATE 1110tifs in their promoters (Fig. 4). Due to its severe 
susceptibility to L fI1onocyrogenes, despite efficient production of nitric oxide and 
sLLpcroxidc, together with its role in meJiating IFN-y stimulated transcription or innate 
defense gelles, the C/EBPrr/- mOllse model was therej(HI: considered a useful tool to identify 
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Figure 16. Regulation of CIEBP~-mediated transcription by IFN-y. (A) IFN-y signalling 
via the IFN receptor II triggers tyrosine phosphorylation of ST ATl via JAKl and JAK2. The 
ST AT 1 dimer migrates to the nucleus and initiates the transcription of genes that possess the 
GAS in their promoter. (B) Similarly, IFN-a,~ signalling via IFN receptor I triggers 
phosphorylation of ST AT 1 and ST A T2 via J AK 1 and TYK2 respectively. In the nucleus the 
ST A Tl :STAT2 heterodimer binds with ISGF3y to form the ISGF3 complex that initiates 
transcription of genes containing an ISRE. (C) IFN-y signalling via IFN receptor II triggers 
activation of MAPK pathways that converge on C!EBP~ resulting in its activation by 
phosphorylation of threonine l89 in the GTPS motif of RD2 and dephosphorylation of serine64 
in the AD. Activation of C/EBP~ induces a conformational change that allows C/EBP~ to 
dimerize with other transcription factors (designated as X) and recruit transcriptional co-
activators, such as p300, in order to transcribe genes containing either a consensus C/EBP~ 
binding site or GATE motif in their promoters e.g. transcription of ISGF3y by C!EBP~ 
through GATE links the IFN-y and IFN-a,~ signalling pathways. Transcription of C/EBP~ 
itself is induced by IFN-y. Figure modified and redrawn from reference (339). 
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C. RESEARCH HYPOTHESIS AND STRA TEGY 
The aim of the current study was was to identify the genes involved in the hypothetical 
listericidal pathway that is independent of nitric oxide and superoxide. Based on the 
hypothetical pathway outlined in (Fig. 17), genes involved in mediating listericidal activity 
would most likely be downstream of C/EBP~. Since activated macrophages and neutrophils 
are the major cell types involved in T cell independent killing of L monocylogenes (114), it 
was therefore postulated that comparison of the gene expression profiles between activated 
WI and CIEBP~·I. macrophages infected with L monocytogenes would increase the 
probability of identifYing the listericidal genes. Moreover, the bone marrow from WI and 
C/EBP~·I. mice would provide a plentiful source of quiescent bone marrow derived 
macrophages (BMDMs) for in vitro infection experiments. 
AIM 
Identify genes Involved In mediating Iistencidal activity 
OPTIMIZE IN VITRO INFECTION IN BMDMs 
» Check if biology of in vitro data reflects literature 
• Cytokines, chemokines , nitric oxide secretion 
• Macrophage listericidal assay 
• Phagosomal escape 
• Check quality of RNA by RT-PCR 
COMPARATIVE DNA MICROARRAY ANALYSIS 
';> Whole mouse genome 
» Infected vs. Non-infected 
» C/EBP~·J· vs, WT 
» Data analysis 
FUNCTIONAL CHARACTERIZATION 
';> L. monocytogenes infection model 
» Gene deficient mouse mOdels 
';> Systems biology 
Figure 17. Research strategy employed to identify genes involved in macrophage effector 
functions against L. monocytogenes that is independent nitric oxide and superoxide. 
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The Erst part of the research strategy was to establish and optimize in vitro infection of WT 
and CIEBPrr/- bone marrow derived macrophages (BMDMs) with L monocytogenes so that 
the biology of the in vitro infection faithfully represented that of in vivo infections as reported 
in literature (333, 364, 366, 370). Furthermore, RNA extracted from L monocylogenes 
infected WT' and C/EBPWI- BMDMs was stringently tested to ensure that it was of high 
quality and that it represented the expected gene expression profile for genes known to be 
differentially expressed in macrophages deficient for C/EBPP (333, 364, 366, 370). 'fhese 
controls thereby provided a solid foundation on which to base the gene expression profiling 
experiments. The second part of strategy was to identify the listericidal genes, which were 
postulatcd to be eli fferentially expressed between the infected WT and C/EBPp-i-
macrophages. A comparative gene expression proliling strategy using whole mousc genome 
oligonucleotide DNA microarrays, rather than suppressive subtractive peR (SSII peR) (J82-
385) or scrial analysis of gene expression (SAGE) (386-388) was f()llowcd, since DNA 
microarrays involved shorter experimental time scales, were more cost effective and required 
relatively simple technical expertise. In contrast, both SSH peR and SAGE are technically 
very demanding and the protocols are extremely time consuming due to a multitude of peR 
and cloning steps. Moreover, both these methuds requires extensive DNA sequencing for the 
identification of the cloned genes, which makes these methods much more expensi ve than 
DNA microarrays. The third part of the research strategy was to functionally characterized the 
roles of candidate genes involved in defense against L. monocytvgenes infection using 
appropriate gene deficient mOllse models. Moreover a systems biology approach would be 
used to investigate the mechanism whereby the candidate genes mediated protection against 
L monocy/ogenes during infection. 
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CONCLUSION 
In the current study, 1.. monocyloKenes was used as a model intracellular pathogen to identify 
genes involved in mediating macrophage bactericidal effector activity. L monocytoKenes has 
developed many molecular adaptations to invade and proliferate within the intracellular 
environment of many difTerent cell types, thereby enabling it to cross the intestinal-, blood-
brain- and placental defense barriers. Several virulence factors mimic the activity of 
eukaryolic molecules and thereby exploit the biological functions o1'thc infected cell to favour 
bacterial survival. These molecular adaptations and elaborate mimicries used by L. 
fI1ol1ocylogenes, has made it an excellent tool t()r the study of cellular processes such as actin-
based motility, growth-factor mediated signalling, endocytosis and cellular adhesion. In 
addition, due to its ability to cross protective defense barriers and induce strong macrophage 
and T cell responses, 1.. fI1onO(y/oKenes has emerged as an excellent model to study the 
pathophysiology of a complex bacterial infection in animals. Furthermore, the availability of 
lhe genome sequence of live 1.. fI10l1ocY/()Kenes serovars (91, 389, 390) has provided an 
excellent platt(mn in which to unravel the genetic basis of 1.. fI1onocytogenes virulence, by 
whole genome comparison with its closely related non-pathogenic species L monocytogenes. 
[n the immunocompetent host, protective immunity against 1.. monocytoKenes evolves 
through several phases, each 0[' which is controlled by different cell types, cytokines and 
cytocidal molecules. These different cells and effector molecules do not participate 
equivalently at all stages of the infection and their importance depends on the time of 
inl'ection, the host's immunologic status, and the site of infection (147,167,317). Activated 
macrophages, dendritic cells, neutrophils and NK cells are critical for immediate control of L. 
nlonocytogenes proli1'eration and they communicate with each other by producing and/or 
responding to pro-in tlammatory cytokines and chemokines, which in turn activate and 
mobilize cHector cell populations to the site of inf'eclion. The current study has addressed the 
hypothesis that macrophages have an alternative killing mechanism that is independent of 
superoxide and nitric oxide (323-325) but dependent on IFN-y (277, 282, 314), TNF (266, 
2(7) and C/EBPrr/- (333). Since lhe mechanism and the genes involved in this alternative 
pathway are largely unknown, the aim ofthis thesis was to identify these macrophage elTector 
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CHAPTER 2 
MATERIALS AN)) METHODS 
METHODS 
1. Culture of Listeria monocytogelles 
Virulent L nlotlocyfogenes (EUD strain) were grown in tryptose-soy broth (Dileo, Detroit, 
MI, USA) until early to mid log-phase of growth (OD6oo=0.2). DMSO was added to a final 
concentration of 10% and aliquots made and stored at··70°C until use. For each experiment a 
vial was thawed and mixed thoroughly to disperse clumps. For each experiment, the titre of 
the inoculum was checked by plating I 00~t1 of IO-lold serial dilutions of the thawed L 
monocytogenes stock on tryptosl.!-soy agar plates. The plates were incubated overnight at 37°C 
and the next day the number of colonies was counted and the colony ()fining units (CFU)/ml 
c<:llculated. All experiments were performed in tbe BSL 2 laboratories at thl.! University of 
( 'ape Town, South Africa. 
2. Culture of ~~vcohacterium tuberculosis 
A~vcoh{]cteril/lll tuhercu/osis (H37Rv) was grown in Middlebrook 7H9 broth (Diteo. Detroit, 
Ml, USA) supplemented with Middlebrook O;\DC enrichment medium (Life Technologies. 
Ciaitilcrshurg. Ml, USA), 0.002 % glyceroL and 0.05 Oil) Tween 80. Mid log-phase cultures 
were harvested, aliquoted, and frozcn at ~XO°C. AileI' thawing, viable cell counts were 
determined by plating 100111 of IO-fold serial dilutions of the cultures on Middlehrook 71-110 
agar plates. The plates were incubated at 37°(, t()]" 21 days and the CFU/ml enumerated. All 
experimcnts were performed in the BSL 3 laboratories at the Cniversity of Cape Town, South 
Africa. 
3. Mice 
cmBPfi+/- on a C57BLl6x129/sv hackgnlund were obtained from V. Poii (Department of 
Genetics, Biology anu Biochemistry, University of Turin, Turin, Italy). A null mutation in the 
C/EBPpr) gene was generated by inserting a nco cassctte into the carboxy-terminal part of the 
gene, coding t~)r the leucine zipper and a portion of the basic domain (Fig. I A). This mutation 
inactivated the full length C/EBPP[} protein and its truncated amino-terminal isot(xm, LIP. 
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PKC8+/· mice on a 11.9/SvxOla background were obtaincd from M. Leitges (DepaJiment of 
Experimental Endocrinology, Medical University, Hanover, Germany). A LacZ/neo cassette 
was inserted into the first transcribed exon of the PKC8 gene resulting in a null allele and 
abolished transcription (Fig. 1 B) All mice were brcd in specific pathogen-free conditions at 
the Animal unit at the University of Capc Town, South Africa. For L. monocytogenes 
infections, mice were kept in filter-cap cages in a biohazard level 1. physical containment 
facility. For M. tuberculosis infections, mice were kept in individually ventilated cages in a 
biohazard level 3 physical containment facility. In any given experiment, mice were matched 
for age (6···10 wecks) and scx. All experiments performed werc in accordance with the Animal 
Research Ethics Committee of the University of Cape 'Town. 
A C/EBPWI+ locus 
R N B NR X N 
I I 'd l I I 
C/EBP~·'· locus 
R N B R ,i X N I I I [ I I I I neo 
B PKCS+I+ locus 
I I ~r I I I 
PKCS·I. locus 
I I I t"zoeo[t-m j I I 
Figure 1. Generation of C/EBPWI. and PKC5-1- mice. (A) C/EBPWI- mice were generated by 
V. Poli by inserting a neo cassette (open box) into the BZIP (grcy hatched box) domain of the 
C/EBP~ gene via homologous rccombination. 13, BamBI; N, NheI; R, Rsal; X, Xbal. (13) 
PKC8-1- mice wcre generate by M. Leitges via homologous recombination which inserted a 
Lac/lneo cassette (open box) into exon I (grey box labeled 1) of the PKC8 gene. 13, BmnI-lI; 
F~, EcoRI; F, F\pl; H, HindIIl. 
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4. Genomic DNA extraction 
I cm mouse tail cuttings were digested ovcrnight in digestion buffer (50mM 'IRIS-BCL pI IS; 
100mM EDTA; 1 OOmM NaCL 1 % SDS, O.5mg/ml Proteinase K) at 56°C with gentle shaking. 
The samples were centrifuged at 14000 rpm for 15 minutes and the clear supernatant 
transferred to a clean microcentrifuge tube. An equal volume isopropanol was added and 
thoroughly mixed. The genomic DNA was allowed to precipitate out of solution by incubating 
at room temperature for 30 minutes and centrifuged at 14000 rpm at 4"C for 30 minutes. The 
genomic DNA pellet was washed in Iml 70%) ethanol, air dried and resuspended in 500p.l 
sterile water. The quantity and quality of the genomic DNA was checked by spectroscopy by 
reading the absorbance at A260 and A2S0 
5. Genotyping peR 
All mice lIsed ill this thesis were genotyped prior to experiments to con1irm their genotype 
using gene specitic primers. 2~t! of genomic DNA was added to 48~t1 of PCR cocktail (l X 
Supertherm peR Buffer. 1.5mM MgCh, 0.2mM dNTPs, O.1251J/~!l Supertherm Taq, 0.25~lM 
forward primer and 0.25pM reverse primer). Control reactions included a (i) no 
1cmplate/water controL (ii) positive control and (iii) negative control. The peR products were 
ampliiied on a MJ thermocycler (Biozym, Hcssisch Oldendorf, Frankfurt, Germany). C/EBPW 
1- mice were gcnotyped using a common primer 5'-TGCiACAAGCTGAGCGAC-3' and a 
primer specilic for either the WT (5'-GGGCTGCTTCiAACA-J') or targeted C/EBPB locus 
(5' -GCCGATTGTCTGTTGTGCCC-J '). The PCR products for the WT allele was 200bp and 
450bp t()r the C/EBpr~ targeted allele. The PCR cycle for CEBP[3 PCR was: 1 cycle at 94"C 
fi:lr:3 minutes; 45 cycles of 94°C for 30 seconds, 59°C for 30 seconds, 72°C It))" 30 seconds; J 
cycle at 72'\: f(x 3 minutes. For PKC8-1- gcnotyping, a common reverse prima (5'-
AACAGCTGTGATGGOATCGAA-J') and a 1()rward primer specitic for either the WT (5'-
ACCCTTCCTGCGCATCTCCT-3') or targeted PKCo locus (5'-
(]ACIGATCTCGTCGTGACCCA- 3') were used. The PCR products for thc WT allele was 
621 bp and 872hp tt)r the PKCo targeted allele. The PCR cycle for was: 1 cycle at 94°C for 3 
minutes; 40 cycles of 94°C f())" 30 seconds, 55°C J()r 30 seconds, 72°C lor 45 seconds; I cycle 
at 72°C It)!" 5 minules. The PCR products were analysed by gel electrophoresis. 
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(). Generation Of C/EBP/f'- Bone Marrow [)erived Macrophages (BM UMs) 
Mice were sacrificed by cervical dislocation and the femur and tibia bones collected. The bone 
marrow cells were tlushed ti'om the bones using DMEM (Gibco, Invitrogen Corporation, 
Carlsbad, CA, USA) containing 10% FCS, 100U/ml penicillin G and 100p.g/ml streptomycin. 
The cells were washed and concentrated by centrifuging at 1200 rpm at 4°C fix 10 minutes. 
The bonc marrow cells were added at a tinal concentration of I x 106 cclls/ml in PLUTZNIK 
mcdia (DMEM containing 10% FCS, 5% horse serum, 2mM L-glutamine, 1 111M Na-pyruvate, 
O.II11M 2-r1-Mercaptocthanol, 30% L929 cell-conditioned medium, 100U/rnl penicillin G, 
1 OO~tg/rnl streptomycin) and transferred into a special gas-permeable 15cm x 6cm Tenon 
coated-bag (Max Planck Institute for Immunobiology, Max Planck, Freiberg, Germany). The 
L929 conditioned medium contained G\1-CSF and \1-CSF, which stimulated the 
differentiation and growth of bone marrow stem cells into macrophages. The open end of the 
bag was heat-sealed and bone marrow stem cells incubated at 37 f1C under 5% C(h f()r to days. 
The supernatant was discarded and the adherent cells were massaged from the Tenon-coated 
bags into DMEM containing 10% FCS, 100U/ml penicillin G, IOOp.g/ml streptomycin. The 
BMDMs were washed twicc in DMEM containing 10% FCS, I OOU/ml penicillin G, 1001l.g/ml 
streptomycin to get rid of residual GM-CSF from the L929 conditioned medium. The 
BMDMs were plated at a density of 5 x lOS BMDMs/mI and incubated overnight at 37°C 
under 5% C02 If activated macrophages were required for intection the next day, IFN-y (RD 
Pharmigen. BD Bioscicnces, San Jose, CA, USA) was added at 100tJ/ml to the BMDMs t(H 
16-24 hours before infection. 
7. L929 conditioned medium 
L929 cells were maintained in DMEM (Gibco, Invitrogen Corporation, Carlsbad, CA, USA) 
containing 10% FCS, 100U/ml penicillin G and lOOp.g/ml streptomycin until 90% confluence. 
The growth media was removed and the cells washed in 10ml 1 x PBS. Cells were removed 
l'i'om the plastic surface of the l1ask by incubation in 5m1 Trypsin/EDTA (Gibco, Invitrogen 
Corporation, Carlsbad, CA, USA) at room temperature for 4 minutes. The cells were washed 
ill 50ml DMEM (Gibco, Invitrogen Corporation, Carlsbad, CA, USA) containing 10% FeS, 
100U/mi penicillin G, lOOJlg/ml streptomycin and seeded at 2 x J()4cclls/ml in lOOml DMEM 
(Gibco, Invitrogen Corporation, Carlsbad, CA, USA) containing 10% FCS, IOOU/ml 
penicillin G, IOOfJg/ml streptomycin. The 1,929 cells were grown in 162cm2 tissue culture 
grade tlasks (Corning Costar Corporation, Cambridge, MA, USA) at 37°C under S°/r) CO2 for 
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7 days. The supernatant was harvested and centrifuged at 2500 rpm for 15 minutes at 4°C to 
get rid of cell debris. The clear supernatants were stored in 50ml aliquots at --20"C. 
8. In vitro Infection with L. mOl1ocytogenes 
Bcf()re each infection experiment, the BMDM cultures were washed three times in DM1:M 
containing 1 o <Yo FCS but without antibiotics. These washing steps ensured that any residual 
antibiotics were washed away. The BMDM monolayers were then simultaneously stimulated 
with lOOU/mJ IFN-y (BD Pharmigen, HD Biosciences, San Jose, CA, USA) and inlected with 
L lrIonocytoxencs at a multiplicity of intection (MOJ) or 10:1 (10 bacilli: 1 macrophage). 
After 1 bour, gentamycin (Sigma-Aldrich, Munich, Germany) was added at 50~lg/ml to kill 
extracellular bacteria. At 2, 4, 8 and 12 hours after inlection, RNA and supernatant samples 
were taken and stored at --80°C. 
9. 111 vivo Infection with L. mono(vtogenes 
I:or each experiment, a vial of frozen L IrIOllocyloxelles stock was thawcd and diluted in PBS 
be1()t·c injection. Mice were injected into the peritoneal cavity with 200p.l PBS containing 2 x 
I O~I L f}wnocy/oRcnes bacilli or without bacteria. The number of viable bacteria in the 
inoculum was determined by plating 10-t()ld serial dilutions on trypticase soy agar plates. 
Plates were incubated at :'1oc and the CFU counted atter 24 hours. The actual infectious dose 
was then calculated. 
to. Secondary in .'b'o Challenge with L. monocytogenes 
Mice werc immunized by a sub-lethal dose (for WT mice) or 2 x 103 L. IrIOII()(;ytogenes 
injected into the intraperitoneal cavilY. Surviving mice were challenged 8 weeks later with a 
secondary i.p. injection of 2 x 104 L. IrIOf1()(y/oRenes. Bacterial load (CHJ) was measured in 
the liver and spleen 2 days after secondary injection. 
11. In vivo Aerosol Infection with Mycobacterium tuberculosis 
All M ./uhercu/o.l,'is experiments were peri(mned in the BSL 3 laboratories at the University of 
Cape Town, South Africa. Pulmollmy infection of mice was perfornlCd using an inhalation 
exposure system (system model A4224, Glas-Col, Terre-Haute, IN). Stock solutions of M 
/lIiJerclI/osis were thawed and diluted in sterile distilled water. To inJect mice with a natural 
dose of 100 CFU/]ung. animals were exposed for 40 minutes to an aerosol generated by 
nebulizing approximately 5.S ml of a suspension containing lO7 live hacteria. Inoculum size 
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was checked 24 hours after intection by determining the bacterial load in the lung of in1Ccted 
mice. Mice were weighed weekly before and aner intection. [n accordance with the Animal 
Research Ethics Committee of the University of Cape Town, mice that lost 2YYo of their 
original weight during the course of infection were sacriticed. Moribund CEBPWI - and IFN-
yR-1- mice were sacri ticed at 6 and 7 weeks post in1ection respectively and their CFUs 
determined in lung, liver and spleen. Surviving WT, PKC8 t/- and PKC8-1- were sacrificed 10 
weeks post infection and their bacterial load in lung, liver and spleen determined 
12. Determination of Bacterial Load in Organs 
Bacterial loads in lung, liver and spleen of intected mice were evaluated at different time 
points after infection with L. mono(ytogenes or M tuherculosis. Organs from sacrificed mice 
were removed aseptically and divided into 2 pieces, one for histology and one i()r bacterial 
load determination. The piece for bacterial burden was weighed and homogenized in 0.05%) 
Tween-SO made in PBS. Ten-fold serial dilutions of the organ lysate was made in 1 x PBS and 
I00J.11 plated in duplicate on tryptose-soy agar plates (tor L. monotylogenes) or Middlebrook 
711 I 0 agar plates containing 10 % OADC (for M. tuberculosis). The L monocytogenes plates 
were incubated at 37°C overnight and the colonies counted the next day. The M tuberculosis 
plates were incubated at 37°C for 19-21 days and the colonies counted. The CFU/organ was 
calculated and expressed as log]() CFU per organ. 
13. Histology 
One lung lobe, a piece of liver and spleen per mouse were iixed in 4 (Yo phosphate-bulTered 
[()rmalin and paraffin-embedded. Sections (2 to 3 ~lIn) were stained with hematoxylin and 
eosin and a modified Ziehl-Nielsen method as described (1). Standard Gram positive staining 
was used to detect L monoc.vtogenes bacilli. All observations were done wilh a Nikon E400 
microscope and the diameter of 250 granulomas was determined using Scion Image, Software 
(Scion, Frederick, MD, USA). 
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14. FACS analysis of Peritoneal Exudate Cells (P~:Cs). 
Mice were inoculated i.p. with 2 x 104 L monocylogenes and sacriticed 2 days after injection. 
PEes \vcre harvested by tlushing the peritoneal cavity wilh 10 mi of sterile [scoves's-
Moditied Dulbecco's Medium (lMDM) supplemented with 10(% FeS, 100 U/ml penicillin 
and 100 Jlg/ml streptomycin (All Gibco. Invitrogen Corporation, Carlsbad, CA, USA). 
Harvested cells were centrifuged at 1200 rpm for 8 minutes and resuspended in 2m! complete 
IMUM supplemented with 10% FCS. 100 U/ml penicillin and 100~lg/ml streptomycin (all 
Gibco). Cells in single cell suspension were counted using an improved neubauer 
haemocytometer. 5 x 105 cells were pooled f()r each experimental mouse group and were 
washed in FACS buffer (PBS supplemented with 0.1 % BSA and 0.05%, Sodium Azide) by 
centrifugation at 1200 rpm for 5 minutes. Cells were then stained for 15 minutes on icc ill 
IOOpl of FACS buffer with a saturating amollnt of anti-Gr-l-FITC (mAb clone RB6-8(5), 
anti-I-Ab·biotin (mAb clone KrI74), anti-CD1Ib-PE (mAb clone M1170) (all from HI> 
Pharmigen, 8D Biosciences. San .lose. CA, USA) or F4/80-PE mAb (Caitag Laboratories, 
Burlingame, CA USA) in the presence of 1 %1 normal rat serum. IJllbound antibody was 
removed by centrifugation in 1 ml FACS bulTer. Pelleted cells were resuspended and incubated 
ror a further 15 minutes on ice with 100~tl ora salurating amount ofstreptavidin-APC (Sf)) in 
FACs buffer. CeJls were washed for a linal time and resuspended in 500~tI FACs butler 
supplemented with 7-AAD (Sigma, Sc Louis, USA). Stained cells were acquired using a 
FACSCalibur now cytometer and cells analyzed using CellQuest software (both BD). Dead 
cells stained with 7-AAD were excluded From analysis. 
15. ELISA 
The levels or cytokines and ehemokines in culture supernatants and sera was measured by 
sandwich ELISA as previously described (2). The coating and biotinylalcd detection antibody 
pairs, stcpavidin-alkalinc-phosphatase, stepavidin-horseradsish peroxidase, and recombinant 
protein standards were purchased from HD Pharmigen (BD Phannigen, BD Biosciences, San 
Jose. CA, USA). In vilro Supernatant smnples t1'om triplicate wells at 2, 4, 8 and 12 hours 
aner infection were collected and stored a1 ····2(tC. Sera samples were collected from inlected 
mice and stored at ·_20'\.~. Maxisorb 96 well ELISA plates (Nalge Nunc International, 
Naperville, IKL,USA) were coakd overnight at 4"C with 50111 or"coating antibody" diluted in 
enating buffer (1 X PBS, 0.02(% sodium azide) at the recommended concentration. For TNF 
L~LlSAs. the plates were coated in carbonate coating buffer (lSmM NaCO], 35mM NalICOJ • 
7lmM NaCI). Plates were washed, blocked 2 hours at 37°C in 250JlI blocking buffer (:2(10 rat 
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tree milk powder, 0.1 % sodium azide in I xPBS) and then washed again. Samples (serum or 
supernatant) were serially diluted two-fold in dilution buffer (4% BSA (fraction V), 0.02% 
sodium azide in I X PBS) and 50111 added to each well. Similarly, the appropriate 
recombinant protein standard was diluted to the recommended concentration, then serially 
diluted three-fold in dj)ution butTer (4% BSA (fraction V), (102% sodium azide in 1 X PBS) 
and 50~tI added to designated control wells, The plates were incubated overnight at 4"C and 
washed. 50111 of the appropriate biotinylated antibody was diluted to the recommended 
concentration in dilution buffer (4% BSA (fraction V), 0.02% sodium azide in I X PBS) and 
50p.l ,vns added to each well. The plates were incubated at 37°C f()l' 3h, washed and 50111 of 
streptavidin-alkaline phosphatase diluted 1: 1000 in dilution bulrer (4%) BSA (It-action V), 
0.()2% sodium azide in 1 X PBS) was added to each well. The plates were incubated {~)r 60 
minutes at 37"(', washed and 50/11 substrate solution (lmg/ml p-nitrophenol-phospahte, 
O.2mM MgCh, IOlyo diethal1olamine, (l.OJl~'O sodium azide) added to each well. The enzymatic 
reaclions were developed at room temperature and was stopped when the most concentrated 
standard reached 1.0 to 1.5 A4U51l1ll OD units. The developing reaction was stopped by adding 
50/11 of 1 M NaOlf to each well. The plates \Vere plates read at A40Snn1 using a VersaMax 
microplate reader (Molecular Devices Corporation, Sunnyvale, CA, U.S.A). For the wash 
steps above, each well was washed 4 times with 300/11 of wash bulIer (2.6SmM KCI, I A7mM 
KlbPO.:l, 8.09mM Na2Hpo.~.2rhO, 136mM NaCI, 0.05% Tween-20, O.(llIX) sodium azide). 
For J [0-10 ELISA reaction development, strcptavidin-horseradish peroxidase and TMB 
Substrate Solutions (Roche Diagnostics GmbH, Mannheim, Germany) were used as per the 
manufacturer's instructions. 
16. Measurement of nitric oxide in culture supernatants 
Cell culture supernatants werc analyzed t()r the production of NO using the Griess reaction 
assay, which measures the concentration of nitrite. a stable product or the reaction of NO with 
()2 (3). BMDM were infected as described and supernatant samples collected at 2, 4, 8 and 12 
hours atter infection and stored at ··20°C until analysis. Supernatant samples and standards 
(I m\1 NO~ solution) were serially diluted three-fold in DMEM containing 10% FeS, 
IOOUlml penici lIin G, IOOIl.g/ml streptomycin (all Gibco, Invitrogen Corporation, Carlsbad, 
CA USA) and 50/11 added to designated wells in a tlat bottomed 96 well plate. 25~t1 of Griess 
Reagent I (I % sulfanilamide in 2.5 lJ;() phosphoric acid) and then 25111 of Griess Reagent (2 
0.1 (Yt) napthyl-ethylene-diaminc in 2.5 % phosphoric acid) were sequentially added to each 
""ell. The plate was incubated at room temperature for 5 minutes to allow the reaction to 
85 
develop. The purplc-pink colour of (he reactions were read at AS40nrn and the reference at 
A()<)onm using VersaMax microplak reader (Molecular Devices Corporation, Sunnyvale, CA, 
IJ.S.A). 
17. Macrophage Bacterial Killing Assay 
BMDMs (2.5 xl 0'1 cells) were plated at Iml per well in a 24-well tissue-culture grade plate. 
The BMDMs were stimulated overnight with 100U/ml IFN-y and the I3MDMs infected with 
r. monocyl()~enes as described. At 2, 4, 8 and 12 hours after infection, the BMDMs were 
washed three times with 1 ml cold 1 X PBS containing 0.68mM CaCh and 0.49mM MgCl2 to 
get rid of extracellular bacteria and residual gentamycin. The BMDMs were lysed by 
repetitive pipetting in 1 ml of 0.051% Triton-X 100. Tell-f()ld serial dilutions of the lysate was 
made in 1 X PBS and lOOjJl plated on tryptose-soy agar plates. 'rhe plates were incubated at 
:17')C for 24 hours and the number or colonies counted and the CFU/ml for each sample 
calculated. 
18. Electron microscopy with low temperature fixation in cacodylate buffer 
BMDMs were stimulated and infected with L. mOI1()cylo~el1es as described. 4 hours after 
infection, the BMDMs were washed twice with 1 X cold PBS containing 0.68mM CaCh and 
O.4YmM MgCh to remow extracellular bacteria. The BMDMs were washed once cacodylate 
butler (0.1 M sodium cacodylate, 5mM CaCb, 5mM MgCb, 0.1 M sucrose pi 17.2) and fixed 
overnight at 4°C in 2.5~;) gluteraldehyde made up in cacodylate buffer lacking sucrose. The 
BMDMs were washed twice in cacodylate buffer (lacking sucrose) and stained with freshly 
prepared osmium staining buffer (1 % osmium tetroxide, 0.05 M ferric cyanide in cacodylate 
bufler (devoid of sucrose» for 1-2 hours at room temperature in the dark. The BMDMs were 
then washed twice in cacodylate buner (lacking sucrose) and scraped from the culture dish. 
The BMDMs were centrifuged at 1200 rpm for 20 minutes and the cell pellet resuspended in 
20~11 or 2% low-mclting-point-agarose prepared in cacodylate butTer (lacking sucrose). The 
agar cell pellet was cut into 1 mM cubes and dehydrated in a series of ethanol and embedded in 
Spurr's resin. Ultra thin sections (90~lM) were cut with a glass knife on a Reichert Ultracut S 
(Leica) ultramicrotome. The ultra thin sections were picked up on uncoated copper grids (300 
mesh) and stained with uranyl acetate and Reynolds lcad( 4). The sections were examined 
using a Zeiss I {)9 transmission electron microscope at 4400X and 20000X magnification. 
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t 9. Fluorescent Microscopy 
BMDM from WT, PKC8+!- and PKC8-1- mice were generated as described and grown on acid-
cleaned 12-mm circular glass coverslips at density of 2.5 x 105 cells/coverslip. 13M DMs were 
activated with 100U/ml IFN-y overnight and infected at MOl of 30: 1 (30 bacilli : 1 
macrophage) as described. At 90 minutes, 180 minutes and 240 minutes post-infection, 
BMDMs were washed twice with PBS containing O.68mM CaCh and 0.49mM MgCb to 
remove extracellular bacteria. The BMlJMs were fixed at room temperature for 15 minutes in 
3.7% 1tmnaldehyde (vol/vol in PBS) and washed twice in pre-warmed PBS. The cells were 
penneabilized in 0.2(% Triton x-loa (vol/vol in PBS) for 10 minutes at 37°C and washed 
twice in PBS and blocked in } % BSA (fraction V) (vol/vol in PBS) It)r 30 minutes at 1'00m 
temperature. The BMDMs were washed twiee with PBS and incubated in }/IOOO diluted 
polyclonal rabbit anti-Listeria antibody (Capricorn Products LLC, Portland, ME, USA) for 30 
minutes at room temperature. The BMDMS were washed twice with PBS and incubated in 
111 (JOO diluted goat anti-rabbit IgG-FITC antibody (Sigma-Aldrich, Munich, Germany) for 30 
minutes at room temperature. The BMDMS were washed twice with PBS and incubated in 
actin staining solution (I 0.3nM rhodamine phalloidin (Molecular Probes, Invitrogen 
Corporation, Carlsbad, CA, USA) in 1 % BSA(lraction V) for 30 minutes. The coverslips were 
washcd twice, air dried and mounted onto glass slides using Prolong AntiFade Mounting 
media (Molecular Probes, Invitrogen Corporation, Carlsbad, CA, USA). BMDMs were 
visualized using deconvoluting fluoresccnt microscope (Zeiss Axiovert 200M, Carl Zeiss, 
G{)1tingen, Clermany) under lOOX oil immersion. Images in both the red and grecn channels 
were saved for 15 non-overlapping random high power field views (HPFY). Images were 
analysed using Axiovision version 3.1 (Carl Zeiss, (Wttingen, Gennany). The total number or 
hacteria in each HPFV was scored in the green channel. 1n the merged red and green image, 
the number of bacteria associated with actin (red-orange-yellow) and trapped in the 
phagosome (green) was scored. Percentage escape is calculated as total number of bacteria 
associated with actin in alll-lPFY divided by the total number of bacteria in all the IlPfV. 
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20. Total RNA Isolation 
Total RNA was extracted from BMDMs using TriReagcllt (Molecular Rcsearch Company, 
Cincinnati, USA) as per the manufacture's instructions. Briet1y, 5 x 105 cclls were lysed 
dircctly in the culture dish in 1 ml of TriReagcnt. 200j.l1 01' chloroform was added for evelY 
I ml of lysate and vortexed thoroughly. The samples were incubated at ronm temperature tor 
15 minutes and centrifuged at 13500 rpm f(x 15 minutes at 4°C. The top aqueous layer was 
transfcrred to a new tube and an equal volume or 100% isopropanol added and mixed. The 
RNA was rrecipitated out of solution by incubating overnight at ---80°C and centrifuging at 
13500 rpm for 30 minutes at 4°C. The RNA pellet was washed twice in 800~d 70(% ethanol, 
air-dried and rcsuspended in 50111 -100p.l of DEPC-treated water. Total RNA was extractcd 
[rom organs as described by Choll1ezynski ct al (5). Organs were homogenized on ice in 3ml 
RNA denaturing solution (4M guanidinium thiocyanatc, 25mM sodium citrate, 0.5% (w/v) 
sodium lauryl sarcosinate, 0.1 M 13-mercaptoelhanol) Ii.)r every 100mg of tissue. An equal 
volume or phenol pH4.0 was added and thoroughly mixed with the Iysatc. For every 1 ml of 
volume lysate 0.05ml 3M sodium acetate (pH 4.cl) and O.lml chloroie)fm-isoamyl alcohol 
(49: 1) were sequentially addcd. The samples were mixed thoroughly for 30 seconds and 
incubated on ice li)r 15 minutes. The samples were centrifuged 14000 rpm for 20 minutes at 
4°C and the tor aqueous layer transferred to a new tube. An cqual volume of 100% 
isopropanol was added and mixed thoroughly. Thc RNA was precipitated by incubating fe)]' ] 
hour at -80°(' and centrifuging at 14000 rpm for 30 minutes at 4°C, The RNA pellet was 
dissolved in 0.3 ml of Solution D and an equal volume or 100%) isopropanol added. 'rhe 
samples were incubated felr 1 hour at -80°C and centrifuged at 14000 rpm Cor 30 minutes at 
4"c' The RNA pellet was washcd twice in 800~LI 75(% ethanol, air dried and resuspended in 
100pl DEpe-treated H20. All purified RNA samples were DNAsel treated, "cleaned up" and 
stored at -80°C. The quality of the RNA was chccked by determining the ratio of' the 
absorbance at A2wl A280 and by running I ~Lg of RNA on a 1 % agarose gel that contained 2.2M 
formaldehyde. The concentration of the RNA \vas determined by measuring the A26o • All 
solutions, except TRIS-conLaining buffers, used f()r the RNA work were treated with DEPC to 
destroy any endogenous RNAses. To each solution, DEPC was added 10 a 1inal concentration 
of 0.1 (Yo and gently shaken overnight at 37"C. 'rhe solutions were then autoclaved for 30 
minutes to remove any traces of DEPC. For TRIS-containing buffers, solutions were prepared 
using DI'J>C-trcated water and an ultra-pure TRIS stock designated for RNA work only. 
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21. DNAsel trcatmcnt and "'cleanup" 
The RNA was DNAse I treated to get rid of contaminating genomic DNA. I-IOJlg or total 
RNA was incuhated with DNAse I cocktail (l X DNAsel buiTer (Prom ega, Madison, WI, 
USA), IOU/Jll DNAsel (Roche Diagnostics GmbH, Mannheim, Germany), I U/JlI RNAsin 
(Promcga, Madison, WI, USA) for 60 minutes at 37°C. The DNAsd -treated RNA was 
"cleaned up" using the Qiagen MiniElute R!\A cleanup kit (Qiagen, Valencia. CA, USA) as 
per the manufacturer's instructions. This "clean up" step helped remove contaminating 
genomic DNA, proteins, residual phenol and salts. BrieJly, the volume of the total RNA was 
adjusted to 1 OO~d by adding RNAse-free water. fi-mercaptoethanol was added to Buffer RLT 
hefore use as per the manufacturer's instructions. 350~L1 of Buffer RLT was added to the RNA 
and vortexed. 250JlI of 96% ethanol was added and vigorously vorlexed to precipitate the 
RNA out of solution. Each sample was then applied to a single RNeasy mini-column and 
centrifuged at 10 000 rpm tt)r 15 seconds at room temperature. The now-through was 
discarded and the R"Jeasy mini-column transferred to a new 2ml collection tube. The mini-
column was washed with 500JlJ Buffer RPE and centrifuged at 10 000 rpm for 15 seconds at 
room temperature. The wash step was repeated and the mini-column centrifuged at 10 000 
rpm for 2 minutes. The mini-column transferred to a new 2ml collection tube and centrifuged 
at 10 000 rpm fix 2 minutes at room temperature to dry the membrane. The mini-column 
transferred to a new 1.5ml elution tube and 30~t1 of RNAse-free waleI' was added directly on 
to the membrane and incubated for 5 minutes at room temperature. The mini-column was then 
centrifuged at 10 000 rpm for I minute at room temperature to elute the RNA. The elution 
step was repeated and both 30Jl' RNA eluates pooled. The elimination of contaminating 
genomic DNA was confirmed by RT-PCR using primers that bound to genomic DNA. The 
quality and quantity of the RNA was checked by spectroscopy and denaturing gel 
electrophoresis using standard methods (6). The A:~6(/ A280 ratio was measured and an aliquot 
was run on a 1 (Yo agarose containing 2.2M formaldehyde. The RNA was stored at -80°(' 
unti I used. 
22. c))NA synthesis 
The genomic DNA free RNA was reverse transcribed into cDNA using the !mProm-l[TM 
Rcverse Transcription System (Promega, Madison, WI, USA) as per the manufacturer's 
instructions. 0.5 Jlg of Oligo( dT) 15 primer was added to 1- J OJlg of genomic DNA free RNA in 
a final volume of 20~lJ. The sample was denaturing at 70°C i(x 10 minutes, then cooled on ice 
fbI' 5 minutes. 20Jll or cDNA synthesis cocktail (ImProm-JITM 5X Reaction Buffer, 4mM 
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MgC]2, O.5mM each dNTP, 1 U/jll R1'lAsin, 2.0).Ll ImProrn-IP'M Reverse Transcriptase) was 
added and the samples incubated at 25°C for 5 minutes to anneal the primers. cDNA synthesis 
was extended at 50 lle I()r 60 minutes. The reaction was heat deactivated at 7SoC for S minu1t:s 
and cooled on ice. 'The samples were divided into aliquots and stored at--20°C. 
23. Quantitative RT-PCR 
The cDNA was dilu1t:d I: 1 () in 0.1 mg/ml molecular grade BSA (Roche Diagnostics GmbH. 
Mannheim, Gennany) and 2jll added to 18~L1 PCR cocktail (I X Sensimix d(T) (Quantace, 
Neutral Bay, NSW, Australia) containing 1 X S YBR Greenl, 4.0mM MgCh, O.SjlM forward 
primer, O.5~lM reverse primer, O.lmg/m] molecular grade BSA). PCR products were amplified 
on the Lightcycler (Roche Diagnostics GmbII, Mannheim, Gemlany) using the generic 
programme: 1 cycle at 9SoC fix 10 minutes, 50 cycles of 95"C for 5 seconds, 6(tC for IS 
seconds, 72"C for I 0-60 seconds depending on peR product size. Extension lime was 
calculated based on the fact that DNA Taq Polymerase can cover 2S base pairs (bp) per 
scconu: Temperaturecxtcnd= (peR product size in bp)/(2Sbp/second). Data was acquired at 
so"e for 1 second. A melting curve analysis was performed at the end of the amplification 
program: 95"C J(X 0 seconds, 7SoC for IS seconds, 6SoC for 15 seconds and 9SoC for 0 
seconds with a ramping time or n.l °C/seconds. Quantitative data was analyzed Llsing the "Fit 
Points" and "Standard Curve Method". The r\-2-microglubulin gene was used as the 
hOLlsekeeping gene for data normalization. Primer sequences and product sizes are given in 
Table 1. 
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Table 1. Primer Sequences and Product Sizes 
'Name Forward Sequence IReverse Sequence [Product 
i 
Isize (bp) 
JMCP-I is'-CAG CTC TCT CTT CCT CCA C-3' IS'-ATT TAC GGG TCA ACT TCA CA-3' 1390 
I • I [ 
il3-Actin* ,S'-TGG AAT CCT GTG GCA TCC AG AAA C -3' 15'-TAA AAC GCA GCT CAG TAA C AG TCC G-3' !348 
~ ii
1132mg is'-TGA CCG GCT TGT ATG CTA TC-3' is'-CAG TGT GAG CCA GGA TAT AG-3' 1222 
IIL-I8 5'-TGG TTC CAT GCT TTC TGG -3' IS'-TCC GTA TTA CTG CGG TTG T -3' b79 
I I I 
I ! , 
ITNF is'-TCT CAT CAG TTC TAT GGC CC-3' !S'-GGG AGT AGA CAA GGT ACA AC -3' 1212 
f : I 
. I ' 
!IFN-y [S'-GCT CTG AGA CAA TGA ACG CT-3' [S'-AAA GAG A TA A TC TGG CTC TGC-3' [227 
, I 
ilL-6 5'-GTT CTC TGG GAA ATC GTG GA -3' S'-TGT ACT CCA GGT AGC TA T GG-3' 
i 




l'IL-12p35 S'-GA T GAC A TG GTG AAG ACG GCC -3' 15'-GGA GGT TTC TGG CGC AGA GT -3' 1402 • I I I 
rIL-12p40 is'- CTG GCC AGT ACA CCT GCC AC-3' 15 '-GTG CTT CCA ACG CCA GTT C -3' 1384 
j I I 
I I I 
!INOS 15'-AGC TCC TCC CAG GAC CAC AC -3' IS'-ACG CTG AGT ACC TCA TTG GC -3' !481 
I i I 
IPKC8 is'-CGGGCTACGTTTTATGC -3' is'-TCCAACGGGGATAGTG -3' 1367 
I 
ICLECSF9 !S'-GGA AGA ATG AAT TCA ACC AAA T-3' S'-AAA GGT GTA TCA TCC ACC CA-3' 486 
I I i 
IISGF3y 15'-CAT ATT CAA GGC TTG GGC AC-3' IS'-GCC ACC ATA GAT GAA GGT GA-3' 1496 
I i I 
IIC/EBPI3 is'-ccc A TG GAA GTG GCC AAC T-3' IS'-GCG AAG AGG TCG GAG AGG AA-3' \382 
! I I 
lG-CSF :S'-TCCCAAACTGGGTTCT -3' 15'-CTTTA TTA TCCGCAAGCT -3' 1278 
1* binds to genomic DNA and eDNA 
! 
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2 .... Microarray Design and Overview 
A 2 x 2 f~lctorial experimental design was used to compare the gene expression patterns of treated 
vs. non-treated BMDMs for WT and CEI3Pf3-I- mice. A 2 x 2 factorial design means that 
comparison between 2 factors (treatment vs. untreated) are being also compared with another 2 
factors, namely the WT and CEI3PWI- mice genetic backgrounds. An outline of the design shown 
in I~'igure 2. "Treated" refers to BMDMs that were simultaneously stimulated with IOOU/mIIFN-y 
and intected with L. monocylOgenes at a MOl of 10: I (10 bacilli: I macrophage) for 4 hours. 
"'l Jntreated" refers to media controls. Due to budget limitations, biological replicates were done 
instead of technical repeats and a "balanced dye" approach lIsed instead of dye-swaps to 
compensate for dye-labelling bias. "Dye balance" means that each condition is measured equally 
otten with the Cy3 dye as with (he Cy5 dye. Therefore, the "treated" samples for each biological 
repeat was labelled with the opposite Cy-dye than in the previous biological re~1l·at. The same 
principle was applied to "untreated" controls and is outlined in Figure 2. There were 4 biological 
rcreat experiments which werc analysed over g individual arrays (Fig. 2). Each biological 
cxperiment was analyzed using 2 microarrays: the first microarray compared WTUe;Jled vs. 
WTLlIl11l""Il'd and the second microarray compared K01rl';Jled vs. KOUI11rcatl'lJ. None of the samples from 
the biological repeat experiments were pooled. I~ach biological infection exreriment was done 
independently of' each other. The RNA fIJI" each biological replicate was extracted separately at 4 
hllllrs post-infection using TriReagent (Molecular Research Company, Cincinnati, USA) and 
DNAsel treated and cleaned up using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA) as per 
the manufacturer's instructions. The mRNA was linearly amplified and labelled using the Amino 
Allyl MessageAmpTM II CyDye aRNA Amplilication (Ambion, Austin, Texas, USA) as per the 
manufacturer's instructions. The labelled cDNA was ruritied and hybridized to spotted Mouse 
Fxonic Evidence Based Oligonucleotide (1IIumina. San Diego, CA, USA) microarrays printed at 
the capar Microarray Facility (University of Cape Town, South Africa). The microarrays were 
processed in batches of:2 or 4 over a period of' 4 weeks. Table 2 summarizes the information for 
all samples and hybridization experiments for the four independent biological experiments. 
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Figure 2. Microarray Design: The gene expression patterns of treated vs. untreated BMDMs 
within each genotype were compared. The "treated" and "untreated" samples are denoted by a 
subscripted "t" and "u" respectively. Each white rectangle represents a two channel microarray. 
The back of the black arrow represents sample labelled with Cy3 (green) and the front of the 
arrow represents labelling with Cy5 (red). "Treated" refers to BMDMs that were simultaneously 
stimulated with 100U/ml IFN-y and infected with L. monocytogenes at a MOl of 10: I at 4 hours 
post-infection. "Untreated" refers to media controls. For each biological experiment there were 2 
microarray slides, one for the C/EBP~+I+ (WT) samples and the second for the C/EBPWI- (KO) 
samples. There were 4 independent biological repeat experiments which were analysed over 8 
individual arrays. Differentially expressed genes between the WT and CIEBPWI- were identified 
by a paired T-Test based on permutation and Bonferroni Correction. 
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Table 2. RNA samples, treatments, labelling, and microarrays. Four independent biological 
infection experiments were analysed over 8 individual arrays. In the treatment column "+" refers 
to BMDMs simultaneously stimulated with IFN-y and infected with L. monocytogenes at a MOl 
of 10:1 (10 bacilli: 1 macrophage)and "-" refers to untreated media controls. RNA was purified 
at 4 hours post-infection and the mRNA linearly amplified and labelled with either Cy5 (red) or 
Cy3 (green) fluorescent dyes. The labelled samples were hybridised to spotted MEEBO 
oligonucleotide arrays which were printed at the "capar" Microarray Facility at the University of 
Cape Town, South Africa. Microarray slides were identified by their unique barcode numbers. 
Billillgica I Sam pic lahd T rt':t t 11\(,' .. t Cy-tlyt' Ilyhritlizlltio .. til 
cxpcl"imcnt lahl'l Slidl' (B'lrclllit' #) 
] KOltreated + Cy3 12301884 
I K 0 I untrea ted - Cy5 12301884 
1 WTltreated + Cy5 12301864 
1 W T I untreated - Cy3 12301864 
2 K02treated + Cy5 12301883 
2 K02untreated - Cy3 1230]883 
2 WT2treated I + Cy3 12301862 
2 WT2untreated - Cy5 12301862 
3 K03treated + Cy3 12301878 
3 K 0 3 untrealed - Cy5 12301878 
3 WT3trealed + Cy5 12301881 
3 WT3untreated - Cy3 12301881 t 
4 K04treated + Cy5 12301882 
4 K 04unlTeated - Cy3 12301882 I 
4 WT4treated + Cy3 12301856 
4 WT 4untreated - Cy5 12301856 
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25. Microarray Total RNA Isolation 
13M DMs were generated from C/EBP~~-deficient (C/EBPrr/') and wild-type (W-r) mIce as 
described in section 6. The BMDMs were IFN-y-activated and infected with L. Inonocytogenes at 
a MOl 10: I as described in section 8. At 4 hours post-infection, RNA was extracted and using 
TriReagent (Molecular Research Company, Cincinnati, USA) and DNAsel treated and cleaned up 
using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA) as described in sections 20 and 21. 
26. Generation And Labelling Of eDNA 
The mRNA was linearly amplified and labelled using the Amino Allyl MessageAmpTM II CyDye 
aRNA Amplification (Ambion, Austin, Texas, USA) as per the manufacturer's instructions. Since 
the MessageAmp 11 procedure was very sensitive to temperature, all thermocyclers and incubators 
were preheated to ensure that the correct temperature had been reached and stabilized. Tube 
holders were also pre-warmed in the incubator before placing the reaction tubes in them. For all 
enzymatic reactions, a hybridization oven was used to avoid the formation of condensation in the 
reaction tubes. Condensation would change the composition of reaction mixtures and therefore 
greatly reduce yield. 
27. Reverse Transcription to Synthesize First Strand eDNA 
In a 0.5fLl tube, \pJ T7 Oligo(dT) Primer was added to \)lg or total RNA and the volume adjusted 
to 12~LI with RNAse-free water. The reactions were incubated at 70°C t(H minutes in a 
therrnocycler and snap-cooled on ice for 5 minutes. The reactions were centriruged at 13000 rpm 
for 30 seconds to bring down the contents 0 f the tube and placed on icc. The reverse transcri ption 
master mix (I X First Strand Buffer, dNTP mix, RNAse Inhibitor and ArrayScript reverse 
T'ranscriptase) was made at room temperature as per the manufacturer's instructions. The master 
mix was gently mixed by pipetting and 8pJ added to each sample and incubated at 42°C in a 
hybridization oven. The samples were then brielly centrifuged at 13000 rpm fix 30 seconds to 
bring down the contents or the tube and placed on icc until ready to proceed with second strand 
synthesis. 
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28. Second Strand cDNA Synthesis 
The second strand master mix (1 X Second Strand Buffer, dNTP mix, DNA Polymemse, RNAse 
II) was assembk:d 011 ice as per the manufacturer's instructions and mixed by gentle pipetting. 
80~!1 of second strand master mix was added to each sample. The sample and master mix was 
mixed by genLle pipetting up and down 2 to 3 times, then flicking 2 to 3 times. The samples were 
centrifuged at 13000 rpm fIX 30 seconds to bring down the contents of the tube. The samples 
were incubated at 16DC in a pre-cooled thermocycler ror 2 hours. The cDNA samples were 
immediately purified using the spin columns provided in the kit. 
29. cDNA Purification 
250).tI of cDNA Binding Buffer was added to each sample and mixed thoroughly by pipetting up 
and down 2 to 3 times and Ilicking 3 to 4 times. The samples were centrifuged at 13000 rpm for 
30 seconds to bring down the contents or the tube. The cDNA sample\cDNA Binding Buffer 
mixture was added onto the center or the cDNA !ilter cartridge and centrifuged for I minute at 
10000 rpm at room temperature. The !low-through was discarded and the cDNA rilter cartridge 
placed in a new wash tube. 500~!1 of wash bulfer was added to each cDNA filter cartridge and 
centrifuged for I minute at 10000 rpm at room temperature. The now-through was discarded and 
the cDNA !ilter cartridge centrifuged lor an extra I minute to remove trace amounts of wash 
buffer. The cDNA lilter cartridge was placed in a new cDNA elution tube and I O~!I of pre-
warmed (SO-5S"C) nuclease-free water was added directly onto the membrane and incubated at 
room temperature for S minutes. 'rhe cDNA filter cartridge was centrifuged for I.S minutes at 
I (lOOO rpm at room temperature. The elution step was repeated and the cDNA eluates pooled (.~ 16 
!ll). The eDNA was used immediately for mRNA amplification by in vitro transcription. 
30. In Vitro Transcription to Synthesize aRNA (single round amplification) 
The in vitro transcription (lVT) master mix (aaUTP, ATP, C,[,P, GTP, UTP, X '1'4 Reaction 
BulTer, T7 Enzyme Mix) was made up at room temperature as per the manuracturer's 
instructions. The ratio of aaUTP:UTP used was I: 1. T'he Iv'r master mix was gently vortexed and 
centrifuged at 13000 rpm for 30 seconds to bring down the contents of the tube. 26~!1 of the I VT 
l1lastl~r mix was added to each reaction and thoroughly mixed by pipetting up and down 2 to 3 
times, then flicking the tube 3 to 4 times. '['hc samples were centrifuged at 13000 rpm for 30 
seconds to bring down the contcnts or the tube. The samples were incubated 37"C III a 
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hybridization oven for 14 hours. 60lllnuclease-l'ree water was added to each aRNA sample (final 
volume equaled 1 00 ~!I) to stop the IVT reaction. The aRNA samples were immediately purified 
using the spin columns provided in the kit. 
31. al~NA Purification 
350~t1 of aRNA Binding Buffer was added to each sample and mix thoroughly by pipetting up and 
down 2 to 3 times and flicking 3 to 4 times. 250 III of analytical grade 96% ethanol was added to 
each aRNA sample and pipetted up and down 3 times. The sample was then immediately added 
onto the center of the aRNA filter cartridge and centrifuged for I minute at 10000 rpm at room 
temperature. The flow-through was discarded and the aRNA filter cartridge placed in a new 2.0ml 
collection tube. 650111 of Wash ButTer was added to each aRNA filter cartridge and centrifuged 
for I minute at 10000 rpm at room temperature. The flow-through was discarded and the aRNA 
filter cartridge centrifuged f()r an extra I minute to remove trace amounts of wash buffer. The 
aRNA filter cartridge was placed in a new aRNA elution tube. I OO~!I of pre-warmed (55°C) 
nuclease-free water was added directly onto the membrane and incubated at room temperature for 
5 minutes. The aRNA filter cmiridge was centrifuged for 1.5 minutes at 10000 rpm at room 
temperature. The elution step was repeated and the aRNA eluates pooled (200,.tl). The purified 
aRNA was quantitated by spectrophotometric analysis at A260 , A280 and A230 using a NanoDrop® 
ND-IOOOA lJV-Vis Spectrophotometer (Nano[)rop Technologies, Wilmington, DE, USA). The 
size distribution of aRNA was analyzed by denaturing agarose gel analysis. The remaining 
purified aRNA was vacuum dried until completion using a SpeedVac (Savant Instruments Inc, 
Holbrook, NY, USA) set at medium for 10 minutes. The dried aRNA was resuspended in 9~tl 
Coupling Buffer and used immediately for dye coupling. 
32. aRNA:Dye Coupling I~eaction 
For this procedure, all reactions were carried out in the dark because the Cy3 and Cy5 dyes were 
light sensitive. All reagents and reaction tubes were wrapped in foil. 'fhe Cy3 or Cy5 dye was 
resuspended in II JlI ultra-pure DMSO and gently vOliexed. 'fhe I I III of resuspended dye was 
added to the aRNA that was resuspended in Coupling Buffer and gently vortexed. The dye 
coupling reaction was incubated at room temperature f()f 30 minutes in a dark closed drawer. To 
quench the coupling reaction, 4.5)tl of 4M hydroxylamine was added to each reaction and gently 
vortexed. The quenching reaction was incubated in the dark at room temperature for 15 minutes. 
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During this reaction. the large molar excess of hydroxylamine quenched the amine-reactive 
groups on un-reacted dye molecules. The volume of the reactions was brought up to 30)11 by 
adding 5.5p.1 RNAse-free water to each sample. The dye-coupled aRNA was immediately purified 
using the aRNA filter cartridge supplied in the kit. 
33. Dye Labelled aRNA Purification 
I 05~tI of aRNA Binding Buffer was added to each sample and mix thoroughly by pipetting up and 
down 2 to 3 times and flicking 3 to 4 times. 75)11 of analytical grade 96% ethanol was added to 
each labeled aRNA sample and pipetted up and down 3 times. The sample was then immediately 
added onto the center of the labeled aRNA filter cartridge and centrifuged for I minute at 10000 
rpm at room temperature. The flow-through was discarded and the labeled aRNA filter cartridge 
placed in a new 2ml collection tube. 500!-, I of Wash Buffer was added to each labeled aRNA filter 
cartridge and centri fuged for I minute at 10000 rpm at room temperatu reo The now-th rough was 
discarded and the labeled aRNA [liter cartridge centrifuged for an extra I minute to remove trace 
amounts of Wash Buffer. The labeled aRNA tilter cartridge was placed in a new labeled aRNA 
elution tube. 10)11 of pre-warmed (55"(') lIuclease-Cree water was added directly onto the 
membrane and incubated at room temperature for 5 minutes. The labeled aRNA filter cartridge 
was centrifuged for 1.5 minutes at IO()OO rpm at mom temperature. The elution step was repeated 
and the aRNA eluates pooled (-~20!-l1). The quantity or the labeled aRNA and the number of dye 
molecules incorporated was measured by spectrophotometric Llsing the NanoDrop® N D-I OOOA 
UV-Vis Spectrophotometer (NanoDrop Technologies, Wilmington. DE, USA) For labeled aRNA 
quantitation the absorbance at 260nm, 280nm and 230nm were measured. The success of the 
aRNA labeling was determined successful if the frequency of dye incorporation (1"01) into the 
aRNA was between 30-60 dye molecules per 1000bp of aRNA. The frequency of dye 
incorporation (I.'OJ) was determined by measuring the absorbances at 550nl11 (Cy3) and 650nm 
(Cy5) and the 1701 calculated using the equation below. 4!-,.g of each pure labeled aRNA was 
Illixed together and RNAse-free water added to 30)11. The aRNA probe mixture was placed on ice 
unti I ready ('or hybrid ization. 
Freq uency of 
incorporation 
# dye molecules 
1000 base pairs 
x 
9010cm· 1 M-1 
X 1000 
nye Extinction Coefficient 
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Where: 






* Extinction Coefficient at AIl1ClX in cm- 1 M-\ 
34. Hybridization Coverslip preparation 
Coverslips (Eric Scientific Company, Portsmouth, NI-I, USA) were washed in 100% acetone Ic)r I 
hour, in 0.2 %) SDS for 10 minutes, then twice in double distilled water for 10 minutes for each 
wash. All wash steps were done at room temperature with gentle agitation. The coverslips were 
dried in an oven at 42()C for 10 minutes. 
35. J>rehybridization 
The Mouse Exonic Evidence Based Oligonucleolide(MITBO) (1IIumina, San Diego, CA, USA) 
spotted microarrays were printed at the capar Microarray Facility (University of Cape Town, 
Soulh Africa), The pre-hybridization buffer (5X sse 0.1 % SDS, 1% BSA) and :2 X hybridisatiol1 
bllrrer (50% I ()["lll a III ide, lOX SSC, 0.2% SDS) were made fresh and preheated to 42°C ['or 30 
minutes just belore usc. Only 2 or 4 microarray slides were processed in one batch. Each MEEI30 
microarray slide was placed in a hybridisation chamber (ArrayJt, Sunnyvale, CA ,USA) with the 
gene spots facing up. The cleaned coverslip was placed over the slide and 200~1 of the prc-
hybridization solution gently pipctted under the coverslip. The chamber was sealed and 
submerged in a plastic container containing water preheated to 42°C. The plastic container was 
placed in a hybridisation preheated 10 42"C and the slides were pre-hybridized for 30 minutes. 
The slides were washed 5 times in doublc distilled water. Each wash was done at room 
temperature for 30-60 seconds. The slides werc then dippcd ill 100(% isopropanol and dried by 
centri fugation in swinging buckel rotor lor 5 minutes at 1000 rpm at room temperature, The dried 
slides were placed in a hybridization chamber and the cleaned hybridization coverslip carefully 
placcd over the array. 'fhe microarray slides were llsed immediately for hybridization. 
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36. Hybridization 
The 2 X hybridisation buffer (50%flmnamide, lOX sse, 0.2% SDS) was made fresh and 
preheated to 42°C fiJr 30 minutes just before usc. 28~t1 ofthe heated 2 X hybridization butler was 
mixed with the 30jll aRNA probe mixture. The probe was then heat denatured at 90°C for 3 
minutes and then cooled to 42°C. The denatured probe was added very carefully to the pre-
hybridized micromray slide at the bottom end of coverslip. Any air bubbles were worked toward 
the edge by gently tapping the coverslip surface. The hybridization chamber was sealed wrapped 
in Il)il to keep out light. The chamber was then submerged in a plastic container containing water 
tub preheated to 42°C. The hybridization reactions were incubated at 42"C in a hybridization oven 
for 16-20 hours. The plastic container was also wrapped with foil to retain humidity and block out 
lighl. 
37. Post-bybridization Washing 
The low stringency wash buf'fer (2 X SSe. ().I(~o SDS), medium-stringency wash butTer (l.OX 
SSe) and high-stringency wash buffer (O.02X SSC) were made fresh. All staining dishes were 
covered with foi [ to make them I ight tight and the laboratory lights were turned ofC in order to 
minimize the exposure of the microarray slides to light. The hybridization chamber was unsealed, 
the microarray slide gently removed from the chamber. The microarray slide was submerged into 
a dish containing low stringency wash bulTer (2 X sse, 0.1 % SDS) and gently agitated at to 
remove the coverslip. 'fhe microarray slide was washed in the low stringency wash buffer for 4 
minutes at room temperature with gentle agitation. 'fhe microarray slide was then washed twice in 
medium stringency wash butler (1.0X sse) at room temperature for 4 minutes. The microarray 
was washed in high-stringency wash burfer (0.02X SSC) slide for each wash. The slides were 
then dipped 5 times in 100<% isopropanol and dried by centrifugation in swinging bucket rotor for 
5 minutes at 1000 rpm at room temperature. The slides were kept in a light-tight container and 
scanned immediately. 
38. Scanning and Image Analysis 
The 111 icroarray sl ides were scanned uSlllg an Axon GenePix 4000A (Axon 
Instruments/Molecular Devices Corporation, Sunnyvale, e A, U.S.A) scanner and GenePix Pro 
5.1.0.19 software running on a Windows XP operating system. The scan power was set to 
100 I 00, the resolution to 10um and the pixel size to 10. The internal scanner tem perature 
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averaged between 37"C to 38()C. The number or lines averaged during the scanning process was 
set lo 2. The microarray slides were scanned at 635nm and 532nm wavelengths and the genelspot 
ratios were set for 635n111/53211111. No normalization or background subtraction was done at this 
stage. Each microarray slide was initially scanned in the "Preview Mode" to optimise the photo-
multiplier (PMT) settings so that the overall fluorescence in the red and green channels were 
balanced. The channels were considered balanced when the ratio 0[" overall tluorescence in the 
green and read channels were equal to I. 'fhe microarray slide was then scanned at the optimized 
PMT settings and the image saved as ati IT file. Each slide was scanned a maximum of 3 times to 
avnid damaging the dye mo[ecules resulting in subsequent loss of quantitative 1l0rescence data. 
The array list and grid was loaded over the tifT images using the GenePix 5.1.0.19 software. 
Individual spots were aligned using the single irregular and lor regular feature tool. Each spot was 
individually checked ror quality and to see if it was aligned to the grid. Spots were flagged as bad 
ir they were (I) printed on top of each other, (2) dilated, (3) looked like doughnuts, (4) were 
irregular in morphology, (5) had a cornet tailor (6) contained particles or scratches. Once the 
grids were aligned, the settings were saved and the quantitative gene expression data exported as 
a "Gene Pix Resu[ts" (.gpr) file. 
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39. Microarray Image and Data Analysis 
All image and data analysis was conducted in the R environment for statistical computing and 
programming using the following packages (7), BioConductor (8), Limma (9-11) and Smida (J 2). 
R version 2.2.0. was downloaded from http://cbio.uct.ac.za/CRANJ and BioConductor, L1MMA 
and SMIDA from http://www.bioconductor.orgl. R was run on a Windows XP operating system. 
The gpr files, Targets file, SpotTypes file and R-script were placed in the same working directory. 
The Targets file was used by R to identify the gpr files and which samples (reference or treated) 
were labelled with Cy3 or Cy5. The SpotTypes file identified which genes on the array were 
experimental and which were controls. The gpr. files were read by the Limma programme and 
genes that were flagged as "bad" during the gridding process were given a weighting 0.1. This 
meant that the "bad" spots would not be excluded from further analyses, but only 10% of their 
values would be used. The layout of the array was composed of 4 x 8 grids, where each grid was 
composed of 35 rows x 35 columns. This layout was entered into the Limma programme which 
was then used for subsequent image plots. The background for each array was corrected using a 
"probabil istic" method rather than subtraction (12). The variation in background, foreground and 
log-ratios (treated vs. untreated; also called M-values) for each array was assessed using image 
plots. The balance of the densities of the red and green channels was evaluated by density plots. 
Systematic bias and print-tip artifacts were identified by whole array and print-group Ratio-
Intensity plots (also called MA-plots) before normalization. Evaluation of these plots helped 
decide which normalization method would be best to use. The data within each array was 
normalized using print-group LOWESS. The effectiveness of normalization in removing the 
systematic and printing biases was assessed by image plots of the spatially normalized M values 
and MA plots and box plots for each array and its print-tip groups. The data between arrays were 
normalized using the slide-scale normalization method and the effectiveness of the normalization 
was assessed by density plots and box plots. The duplicate spots in the normalized data were 
merged and averaged, taking into account gene weights for bad spots. The M and A values of the 
normalized and averaged data was saved and read into the TM4 Multi-experiment Viewer (MeV) 
Software Package (13). Differentially expressed (DE) genes were identified by a paired T-Test 
where p-values were calculated based on 100 permutations per gene. Significance was determined 
by Standard Bonferroni Correction (14, 15). The T-Test used Welch approximation since unequal 
variances between samples was assumed. The alpha value (the overall threshold p-value) was set 
to 0.0 I and the false discovery control rate was to set to "fast but conservative". The differentially 
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expressed genes were hierarchically clustered using using Euclidian distance and average link 
clustering. 
40. Reproducibility of Microarray Experiments 
Reproducibility between arrays was assessed by linear regression analysis. The M-values of one 
array was plotted against its biological replicate value in another array. The more reproducible the 
data was between the arrays, the closer the R2 value was to 1. Biological replicates were 
considered reproducible if the R2 ~0.3, since Churchill et al found that reproducibility between 
biological replicates can be as low as R2 = 0.3 (16). Reproducibility within each array was 
assessed by calculating the standard deviation for each replicate gene on the array. Those replicate 
genes with a standard deviation greater than 0.2 were questionable and unreliable. The standard 
deviation value of >0.2 was chosen since this was the cut-off value used by many researcher to 
define questionable data (17). However, a standard deviation cut-off of 0.2 was too stringent for 
the data from this study (discussed in chapter 4), therefore the less conservative value of 0.3, was 
used in this study to trim unrel iable data from the microarray data set. Statistical analyses were 
performed in Microsoft Excel. 
41. Functional Clustering and Promoter Analysis 
The DE genes were functionally clustered according to their functional annotations using the 
FatiGOplus program (18). The Unigene gene symbols for the DE genes were submitted into 
FatiGOPlus web page found at http://babelomics.bioinfo.cipf.es/fatigoplus/cgi-bin/ fatigoplus.cgi . 
Annotations for SwissProt keywords, InterPro motifs, KEGG signalling pathways and Gene 
Ontology (GO) levels I to 9 for Biological Processes, Molecular Functions and Cellular 
Component, were included in the analysis. The results were saved and the annotation data parsed 
into Microsoft Excel. 
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42. Promoter Analysis 
The P-MATCH (19) program was used to identify putative transcription factor binding sites in 
the promoters of DE genes. The first 1000bp of the promoter sequences were downloaded from 
the University of California Santa Cruz RefSeq Gene Table Browser found at 
hnp://www.genome.ucsc.edu/cgi-binJhgTables?command=start. The RefSeq gene accession 
numbers for each DE gene was pasted as a list and submitted into the Gene Table Browser and 
the following options selected: "genomic DNA", "promoter region only", "1 OOObp upstream of 
transcriptional start site". The promoter sequences were saved as text files and parsed into the P-
MACTH programme that searches for potential binding sites for transcription factors in any given 
sequence. A custom ized set of transcri ption factor matrices were selected to analyze the promoter 
sequences of the DE genes. The immune cell-specific profile provided by P-MATCH contains the 
matrices for transcription factors that are known to be active during immune responses in T-, B-, 
mast, myeloid, natural killer cells and macrophages. This profile was further customized by 
adding matrices for transcription factors that interact with C/EBPj3 (Table 3). Only high quality 
matrices were used for the analysis and the "minimize false positives" option was selected. High 
quality matrices are defined as those matrices that give the lowest frequency of false positive 
matches. 
104 
Table 3. Transcription Factors Included in the Promoter Analysis 
AMLI (lMGI NF-KBI RARa2 TCF-I(P) 
AlVILi a HMG I(Y) NF-KB2 RARIJ TO:-IA 
A\1L I b HMGY oct-B2 RAR[31 TCF-IB 
AMLlc Ik-I p300 RAR[32 TCF Ie 
AP-J Ik-2 PEBP2 RAR~B TCF-2 
ATF-4 Ik-3 PEBP2a RARy reF 
C/EBPu Ik-4 PEBP2uAI RARyl TCFI31 
e/EB!>13 Ik-5 PEBP2aA2 RARy2 VDR 
ClEBP8 IRF-I PEBP2aB1 Rc 
C/EBPe IRF-2 P[~BP2C(B2 RXRa 
CiEBPy JunB PI:BP2(3 RXRr3 
c-Ets- J JunD PEBP2[31 RXR~)I 
c-l:::ts-2 LEF-I PEBP2rn RXR[32 
c-Fos LyF-1 POU2FI RXRy 
CHOP-IO Lyl-I POU2F1a Sox4 
c-.run MAF POU2F2 (Oct-2.1) Spl 
c-Maf MAZR POU2F2 (Oct-2.3) SRF 
EeR I MZF-I POU2Fl (Ocl-2.4) STAT I 
EGR1 NF-AT POU2F2 (Oct-2.6) STATla 
EGR3 NFA T-I POU2F2C ST ATI f3 
Elf-1 NF-AT3 POtJ3F I STAT2 
Hk-J NF-ATe P()U4Fl(l) STAT] 
FosB NF-ATp pRb STAT4 
FOX04 NF-ATx PlJ.1 STAT6 
GATA-3 NF-EM5 RAR Tal-l 
GATA-4 NF-JUN RARa TBP 
liES NF-KB RARal TCF-J 
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43. Literature Profiling 
The literature profi I ing strategy used to select candidate genes for further study is outlined in 
Figure 3. The Milano Literature mining tool (20) was used to search the PubMed (21) database to 
see if any of the differentially expressed genes has been shown to playa role in infectious 
diseases caused by intracellular pathogens such as Listeria monocytogenes, Mycobacterium 
tuberculosis, Brucella abortus, Salmonella typhimurium and Leishmania major. In addition, 
searches were done to determine if the differentially expressed genes played a role in innate 
immunity, bactericidal functions, phagocytosis, endocytosis, phagosome maturation and phago-
lysosome fusion. Furthermore, any links to immune signalling pathways regulated by cytokines, 
Rab GTPases, C/EBPf3 and NF-KB were investigated. Nested keyword searches using gene 
aliases coupled to the search terms were done. Manual literature searches were done for a smaller 
set of candidate genes using PubMed (21), AceView (22), OMIM (23) and Entrez Gene (24) 
databases. The rSMR (25, 26), BayGenomics (26), DeltaOne (27) and Entrez Gene (24) databases 
were searched to find transgenic and gene deficient mouse models for candidate genes. The 
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Figure 3. Literature Mining Strategy to identify candidate genes for further investigation. 
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44. Systems Biology Protein-Protein Interaction Network 
Protein-protein interaction data for genes of interest were downloaded from Entrez Gene, Human 
Protein Reference Database (HPRD) and Biomolecular Interaction Network Database (BIND). 
The network was created by downloading the interaction data for all the first, second and third 
"neighbours" of Rab5a, PKC8 and G-CSF. The tenn "first neighbours" refers to proteins that 
interact directly with the protein of interest, while "second neighbours" are those proteins that 
interact with the "first neighbour" proteins and "third neighbours" are proteins that interact with 
the "second neighbour" proteins: e.g. in Figure 4 A the first neighbours of protein A are coloured 
in blue and the second neighbours in pink. [t possible that two different proteins have the same 
first and/or second neighbour (Fig. 4 B) thereby creating a small network. The protein-protein 
interaction data was saved in simple interaction file (sit) format. visualized and analyzed using 
the Cytoscape 2.2 software programme (28). 
A 
A 
Figure 4. Creation of Protein-Protein Interaction Networks. Proteins are depicted as coloured 
circles and protein-protein interactions as black lines. (A) The first neighbours (NI, blue circles) 
of protein A interact directly with protein A. The second neighbours of protein A (N2, pink 
circles) interact with the first neighbours of protein A, hence they are two interactions away from 
protein A. (B) The first neighbour of protein B is also the second neighbour of protein A (green, 
circle), and protein B is the third neighbour of protein A. Similarly protein-protein interactions 
occur between the first, second and third neighbours of protein A and protein B, thus creating an 
interaction network. 
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45. MIAME Compliance and Public Database submission 
In accordance with Minimum Information about Microarray Experiments (MIA ME) compliance 
(29), the m icroarray design, methodology and data has been deposited in the MIAME compliant 
Gene Expression Omnibus database. The data can be accessed at the website below using the 
accession number GSE6256: http://www.ncbi .nlm .nih .gov/geo! 
46. Sta tistica I analysis. 
All in vitro and in vivo data, was statistically analyzed using Student's T-tests (two-tailed with 
unequal variance) and values of p<0.05 were considered significant. Survival data was analyzed 
by Kaplan-Meier using the log-rank test to compare survival data. Each experiment was repeated 
at least once to ensure reproducibility. Differentially expressed (DE) genes were identified by a 
paired T-Test using Welch approximation where p-values were calculated based on 100 
pennutations per gene. Significance was detennined by Standard Bonferroni Correction (14, 15). 
The alpha value (the overall threshold p-value) was set to 0.01 and the false discovery control rate 
was to set to "fast but conservative". 
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REAGENTS AND SUPPLIERS: 
Reagent or Kit Supplier 
3,3',5,5'-tctramethylbcnzidine (TMB) Rochc Diagnostics GmbH, Mannheim, Germany 
~ -~-~------------.-- -------"--.---."-<---.--.--.---.. ---~.-~-~-- -.--.-----~-~.-------------~----~~-----.-----.---
7-Amino Actinomycin D (AAD) Sigma-Aldrich, Munich, Germany _. ___ ~ ________ ._ __ ... _0_ .... _-_·_-- _ .._.___ _ ________ . ______________ .. ____ .. _______ _ 
Acctone Sigma-A Idrich, Munich, Germany 
--.--.. --.-----.-~--------.~----~---.-.-.--------.. - ------------------------------------_ .. _---
Amino Allyl McssageAmpTM JJ CyDye Ambinn, Austin, Texas, USA 
aRNA Amplification Kit 
- -- - - ------------------------- ------------------------ -------------------- -----------~--------
ammonium chloride BDH Chemicals Ltd., Poole, 
anti-CD II b (clone M 1/70) BD Pharmigen, BD Biosciences, San Jose, CA, USA 
anti-F4/80 Caltag Laboratories, Burlingame, CA, USA 
anti-Gr-I (clone RB6-8G5) BD Pharm BD Biosciences, San .lose, CA, USA 
-----.-.------------.-----.-------~--
anti-I-Ab (clone KH74) BI) Pharmigen, BD Biosciences, San .Jose, CA, USA 
anti-rabbit IgG-FJTC Sigma-Aldrich, Munich, Germany 
___ ~_._._._" __ .. _. __ • _________ • ____________________ ~ __________________________ m_ ... _. _______________ • _____________________ " ____ • _______________ • ____ _ 
b-Mercaptoethanol Sigma-Aldrich, Munich, Germany 
---- -- ---------------_._----- -------_._---------------------- --_.<-----'. ----.. ---.----~-----------.-.---.-.------.-------.----
Bovin~ Serum Albumin (fraction V) Roche Diagnostics GmbH, Manl1heim, Germany 
Bovine Serum Albumin(BSA) (molecular Roche Diagnostics GmbH, Mannheim, Germany 
grade at 20Il1g/ll1l) 
calcium chloride BDH Chemicals Ltd., Poole, I:ngland 
.. "-~--.--.---.--.. --.. --.~--------------------.----------- ---.---.~---.----.. ----~-------.~---.---------- -- - - -----------. 
Chlorolt)rm 13DI-1 Chemicals Ltd., Poole, England 
----.~-.----------------~--~~~------.-----.-- ---~------------
c i!~_u ~~~_!f.~~~~~r:.(~_~~r_s 1 iR~l!.2 -~1111J.___ T\'1..~~kL~(~~~)~~-t!:~2' S~ rp lies, So ~ th_ A !f~_~~ _____________ _ 
Concanavalin A (Con A) Sigma-Aldrich, Munich, Germany 
------- -- ----~-----.-'"--.---- _._._._-------_._--------_ ... ------.~-. -"--.----------------------~----"-----~--~-.-----
diethanolamine Merck Laboratory Supplies, South Africa 
--.---------~-.---~-------------- ----.. ------~--- ----------------.-------~-~---------
[~iet~lx~p~~~)~~I~b~~.'l~_ (D E~S~~_~____________ ~}gm~~0_!9!ic h ,~ u n ~~h, (J~~l~ an y_~ ____________ _ 
d ~ll~e_tJ1xl~~!P_h~~i~~ __ (!?~ SO) ~i gma_=-J\I~j.ri c 11, M u n i ch, Gerl1lal~ _____ ~ __________ _ 
DNAse I (I OUhtl) Roche I )iagnostics GmbH, Mannheill1, Germany 
----------------_.,-"---,_.---- "---~-----,--.--.----~----.. --------.--.-.~----------~- .. -------~--
dNTPs (I OOpM) Promcga, Madison, WI, USA 
-.---------- -----~- --~-----~-.-.-------. ----_._-- .. _-- -- ------.--------~ --_ .. -----~--------
Dulbecco's Modified Eagle's Medium Cibco, Invitrogen Corporation, Carlsbad, CA, USA 
(DIVlEM) for Cell Culture 
__ m __ ~_ •• _______________________ • __________ • _~ ____ • __ ~ _______ •• __ • ________________ • _______________ ,_~ •• "_ 
EDTA BUB Chemicals Ltd., Poole, England 
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Reagent or Kit Supplier 
~~~i-'-l_~t_~i~ ______________________________ ~ i !{r~l~=~I_~!".i_~I~_~~ n ic~:.5ier~_a!:1X____________ _____ _ 
~)l_~~l~ !_~ bso I ~_te) ______________________ !3 D ~g~~~i_~a I s I ,td 2!~?O l.s,-_fi~ gl ~~~_________ ______ _ 
Fat fi'ce milk powder (Srar House Brand) Spar Groccry Store Franchise, South Africa 
"---~-.-------- _.- ---------... ----------.. ~--------~--.--.~--
fcrric cyanide 
------._----- -.---------.---.-----------~-~---~--- ---
Fetal Calf Serum (FCS 
Fetal Calf Serum (FCS 
Sigma-Aldrich, Munich, Germany 
-~.~-~-------- .. -.-~-~-~------------~-- .. ---~-.---------_._--
Delta 13ioproducts, Johannesburg, Ciaulcng Province, 
South Africa 
Ciibco, Invitrogen Corporation, Carlsbad, CA, USA 
--------_._._._-- --.-------.. -----~- .. -----.---- -------------------------.-.------.-------.----~-~-. 
f()nl~~~(i~~t'!~ ____________________________ _ ~y li~~_~~!~a I s LtcG!-.?o le,r~11 ~_I~.!:1~ ____________ _ 
Formamidc Sigma-Aldrich, Munich, Ciermany 
.-.--.-----".-.-----".--~.- - .-.-- . -"_._---- ---- -- ------------------------_.- --- - -- ----------
Fonnamide, redistilled (microarray) Life Technologies, Gaithersburg, M I, USA 
------_ .. _.-----------_._----------------_.----- --_.... --.----~ .. --~---------.---------- -.. ----------~.---~---------
gluleraldehyde (electron microscopy Sigma-Aldrich, Munich, Germany 
grade) 
glycery-'--__________________ .~ __ _______ B[?~:!i'h~ni~~ls IJtd., Poole, ~~ngl'-~~151 ______________ ._ 
guanidiniulll thiocyanate BDH Chemicals Ltd., Poole, land 
----------------- --------------------------------------------j----------------------------------------"-------------------- -------1 
hcmatoxylin stain Sigma-Aldrich, Munich, Germany 
----_._---------------_._----- .. ------.--~---.-.------.-- ---~--~-.-------.~-.. -----.--------.--------------.----_._--
horse serum Gibco, Invitrogen Corporation, Carlsbad, CA, LJSA 
.,-_._-- -_._--... _. --- ---------"'- --"----"-_._--------------------"--. ----------- -.-----.---.. -.---~------.---------------.-- --------
hybriJisation chamber Arraylt, Sunnyvale, CA ,USA 
----
Hybridization Coverslips Eric Scientific Company, Portsmouth, NH, USA 
.. -._-- ,-._.----, -~.---------~-------------.--.-.-.----- ---.------~----.----------------.-------~--------.-.-------~--
Hybridization Coverslips (Hybrislip) Sigma-Aldrich, Munich, Germany 
.-.. -----------~-,-.--~-~ -~.~---.----~-------------- .- ---.----~--"~~------.. --- -------------_. __ ._-----
IFN-y (recombinant protein for 13D Pharmigen, BD Biosciences, San Jose, CA, USA 
stimulation 
!~~~:IB i oti ny I ated _~~':!!: i bod~___ ________ ___ X~ D _~~~t~~i!?~~,J3Q B i o~~~nc~_s.~-':" all J os~,--~.0~ SA 
IFN-1 Coating<lntibo(iY' ____________ !3I?Xh~ln!li~e~,_[3D Bios~ier-1c_~~,-_S~n .Jose, CA, U~~ 
lI~'N Rccombinant Protein Standard BD Pharmigen, BD Biosciences, San Jose, CA, USA 
----------f-----------------------------
lJ-,=13J?3 5_!}_i~0 __ ~xJ_ate~3~~t!_~_(~~________ !:3g_~_h~l!~ !~~~_~J:~_io_sc_, ie_n_ce~ __ ?~~_.J_os_·e.: C~_~:I~_~_ 
IJ:"-=13p35_~·()~~0_~~~1ntibod~ ________ SD Pharm ill) Biosciences, San Jose, CA, USA 
IL-12p35 Recombinant Protein Standard I3D Pharm BD Biosciences, San Jose, CA, USA 
----_._----_.----------_. -------------------
_~~I ~_e~~~J~~~~y lale~~.t:i~odL_____ !~:~h_~~l2i1?~_~ B D B io~~ enc~~,- Sa~_} os~~ __ ~~-,-_~ S ~ __ 
J_I~I ~p_4.9~()at~2~ ant i ~5)d ~ __________________ ~_'2J)~~~I:~i!?en, B D B i osc i ~~ c~_~, __ ~~~~~~~_~~'__~~ SA _ 
J L 12p40 Recombinant Protcin Standard BD Pharmigen, BD Biosciences, San Jose, CA, USA 
---- -------,-_._--".-- --._-_._--_. ------------- ----.----.-.----------------------------------.~.-----._-
11,-18 Biotinylated antibody BD Pharmigen, BD Biosciences, San Jose, CA, USA 
IL-18 Coating antibody HI) Pharmigcn, HD Biosciences, San Jose, CA, USA 
--"--------.-----.--.. ---------"~-----------~-------.. --.-.------------------.-".------.-~-.----------------
IL-18 Recombinant Protein Standard BD Pharmigen, BD Biosciences, San Jose, CA, USA 
-.---~----.-~--------.-.---~----- ------.. --------"-~----~-------------,-------.. ---
11,-6 Biotinylated antibody [3D Pharmigen, BD Biosciences, San Jose, CA, USA 
IL-6 Coati antibody BD Pharmigen, BD Biosciences, San Jose, CA, USA 
IL-6 Recombinant Protein Standard I1D Pharmigen, BD Biosciences, San Jose, CA, USA 
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Reagent or Kit Supplier 
1m Proll1-1 pM Reverse Transcription Prom ega, Madison, WI, USA 
~)'~!-~!~-------------- - --~--- -- --- -- ----------------~--------------- ---
Iscoves's Modi1ied Dulbecco's 
Eagle's Medium (lMDMM) 
Culture 
ModifiedGibco, Invitrogen Corporation, Carlsbad, CA, USA 
lor Cell 
- -- --- _._- "-- -
iso~nl)ll ~~~o~()I _______ ~ __________________ ~i_~~~_0Idr~~-,-_~_~~~~~erll1a~ ______________ _ 
i~~)p~~p~~no 1 _________________________ 1?_[2_~L~:~~m ~~~~~_~_~~ Poo ~,_ En g ~~_~ ___________________ _ 
Isopropanol (microarray) Fisher Scientific 
~-.--.--~-- ---.-.~~- ~--- .~---.. --- -~ - - --"----------~-- ---... --.----,--"~-".--------~-----.-------- .. -.---~-----~----------
L-glutamine Gibco, Invitrogen Corporation, Carlsbad, CA, USA _______________ ____ _________________________________________ _ _______ -__ _ _________ ~ ________ ~ __ J 
r~p~)~) I ysaccl~:i ~eJ L P S _) ___________ S i g~l a_-~~ c h, ~_~~l i c1~~gen~~I~r___ ___ _________ _ 
low melting point agarose Promega, Madison, WI, USA 
---- - .-.- --~-~--~--~-----------'"-------------------------- ---.------.----... ---------------~-~-----.-.----.----------_. __ .-
magnesium chloride BDH Chemicals Ltd., Poole, England 
--."'----.--------.-~-----.-------------------.---~-.--------~-----------
magnesium chloride BDII Chemicals Ltd., Poole, England 
-----_ .. _- ----,---.- -- -" . - ------"-.-.,---.~----------------".-.--.-------- _._-------------------- -_. __ .---.-~-------.----------->-------.---.-
MCP-l Biotinylated antibody HD Pharm Bf) Biosciences, San Jose, CA, USA 
----, -----~. '--~-------'-'------------'---~-'---~~'--'-~~-
MCP-I Coating antibody HD Phann HD Biosciences, San Josc, CA, USA 
--------------------------_._----------- ---------j-------------=-
MCP-I Recombinant Protein Standard BD Phnrmigen, BD Biosciences, Snn Jose, CA, USA 
"----- - - .. ------~--.------.-~-.------.--~--- --------- ----.--.~.---------------~------~---------.------.---
MEE130 Oligonucleotide Array Spotted capar Microarray Facility, University or Cape Town, 
Arrays South Africa 
--_._- ------------------_. __ ._--------------- -------.. -----------~-----,--------.-------.-"-- --.----------------.--------------~---
Microarray Slide (GAPSII Coated Slides) Corning Costar Corporation, Cambridge, MA, USA 
Middlebrook 7H9 broth Difcll, Detroit, lVII, USA 
Middlehrook ADC enrichment medium Difco, Detroit, MI, USA 
Middlebrook OADC enrichment medium Life Technologies, Gaithersburg, MI, USA 
-- "-~----~~-------------~- "------------.-~--".------ --_.------ ------------"_. --------------------------~--------~.---
Mouse Fxonic Evidence Based 11lumina, San Diego, CA, USA 
Oligonucleotide(1Vi [E(30) Set 
/1- J - naptl~~!~!~~)-'!~~e(!~~~J~_~________________ Si gma_~~~ri_~!~~~~n i c h, G~~I12~~~~ _____ ~ ___ _ 
normal rat serum HD Pharmigcn, BD Biosciences, San Jose, CA, USA 
~.---------"---------------------.--------.-----.-~-.--- _._------- -- ~-------------.- -- ".-- -------------------~--.--------~.----
odium lauryl sarcosinate BDH Chemicals Ltd., Poole, England 
--.. --.---~-.-- ---------.~-----"-------. --------~-"-----.----------------.-~---------~---"---~---
Oligonucleotide Primers DNA Synthesis Laboratory, Dept. Molecular and 
Cellular Biology, University of Cape Town, South 
Africa 
osmium tetroxide Sigma-Aldrich, Munich, Germany 
-------_._-_._------ ----- ------ ---------------~---------------- -----.-"----.-----~- ---._"-_._._-----_._------"--- --------------~----.---.- ----
~~a~!~_~!~~~~~el~~-""_~! ~ 0 n al11_~~ ________ ~iJ~r~~_=~_19_~~~~~,-_1V2~~~i~~, Germ_~I_1X ___________________ . _______ _ 
Penicillin G and Streptomycin SolutionGibco, Invitrogen Corporation, Carlsbad, CA, USA 
( I OOX) 
1-------------- -- ------------------.------~------ ---------.------------ --------- --------------------
Peroxidase Substrate (Solution B) Roche Diagnostics GmbH, Mannheim, Germany 
--.-----~-, -- -- ----------------.--- -------~ .~-----"-~~----------.-------~----.- ------_._--------------------
phenol pH4.0 ...... _._ Sigma-Aldrich,_~ul1ich,_g~~El1~~11~ ____ _ 
~!l_()~~()_~C_~~i~ ______ ~__________ ~'?_~~_~-'_~~:~!cals L~~-,-Poo le-,-_Eng ~~~~ ___ ~____ ______ _ 
Polyacry1cnrrier Molecular Research Company, Cincinnati, USA 
___ • __ • ______ , _____ ~~~'"'"_~_~ __ •• ___ ""~u."_._."~'""'_" ___ "'._._'r_~'" ____ ~,_ ~ ,_"_ . . m _________ ._____ _ _ ,_ ___ __ _._. _________ •• _____________________ ~~ ________ • __ ~ __ 
11 I 
Reagent or Kit Supplier 
polyclonul rabbit anti-Listeria antibody Capricorn Products LLC, Portland, Mr~, USA 
- ----- - -~-----~-------------- ---------------------------------
potassillll}_ cl~()ri~i~ _________________ I~QLr~~2.~nicals Ltd.-'---P0..9~~'.~~~~and ______________ _ 
P~)t~~s!u ~ ~ i~L~r()!?~l __ p~~~P_~~tl:____ ___ ___ B D !i5' he~J~~I~ __ ~_~~._,!~~.!s~~lJ{~~11~ _______ _ 
Prolong Antifade Mounting Media Molecular Probes, Invitrogen Corporation, Carlsbad, 
USA 
- ----- - - ---------------------------------I-=-~--::.:?---=~-
!~(~t~!na~ K _ _ ____________ ~~~)~~_!)i~~~osti9_~GmbH, ~~~.':l_~~L~_' (:;~~~1_1_at~ ________ _ 
Qiagen MiniElute RNA cleanup kit Qiagen, Valencia, CA, USA 
----- --- - .. ---~~"----.----.-----------------,---~--------------- ------- .---~--.--.-.------.-----.-.--- ------.----~---.----... ------- -_ .... 
Reynolds lead Electron Microscopy Sciences, Fort Washington, J> A, 
USA 
-- --
rhodamine phalloidin Molecular Probes, Invitrogen Corporation, Carlsbad, 
lJSA 
RNasin (I U/~tl) Promega, Mudison, WI, USA 
RNcasy Midi Kit Qiagen. Valencia, CA, USA 
-----------~.---.-------- .--- ------.---------.~-- ----~--~--.---~.---~--------------------- ---.----~---<~-------
RNcHsy RNA Extraction Mini Kit Qiagcn, Valencia, CA, USA 
-----------_. __ ._-_.-._----------
RQ I DNAse I buffer (lOX) Promcga, Madison, WI, USA 
Saline Sodium Citrate (SSe) Solution (20 Sigma-Aldrich, Munich, Germany 
X) 
Scnsimix d(T) Mastermix Kit Quantacc, Neutral NSW, Australia 
- ---_.- ------------_ .. _-------------------
sodium acetate BDH Chcmicals Ltd., Poole. England 
Sodium Azidc 
sodium bicarbonate BDH (~hemicals Ltd .. Poole, l~ngland 
--_. - .... ~---- ~-.-----.-----.------- -------_._--_._--_._._-_. __ ._-- -----.--~"-----.-~-------.--- .-------------_._------------------
SodiulTl cacodylate BDH Chemicals Ltd., Poole, [~:ngland 
------.. --~-~-------.-.. ----------------------------- -------".~--.--------... ----. -.-----,----~---.--.. ------.-.-------
sodium carbonate BDH Chemicals Ltd., Poole, I:;:ngland 
.--"--------~------."--.- ---.----_._-----_._------_ .. _._-- ------- -------------.~----.--.. ------.-------------.--- --_._ .. _._---------- --_.-
Sodium Chloride BDH Chemicals Ltd., Poole, England 
----- ----.-------.. -.---.~------.------.---- _. ----_._------ --~-.--~~~-~--.-------~---"-~~.~--,---.-----.-.---.-------~-
sodium citrate BDII Chcmicals Ltd., Poole, r~ngland 
-"-- ----------~------~--"--.".-----~-----.----.- ----- .. _--_._-- - .. ---- -._-.-~'- - .. ~-----~-.---~---~ - ---.~.--------.- ----- - -----_._- ~-,-,-.-----
~od i u m __ ~~~)_~~~l~~~~J~~':_(S DS ),_~~~ _____ ~gJ_I_~11~r11j~~11_~!"!~'_£~? I e, _~~ng ~~~ _________________ _ 
~~)~li_~':l2_1~_~ru~~~~_____________________ G i~_~~, __ I~l_~i~~()J,_~~ __ S~o rporat ion, Carl sbad, ~A ,J:~~~ __ 
S!~p.~~~dJ~.:_~~~~li':l_c_-:Phosphatase _______ BI?_£~(l~nige~l_'_~~[)_Biosciences, S~~:!.()~,:~S:~0-,- USA_ 
~1!~p~~i~j~~::~!}(='__ __ ___________________ [~Q_!}_ll<:tr~~~en, ~ B i os_c i e~~e __ ~_~_~_~J~~':: (~0~_ SA 
sucrose BDH Chcmicals Ltd., Poole, England 
sulfanilamidc Sigma-Aldrich, Munich, Germ:_my 
--------"--~.------------------ ~---~--------. _. __ ._.- .. --"---.--.--.----------.---.-~-----.-".----.----------~-------.--.-~--
SYBR Greenl Roche Diagnostics GmbH, Mannheim, Cicrmany 
--.--.-~------------.- ------_. __ . __ ... _- ----- - - -- _. --- --- _. -- - --- ---------"------~---"----.----- -- -------. - -- _. ~---~-- _ ... __ ._------_._-
Tellon coated-bag Max Planck Institute for lmmunobiology. Max 
~f~~~;i:~~~:~~~~it::~ i~(~=~~A-)_j\~j~~£;~~;~;e~':~~~:~nJ~2f:r~};yZs_a 
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Reagent or Kit Supplier 
F Recombinant Protein Standard 
Solution (lOX) 
copper grids (300 mesh) 
BD Pharmigcn, BD Biosciences. San Jose, CA, USA 
BD Pharmigen, BD Biosciences, San Jose, CA, USA 
Molecular Research Company, Cincinnati, USA 
Chemicals Ltd., Poole, England 
I Chemicals Ltd., Poole. England 
Invitrogen Corporation, Carlsbad, CA, USA 
Detroit, \11, USA 
Chemicals Ud., Poole, England 
Merck Laboratory Supplies, South Africa 
Idrich, Munich. Germany 





Ace View Database http://www.ncbi.nlm.nih.gov/[EB/Research/Acembly/index.h 
tml 
Axiovision version 3. j Carl Zeiss, Gl)ttingen, Germany 
BayGenom irs Database http://baygenomics.ucsf.edu/cgi-
bi n/BayDbAccess.py?TYPE=search 
BioConduclor (BioCLite) http://www . bioconductor .org/. 
Capar Microarray Facility Website htl p:/ /w'vvw .capar.ucLac.za/default.htm I 
.... _---"----- -~.----.~ - --._ .. _--------- ---------.-~--,,---------,--- "--------
CellQucst Becton-Dickinson, BD Biosciences. San .lose, CA, USA 
CyDye Incorporation Calcu [alor http://www. prontosystems.cOln/techn ical~supportlca[culator. 
De ItaOne Database http://www.deltagen.com/deltaone/blast.htm I 
DNA MAN version4.1.3. Lynnon 13ioSo1t LJSA 
Entrez Gene Database 
FatiGOpl us 




Milano Literature Mining Tool 
http://www .ncbi.n Im.n i h .gov /entrez/ query. fcg i?db=gene 
hHp://babe 10m ics.bioinf().ci pf.es/fatigop lus/ cgi-
hin/fatigoplus.cgi 
Molecular Devices Corporation, Sunnyvale, CA, U.S.A 
http://www.intonnatics.jax.org/imsr/index.jsp 
http://www . bioconductor.org/. 
http://milano.md.huji.ac.i I. 
OMIM Database http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIIVI 
PubMed Database http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db''=Pub M ed 
- ----~---~--------~------~-~- --- ---~----------------------------------.-----.~------------··---------~-I 
R version 2.2.0 
Scion Image Software 
Smida 
TM4 Multi-experiment Viewer 
(MeV) version 3.1 
http://cbio.lIct.ac.za/CRAN/ 
Scion, Frederick, MD, USA 
http://www.bioconductor.org/. 
http://www.tm4.org/ 
University of Southern California's http://www.genol11e.ucsc.edu/cgi-
RdSeq G~ne Table Brower bin/hgTables?col11mand=start 
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SOFTWARE SCRIPTS WRITTEN FOR IMAGE ANALYSIS lJSING LIMMA 
sctwd("C:\\A nita\\Ncw _iVI EEBO __ mouse __ oI igo_1l1 icroarray\\R Data Analysis") 
library(l i mma) 
## Read 'largcts 
targets <- rcadTargetsO 
## Read CPR Jiles into R. Give wcight 0.1 to flags with GcncPix flag less than 0 
RG <- rcad.maimagcs(targets$FilcNamc. sourec =~ "gencpix". wt.tIJn=wtllags(O, I)) 
#If Sct print layout 
RCi$printer <- getLayout(RG$gencs) 
spouypcs<-rcadSpot'l'ypesO 




RG$R[.I J<-bkg.norm(xpr= RG$Rl.1 ].cmpty=200,method="probabilistic",dat.log.scak~=-=FA LSE) 
R G$ R r,2 ]<-bkg.norm( x pr= R Ci$ R [.2] .Clll ptyc-'200,rnethodO-"'''probabi listie" ,daLlog.scale=FALS E) 
R Ci$ R [.31 <-bkg.norrn( xpr== R Ci$R 1.31.em ptyc"200,method=="probabi listie" ,dat.log.sea Ic=-=TA LS E) 
RG$Rl.4 J<-bkg.norm(xpr=R G$ R[ ,4[ ,cmptYO-cc200,l11cthod=""probabil istic" ,dat.log.scale=+ALS E) 
RCJ$ RI ,5]<-bkg.norm(xpr=c=RG$RI,5],cl11 pty=200.mcthod c'="probabi listie" .dat.log.sca le=~FA LSE) 
RC i$RI ,6]<-bkg.norm( xpr=RG$R 1,6j,em ptr-200,l11ethod="probabiJ istic".daLlog.sca le="FALSE) 
RG$ RI. 7j<-bkg.llorm( xpr=RG$R[, 71,cm pty=200,method=-="probabi listie" .dat.log.scaJe=FALSE) 
R G$ R [,R]<-bkg.l1orm( xpr=R G$R [,8] ,em pty==200.l1lcthod==" probab i list ic" ,dat.log.seal e=F A LS E) 
RG$GI.I]<-bkg.llorm(xprcc'RG$Gj, I ],cmpty="200,mcthod="probabi listie",dat.log.sealc=FA LSE) 
RG$Gr ,21<-bkg.norm( xpr="'RG$Cir 2],cm ptr200,l11cthod""" probabi listie" ,daLlog.scalc=FA I ,SE) 
RG$G[.3]<-bkg.norm(xpr=RG$G[.3],clllpty=200,mcthod="probabilistie",daLlog.seale'oFALSE) 
RC ;$(11.4 I <-bkg.norm(xpr=RC$C 1.4] ,elll pty=200,method=-'''probabi listie" .da1.log.scaJe=FALSE) 
R C/$C J[ ,5]<-bkg.norm( xpr=R G$GI ,5] ,em pty=c200,mcthod="probabi listie" ,dat.log.scale=-FALSE) 
RCi$GI ,6]<-bkg.norm(xpr,c=RG$G[,6 J ,cmpty=200,mcthod=c="probabi listie" ,dat.log.sealc=F ALSE) 
Rl;$G l, 7 J<-bkg.norm( xpr=RG$G[. 7[ ,cmpty=200.method="probabi listie" ,da1.log.sea ie=FA LS E) 
R G$e; [,R ]<-bkg.norm(xpr=R G$G[,8] .em pty,cc200.mcthod"':"probahi I istic" ,daLlog.scale=FALS E) 
if Plot densities of Raw Data 
l'v1A. b<-norrnal izc With inArrays(RG,mcthod==="nonc" ,bC.lllcthod=~"none") 
plotDcnsitics( iVlA.b) 
Ii Look althe variation of background values over each array. 
f(x (i in 1:8) 
{ 
xl10 
imagcplot(\og2(RG$Rb[,il to. I ). RG$printcr, low="white", high="rcd") 
x II () 
imagcpiot(log2(RG$Gbl.i 1+0. J). RG$printcr, lowo:="whitc", high::="green") 
liS 
tilmage plots of the red and green foreground for eaeh array: 
f(Jr (i in 1 :8){ 
xiiO 
imageplot(log2(RG$R[,i J+O.l), RG$printer, low=c="white", high="red") 
xll0 
imageplot(1og2(RG$G[,i]+0.1), RG$printer, 10w='''wl1ite'', high-c="green") 
/I Image plot of the un-normalized log-ratios or M-values for each array: 
for (i in 1:8)( 
xiiO 
imageplot(MA.b$M[,q, RG$printer, zlirn'--=c(-3,J)) 
#/1 MA Plots for each whole array before dye normalization 
f(x (i in 1 :8){ 
x I I () 




## MA Plots for each army by printtipgroup bef()re before dye normalization 




## Nort1l3lize within arrays using print-tip loess 
M A. p<-normal izc W ilh inA rrays(R G,l1lclhod"pri nttiploess" ,bc.l1lethod="none") 
plotDensities(MA.p) 
# Image plot of the spatially normalized log-ratios(M-values 
['or (i in 1 :8){ 
xiiO 
imageplot( MA.p$IVI[,i], RG$printer, zlim=c( -3,3)) 
!Iii MA Plots for each whole array aner print-tip normalization 
Ii)!' (i in 1:8)[ 
plotMA( M A .p,array= i,main=paste(" Array", format(i),sep=" ") 






## Normalize between Arrays 
MA. ps<-norma I izeBet weenArrays(MA.p,method=="scale") 
plotDensities(MA.ps) 
## ILkntily and merge replicates. Sort by gene ID to get spacing regular and average over 
d u pi iCalt~ spots 
i <- order(MA.pAq$genes$ID) 
MA.pAq.o<- MA.pAq[i,] 
a veM <-matri x( O,ncol=8,nrow=length( unique(MA. pAq.o$genes$1 D))) 
avcA <-matrix( O,ncol"cc8,nrow=length( uniquc( M A.pAq.o$genes$1 D))) 
fix U in 1:8) 





MA. pAq .o$genes<-M A. pAq .o$gellesr !dupl icaled( M A.pAq .o$genes$! D),I 
## MA plots of normalized and averaged dala 
ror (i in I :8){ 
plotMA(M A. pAq .o,array= 1 ,main"=paste(" Array", format(i),sep==" "),cex 0---00.3) 
Ii nes( 10wess(F=MA.pAq .0$A [, i],y"=M A. pAq .0$ M [, i )),col==='2) 
xiiO 
Ii save M-values to file Oil C:drive 
Mvals<-chilld(MA.pAq.o$genes$ID,MA.pAq.o$genes$Name,MA.pAq.o$M) 
write. table(M vals, fi le="c:\\M vals" ,sep=: "\t" ,row .names=FALS E) 




Axiovert 100M DeconvolutingCarl Zeiss, Gijttingcn, Germany 
Fluorescent Microscope 
Axon GenePix 4000/\ Scanner Axon Ins1ruments/Molecular Devices Corporation, 
Sunnyvale, CA, U.S.A 
l'ACSCalihur Becton-Dickinson, HD Biosciences, San Jose, CA, USA 
Lightcycler Roche Diagnostics GmbH, Mannheim, Germany 
MJ 1hermocycler Biozym, llessisch OldendorC Frankfurt, Germany 
NanoDrop ND-IOOOA UV-VisNano[)rop Technologies, Wilmington, DE. USA 
S pectrophotomcter 
Nikol1 E400 microscope Nikon E400 microscope 
SpcedVac Savant Instruments Inc, Holbrook, NY, USA 
Zeiss 109 lransmission electron Carl Zeiss, GiHtingen, Germany 
microscope. 
VersaMax microplate reader Molecular Devices Corporation, Sunnyvale, CA, U.S.A 
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General Lab Solutions 
Mouse Tail Digestion Buffer 
12.5ml 1M TRIS-IICL, pH8 
50ml 500mM EDTA, pH8.0 
12.5ml 1 M NaCI 
25ml 101% SDS 
2.5ml 10mg/mi Proteinase K 
Add 12.5ml of 1 M TRlS-\-ICL (pHS), 50ml or 500mM EDTA (pH8.0), 12.5ml of 1M NaCI and 
25ml of 101% SDS to 140ml of ddH20. Bring up the final volume to 250ml and tilter sterilize 
with a O.22~lM filter (Millipore Corporation, Bedford, USA). Aliquot into sterile tubes and store 
at -lO"e. Thaw burter and add IOmg/ml Proteinase K at a I: 100 dilution. 
lOmg/ml Proteinase K 
I g Proteinase K 
Weigh out 1 g of Protcinase K and dissolve in 100mi of dd11 20. Filter sterilize with a 0.22]lM 
[iltcr (Millipore Corporation, Bedford, USA) and aliquot into sterile tubes. Store at _20°C and use 
at a I: I 00 dilution in Mouse Tail Digestion Buffer. 
O.5M EDTA, pH 8.0 
9J.06g tmTA 
Weigh out 9J.06g of EDTA and dissolve in 450ml ddH 20. Adjust pll to 8.0 and bring final 
volume to 500ml. Autoclave and store at room temperature. 
2M NaCI 
11.688g NaCI 
Weigh out I 1.688g or NaCI and dissolve in 90ml of ddH20. Bring final volume to 100mi and 




Weigh out 109 of SDS and dissolve 111 l)OmJ of dd~hO. Bring tinal volume to 100011 and 
autoclave. Store at room temperature. 
1 M TRIS-HCl, pH8.0 
60.55g TRIS-HCI 
Weigh out 60.55g of TRIS-IICI and dissolve in 450mlddH20. Adjust pi { to 8.0 and bring final 
volume to 500ml. Autoclave and store at room temperature. 





Weigh out chemicals and dissolve in 900ml 0l'ddH20 and adjust pH to 7.4. Bring final volume to 
1000ml and tilter sterilize \vith a 0.221!M tilter (\IIillipore Corporation, Bedford, USA). Store at 
4"C or room temperature. 
] X PHS (with CaCb and MgCh) 
8g Nael 
O.2g Kel 
1,44g Na::,f' P04.2fbO 
O.24g KlbP04 
I OOmg Cael;> 2FI~0 
1 OOmg MgCll 61-1::0 
Weigh out chemicals and dissolve inl)OOml ofddlhO and adjust pH to 7.4. Bring final volume to 
IOOOml and 1ilter sterilize with a 0.22IlM rilter (Millipore Corporation, Bcdfbrd, USA). Store at 
4"(' or 1'00111 temperature. 
120 
3.7°/.) formaldehyde (vol/vol in PBS) 
48.68ml 38(% formaldehyde 
500ml I X PBS 
Mix together 48.68ml of 38% formaldehyde and 400ml of J X PBS. Bring up volume to 500rnl 
and tilter sterilize with a O.22pM tilter (Millipore Corporation, Bedford, USA). Aliquot into 
sterile tubes and store at 4°C. 
4 %) phosphate-buffer·ed formalin 
52.63ml 38(% t(xmaldehyde 
500ml I X PBS 
Mix together 52.631111 of 38% formaldehyde and 400ml of I X PBS. Bring up volullle to 500ml 
and tilter sterilize with a O.22pM tilter (Millipore Corporation, Bedford, USA). Aliquot into 
sterile tubes and store at 4°C. 
1011.) glycerol 
IOml 100% Glycerol 
90ml I X PBS 
Mix together 10mi of 100% of Glycerol and 90ml of I X PBS. Autoclave and store at 
tem peratu re. 
10 % Tween-SO 
101111 100% Tween-80 
90ml I X PBS 
Mix together 10mi of 100% Tween-80 and 90mi of I X PBS. Autoclave and store at temperature. 
10'Yo Tl"iton-X 100 
10m I 100% Triton-X 1 00 
90ml 1 X PBS 




2m I 10% Triton-XI 00 
98ml I X PBS 
Mix together 2ml or 10(% Triton-X 100 and 98ml or 1 X PBS. Autoclave and store at temperature. 
1 %, BSA (Fraction V) 
I g BSA (rraction V) 
100mi I X PBS 
Weigh out 1 g or BSA (fraction V) and dissolve in 95ml of I X PBS. Bring up the final volume to 
100mi and filter sterilize with a O.22pM lilter (Millipore Corporation, Bedford, USA). Aliquot 
into sterile tubes and store at -20"C. 
Bacterial Solutions 
Tryptose-Soy Agar Plates. 
30g Tryptose-Soy Broth 
25g Bacto Agar 
Weigh out 30g of Tryptose-Soy Broth and 25g of Bacto Agar and dissolve in 1000mi of ddl 120. 
Autoclave and pour into sterile bacterial grade plastic petridishes in a sterile laminar Ilow hood 
and allow the agar to set. Invert the plates and incubate overnight at J7"C. Pack plates in sterile 
plastic hags and store in the inverted position a14"C. 
Tryptose-Soy Broth 
30g Tryptose-Soy Brot h 
Weigh out JOg or Tryptose-Soy Broth and dissolve in IOOOml of dMbO. Autoclave and store at 
room temperature. 
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Middlebrook 71110 agar plates 
199 Middlebrook 711 10 agar 
100mi Middlebrook OADC enrichment medium 
Sml glycerol 
Weigh out 199 of Middlebrook 7H I 0 agar and dissolve in 900ml 0(' ddH20 containing Sml of 
100% glycerol. Autoclave at 121"(, for 10 minutes only and cool agar to SO-SSo('. Aseptically add 
lOOml Middlebrook OADC enrichment medium. Pour into sterile bacterial grade plastic 
pdridishes with 2 compattments under a sterile laminar now hood and allow the agar to set. Pack 
the plates in sterile plastic bags and store in the inverted position at 4°C. 
Middlebrook 711 10 Broth 
4.7g Middlebrook 71110 Broth 
100mi Middlebrook ADC enrichment medium 
2m! 100% glycerol 
O.Sg Tween-80 
Weigh out 4.7g Middlebrook 7H I 0 broth and dissolve in 900ml of ddlbO containing 2ml 100% 
glycerol and O.Sg Tween-80. Autoclave for I () minutes at 1210C and cool to SO-5SoC and 
aseptically add 100ml Middlebrook ADC enrichment medium. Store at room temperature. 
n.05(% Triton-X 100 in 1 X PBS 
SOO~t1 10% Triton-X 1 00 
99.S 1 X PBS 
Mix together 10mi of 10% Triton-Xl00 and 95ml of 1 X PBS. Bring lip the final volume to 
100m 1 and autoclave. Store at tem perature. 
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Ccll Culture Solutions 
Fctal Calf Serum (FCS) 
500ml FeS 
Thaw one 500rn I bott Ie 0 r res at 37°e and heat inactivate at 56°C for 30 min utes with 
intermittent agitation. Make 25ml aliquots and store at -20°C. 
Horse Serum 
500ml Horse Serum 
Thaw one SOOml bottle of horse serum at 37°C and heat inactivate at 56')C for 30 minutes with 
i!lterm itlent agi tation. Make 25m I al iq uots and store at -200 e. 
Dulbccco's Modified Eagle's Medium (DMEM) 
13.38g DMEM powder 
100mi Fetal calfserum 
10mi 100X Penicillill G and Streptomycin Solution 
Weigh out 13.38g of DMEM powder and 3.7g or sodium bicarbonate and dissolve in 800m! 
ddl+-,O. Add IOOml heat decomplemented fetal calf serum and IOml of IOOX Penicillin G and 
Streptomycin Solution. Bring the final volume to 1000mi and tilter sterilize with a O.22/-lM filter 
(Millipore Corporation, Bedford, USA). Store at 4°C. 
Iscovcs's Modified [)MEM ([MDM) 
17.66g IMDM powder 
100mi Fetal calrserum 
10mi 100X Penicillin G and Streptomycin Solution 
Weigh out 17.66g of IMDM powder and 3'()24g of sodium bicarbonate and dissolve in 800ml 
ddll~O. Adjust pH to between 7.2 --- 7.4 with 1M NaO] I. Add 100ml heat decomplemcnted fetal 
calf scrum and I Oml of 100X Penicillin G and Streptomycin Solution. Bring the final volume to 




264ml DMEM (with IOOU/ml penicillin G, I()O~l.g/ml streptomycin) 
5()ml FCS (heat decomplemented) 
251111 Horse serum (heat decomplcmcnted) 
5ml 200mM L-glutamine 
5ml I OOmM Na-pyruvatc 
Iml I OOOX 2-13-Mercaptoethanol 
150ml L929 cell-conditioned medium 
Add all the reagents together and lilter sterilize with a O.22~M filter (Millipore Corporation, 
Bedf(xd, USA). Always make fresh just hef(xe lise. 
2(10mM L-Glutamine 
2.922g L-Glutamine 
Weigh out 2.922g L-Glutamine and dissolve in I OOml of ddH 20 and tilter sterilize with a O.22~M 
filter (Millipore Corporation, Bedf(xd, USA). Make 5ml aliquots and store at -20°e. 
WOOX 2-p-Mercaptoethallol 
698p I 2-13-Mercaptoethanol 
Add 698~1 of 2-~-Mercaptoethanol to IOOml of ddl~20. Filter sterilize with a 0.22J.1M filter 
(Millipore Corporation, Bedford, USA) and store at 4°C. 
100mM Sodium Pyruvate 
1.1 g Sodium Pyruvate 
Weigh out l.lg sodium pyruvate and dissolve in 100mi ddH20. Filter sterilize with a O.22J.1M 
filter (Milliporc Corporation, Bedford, USA) and store at 4°e. 
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Weigh out chemicals and dissolve in IOOOml of'd&bO. Filter sterilize with a O.22)lM filter 
(Millipore Corporation. Bedford, USA) and store at 4°C. 
1 X Trypsin/EDT A Solution 
lOX Trypsin/EDTA Solution (Gibco, Invitrogen Corporation, Carlsbad. CA. USA) 
Add IOml of 10 X Trypsin/EDTA Solution to 90 III I o!'c1dH 20, rilter sterilize with a 0.22 ~lM filter 
(Millipore Corporation, Bedford, USA) and store at 4"C. 
Immunology Solutions 
ELISA Coating Buffer 
O.2g NaN; 
Weigh out NaN] and dissolve in 900ml of I X PBS, bring the final volume to I OOOml and store at 
room temperature. 




Weigh out chemicals ancl dissolve in 900ml or ddl-l20, Adjust pH to 9.5 with I M Citric Acid. 
Bring the final volume to IOOOml and filter sterilize with a O.22~lM filter (Millipore Corporation, 
Bedford, USA) and store at 4°C. 
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ELJSA Blocking Buffer 
20g Powder Milk 
O.2g NaN 3 
Weigh out chernicals and dissolve in 900ml of 1 X PBS, bring the final volume to IOOOml and 
store at 4"('. 
ELISA Dilution Buffer 
109 BSA 
O.2g NaN, 
Weigh out chemicals and dissolve in 900ml of I X PBS, bring the final volume to 1000ml and 
store at 4°C. 
F:LISA Washing Buffer (20 X) 
20g KCL 
20g KI bllpn~.2IhO 
SOOg NaCI 
501111 Tween-20 
100mi 10% NaN.) 
Weigh out chemicals and dissolve in 4500ml double distilled water (ddl (20). Add 50ml of 
'T'weell-20 and 100ml of 10% NaN]. Bring final volume to 5000ml and store at room temperature. 
Dilute I :20 in ddH.,O [or a I X working concentration buffer. 




Weigh out chemicals and dissolve in 700ml of dclll~O. Add 97ml of liquefied diethanolamine and 
adjust pH to 9.8. Bring the final volume to I OOOml and store at 4°C. 
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FLiS/\ Substrate Huffer (for horseradish peroxidase conjugates) 
TMB Peroxidase Substrate Solution A (Roche Diagnostics GmbH, Mannheim, Germany) 
Peroxidase Substrate Solution B (Roche Diagnostics GmbH, Mannheim, Ciermany) 
1M fbP04 
Just bef'ore use, mix equal volumes of Ti\!IB Peroxidase Substrate (Solution A) with Peroxidase 
Substrate Solution B. Add 50111 per well and let the reaction develop at room temperature f()r 5 
minutes. Stop the reaction by adding SOp.1 or 1M 1I 3P04 
Griess n.eagent Standard (lmM NaN02) 
6.899mg NaN0 2 
Weigh out 6.899mg ofNaN02 and dissolve in I OOml of ddH 20 and store at 4"C. 
Griess n.cagen t 1 
Ig sulfanilamide 
I OOml 2SYU phosphoric acid 
Weigh out I g sui Canilamide and dissolve in 100mi of 2.5 % phosphoric acid. Cover bottle in foil 
to protect from light and store at 4°C. 
Griess Reagen t 2 
O.lg napthyl-ethylene-diaminc 
I OOml 2.5 %lphosphoric acid 
Weigh out O.lg napthyl-ethylene-diamine and dissolve in IOOml of2.5 % phosphoric acid. Cover 
boUle in I'oil to protect from light and store at ,f'C. 
2SYo phosphoric acid 
3ml 85% phosphoric acid 
Add 3ml of8SCYo phosphoric acid slowly to 90rnl ofddl-bO. Bring up volume to 100m] and store 
at roorn temperature. 
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Microscopy Solutions 
6.6f1M Rhodamine Phalloidin Stock 
I vial rhodamine phalloidin (300Units) 
1.5ml methanol (ultra pure) 
Dissolve I vial of rhodamine phalloidin (300lJnits) in 1.5 ml methanol. Make 10].11 al iquols and 
wrap in foil to protect from light. Store in the dark at ~20°C. 1)0 not free/thaw more than once. 
Cacodylate Huffer (with or without sucrose) 
5.35g sodium cacodylate 
254mg Cael: 211 20 
I X4mg MgCb 61bO 
X.5g sucrose 
Weigh out 5.35g of' sodium cacodylate and dissolve in 220ml ddH20. Adjust pH to 7.2 with 1M 
11('1 and adjust volume to 250ml. Add the MgCh and eaCh If required, add 8.5g sucrose and 
bring volumc to 250m!. Store at 4'\:. 
0.5\\1 Ferric Cyanide 
2.112g 1t:rric cyanide 
Weigh out and dissolve 2.1 12g of ferril.: cyanide in ddH20. Make Always make frcsh just hefore 
use. This solution is highly toxic. Use it under the flow hood at all timcs. Adhere 10 all University 
Health and Safety precautions relevant to this solution. 
2.5°1t, Gluteraldehydc in Cacodylate Huffer 
25% gluteraldehyde stock (electron microscopy grade) 
Add 2ml of 25% gluteraldehyde to 18ml cacodylate buffer containing sucrose. Always make 
fresh just before usc. 
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4(% Osmium Tetroxide 
IgOs04 
Weigh out and dissolve I g of OsO,~ in 25ml ddlbO. Cover in foil to protect the solution from 
light and store at 4°C. The solution can be kept for several months at 4°C, and can be used so long 
as it has 110t turned black during storage. This solution is highly toxic. Use it under the flow hood 
at all times. Adhere to all University Health and Safety precautions relevant to this solution. 
1 %, OS04 and O.OSM (;'crric Cyanide Staining Solution 
4%\ Osmium Tetroxide 
O.5M Ferric Cyanide (freshly made) 
Prepare this solution just prior to use. Add 2ml of 4%) OS04 solution and 200111 of O.OSM ferric 
cyanide (freshly prepared) to 6ml of cacodylate burter pH7.0 devoid of sucrose (the solution will 
turn brown). Use the solution immediately. 
Reynolds Lead Solution 
lead nitrate 
L 76g sod i Lim citrate 
8ml I M sodium hydroxide 
Boil 750011 of ddH::O for at least 30 minutes in order to boil off carbon dioxide. Weigh out 1.33g 
of lead nitrate and carefully add to a 501111 volumetric Hask. Add 30ml of the boiled water to the 
50ml volumetric llask and shake. Add 1.76g of sodium citrate to SOrnl volumetric flask and shake 
vigorously for 2 minutes. The solution will turn milky white.Let solution stand for 30 minutes 
with occasional shaking by inversion. Add 81111 of I M sodium hydroxide solution (freshly made) 
and mix by inversion. 'fhe solution should clear. Bring up the volume to 50mJ. Aliquot into 10m! 
portions using a syringe into air-tight bottles that contain a rubber or cork stopper in the bottle 
neck. Slore at 4"C. 
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Uranyl Acetatc Solution 
6.25g uranyl acetate 
Weigh out 6.25 grams of uranyl acetate powder into an amber glass bottle. Add 100mi ddH~O 
into the amber bottle and sonicate the uranyl acetate solution for I hour under a fume hood. When 
sonication is complete, wrap some Parafilm around the cover of the amber bottle and store at 4°C. 
RNA and Microarray Solutions 
DEPC-trcatcd H20 
IOOOml ddlhO 
11111 Diethylpyrocarbonate (DEPC) 
Add J 1111 of DEPe to I OOOml of deilbO and incubate overnight at 37°e with agitation. Autoclave 
to sterilize and heat deactivate the DEPC. Aliquot in RNAse-free tubes and store at room 
temperature. 
70% Ethanol 
70ml absolute ethanol 
30ml DEPC-treated IbO 
Add 30ml of DEPC-treated H20 to 70ml absolute ethanol and mix well. Aliquot in RNAse-free 
tubes and store at rool11 temperature. 
75(Yo Ethanol 
75ml absolute ethanol 
25ml DEPC-treated H20 
Add 25ml of [)EPC-treated IhO to 75ml absolute ethanol and mix well. Aliquot in RNAse-free 
tubes and store at room temperature. 
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Chloroform-Isoamyl Alcohol (49:1) 
I ml isoamyl alcohol 
4l)m I eh loroform 
Add I ml of isoamyl alcohol to 49ml of' chloroform in a in RNAse-free glass bottle. Cover bottle 
in foil and store at 4°C. 
3M Sodium Acetate 
408.3g sodium acetate.3~hO 
glacial acetic acid 
1.0ml DEPC 
Weigh and dissolve 408.3g of sodium acetate.3fl10 in 700 rnl of ddH20. Adjust the pH to 
with glacial acetic acid and bring the linal volume to 10001111. Add I m I or DEPC and incubate 
overnight at 37"(' with agitation. Autoclave to sterilize and heat deactivate the DEPC. Aliquot ill 
RNAse-free tubes and store at room temperature. 
0.75M Sodium Citrate Ph7.0 
II 0.29g of sodium citrate 
Weigh I I 0.29g of sodium citrate and dissolve in 450ml of ddl'hO. Adjust the pll to 7.0 and bring 
the final volume to 500ml. Add O.5ml of DEPC and incubate overnight at 37'Y,' with agitation. 
Autoclave to sterilize and heat deactivate the DEPC. Aliquot in RNAse-fh~e tubes and store at 
room temperature. 
0.5%. Sodium Lauryl Sarcosinate 
5g sodium lauryl sarcosinate 
Weigh out 5g or sodium lauryl sarcosinate and dissolve in 950ml or d&hO and bring the final 
volume to IOOOml. Add I ml of DEPC and incubate overnight at 37°C with agitation. Autoclave 
to sterilize and heat deactivate the DEPC. Aliquot in RNAse-free tubes and store at room 
temperature. 
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RNA Denaturing Solution "Solution D" 
2S0g guanidinium thiocyanate 
17.6ml O.75M sodium citrate pll7.0 
26.4ml 0.5% (w/v) sodium lauryl sarcosinate 
360~!1 14.4M 2-fl-mercaptoethanol 
Weigh out and dissolve 2S0g of guanidinium thiocyanate in 293 ml of dd~bO, 17.6 ml of 0.75M 
sodium citrate (pH 7.C» and 26.4 ml of 10(% sodium lallryl sarcosinate. Dissolve using a heated 
magnetic stirrer set at 6S°C. Cover the bottle in 10il as this solution is sensitive to light. Solution 
D may be stored t()r months at 4°C but the guanidinium will precipitate out of solution, therefore 
pre-warm the solution before using it to dissolve the crystals. Add 360~tl J 4.4M 2-~~­
mercaptocthanol per 50 ml of Solution D just bef()re lise. 
RNA Loading Buffer 
14.0~tl 12.3M Formaldehyde 
50.0~1 100% Formamide 
I ().O~I lOX MEA Bulfer 
1 ~I IOmg/ml Ethidium Bromide 
Make up the buffer fresh each time. Add all reagents together and mix well. Add 7.4~tl of loading 
buffer to 2.6~tl of RNA. This recipe is enough for 10 samples 
to X MEA (1~lectrophoresis Buffer 
0.2 M MOPS, pll 7.0 
6.67ml 3M sodium acetate, pHS.2 
O.5M EDTA pH 8.0 
Weigh out and dissolve 41.8 g of MOPS in 700 ml of sterile DEPC-treated IhO. Adjust the pH to 
7.0 with 1M NaOl1. Add 6.67ml of DEPC-treated 3M sodium acetate and 20ml of DEPC-treated 
O.5M I~DTA (pH 8'()). Adjust the volume of the solution to IOOOml with DEpe-treated l-bO. Add 
I ml DEPC and incubate overnight at 37"C with shaking. Autoclave to heat deactivate the DEPe 
and to sterilize (autoclaving turns the solution yellow but does not affect the pll). Store at 4"C 
wrapped in foil to protect from light. 
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Pre-Hybridization Buffcr 
50~tI 20 X sse 
Ip.120% SDS 
20p.1 1% BSA 
129pl ddl-bO 
Mix together 50pl of 20 X sse, \ pi of 20% S DS, 20pl of 1% HSA and 129pl of ddl-hO. Make 
buffer fresh each time and incubate at 42°C until use. This recipe is enough for I microarray slide. 
2 X Hybridisation Buffer 
IOOpl 50% formamide 
I OO~!1 20 X sse 
2p.1 20(% SDS 
Mix together in sequential orderlOOp.1 of 50% formam ide, 100pl of 20 X sse and 2~tI of 20(% 
SDS. Make buffer fresh each time and incubate at 42°e until lise. This recipe is enough for 
microarray slide. 
Low Stringency Wash Buffcr 
20ml20 X sse 
1 ml 2()O;'!) SDS 
179ml ddl1 J O 
Mix together 20ml 01'20 X sse, Iml of20% SDS and 179ml ofddH20. Make buffer fresh each 
lime. 
Mcdium-Stringency Wash Buffer 
IOml20 X sse 
190ml ddlh() 
Mix togetherlOml of20 X sse and 190ml ofddlhO. Make buller fresh each time. 
lligh-Stringcllcy Wash Buffer 
2ml20 X sse 
198ml ddlhO 
Mix together 2ml 01'20 X sse and 198ml of ddl/20. Make butler fresh each time. 
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CHAPTER 3 
Gf<:Nf<:RATION AND INFECTION OF BONE 
MACROPHAGES WrT'H LISTERIA MONOCYTOGENES 
SlfMMARY 
MARllOW DERIVED 
The chief aims or this chapter were to estahlish in vitro infection of hone marrow derived 
macrophages (BMDMs) with L. m()n()cyt()~el1es and to compare the suhsequent innate 
immune responses between infected WT macrophages and macrophages genetically deficient 
flu C/FBP~i (C/EBPWI-). 1.. monocyto}!,enes was used in the cunent study as a model 
intracellular pathogen to identify genes involved in mediating macrophage bactericidal 
effector activity. Host protection to 1.. monocyto~enes involves the activation or cellular 
immune responses resulting in Lhe activation of macrophage bactericidal enector functions. 
granuloma lormation and protective Til I-type responses. I FN-y and TNF are key cytokines 
essential for full macrophage activation (1. 2), resulting in enhanced production of cytokines. 
chcmokines and hactericidal molecules such as reactive oxygen intermediates (ROJ) and 
reactive nitrogen intermediates (RNl). Several in I'ivo infection studies using mice deficient 
for iNOS or variolls components of NADPII phagocyte oxidase. showed that hacterial killing 
took place despite the lack of ROJ and RNJ (3-7). These studies suggested that macrophages 
have an alternative killing mechanism that is independent of ROI and RNI. Furthermore, 
studies using mice deficient for genes involved in TNF and/or IFN-y signalling emphasized 
the existence of an alternative unknown killing mechanism that is independent of ROJ or RNI 
c;-7), hut dependent on IFN-y, TNF and (,/EBPI3 (8-10). The most downstream molecule in 
this bypothetical pathway would be (,/EI3Pr~, since the C/EBPW I- mice induced IFN-y and 
TNF at levels equivalent to WT mice during L. monocytogenes infection (10). Macrophage 
genes involved in mediating listericidal activity would therefore most likely he downstream of 
CIEBP~ in this unknown killing pathway. Comparison or-the gene expression profiles ofW'f 
and CIEBP[3·I-activated macro phages infected with L monocyto}!,enes would therefore 
increase the prohahility of identi lying these listericidal etTector genes. However, hel()rc RNA 
was extracted and the gene expression profiling experiments executed, several biological 
parameters were compared to literature to ensure that the in vitro infection experiments 
rc1lcctl~d the" hiology" of in vivo infections. Only if all the results concurred with literature, 
was the in vitro experiment judged sllccessl'ul and the RNA used for gene expression analysis. 
Furthermore, in order to mimick as closely as possihle the hiology of in vivo intections, 
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macrophages were only stimulated with IFN-y upon infection with L m()n()cyt()~enes. 
Both WT and CIEBPrr/- infected macrophages were fully activated and secrctcd equivalent 
amounts ofpro-inl1ammatory mediators such as IL-6, IL-12, IL-18, TNI', MCP-l and nitric 
oxide. However, despite full macrophage activation C/EBPrr/- macrophages had 30% more 
escaped Listeria bacilli in the cytoplasm than the WT macrophagcs at 4 hours p.i .. 
Consequent Iy, the C/EBPlr/- macro phages displayed uncontrolled bacilli growth and at 12 
hours after of infection contained 6-f()ld more bacteria than the WT macrophages. 
Furthermore, the C/EBPWI- macro phages had impaired induction of G-CSF, CLECSF9, IL-
12p35 and ISGF3y genes, whose transcription is dependent on C/EBPj3 (10-13). Altogether, 
these results demonstrated that the observed phenotypc of C/EBPW1- macrophages wcre 
n:prescntalive of those reported in the literature and confirmed that the '"biology" of the in 
vitro infection expcriments ref1ected that of in vivo infections. The infection experiment was 
rcpeated f()llr timl?s independently or each other and RNA extracted at 4 hours p.i. for 
microarray analysis, since this was the earliest time point where a significant difference 
bctween WT and C/EBPWI- macrophage listcricidal activity was observed. Thc increased 
bacterial load and impaired killing in the C/EBPlr/- macrophages was considered a 
conscquence of differential expressIOn of genes, between lhe WT and C/I~Bprr/­
macrophages, that were required for mediating listericidal activity. The quality and purity of 
the RNA was high and was biologically relevant as shown by quantitative RT-PCR i()r 
C/EBPj3 target genes. Although the yield of RNA was low j()r somc cxperiments, there was 




I. Efficient Activation of C/EBPjr/- BMDMs 
Bone marrow derived macrophages (BMDMs) were successfully generated from the WT and 
UFBPrr/- mice. The yield of bone marrow stem cells per mouse prior to dilTerentiation was 
comparable for both WT and C/EBP~ -1- However, alter 10 days of ill vitro differentiation in 
conditioned medium containing granulocyte macrophage colony stimulating {actor (GM-CSF) 
and macrophage colony stimulating factor (M-CSF), the yield or ditTerentiated macrophages 
was significantly lower for the C/EBPp-/- mice (Fig. I). Macrophages trom WT and C/EBPWI-
mice were simultaneously stimulated with fFN-y and infected with L. mmuHytogenes at a 
MOl of 10 bacilli: I macrophage. Macrophage activation was assessed by measuring the 
levels of pro-inllammatory mediators (Fig. 2) in the cell culture supernatants. Both WT and 
C/E13PW i - macrophages efficiently induced TNF, I L-12, IL-6, IL-IS, and MCP-l which 
increased until the last time-point in the assay. As expected from the literature, there was no 
significant difference in the level of induction of these mediators between the W'f and 
C/EBPWI- macro phages during L monocytogenes in1'cction (10). The only exception was for 
I L-1S, which at 4 hours p.i. was> 1 0 fold lower in the C/EBPrr/- macrophages as compared to 
WT. Although not statistically significant, the levels for TNF, lL-6 and IL-IS were generally 
lower, whereas lL-lO was higher in the C/EBPWI- macrophages than the WT. These results 
demonstrated that C/EBPWI- macrophages were fully activated as compared to WT, since they 










Figure 1. Decreased in vitro differentiation of C/EBP~-I- bone marrow stem ceJJs into 
macro phages. Bone marrow stcm cclls were grown for 10 days in 30% L929 conditioned 
media containing GM-CSF which stimulated the ditferentiation of the stern cells into 
rnacrophagcs. Data are represented as averages and SEM of S independent experiments (* p 
<OJ))). 
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Figure 2. [,:fflcient induction of pro-inflammatory mediators in C/EIlPJr/- macrophages 
during in vitro L. mOllocytogenes infection. Macrophagcs from WT (Jillcd squares) and 
C/EBPWI. (open squares) were generated and infected with L monocytogL'nL's at MOl of 10 
bacilli: I macrophage. Supernatants Irom triplicate wells were collected at 2, 4, 8 and 12 
hours post-infection and levels of cytokincs and chemokine MCP-l was measured by ELlSA. 
Data are represented as averages and SEM of 3 independent experiments done in triplicate (* 
p<0.05). 
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2. Enhanced bacterial growth and increased bacterial escape from C/EBPp-/-
phagosomes following L. mOllocytogelles infection. 
WT and C/ErWrr/- macrophages were simultaneously stimulated with lFN-y and infected with 
/'. lI1onocylogenes for 2, 4, 8 and 12 hours. Despite having levels of nitrite, which is indicative 
of nitric oxide production, that were equivalent to WT (Fig. 3 A), C/EBPWI- macrophages had 
significantly increased bacterial growth at 4, 8 and 1:2 hours p.i. (Fig. 3 B). In contrast, WT 
macrophages were able to restrict bacterial growth and maintained a steady state plateau 
during the 12 hour period. Both WT and C/FBPWI- macrophagcs contained equivalent 
numbers or bacteria at 2 hours p.l., indicating no significant defect with respect to 
phagocytosis in the C/EBPWI- maerophages. To determine if the increased bacterial growth 
was due to enhanced bacterial escape from phagosomes, macrophages were infected with 
Usleria and bacterial escape measured by electron microscopy (Fig. 4). The number of 
bacteria in the cytoplasm or enclosed by a double membrane (phagosome) were scored and 
the percentage or escape calculated as described in the methods. The majority of the bacteria 
in the WT macrophages were contined within phagosomes (Fig. 4 A), whereas many bacilli in 
the C/Ef-Wrr/- macrophages were free in the cytoplasm and in the process of moving as shown 
by the actin "comet tails" (Fig. 4 B). Furthermore, several bacilli in thc C/EBPrr/-
macrophages were in the process of cell division (Fig. 4 C). The C/EBPWI-macrophages had 
significantly 30% more escaped L. monocylogenes in the cytoplasm than the WT (Fig. 4 D). 
These results demonstrated that although C/EBPrr/- macrophages were activated and 
produced protective, pro-inflammatory mediators and nitric oxide, they were nevertheless 
unable to control Listeria growth due to their inability to confine Listeria within lhe 
phagosome. 
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Hgure 3. Impaired bacterial killing in CIEBPp-/- macrophages despite efficient induction 
of bactericidal mediators. Macrophages from WT (filled squares), C/EBPrr/- (open squares) 
were generated and infected with L. mono(ytogenes. At 2,4, 8 and 12 hours after intection the 
(A) levels of nitrite, which is indicative of nilric oxide production and the (R) hacterial load 














Figure 4. Increased escape of L. monocytogenes from CIEBPWI- pbagosomes. WT and 
CIEBP~-I- macrophages were infected with L. monocylogenes and were processed for electron 
microscopy at 4 hours p.i .. L. monocytogenes bacilli are indicated by arrows labelled L.m. (A) 
The majority of the bacilli in the WT macrophages were confined within phagosomes, 
whereas (B) many bacilli in C/EBP~-I- macrophages were free in the cytoplasm and in the 
process of moving as shown by the actin "comet tails" (arrows labelled A). (C) Many of the 
bacilli in the C/EBPWI- macrophages were in the process of cell division, as shown by the 
dividing membrane (black arrow). (D) The CIEBP~-I- (open bars) macrophages had 
significantly greater L. monocytogenes phagosomaJ escape as compared to the WT (filled 
bars). Electron micrographs are representative of 3 independent experiments. Data in graph 
(D) is the average and SEM of 3 independent experiments (* p<O.05). Magnification for (A) 
and (B) is 4400X, (C) is 20000X. 
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3. Purification of total RNA from activated BMDMs infected with L. monocytogenes 
WT and CIEBP~·I. macropbages were simultaneously stimulated with IFN-y and infected with 
L. monocylogenes. RNA extracted at 4 hours p.i. for microarray analysis, since this was 
earliest instance time point where a significant difference between WT and CIEBPp-/. 
macrophage listericidal activity was observed (Fig. 3 B). Since the difference in listericidal 
activity was a consequence of differential expression of listericidal genes in the CIEBP~·I. 
macrophages as compared to WT, RNA was collected for comparative microarray analysis in 
order to identify the listericidal genes. RNA was isolated from four independent biological 
experiments and DNAseI treated to get rid of contaminating genomic DNA (Fig. 5 A). The 
quality and quantity of the RNA was checked by denaturing gel electrophoresis (Fig. 5 B) and 
spectroscopy (Table 1.). The ratio of 28S to 18S eukaryotic ribosomal RNA bands were 
visually estimated to be approximately 2:1, indicating that the RNA was intact and of high 
integrity. The purity of the RNA was high for all samples as indicated by A26o/A28o ratios, 
which for pure RNA is equal to 2.0 (14). The yield of RNA for each experiment differed and 
ranged from 8.2~g to 115~g. Since the standard protocols at the capar Microarray Facility 
required at least 50~g of total RNA for each microarray hybridization, the mRNA in each 
sample would have to be linearly amplified in order to generate enough sample for microarray 
hybridization (discussed in chapter 4). 
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Figure 5. Denaturing 1 % agarose gel electrophoresis of total RNA purified for 
microarray analysis. WT and CIEBPp-/. macrophages were activated and infected with L. 
monocylogenes and total RNA purified at 4 hours p.i .. (A) Total RNA contaminated with 
genomic DNA (gDNA); (B) DNAse I-treated and purified total RNA. The 28S and I8S 
ribosomal RNA bands are indicated. WTI and KOI denote the RNA extracted from WT and 
C/EBP~-I- (KO) macrophages for the first infection experiment. The same labelling scheme 
applies for infection experiments 2, 3, and 4. 
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Table 1. Quantification and purity of total RNA purified for microarray analysis. 
Total RNA was purified from L. monocytogenes infected WT and C/EBPWI - activated 
macrophages at 4 hours p.i .. The RNA was DNAse I treated to get rid of contaminating 
genomic DNA. WT1 and K01 represent the RNA extracted from WT and C/EBPp-l- (KO) 
macrophages for the first infection experiment. The same labelling scheme applies for 
infection experiments 2, 3, and 4: In the treatment column "-" refers to media controls and 
"-1-" to samples activated by IFN-y and infected with L. monocytogenes. 
Experiment Treatment A2l1O A2!10 A 2Ml/A2!10 RNA conc. yield (~g) 
(~g/~l) 
WT1 10.66 5.08 2.1 0.43 24.15 
--.~---.---~----- .--------~---.----'--.----. -.-- -----.-.-----~-- ----.--------- --_._--_.- .. --.-----------
WTl t- 8.88 4.21 2.1 0.36 19.95 
--.. -------- r-------·-- ----~--~--
KOI 1l.73 5.56 2.1 0.47 26.68 
KOI + 3.90 1.84 2.1 0.16 8.20 
--.-----.---------.--.-.--- -.-------f----. --.- ---. 
WT2 27.40 12.93 2.1 1.10 63.67 
--_._-_._ .. _._._---_._ .. - +---.. --~----+-.------. -------_. __ .. _.- ---------_._- ---_ .. _._----------j----
WT2 + 32.88 15.51 2.1 1.32 76.60 
.--- -- .... --
K02 41.04 19.45 2.1 1.64 95.85 
-r--------~·------·-·-_t_-- ---------------_. - _ .... 
K02 19.27 2.1 1.63 94.96 + 40.66 
._ .. _-------_._-------+._--------------+._-_ .. _--_. --_._-_._---_ .. _-
WT3 22.60 10.71 2.1 0.90 52.33 
_._--------j------_._--_. __ ._-_. ------_ ... __ ._-- ---_._---
WT3 -1- 11.90 5.67 2.1 0.48 27.09 
I----------·-----+·--~--·------+-------- ---.- --------.---- ----------- -------.- - .-.---- ~--.--------
K03 26.37 12.44 2.1 1.05 61.23 
-- _._._--_.-... _ ..... --- ._.j---_. __ ._------_ .. _--I-- ---------- --------.------ .-----.------- ----.---.-- - --~.-.----.--
K03 + 17.93 8.50 2.1 0.72 41.32 
--.----.--~--- ------t-------------------j---·-----·---·---· ---.-.--------- ---.-.--~. 
WT4 0.38 0.22 1.7 0.30 64.23 
---_._--+._- .-~ ._----- --_._-------_ .. __ . ---------_. __ . -.-~----
WT4 + 0.33 0.18 1.8 0.26 55.67 
.- -------.--. ----.-.--------f-----.---------. --~-.~.---
K04 0.68 0.36 1.9 0.54 115.07 
--- --.-------------+.---------------j-~- ._._----- - .- ._---------_._--- .-----~-- - -_ .. -
K04 + 0.49 0.27 1.8 0.39 82.89 
L._. __ . __________ . __ .. _____ ~ __ . __ ._. __________ ,_._. __________ . ____ . ___ . ______ ._. __ . ______________ ~_ _ ________ . ____ .____ _ ________ ._._ 
I n order to determine if the RNA was "biologically representative" of in vivo and in vitro data 
reported f()f C/EBPI3-1- mice, the induction of CIEBPB target genes G-CSF, CLECSF9, IL-
12p35 and ISGF3y was measured by quantitative real-time RT-PCR. An aliquot of the RNA 
that was 10 be used tor RNA analysis was used to make cDNA for the RT-PCR analysis. 
ClEBPl3 was shown to be essential for the induction of G-CSF during innate immunity against 
L mOllocytogenes (10), Afycohucferium tuberculosis (15) and Bmcella abortus (16). Ci-CSF 
was found to be important /(Jr bactericidal killing by promoting membrane fusion between 
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pathogen-containing phagosomes and endosomes (16). Similarly, C/EBP[) was shown to be 
essential ror induction of CLECSF9 in response to LPS, TNF, 11,-6, and IFN-y stimulation 
(12) and for lL-12p35 induction during Candida albicans infection (11). In addition, C/EBP[3 
was shown to transcriptionally induce ISGF3y, a component of the ISGF3 protein complex 
that is essential for 1FN signaling (13). As expected, the C/EBPWI- macro phages had impaired 
induction of G-CSF, CLECSF9, J L-12p35 and ISGF3y (Fig. 6). Furthermore, the 
amplification of the RT-PCR products was very et1icicnt and robust, indicating that the 
quality of the RNA to be used for microarray \vas 01" high quality. 
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Figure 6. Impaired induction of C/EBPP target genes in C/EBPp-/- macrophages during 
1.. monocytogt!llt!s infection. Quantitative RT-PCR of C/EBP~~ target genes in WT (tilled 
bars) and CIEBPW
I
- (open bars) activated macrophages at 4 hours p.i. cDNA was generated 
from the same batch of total RNA that was lIsed for microarray analysis. Data represents the 
averages and SEM of 3 independent experiments. 
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DISCCUSION 
The aims of this chapter were to estahlish and evaluate the in vitro infection of BMDMs with 
L lIlol1ocylogenes, compare the innate immune responses between infected WT and C/EBPf3-1-
macro phages and to purify RNA from the infected WT and C/EBPWI- macrophages for 
comparative gene expression profiling. In this study L. monocyto?:enes was used as a model 
intracellular pathogen to identify macrophage genes involved illl1lediating listericidal activity. 
Host protection to L. lIlonoqtogelles involves the activation of macrophage hactericidal 
effector functions, granuloma formation and protective Th I-type responses. Key cytokines 
required during the innate immune phase are 1 FN-y and 'fNF, which promote macrophage 
activation and production pro-inl1ammatory mediators and anti-microhial molecules such as 
ROI and RNl. 
Several in vivo infection studies using mice deficient for iNOS, p47phox, gp91 phox or hoth 
gp9Iphox and iNOS, showed that hacterial killing took place despite the lack of ROI and RNI 
(3-7). Furthermore, studies using mice deficient for genes such as IFN-y (17,18), IFN-yR (S, 
17), ICSBP (19), IRF2 (19), RclB (20), TNFRp55 (21, 22), and C/EBPl3 (l0) also 
demonstrated that that macro phages have an alternative unknown killing mechanism that is 
independent of ROI or RNI. 'rhis unknow11 mechanism is most likely driven by IFN-y and 
TNF, Sll1ce these cytokines are essential tor the cytocidal/cytostatic and 
bactericidal/bacteriostatic activity of macrophages respectively (8, 9). The most downstream 
molecule in this alternative killing pathway would be C'/EBPf3, since the C/EBPWI-
macrophages expressed normal levels of lFN-y and TNF as compared to W'[' (10, 15). 
l;urthermore, since the macrophage efteclor genes would most likely be downstream of 
C/EBP~ in the unknown killing pathway, comparative gene expression analysis between WT 
and C/EBPf3-1- macrophages infected with Listeria would theret()fe increase the probability of 
identifying these eflector genes. However, before proceeding with the RNA extractions and 
the microarray experiments, several parameters of the infection experiment needed to be 
checked to (1) determine if the biology of the in vilro infection was equivalent to that of the in 
vivo infections, (2) determine the best time-point at which to extract RNA for microarray 
analysis and (3) puri1y and assess the quality of RNA to be used (or microarray analysis. In 
order to mimic the biology of the in vit'o infection experiments, macro phages were not pre-
activated with IFN-y prior to intCction with L lnOf1ocytogenes. Instead, macrophages were 
stimulated with IFN-y and infected with L. tnol1ocylogenes at the same time. This particular 
infection protocol was used since it ret1ected more closely the biology of natural infections, 
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where macrophages do not exist in a pre-activated state, but rather undergo activation upon 
infection. The biology of the in vitro data was assessed by measuring the production of pro-
inl1ammatory mediators, nitric oxide, transcription of C/EBP~ target genes, phagosomal 
escape and listericidal activity. The generation of l3MDMs from stem cells was successfully 
optimized, although the yield was 3 times lower for the C/EBPWI. mice. 'rhis was not 
unexpected, since C/EBP~) has been shown to be important for macrophage diJTerentiation 
and is highly up-regulated during the differentiation process (23). Moreover, thc lack of G-
CSF in the C/E8Pp-/. bone marrow stem cells may also account for the decreased yield of 
hone marrow derived macrophages. Studies using G-CSF deJicient (G-CSF/.) mice 
demonstrated that G-CSF is required for the differentiation of bone marrow stem cells into 
macrophages(24). r n the O-CSI;·I. mice, the Frequency of bone marrow progenitor 
macrophage colony forming cells were signiticantly reduced as compared to WT mice, 
resulting in marked decreased yield of macrophages (24). 
Both WT and C/E8PWI. macrophages were equivalently activated during 1.. monocytogenes 
infection since they both induced significantly high levels of IL-6, IL-12, IL-18, TNF and 
MCP-l as compared to their media controls. Moreover, in spite of slightly higher levels of 1 L-
10, the C/EBPp-/. macrophages were activated to the same extent as WT, since there was no 
significant difference in the levels or induction of these pro-inl1ammatory mediators between 
these two groups. However, 1 L-18 levels were signi1icantly lower in the C/E8PI),I' 
macrophages at 4 hours p.i., but reached levels comparable to WT at latcr time points. 
Furthermore, the levels of nitrite, which is indicative of nitric oxide, were equivalent for both 
CJEBPWI. and WT macrophages. However, despite full macrophage activation, the C/EBPWI. 
macrophages had 30% greater listerial escape from the phagosome and uncontrolled bacilli 
growth. Kinetic analyses of macrophage activation and listericidal activity were performed at 
2, 4, 8 and 12 hours atter iniCction in order to determine the best time point to collect RNA 
for microarray analysis. No signi1icant differences between t.he WT and C/I~13prr/' 
macrophage activation were observed over a 12 hour period, since both groups e1liciently 
induced protective pro-inflammatory cytokincs, chemokine MCP-1 and nitric oxide. 
I lowever, significant differences in listericidal activity were observed between the two groups 
at 4, 8 and 12 hours p.i .. Since the increased bacterial load and impaired killing in the 
C/FBPI3-1- macrophages was a consequence of differential expression or listericidal genes in 
C/EBPWI. macrophages as compared to WT, total RNA was therefore puriJied from infected 
samples and controls at 4 hours p.i .. The quality of the RNA was excellent, since cDNA 
148 
generated from it robustly amplilied in several quantitative RT-PCR reactions using the 
Ughtcycler, which is a real-time Rf-PCR instrument that is highly sensitive to impurities and 
requires a high quality cDNA template. 111 addition, quantitative Rf-peR con/inned that 
C/EBr[3-!- macrophages had impaired induction of C/EBP[) target genes as reported in 
literature (10-13), All together, tbese results demonstrated and conJirmed thc phenotype of 
C/EUf)ff
i
- macrophages infected in vitro with L monocy/ogenes was the same as reported in 
the literature (10-1 J) and therefore provided a solid foundation on which to base the gene 
expression profiling experiments. The infection experiment was repeated four times 
independently or each other and RNA extracted at 4 hours p.i. for microarray analysis. 
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CHAPTI~ll4 
II)ENTIFICATION OF GENES INVOVLED IN MACROPHAGE EFFECTOR 
FUNCTIONS AGAINST L. MONOCYTOGENES BY DNA MICllOARRA Y. 
SUMMARY 
The anti-listerial transcriptional response of IFN-y-activated macrophages from WT and 
C/EBPWI - mice infected with L. mono(ytogenes was successfully profiled at 4h post-infection 
using oligonucleotide microarrays. Image analysis revealed that there were several lIuality and 
printing defects which resulted in systematic variation within and between the arrays. A 
selluential normalization procedure within and between arrays was lIsed to remove, as much 
as possible, systematic variation from the data. However, statistical evaluation of the 
normalized microarray data showed that the technical reproducibility within each array and 
between replil.:ate experiments was poor. Removal of questionable and unreliable data 
increased the reproduci bi lity and rei iabi I ity of the m icroarray data, although it did necessitate 
trimming 49~;() of the genes from the data set. Despite the poor performance on statistical 
level. the microarray data still contained biologically meaningful data. For example, genes 
encoding several pro-inflammatory cytokincs, chemokines, iNOS and genes important for 
macrophage activation and M HC class I I presentation were significantly up-regulated in both 
the WT and C/EBPW I - infected macrophages. Moreover, the induction of C/EBPf1 and its 
target genes, G-CSF, CLECSF9, IL- I 2p35 and ISGF3y was impaired in the C/EIWrr/-
macrophages. Differentially expressed (DE) genes were identified by a two sample paired T-
Test based on permutation rather than distribution. A Bonlcrroni correction was applied to the 
p values to adjust 1'01' multiple testing. Five percent (1268 genes) of the mouse genome was 
differentially expressed between the WT and C/EBPp-I- activated macro phages infected with 
L. mono(l'togenes. Functional clustering of genes showed that 2.0%) of the DE genes were 
involved in host immunity and defense, 3.' (Yo in the production of ROI, 4.6(Yo in the regulation 
of transcription, 16.1 % in signalling and 8.9% wen: involved in phagosome maturation, 
phago-Iysosome rusion. Moreover, promoter analysis identified that 18.0% of the DE genes 
had putative binding sites I~)r C/EBPP and 47.3% had binding sites for transcription factors 
that interacted with C/EBP~l A focused functional clustering strategy was used to reduce the 
number or candidate genes from 1268 down to 220 genes. Literature profiling or these 220 
candidate genes revealed that several were already puhlished in literature to playa role in 
defense against L. monocyfogenes. Since the aim or the microarray experiment was to identify 
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listericidal genes In the activation and killing pathway downstream of C/EBpr~, PKCo was 
considered the most promising candidate gene since it is involved in humoral defense, 
immune signalling and production of superoxide. Moreover, PKC8 is involved in the 
regulation of transcription and promoter analysis revealed that it may itself be a 
transcriptionally regulated by C/EBPf). In B cells stimulated with LPS, PKCi5 was shown to 
negatively regulate C/[BPr3 transcriptional activity. Studies by Wadsworth and (ioldtine 
using rottlerin, a putative specific PKCo inhibitor, indirectly suggested that PKCi5 promoted 
phagosomal escape however no direct evidence showing a correlation between the listerial 
phagosomal escape and PKCi5 activity was presented. Furthermore, the up-regulation of 
PKCo in the highly susceptible C/8SPWI- macrophages infected with L. lI1ol1ocytogenes was 
validated by quantitative RT-PCR. Taken together, these data suggested that PKC8 may be 
detrimental to the host during L. monocytogenl's infection, however this premise has never 
been tested. Since the role of PKC8 in innate immunity to intmcellular pathogens has not been 
directly investigated to date, the PKCo gene deficient mouse model was used in the current 
study to functionally characterize the role or PKCo during L. f170l1ocytogenes infection. PKCo 
gene deJicient mice were used rather than rottlerin, since this putative PKCi5 speciJic inhibitor 




1. RNA Amplification, Labelling and hybridization to MEEBO Oligonucleotide 
MicroalTays 
Total RNA was purified from L. tnorlocytogenes infected WT and ClEBPp-l- activated 
macrophages at 4 hours p.i. The total RNA was DNAsel treated and re-purified to get rid of' 
contaminating genomic DNA, salts and phenol which may inhibit cDNA synthesis. Although 
the quality or the RNA was excellent as discLissed in Chapter ], the yield was too low for 
standard microarray protocols used at the capar Microarray Facility, which required at least 
50pg total RNA for each hybridization. 'I'his is a common problem with gene expression 
pro1iling by microarray. Routinely 10 to IOOexg or total RNA or 2 to 5cxg of mRNA for each 
sample is required for a single labeling and hybridization reaction. To overcome this 
limitation, especially in the case of gene expression analysis of small biopsies, fine needle 
aspiration or laser capture microdissection samples, a linear RNA amplification method was 
developed by van Gelder et al (3). In this method, the mRNA in the total RNA sample is 
reverse transcribed into double stranded DNA using oligo-d(T) primers that contain a T7 
RNA polymerase promoter 5' to the polythymidyate (d(T") region. After second-strand cDNA 
synthesis. a T7 RNA polymerase is Llsed to generate amplified anti-sense RNA (aRNA). 
((owever. one major concern of' this procedure is the lidelity of the amplification process, 
since not all mRNAs may ampliry equally well. Unequal amplification of RNA could lead to 
the erroneous identification of genes as being differentially expressed when in fact their 
dilTerential expression is due to biased RNA amplification rather than biology. 
Hypothetically, there may be two kinds of biases during the RNA amplification procedure. 
The first bias may be sequence-dependent which is caused by the complicated secondary 
structure of RNA, the full length orthe mRNA, the length of polyA tail and/or the sequence-
specific el'ficieney or the T7 RNA polymerase. These sequence-dependent biases could 
change the relative mRNA abundance for some genes in the amplified RNA. The second bias 
may be abundance-dependent and is caused by the copy number of the RNA. Since the 
mRNA copy numbers are different between the test sample and the reference sample, the 
resulting ratios may not depict the true expression profile of the two samples. A study hy Li et 
al showed that biases introduced in the processes of RNA amplification were minimal and 
were sequence-dependent but not abundance-dependent (4). Several groups have also shown 
that the biases introduced during the RNA amplification procedure are minimal (5, 6). In one 
of these studies, the differential expression or only 3-4 % of genes idenlified as being outliers, 
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could not be validate by quantitative RT-PCR (6). Moreover, RNA amplification has been 
repol1ed to improve the reproducibility of' microarray expression profiles for a wide range of 
RI\lA inputs (5, 6). However, it is prudent to test if linear amplification has taken place by 
spiking the RNA amplification reactions with different doses of control RNAs e.g. Lucidea 
doping controls I'rom Amcrsham Biosciences. FUl1hermore, to ensure that genes identified as 
outl iers are tru Iy di fferentially expressed, it is im portant to quantitate their expression level s 
in the unal1lplifted RNA from the same batch or RNA that was lIsed for RNA amplification 
and microarray hybridization. Therct()re, in this study, the mRNA fraction of the lotal RNA 
was linearly amplified to generate enough probe fIJI' microarray analysis. However, at the tillle 
or the microarray experiments in this study, lhese doping RNA controls were not available. 
Therefore the linearity of the RNA amplification procedure could not be assessed. 
First strand cDNA was successfu Ily reversed transcribed llSlllg 01 igo d('1') prtmers that 
contained a T7 promoter sequence. Second strand cDNA synthesis converted the single-
stranded cDNA into double-stranded cDNA that was then in vitro transcribed using '1'7 RNA 
polYlllerase to synthesize aRNA. During the in vitro transcription (IVT) amplification 
reaction. amino allyl modified dUTP (aaUTP) was incorporated into the aRNA at a ratio of 1 
UTP: I aaUTP. The aaUTP contained a reactive primary amino group on the CS position 01' 
the uracil that could be chemically coupled to N-hydroxysuccinimidyl ester-derivatized dyes 
(NilS dyes) sllch as Cy3 and CyS. The amplification of the RNA samples was highly 
successful as shown by the excellent yields, quality and purity: the ampli1ied RNA (aRNA) 
appeared as a smear extending above the 28S rRNA band to just above the SS rRNA band, 
and was of high qual ity since no degradation was observed (Fig. I). The purity of the aR NA 
was excellent as revealed by A:.h()/ A2XlI ratios that were close to 2.0 (Table I). Furthermore, the 
yield of' aRNA was exceptionally good, since:...1 OOpg aRNA was generated from I p.g of total 
RNA Crable I). The purified aRNA was successfully labelled with either Cy3 or CyS via a 
coupling reaction between the amino ally modilied UTP residues on the aRNA and the amine 
reactive Cy-dyes. The frequency of dye incorporation (FOI) into the purified aRNA was 
excellent and between 39-S7 dye molecules were incorporated per 1000 nucleotides or aRNA 
(Table 2). The yield, quality and dye-labelling of the aRNA probes was first-rale, and the 
microarray hybridi;:ation step was proceeded with confidence. 
Bctore hybridization of the labelled uRN!\, the arrays were prehybridized to wash away any 
unbound oligonucleotides that did not bind to the slide during to the printing process. In 
additioll, the prehybridization step reduced non-specific background hybridization by 
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blocking the reactive groups on the surface of the slide which could have bound labelled 
aRNA. Furthermore, in order to reduce evaporation of the labelled aRNA, the hybridizations 
were carried out at 42°C. However, it was later discovered that the hybridization apparatus 
used was inadequate as it did not maintain the temperature at 42°C throughout the 
hybridization step. Instead, the hybridization apparatus, a plastic container filled with water 
pre-warmed to 42°C placed in a hybridization oven heated to 42°C, cooled to 35°C. 
Unfortunately since, half of the experiment (4 microarrays) had already been processed using 
the faulty system and economic constraints did not allow for repeat hybridizations, it was 
decided to process the remaining experiments under the same conditions to maintain 
consistency. Moreover, since the hybridization buffer contained 50% formam ide, it was 
hoped that any non-specific hybridization due to the lower temperature would be prevented by 
the high percentage of formamide in the hybridization buffer. Consequently a calibrated 
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Figure 1. Denaturing 1 % agarose gel electrophoresis of purified aRNA. 
Shown is an example of high quality aRNA that is representative of all samples used in the 
microarray experiment. Lane I contains l).lg total RNA; lanes 2 - 5 contains 2-3).lg of aRNA 
generated from RNA isolated from WT and C/EBPWI - (KO) macro phages from the first 
biological experiment that were either untreated media controls (-) or activated with IFN-y 
and infected with L. monocytogenes (+). Arrows indicate the position of the rRNA bands 
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Table 1. Quality and yield of purified unlabelled aRNA. Puritied total RNA (I ~lg) was 
reversed transcribed using 01 igo del') primers that contained a T7 promoter sequence, Second 
strand cDNA synthesis convelted the single-stranded cDNA into double-stranded cDNA that 
was then in vitro transcribed (IVT) using T7 RNA polymerase to synthesize aRNA. WT I and 
KO I represent aRNA samples from the first biological infection experiment. The same 
labelling scheme applies for infection experiments 2, 3, and 4. In the treatment column "-" 
refers to untreated media controls and "+" refers to samples activated by IFN-y and infected 
with L l17onocytogenes. 
Sample Treatment Au,tI A211t1 Au,o/A2I1n Conc. (flg/,d) Yield (tlg) 
KOI + 16.76 8.14 2.06 0.67 
--.-
9.50 2.04 0.78 
.. ------------------- --------- .. ------- _ .. ---- ---------
WTI + 34.57 16.78 2.06 1.73 
-.-------. ---------------- ------.. ----.-.-- --- ... --.... -----------1--- ---
WTI 29.54 
19.98 












--.. ----- --.. --------- f---------- ----- - --.. --------. - .. -- --------.----
K03 18.17 8.95 2.03 0.73 
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WT3 + 19.41 9.56 2.03 0.78 
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Table 2. Frequency of Cy-dye incorporation into purified labelled aRNA. Purified aRNA 
from WT and C/EBPrr/- (KO) macro phages were labelled with either Cy3 or Cy5 via a 
coupling reaction between the amino ally mudi/ied LJTP residues on the aRNA and the amine 
reactive Cy-dyes. WT I and KO I represent aRNA samples from the first biological infection 
experiment. The same labelling scheme applies for infection experiments 2, 3, and 4. In the 
treatment column "-" refers to untreated media controls and "+" refers to samples adivated by 
lFN-yand infected with L. tnoflocylogelles. The frequency of incorporation (FOI) represents 
the number orCy dye molecules incorportlled per 1000 nucleotides. (nd = not determined) 
Sample Treatment [)yc Au.o/A2I1u Au.u A~~o AMio aRNA FOI 
Label (Cy3) (Cy5) (~g) 
+ Cy3 2.06 0.259 0.238 nd 19.17 55 1-:.01 
KOI 
"~f------'~---"-'--- -.---- ------.... --.- ----.-.-. -------.-.. ----~.--- ---.. ----. 
Cy5 .04 0.263 nd 0.323 19.46 44 
:~ -,-= ~~ .... ~~~~ .....•. ~ ~~: ~= •.. ~E ..•. ~:227 .-~~:~i::'~ == :~ .. -
--- -~- --- ------------- ----- ----.---- ------ --J--.---. ------
K02 Cy3 .05 0.281 0.24 nd 20.79 51 
WT2 + Cy3 2.06 0.279 0.241 nd 70.65 52 
.-._--_._._--+._---- _. __ ._-----.--_.- .. _._-
WT2 Cy5 2.09 0.26 nd 0.347 19.24 48 
~.-.-.----+---.--.-.-........ -.-... t-
K03 + Cy3 1.74 0.235 0.175 nd 17.39 5 
-- -.. -.--j-.----------.-i .. ---.-.. --- ---.... --.. -- .. ----.. - ------- .. --- .---.. -. ---------.. --.------
K03 Cy5 1.78 0.281 nd 0.309 40 
._._-_ ... _._--._-- -----
WT3 + Cy5 1.85 0.245 nd 0.268 39 
WT3 Cy3 1.76 0.284 0.194 nd 
.. _--- _ .... -. ... __ ._-._---- _. __ ._ ... -
K04 + Cy5 1.86 0.115 /ld 0.138 8.51 43 
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2. Scanning and Image Analysis 
Alter washing away unbound labelled aRNA probe, the microarray arrays were scanned using 
optimized photo-multiplier-tube (PMT) settings so that the overall fluorescem:e in the red and 
green channels were balanced. Scanned microarray images were saved and analyzed using 
GenePix 5.1 software. The image analysis process consisted of three general steps: (i) the 
addressing/gridding step where the co-ordinates and identity of each spot on the array were 
delinecL (ii) segmentation step where pixels were classified as either foreground (within the 
printed spot) or background and (iii) intensity extraction where the red and green fluorescence 
foreground and background intensity pairs were calculated for each spot. 
Thc addressing for each spot was dif'licult, bccause many of the grids were printed slightly 
"skcw" resulting in displacement of spots from the expected location. These displacements 
and irregular spacing of spots were 1110st likely caused by misalignment of the gridding robot 
and/or bent damaged pins. Furthermore, only 50%) to 60% of the spots on the arrays gave a 
detectable fluorescent signal. Consequently the "missing" spots were flagged as "not found" 
during the addressing step. Segmentation for each spot on the arrays was done by manual 
alignment using the single irregular and/or the regular feature tool. This method was chosen 
because it allowed the diameter of the "circlc" that defined the forcground of the spot to be 
estimated independcntly of other spots. Moreover, the segmentation algorithm implemented 
by this feature did not place restrictions on the shape of the spot, and efficiently allowed spots 
that were oval or irregularly shaped to be defined. The intensity extraction step was 
automatically carried out by the GenePix software, and was based on the principle lhat (i) 
each pixcl in a scanned image represented the level of hybridization at a specitic location on 
the slide and (ii) that the total amount or hybridization for a particular spotted DNA sequence 
was proportional to the total tluoresccnce at the spot. The natural measurc or spot intensity 
was thercfore the sum of pixel intensities within thc spot. The background Iluoresccnce for 
each spot was estimated by measuring the local background intensity in the region that was 
furtherest away from all four surrounding spots. In addition. the GenePix software also 
calculated other quality control metrics for spot size, morphology and tlags. 
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Visual inspection of the scanned 11uorescent microarray images reveakd several quality and 
printing defects summarized in Table 3. For example, several bright spots on the arrays had 
comet tails that masked the true signal or surrounding spots (rig. 2 A). About IO'Yo or the 
spots on the array were either printed on top of each other or merged into each other (Fig. 2 B, 
C), resulting in significant loss or data. This was paliicularly bad in grid numher 31 for all 
arrays, where spots within the first 8 rows had merged (Fig. 2 C). most likely due to 
misalignment of the gridding robot and/or bent/damaged printing pins. The general size and 
morphology of the spots were inconsistent over the whole array and several dilated spots were 
observed (Fig. 2. D). Furthermore, several grids were printed skew, resulting in irregular spot-
to-spot spacing within the 35x35 array, which made the assignment of gene IDs difficult. 
Table 3. Summary of visual quality and printing issues for all arrays. Visual inspection of 
Iluorescent m icroarray images revealed severa I qual ity and printing defects. The severity 01' 
each problem was rated by + signs, where + is present, + + had and + + + very bad. 
WTl WT2 WT3 WT4 KOI K02 K03 K04 
Comet tails j- ++ ++ ++ + ++ ++ -+ 
-------- --~------ -~------- ---------1-------+-------- --------
Merged spots ++-+ +++ ++-+ +++ +++ +++ +++ +++ 
------~----------------------- ----- ------------------------ -------- -~---- ---------- -------
Spots on top of each + -+ + + t + + + + t +- + + + + + + + + + + -+ + + 
other 
~~iil:~~~~;~~'---- . ~-~ : ~-~~ ,;==;-_-='~~~<~~;~1 
- -------------------~-------------- -- ---- ~---------t_--- -------1----- - --------] 
;;~::~E:~~0~~;~~-: -': ,--:- ~ : ; ;- ~=_~;~~ 
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Figure 2. Microarray Printing and Quality Issues. Visual inspection of the fluorescent 
images revealed that the arrays had several quality and printing defects (arrows) as 
demonstrated by (A) comet tails that streak out from bright spots, (B) spots printed on top of 
each other that consequently spread out (C) spots that merged into each other and (D) dilated 
spots. Shown here are grids from the array for the third biological experiment where the 
aRNA from WT macrophages untreated (media controls; labelled with green Cy3) or 
activated with TFN-y and infected with L. monocytogenes (labelled with red Cy5) was 
compared. Each square represents a grid of genes that were printed in 35 x 35 array and each 
microarray contained 32 grids. Each fluorescent spot represents an individual gene. Spots that 
appear yellow indicate that the particular gene is expressed in both the untreated macrophages 
and TFN-y activated and L. monocytogenes infected macrophages. Green or red spots indicate 
that the gene is expressed only in the untreated macrophages or the TFN-y and infected 
macrophages respectively. Shown in A, B, C and 0 are grids 5, 25, 32 and 4 respectively for 
array WT3. 
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The reasons for the observed printing defects can only be speculated since the arrays were 
printed by the capar Microarray facility and the physical printing process was not part of this 
dissel1alion. 'I'he comet tails may have been caused by (i) printing too high a concentration of 
DNA resulting in overloading the binding capacity of the slide, (ii) inadequate fixation of 
DNA to the slide due to poor LJV cross-linking or inadequate baking, (iii) poor post-print 
washing technique and/or (iv) damaged and/or defective printing pins which delivered an 
excessive amount of DNA during the printing process. In addition, some of the above defects 
may also have been worsened by the hybridization of very highly expressed genes in the 
samples or by accidental movement of the coverslip while adding the labelled probes to the 
array. Misalignment of the gridding robot and bent/damaged printing pins may have 
accounted for spots being prinled with irregular spacing resulting in "skew grids", as well as 
causing spots to be printed on top of each other and merging together. Moreover, damaged, 
bent and/or blocked printing pins may have delivered excessive amount of DNA to spots, 
causing them to "bleed out" due to capillary action resulting in dilated spots. In addition, 
some of the spots could not be addressed (i.e. given a gene ID) since they were not printed in 
the expected location. Consequently several spots could not be confidently identitied and 
were classified as "missing". However, several "displaced" spots that were printed in a 
position other than their expected location could still be confidently identified. For example, a 
spot printed equidistantly between the expected location for gene A and gene B can not 
confidently be given the identity of either gene A or B. However, a spot printed off centre 
from the expected location of gene A can be confidently addressed as gene A. Furthermore, 
some of lhc above defects may also have been worsened by "human handling techniques" 
where palticle contamination from dust in the work area, gloves or particulates in the wash 
bufTers may have been introduced. 
Although hybridization of the labelled probes was performed at 35°C instead of 42°C, no 
noticeable non-specific hybridization was observed by eye. Open ··non-fluorescent" areas 
indicated that not every spot on the array had bound labelled probe, which would be expected 
if non-specific binding had taken place. Moreover, several bright green or red spots were 
observed, indicating that differentially expressed RNAs had bound specillcally to their 
oligonucleotide target spot on the array (Fig. 3.). Had non-specific binding taken place, the 
background fluorescence may have been high and the majority of the spots on the array would 
have fluoresced yellow. Although there were several quality issues, the array still contained 
biologically meaningful data, since induction of pro-inflammatory genes was clearly up-
regulated in the '"treated" samples and appeared as bright green or red spots depending on the 
162 
Cy-dye label of the treated sample (Fig. 3). Moreover, since most of the negative control 
genes did not have any significant fluorescent signal above background, the specificity of the 
hybridization reaction, despite the low temperature of 3SoC, appeared to be reliable. Once the 
grids were aligned for each spot, the fluorescent intensity for each spot and its estimated 
background fluorescence was measured and exported as a "GenePix Results" (.gpr) file for 
analysis. 
Figure 3. Apparent specific hybridization at 35°C. Although hybridization of the labelled 
probes was performed at 3SoC instead of 42°C, no noticeable non-specific hybridization was 
observed. Several bright green or red spots can be seen, indicating that differentially 
expressed aRNAs have bound specifically to their oligonucleotide target spot on the array. 
Differential hybridization of pro-inflammatory genes known to be induced in activated 
macro phages during L. monocytogenes infection can be seen: the levels of mRNA for IL-6, 
IL-P and TNF in macro phages activated with IFN-y and infected with L. monocytogenes 
(labelled with green Cy3) was much higher than in the untreated macrophages (labelled red 
with CyS), and these spots therefore appeared bright green. Shown is a grid 10 of 32 from the 
WT2 array for the second biological experiment where the aRNA from WT macro phages 
untreated or activated with IFN-y and infected with L. monocytogenes was compared. The 
insets for IL-6, IL-P and TNF are taken from grids 24, 25 and 16 respectively from WT2 
array. 
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3. Identification and Normalization of Systematic Bias 
Visual inspection of the fluoresccnt images revealed that there were several qual ity issues and 
systematic biases, In order to accurately and precisely measure gene expression changes, it 
was important to remove any systematic variation in the microarray data that may obscure the 
true experimental variation between the WT and ClEBPp-/- infected macro phages. If the 
systematic variation was not removed, it Illay have resulted in the failure to identify truly 
differentially expressed genes (false negatives), as wdl as in the identification of genes not 
truly differentially expressed between the two samples (false positives). The goal of 
normalization was to identify and remove these systematic variations while retaining the 
biological inlllrlllation. However, complex normalization procedures may also remove 
biological information. To avoid this, a simple sequential normalization procedure was 
followed as recommended by Wit and McClure (7): first the data within each array was 
normalized followed by normalization of data between all the arrays. Furthermore, a specific 
sequence of steps was followed for the within-array normalization: first spatial effects were 
removed, thcn the background corrected and lastly dye bias effects were removed. Thereafter 
hetween-array normalization re-scaled the data across all arrays. All image and normalization 
procedures were conducted in the R version 2,2.0. environment for statistical computing and 
programming (8) using packages 13ioConductor (9). Limma (\0-12) and Smida (7). 
Sources of systematic variation (not related with variation due to biological causes) include: 
(i) differences in the labelling (i.e. dye hiases), (ii) differences in the sample preparation, (iii) 
difrerences in the hybridization, (iv) differences in the photo-detection and (v) auto-
Iluorescence. The most common systematic variation is caused by dye bias, where the red 
channel intensities tend to be lower than the green channel intensities. 'rhe Cy3 and Cy5 dyes 
used for labeling the aRNA probes have slightly dillerent physical properties with respect to 
their quantum yield, size, half-life, heat- and light-sensitivity. These differences resulted in 
dil'terential incorporation of the dyes into the labeled aRNA and differential hybridization of 
the labeled aRNA probes onto the array. Furthermore, the imbalance between the red and 
green spot intensities was not constant for all spots within and between arrays. Red (Cy5) and 
green (Cy3) spot intensities varied as a result in differences of location of'the spot on the 
array, the arraying pins used and experimental variation in the hyhridization process. As a 
consequence the red and green channels orthe array had slightly different d'ficiencies, which 
made direct comparison of the gene expression data unfeasihle. 
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Dye-swap nonnalization is often used to nonnalize for dye biases, where hybridizations are 
repeated twice with dyes swapped and the expression value for each spot over the Cy3 and 
Cy5 channel are averaged. However, the dye bias effects often differ from array to array and 
there is no guarantee that dye swap nonnalization effectively removes the dye bias. Moreover, 
dye swap experiments were not economically feasible. Therefore in this study, a "balanced 
dye" approach was used, where each treatment condition for all four biological replicates 
were labelled equally often with the Cy3 dye as with the Cy5 dye (Fig. 4). In this manner the 
dye labelling bias was compensated for. 
Figure 4. Balanced dye labeling strategy to compensate for dye bias. In the balanced dye 
labell ing strategy, each treatment condition for all four biological replicates were labelled 
equally often with the Cy3 dye as with the Cy5 dye. Each white rectangle represents a two 
colour DNA microarray where the aRNA fonn IFN-y activated macrophages infected L. 
monocytogenes ("treated") is compared to aRNA from untreated macrophages. Samples 
labelled with Cy3 are shown in green and samples labelled with Cy5 are shown in red. The 
"treated" and "untreated" samples are denoted by a subscripted "t" and "u" respectively. For 
each biological experiment there were 2 microarray sl ides, one for the C/EBPj3+I+ (WT) 
samples and the second for the C/EBPp-/. (KO) samples. 
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Other widely used nonnalization methods are (i) global intensity-independent normalization, 
(ii) global intensity-dependent locally }±'§~ighted ,£catter plot ,£moothing (LOWESS) 
normalization and (iii) print-group LOWESS normalization (local intensity-dependent). 
Global normalization assumes that the efficiencies of Cy5 and Cy3 dye differ by a constant 
value and that most of the genes on the array are not differentially expressed. The average of 
the log ratios for all the genes on the array is therefore assumed to be zero. If this was the 
case, then the summed intensity values for each channel should be equal, and where they 
dilTered, a normalization factor could be calculated and used to rescale the intensity values for 
each gene on the array (13). However, this method did not correct ()(' spatial differences or 
['or intensity biases or the dye. For example the CyJ dye may incorporate into the aRNA more 
ctficiently at lower intensities than the Cy5 dye. Global LOWESS normalization 
acknowledges that the variation between the red and green channels is not always constant 
and can change as a function of the signal intensity (i.e. is intensity-dependent). In this 
method, the intensity variation can be corrected by generating a best fit curve through the 
middle of a Ratio-Intensity plot of the microarray data and this line becomes the new zero line 
for the vertical axis (14). In the Ratio-Intensity plot, the ratio of the red (R) and green (G) 
intensities (log2(R/G); also called the M value) for each spot is plotted against the average 
signal intensity (O.5*(log2R + log2G); also called the A value) for each spot. In this analysis, 
the M value in the (M, A) pair is shifted by a quantity ('cccc(A) depending on the A value. This 
constant, erA) is estimated by using the LOWJ:::SS function (J 5), which acts as a kind of 
regression analysis, and peri()fllls robust I i near Iits by calculating a mov i ng average a long the 
A axis, using data frolll an unselected set of' genes on the array. Robust in this context means 
that the curve is not affected by a small to moderate percentage of difTerentially expressed 
genes. The fraction of data to be used fix smoothing at each point can be defined by the 
researcher. This method assumes that (i) relatively few genes are differentially expressed and 
(ii) that no systematic relationship exists between the differential gene expression and the 
location of spots on the array. However. in practice lhis is not true since spatial bias is a very 
common problem and is often caused by hybridization artifacts, print tip andlor plate effects 
that occurred during array printing. Print-group LOWESS normalization can correct for both 
intensity-dependent bias and spatial bias, by performing LOWESS fits for the data within 
each print group. The basic assumptions of this method are that (i) the majority of the genes 
are not d ifferentiall y expressed and (i i) that the number of up-regulated genes is 
approximately equal to the number of down regulated genes. Therefore, all the genes on the 
microarray are used for pri nt-group LO W ESS norma I ization. Moreover, print-group 
LOWESS normalization is only effective if the print-group is greater than 1000 spots per 
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print-group and that the above assumptions holds true Cor each print-group. Normalization 
between arrays adjusts the M values across all of the arrays so Ihat they are on the same scale. 
This essentially prevents one or more arrays having undue weight when averaging thelog ratio 
across arrays. However. normalization between arrays is only effective if the data does not 
contain "missing values", which can result from excluding flagged data and using background 
subtraction. 
Image plots of the red and green background helped identify damaged arrays, spatial patterns 
and/or miscellaneous strange patterns. A Ithough not detected by visual inspection of the 
tluorescent images, the image plots clearly showed that all the arrays except WT4 had high 
background levels in both the red and green channels (Figs. 5, 6). Moreover, within each 
array, the level or red and green background hybridization appeared uniform. except for small 
areas/patches that appeared darker. Since these dark patches were local ized to small areas, 
they wert~ most likely caused by printing defects rather than uneven hybridization, which 
would have affccted larger areas of the array. Since the high background may mask/bias the 
true intensity value of spots, the microarray data needed to be corrected to remove the bias 
attributed by the high background. Background subtraction is the most commol1 method for 
background correction, where the local background fluorescence is subtracted from the total 
spot intensity. However, background subtraction was found to actually increase the variance 
in the data, which is evident by the wide spreading of points at the low fluorescent intensities 
(Figs. 7, 8 "subtraction" panel). In contrast. glohal background normalization using the 
probabilistic method (16), stabilized the variance. which can be seen hy the tight clustering of 
data points at low intensities (Figs. 7, 8 "probabilistic" panel). The "probabilistic" method 
calculated the conditional expectation of the true signal given the observed signal using the 
equation: E(si I si + hi), where the observed signal was considered to be the sum of the true 
signal (si) and the background (hi), which arc assumed to follow exponential and normal 
distributions respectively. Estimates of the background distribution's mean and standard 
deviation were calculated from the tluorescent values of a defined set of empty spots over the 
array. 
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Figure 5. Image plots of the background fluorescence in the red channel. Shown here are 
image plots of the red background fluorescence for each individual array which is made up of 
4 x 8 grids. Each rectangle represents a DNA microarray slide and the smaller squares 
represent the grids. The grids for array KO I are numbered from left to right and grid number 
I is highlighted within the dashed box . The same grid numbering scheme applies for all the 
arrays. The level of brightness is proportional to the level of background fluorescence. WT I 
and KO I represent DNA microarray slides from the first biological infection experiment. KG 
represents CfEBPWI .. The same labelling scheme applies for infection experiments 2, 3, and 4. 
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Figure 6. Image plots of the background fluorescence in the green channel. Shown here 
are image plots of the green background fluorescence for each individual array which is made 
up of 4 x 8 grids. Each rectangle represents a DNA microarray slide and the smaller squares 
represent the grids. The grids for array KO 1 are numbered from left to right and grid number 
1 is highlighted within the dashed box. The same grid numbering scheme applies for all the 
arrays. The level of brightness is proportional to the level of background fluorescence. WT I 
and KOl represent DNA microarray slides from the first biological infection experiment. KO 
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Figure 7. Comparison of background correction methods for CIEBPp-/- arrays. Shown 
here are Ratio-Intensity plots of microarray data from the C/EBPWI- arrays that were 
background corrected by subtraction (left panel) or by probabi listic adjustment (right panel). 
The average signal intensity (represented as an "A value") represents A = [0.5 * (log2R + 
log2G)]. The M values represent the differential ratio of IOg2(R/G). Rand G represented the 
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Figure 8. Comparison of background correction methods for WT arrays. Shown here are 
Ratio-Intensity plots of microarray data from the WT arrays that were background corrected 
by subtraction (left panel) or by probabilistic adjustment (right panel). The M values represent 
the differential ratio of log2(R/G). The average signal intensity (represented as an "A value") 
represents A = [0.5 * (log2R + log2G)]. Rand G represented the background corrected Red 
and Green intensities respectively. 
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Although probabilistic global background normalization removed the high background, Ratio-
Intensity plots revealed that there was significant dye bias, especially at the lower intensities, 
The intensity-dependent relationship between the "average signal" (A value) and expression 
ratio (M value) t()r each array can be seen by the curvature of the data and dipping of the 
LOWESS line at lower intensities, which was particularly bad for KO I, K02, K04, WT2 and 
WT4 arrays (Figs. 9, 10 ""Background corrected" panel). The marked decreased background 
/luorescence for the WT4 and K04 arrays, as compared to thc other arrays, may be due 
fragmentation of the aRNA in the WT and K04 aRNA samples. For this pair of samples, the 
microarray slides were accidentally broken in the swinging bucket centrifuge during the post-
hybridization washing steps. Consequently, the "back-up" labelled aRNA for W'f4 and K04 
samples, which had been stored at -20°C, were thawed and lIsed for hybridization on new 
MEEBO arrays. The single freeze thaw cycle of the labelled aRNA for these samples may 
have partially fragmented the aRNA. Interestingly, the fragmentation or aRNA bas been 
shown to actually improve hybridization kinetics on oligonucleotide printed microarrays (17). 
Therefore the shol1er aRNA sequences in the WT4 and K04 samples my have bound more 
speciiically to tbeir target probes and less non-specifically to the background of microarray 
slides. Consequently, the background fluorescence for the WT4 and K04 microarrays were 
much lower than the other microarrays in this study. Moreover density plots of the 
background corrected data conlirrned the presence of significant dye bias (Fig. 11 A), as 
demonstrated by the spread between green and red density lines for each array. Had there 
been no dye bias, the density lines for the red and green channels would have been 
superimposed on each other. Furthermore, the mean pixel intensities (log 2) of the red and 
green foregrounds ranged from 0 to 16, and centred around 5, which indicated that the 
hybridization worked well and that there was no saturation of signal during the scanning 
process. Had either of these conditions occurred, the pixel intensity values would have 
clustered either at the high or low end of the scale respectively. Since the assumption was 
made that the majority of the genes on the arrays, representing the entire mouse genome, were 
not differentially expressed during infection, the mean M values were expccted to be centered 
around zero. Ilowever, differcntial dye bias affecting the arrays resulted in different spreads 
of M values for each array, resulting in their median M values deviating around zero (Fig. 12 
A). In addition, the degree of intensity-dependent dye bias was not consistent over the array, 
and varied by print group, as shown by the deviation from zero and the ditlering degree of 
curvature of the LOWESS lines for each print group (Figs. 13, 14). This was particularly 


























































Figure 9. Identification of intensity-dependent dye biases in CIEBPWI- arrays. Shown 
here are Ratio-Intensity plots of background corrected C!EBPp-/- microarrays before and after 
print-group LOWESS normalization. The "best fit" LOWESS line is shown in red . The M 
values represent the differential ratio of log2(R/G). The average signal intensity is represented 
as "A values", where A = [0.5 * (log2R + ]Og2G)]_ Rand G represent the background 
corrected Red and Green intensities respectively. KO I represents data the KO (C!EBPp-/-) 
array from the first biological experiment. The same labelling scheme applies for infection 
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Figure 10. Identification of intensity-dependent dye biases in WT arrays. Shown here are 
Ratio-Intensity plots of background corrected C/EBPp-/- microalTays before and after print-
group LOWESS normalization_ The "best fit" LOWESS line is shown in red. The M values 
represent the differential ratio of log2(R/G). The average signal intensity is represented as "A 
values", where A = [0.5 * (log2R + log2G)]. Rand G represent the background corrected Red 
and Green intensities respectively. KO I represents data from the KO (C/EBPp-/-) array for the 
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Figure 11. Identification and correction of dye bias in microarray data. Shown here are 
density plots of the smoothed empirical densities for the individual green (green line) and red 
(red line) channels (A) after background correction, (8) after print-group LOWESS 
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Figure 12. Box plots of Ratio-Intensity plots of arrays after within slide and between 
slide normalization. Shown here are box plots of the M values which are (A) background 
corrected only, (B) nonnalized by print-group LOWESS and (C) nonnalized across all arrays 
using a slide-scale re-scaling algorithm.The central box represents the inter-quartile range 
(IQR), which is the difference between the 75th percentile (upper quartile) and 25th percentile 
(lower quartile). The line in the middle of the box represents the median. Extreme values 
(>75th percentile and <25th percentile) are plotted individually. WTl and KOI represent 
microarray data from the first biological infection experiment. WT and KO represent wild-
type (CfEBPp+I+) and C/EBpp-/-respectively. The same labe,lling scheme applies for infection 
experiments 2,3, and 4. 
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Figure. 13. Identification of intensity-dependent spatial dye biases in CIEBPWI- arrays. 
Shown here are Ratio-I ntensity plots of background corrected data by print-group before 
nonnalization. Each large square represents an individual array that is composed of 4 x 8 
grids which are represented as smaller squares. The "best fit" LOWESS line for data in each 
print-group (grid) is shown is red. The M values represent the differential ratio of log2(R/G). 
The average signal intensity is represented as "A values", where A = [0.5 * (log2R + IOg2G)]. 
Rand G represent the background corrected Red and Green intensities respectively. KOI 
represents data from the KO (CIEBPWI-) array for the first biological experiment. The same 
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Figure. 14. Identification of intensity-dependent spatial dye biases in WT arrays. Shown 
here sare Ratio-Intensity plots of background corrected data by print-group before 
nonnalization. Each large square represents an individual array that is composed of 4 x 8 
grids which are represented as smaller squares. The "best fit" LOWESS line for data in each 
print-group (grid) is shown is red. The M values represent the differential ratio of log2(R/G). 
The average signal intensity is represented as "A values", where A = [0.5 * (log2R + log2G)]. 
Rand G represent the background corrected Red and Green intensities respectively. WTI 
represents data from the WT array for the first biological experiment. The same label I ing 
scheme applies for infection experiments 2, 3, and 4. 
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Data shown in the diagnostic plots in figures 9 and 10 indicate that there were significant 
spatial and dye biases that needed to be removed from the microarray data before any 
quantitative analysis could be done. Print-group LOWESS normalization was considered the 
best method to usc to remove these systematic biases, since it corrects ['or both spatial bias 
and smoothes the dependence of log ratios on intensities. However, this method was only 
reliable if (i) the majority of the genes were not di1Terentiaily expressed and (ii) that each 
print-group consisted of at least J 000 genes. Since most of the genes on the fluorescent 
images appeared yellow (not differentially expressed) and the print-groups were composed of 
1225 genes, all the assumptions of print-group LOWESS normalization were satisfied and the 
data within each array were normalized using print-group LOWESS. Furthermore, spots that 
were flagged as bad were given a weighting of 0.1, nonnalized and retained in the data set, 
thereby avoiding the generation of "missing data". Print-group LOWESS normalization 
successfully removed the spatial and dye biases within each array. Density plots showed that 
the distributions of the red and green intensities essentially became the same for each array 
(Fig. II 13) and box plots of tht~ M values showed that the median of the M values was 
centered on zero for all arrays (Fig. 12 B). Moreover, Ratio-Intensity plots of the data no 
longer had the prev iously observed curvature and was more tightly cl ustered along the 
LOWf;:SS line which was linear and centered around zero (Figs. 9, 10 "Print-group LOWESS 
normalized" panel). However, differences in scale and spread of the M values existed between 
the arrays, indicating that the data between arrays needed to be normal ized. Since 
probabilistic background correction and gene weighting had been used during the 
normalization procedure, the microarray data did not contain any "missing values", a 
requirement for between array normalization. The M values between the arrays were therefore 
normalized using a sliding scale normalization, which effectively divided the M values in 
every array by the Median Absolute Devi<Jtion (MAD). Normalization between the arrays 
resulted in the density of the red and green channels being the same for all arrays (Fig. 11 C) 
and the M values having the same median and spread (Fig. 12 C). The sequential 
normalization procedure implemented had therefore effectively removed, as much as possible, 
the systematic biases and ""non-biological" differences from the microarray data. 
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4. Reproducibility of Microarray Experiments 
A Ithough sequential norma I ization of the m icroarray data removed as much systematic biases 
as possible, there was still considerable "non-biological" variability due to the inclusion of 
questionable or inconsistent data. In order to reduce the probability of erroneously classifying 
non-differentially expressed genes as being ditlerential expressed, it was therefore important 
to remove the questionable data before proceed ing with the quantitative gene ex pression 
analysis. Usually, technical replicate or biological replicate experiments are performed to 
identify and reduce the variability of Illicroarray data. Biological replicate experiments use 
RNA isolated from the independent biological sources and measures both the natural 
biological variability and the random variation introduced during the RNA preparation. 
Technil:al replicate experiments measures the natural and systematic variability introduced 
during the experiment. Technical replicates include replicated spots within a single array, 
multiple alternatively spliced cDNAs/oligos ror a paIiicular gene within a single array, or 
repeated hybridizations using the same RNA sample. For example, dye-swap experiments are 
commonly used to compensate for technical variation and dye biases that occurred during 
labeling or hybridization. However, due to budget limitations, technical replicate 
hybridizations and dye-swap experiments were not done in this study. Instead, Illultiple 
replicate spots within each array were used to assess the technical reproducibility of the arrays 
and a balanced dye-labelling approach was used to compensate for dye labelling variation. 
Moreover, since it is the reproducibility of biological replicates that is important for biological 
inference, biological replicate experiments were chosen over technical repeat experiments. 
Reproducibility within each array was assessed by calculating the standard deviation (SD) or 
the M values for each replicated gene on the array. Genes with S[»0.2 were considered 
questionable/unreliable and therefore not reproducible. The SD value of 0.2 was chosen since 
it is the SD cut ofT value that many researchers use to define questionable data (18). A total of 
41 different genes were randomly spotted multiple times across the array. The number of 
replicates per gene varied from 2 to 20 and the total number of replicate spots was 728. The 
reproducibility within all the arrays was poor, where >50% of the replicate genes failed the 
SD<0.2 criteria of reproducibility Crable 4). The only exceptions were for arrays K03 and 
WT I which respectively had 39% and 49% reproducibility among replicated genes. This poor 
reproducibility indicated that there were significant technical sources of variation within the 
experiments. which may include unequal hybridization kinetics across the individual arrays 
and/or variability within the printed arrays. 
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Table 4. Technical reproducibility assessed by replicate genes within each array. The 
Standard deviation of the M valucs for each replicated gene was calculated. M values with a 
SD<0.2 wen: "passed" and cOllsidered reproducible. Similarly, M values with a SD>O.2 were 
""failed" and considered to qucstionable/unreliable. 
KOI K02 K03 K06 WTl WT2 WT3 WT .. 
Total replicate spots 728 728 728 728 728 728 728 728 
~----------------------- ------ 1------ ------- -------- -------------+------j---------
H genes repJ icated 41 41 41 41 41 41 41 41 
-------------------------------------- ---------~ ------ ---------------- --- -------- -------------- -----------
if passes I I 10 16 7 20 I I 15 I () 
------------------------- -----~----- 1------------ -------------- -------------- --------------
H fai Is 30 31 25 34 21 30 26 31 
-------------------------- --------- ----------- -------------1----------- ---------- ----~-I_------- ------- --- --- ---
total replicates 41 41 41 41 41 41 41 41 
i-------------------------r--------i------- --------+----+---- ---- 1------------
% pass 27 24 39 17 49 27 37 24 
% fail 73 76 61 83 51 73 63 76 
In order to reduce the variance and complexity of the microarray gene expression data, the M 
values for the replicate spots wcre merged and averaged over all four biological replicate 
experiments. The reproducibility between biological duplicates was measured by linear 
regression. Biological replicates were considered reproducible if the correlation between their 
M values was greater than 0.3, since Churchill ct al found that reproducibility between 
biological replicates can be as low as R2 2: 0.3 (19). Comparison of "like-treatment" samples, 
e.g. WT Illillreat~d vs. WT311ntr~u(~d within the red (Cy5) or green (Cy3) channel, showed thal the 
reproducibility wilhin each treatment group was satisfactory (R2=0.62) (Fig. 15). Ilowever, 
when the ratio of the intensities, comparing treated vs. untreated samples (M values) were 
calculated, the reproducibility was poor (R2ccc 0.00000 I - 0.13) (Fig. 16). I'his may have been 
due lhe fact that the individual treatment groups alrcady had a considerable amount of 
variation (R2<0.7, Fig 15) and the direct comparison between the treatment groups introduced 
even more variation, due to the additive nature of their inherent variances. Ratio-Intensity 
plots of the biological replicate experiments showed that the majority of the data was 110t 
reproducible between experiments, as shown by the "outliers" which had standard deviations 
(SD) greater than 0.2 (blue data in Fig. 17) or Sf) greater than 0.3 (blue data in Fig. 18) . 
Therefore to improve the reliability and confidence of the microarray data, unreliable or 
questionable data was removed from Lhe microarray data set. As reviewed by Quackenbusch 
et al (18), many researchers define questionable data as those genes which have SD>O.2 
between biological or technical replicate experiments. However, since a SD>0.2 cut-off 
would require trimming 60% of the genes from the data set, it was considered too stringent. 
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Moreover, using the SD>O.2 cut olT criteria would result in the exclusion of key 
immunological genes, such as TNFRp55 (20), IL-lr3 (21, 22), p47phox (23), Pld2 (24), 
Rabgef(25), Zfpl98 (26, 27) and Cyp2b9 (28), which playa significant role during the innate 
inllammatory immune response against L monocytogenes. Since the microarray experiments 
were considered an exploratory study, it was more important to include biologically 
significant genes in the data for future analyses. [:limination of known and other, as yet, 
unidentified biologically relevant genes, would decrease the probability or fulfilling the aims 
or the study, which were to identiCy genes involved in mediating listericidal activity. 
Theref()rt.: a less conservative value of S[»0.3, which is used as a yardstick by several data 
analysis software e.g. GenePix 5.1 to ddine reliable data, was used to trim unreliable data 
from the microarray data set. Removal of these inconsistent/unreliable "outliers" with SD>O.3 
required 49(~,{) of the genes to be trimmed from the data set. However it did resu It in better 
correlation and reproducibility between the biological replicates (R2~"C 0.3 -- OA, Fig_ 17), but 
not to the same extent when a SD>O.2 cut otT was used (R2 ,= 0.2 -~ OA, Fig. 18). Had there 
been no budget limitations, the microarray experiments would have been repeated using 
commercial, high quality microarray slides in order to obtain statistically reliable data. 
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Figu re 15. Reprod ucibility of fluorescent intensities between biological replicate 
experiments. The nonnalized red (Cy5) or green (Cy3) fluorescent intensities for "like" 
treatments labelled with the same dye were plotted against each other for each biological 
experiment. Reproducibility of the fluorescent intensities between the biological experiments 
was measured by linear regression (red line). Biological replicates were considered 
reproducible only if the correlation between the fluorescent intensities was R2~O.3. Treated 
refers to aRNA generated from IFN-y activated macro phages infected with L. monocytogenes. 
Untreated refers to aRNA generated from media control macrophages. WTI and KOI 
represent data from the WT or KO (C/EBP~·/-) arrays for the first biological experiment. The 
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Figure 16. Reproducibility of gene expression ratios between biological replicate 
experiments. The normalized M values for each spot was plotted against each other for each 
biological experiment. Reproducibility of the M values between the biological experiments 
was measured by linear regression (red line). Biological replicates were considered 
reproducible only if the correlation between the M values was R2~O.3. The M value represents 
the ratio of the fluorescent intensities for treated vs. untreated aRNA bound to each spot. 
Treated refers to aRNA generated from IFN-y activated macrophages infected with L. 
monocytogenes. Untreated refers to aRNA generated from media control macrophages. WTI 
and KO 1 represent data from the WT or KO (CfEBPp-I-) arrays for the first biological 
experiment. The same labelling scheme applies for infection experiments 2,3, and 4. 
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Figure 17. Reproducibility of gene expression ratios between "trimmed" biological 
replicate experiments (SD<0.2). The normalized M values for each spot was plotted against 
each other for each biological experiment. M values with SD>0.2 (blue) were considered 
questionable and were removed from the data. Reproducibility between the biological 
experiments was measured by linear regression (red line) of the remaining M values (black). 
Biological replicates were considered reproducible only if the correlation between the M 
values was R2~0.3. The M value represents the ratio of the fluorescent intensities for treated 
vs. untreated aRNA bound to each spot. Treated refers to aRNA generated from IFN-y 
activated macro phages infected with L. monocytogenes. Untreated refers to aRNA generated 
from media control macrophages. WI] and KOI represent data from the WT or KO 
(C/EBPW I-) arrays for the first biological experiment. The same labelling scheme applies for 
infection experiments 2, 3, and 4. 
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Figure 18. Reproducibility of gene expression ratios between "trimmed" biological 
replicate experiments. The nonnalized M values for each spot was plotted against each other 
for each biological experiment. M values with SD>O.3 (blue) were considered questionable 
and were removed from the data. Reproducibility between the biological experiments was 
measured by linear regression (red line) of the remaining M values (black). Biological 
replicates were considered reproducible only if the correlation between the M values was 
R2:::,O.3. The M value represents the ratio of the fluorescent intensities for treated vs. untreated 
aRNA bound to each spot. Treated refers to aRNA generated from IFN-y activated 
macrophages infected with L. monocylogenes. Untreated refers to aRNA generated from 
media control macrophages. WTI and KOI represent data from the WT or KO (ClEBPIl/') 
arrays for the first biological experiment. The same labelling scheme applies for infection 
experiments 2, 3, and 4. 
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5. Biological Relevance of Microarray Data 
Despite the poor reproducibility within and across the microarrays, biologically relevant data 
could still be extracted. Several genes involved in host defense and immune responses were 
significantly up-regulated in both the WT and C/EBPp-/- macrophages during L. 
m()nnev/ogenc.\' infedion (Fig. 19 A). For example, the pro-inflammatory cytokines I L-\ u. 
IL-P.1L-6, [L-12p40, IL-18, TNF and chemokines MIP-I<x, MIP-Ir:l, M[P-2, MCP-I, MCP-3, 
MJ(J and I,],;\C were significantly up-reglliated in both the WT and C/EBPlr/- macrophages. 
Similarly, inducible nitric oxide synthase (iNOS), which catalyzes the formation of 
bactericidal nitric oxide, was efnciently induced in both WT and C/EBPp-/- macrophages. 
Moreover, several genes involved in mediating IFN-y and TNF signalling were highly up-
regulated in both WT and C/EBPWI- macrophagcs. For example, [CSHP, lRF I, [nterferon-
induced protein with tetratricopeptide repeats 2 (llit2), Ifit3, Interferon-induced protein 35 
(lfi35), Interferon activated gene 203 ([1i203) and Interferon activated gene 202B (Iti202b) 
are important for IFN-y-mediated signalling, whereas TNFRp55, TNF receptor superfamily 
member 5 (Tnfrsf5), TNF ligand superfamily member [0 (Tnfsfl 0) and TNF ligand 
superfamily member 4 CTnfs(4) are important for TNF signalling. [n addition, Myd88, the 
adaptor protein essential fix integrating TLR signalling to downstream efkctors, was also 
highly up-regulated in both genotypes. Similarly the genes for Macrophage activation 2 
(Mpa2) and lIistocompatibility 28 (\-128), which are impol1ant for macrophage activation and 
MHC class II expression respectively, were also induced in WT and ClEBPp-l- macro phages. 
More importantly. C/EBPP was up-regulated only in WT macrophages (Fig. 19 R) and the 
induction of C/EBP~3 targd genes such as G-CSF. CLECSF9, [L- [2p35 and [SGF3y were 
impaired in the C/EBPWI macrophages (Fig. 19 13). C/EBPr3 was shown to be essential for the 
induction of G-CSF during innate immunity against L l11onocytogenes (29), Mycohaclerium 
IllherclI/osis (30) and Brucella ahortus (3 [). Similarly, C/EBPP was found to be necessary for 
the induction ofCLECSF9 in response to LPS, TNF. IL-6, and IFN-y stimulation (32) and IL-
12p35 during Candida a/Means infection (33). In addition, C/EBPP was shown to play an 
important role in IFN-y signaling transduction via its transcriptional regulation of [SGF3y, a 
component or the [S(JF3 protein complex that is essential for [FN signaling (34). Since the 
microarray gene expression patterns f()r several immunologically relevant genes 'were as 
expected from the literature, it was concluded that although the microarray gene expression 
data did not have good reproducibility on a statistical level, it did contain biologically relevant 
data. Therefore the decision was made to go ahead and continue with the analysis in order to 
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Figure 19. Microarrays contained biologically relevant data despite poor 
reproducibility. (A) Efficient induction of pro-inflammatory cytokines, chemokines and 
genes involved in host immune responses during L. monocytogenes infection in both the WT 
and C/EBPWI- macrophages. (B) Impaired induction of CfEBPf3 target genes in CfEBPWI-
macro phages. Shown are Eisen plots where columns represent the average of four WT and 
C/EBPWI . (KO) microarray experiments. Rows represent the average expression ratios of 
individual genes, which is the ratio of the mRNA levels for the gene in IFN-y activated 
macro phages infected with L. monocytogenes as compared to untreated macro phages. Genes 
which have higher levels of their encoding mRNA in IFN-y activated macrophages infected 
with L. monocytogenes than in the untreated macrophages are defined as up-regulated and are 
coloured red. Conversely, genes which have lower levels of their encoding mRNA in IFN-y 
activated macrophages infected with L. monocytogenes than in the untreated macro phages are 
defined as down-regulated and are coloured green. The intensity of red or green shading is 
proportional to the level of gene up-regulation or down-regulation respectively. 
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6. Identification of differentially expressed genes 
The aim or the microarray experiment was to identify macrophage genes downstream of 
C/EBPf3 that are involved in mediating listericidal activity. Differentially expressed (DE) 
genes were identified by a paired T-Test that was based on permutation rather than 
distribution, in order to directly control the Type I Family Wise Error Rate (FWER) and 
thereby reduce the probability of erroneously identifying genes to be differentially expressed. 
The Type I error rate is the probability of rejecting the null hypothesis when the null is in Hlct 
true. The null hypothesis in this case was that there was no difference in gene expression 
hetween the infected WT and C/EBPWI- macro phages. Moreover, since there were 26000 
genes to test this meant that 26000 hypothesis tests were needed to be conducted (one 
corresponding to each t-test). If each test with a p<0.05 was considered to be significant, this 
meant that there was a 5% probability of rejecting the null hypothesis when the null was in 
f~lct true. In other words. 5% of the DE genes (1308 genes) would he falsely identified as 
being differentially expressed. If only one gene were being studied. a 5% margin of error 
would not be problematic. Ilowever, since 26000 genes were being tested, having 1308 false 
conclusions in one study was unacceptable. Therefore, it was essential to account for multiple 
testing when identifying ditferentially expressed genes. Many multiple testing procedures are 
designed to directly control the FWER. The most common methods include Bonferroni 
correction, the sequential methods of Hochberg or Holm or the re-sampling-based methods of 
Westfall & Young (35). Generally, these methods involved adjusting the p-value for each test 
(i.e. gene), so that even though the critical p-value for the entire data set was still equal to 
0.05, each gene was evaluated at a lower p-value. Another mUltiple testing method is the 
control of the False Discovery Rate (FDR), where the expected number of false rejections 
among the rejected hypotheses is controlled by the researcher (36). In general, procedures that 
cOlltrol the FWER tend to he more conservative than those that control the FDR. llowever, 
statistical significance is not necessarily the same as biological significance and p-valucs 
should be used to evaluate the strength of the evidence, rathcr than being used as an absolute 
yardstick of significance. Ultimately, what matters most is the biological significance and 
relevance of the data. There/'ore, differentially expressed genes were identified by a paired T-
Test where p-values were based on 100 random permutations per gene and significance was 
determined by Standard Bonferroni Correction (37, 38). Differentially expressed genes were 
defined as those genes whose expression was significantly higher or lower in the C/EBPWI 
macrophagcs as compared to the WT in all 4 biological experiments. A total of 1268 genes 
were identified from the whole mouse genome of approximately 26000 genes to be 
differentially expressed. Furthermore, 55% of the D[ genes were up-regUlated, 45'~;) were 
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down-regulated. Most of the DE genes had relatively small M values. which ranged from -0.8 
to 1.2011 a log2 scale, with the majority clustering between 0.2 - 0.6 on a log2 scale (Fig. 20 
A). The small M values may have been a consequence of the normalization process or may 
naturally have been small and not explicitly large due to slight differences in gene expression 
levels between the WT and C/ElWp-1 macro phages. 
The next important step in the analysis was to choose candidate genes for further study. A 
natural approach was to select the most highly induced or repressed genes. Selection of the 
top ten most highly up-regulated or down-regulated genes in the infected C/EBPWI. 
macro phages revealed that the majority were "unknown" genes for which there was neither 
functional information nor literature (Fig. 20 B). For example, the function or cellular location 
of the genes for Downs syndrome critical region homolog 6 (Oscr6), SET and MYND domain 
containing 4 (Smyd4), 1700009,107Rik, 2310020A21Rik, 2900092C05Rik, 483340lDISRik, 
4930S63F08Rik, S83043SN 17Rik, 8430436L 14Rik, A830027B 17Rik, B230324K02Rik, 
D630030L16Rik and K021S4 are no1 known. Iligh mobility group AT-hook :2 (Hmga2) is 
involved in DNA binding and packaging within the chromosome. It is also involved in the 
regulation of DNA-dependent transcription. Interleukin I family member 6 011 f6) is involved 
in the innammatory immune response and has cytokinc activity. The function of leucine rich 
repeat containing 6 (Lrrc6) is unknown, but it is tempting to speculate that it may be involved 
in recognition andlor binding L. monorytogenes cell wall products. similar to the leucine rich 
domains of the TLRs. Regulator of G-protein signalling S (RgsS) is involved in G-protein 
coupled receptor (OpeR) protein signalling and has GTPase activator activity. G-protein 
coupled receptor I 19 (Opr119) is involved in the GPCR protein signalling pathway. 
Vomeronasal I receptor 134 (V I rb4) is involved in the OpeR protein signalling pathway and 
sensory perception of chemical stimulus. r-:ndothelial lipase (Lipg) is involved in the 
hydrolysis of triacylglycerol. lipids and lipoproteins. RgsS and IL-lf6 \Vere considered 
potential candidates for further study. since they have been shown to play important roles in 
signal transduction and innate immune responses. RgsS is a key regulator of GPCR protein 
signalling and negatively regulates G protein signalling by acting as a GTPase-activating 
protein (GAP) for G alpha subunits of Q nwtein ~oupled receptors (GPCRs) (39). IL-I [6 was 
shown to be important fix pro-inflammatory responses by acting as an IL-I agonist which in 
turn activated NF-KB through the orphan IL-I receptor-related protein 2 (40). However. since 
the proteins encoded by these genes appeared to act early (upstream) in their signalling 
pathways. they were not considered good candidates for effecting bacterial killing. In 
addition, the selection of candidate genes based on the highest fold diflerellce in gene 
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expression levels would not be the wisest method to use, since the assumption would be made 
that the bigger the fold difference, the more signi1kant the biological effect. This may not 
necessarily be true, since it may be possible that a small change in a complex biological 
system can have a much greater far-reaching effect on the entire system than an ovel11y large 
change. For example a small change in the expression levels of' a transcription factor can have 
a far greater biological implication than a large change in the expression levels of a gene 
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Figure 20. Differential expression of genes in the C/EBPWI- macrophages as compared to 
WT. (A) Frequency of M values (10g2 ratios) of the differentially expressed genes which has 
SD--:.:0.2 (filled bars) or SD<0.3 (open bars). (13) The top ten genes in the infected C/EBPrr/-
macrophages with biggest or smallest f()ld difTerence in gene expression as compared to WT 
macro phages. 
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Moreover, since the microarray data represented only one time-point after infection (4 hours), 
biological functions could not be inferred upon the unknown genes based on co-clustering 
with known genes. Clusters based on gene expression data have been shown to be enriched 
t()r genes known to be involved in similar biological process, therefore implying that 
unknown genes in these clusters may also be involved in those processes (41,42). In addition, 
since the micmarray gene expression data lacked kinetic dimension, candidate genes could 
not be selected based on interesting expression patterns during the time course of the 
infection. Instead, the DE genes could only be grouped into four simple patterns of expression 
during L. mOflocytogenes infection (Fig. 21): Group I genes were down-regulated in both WT 
and C/EBPp-/- macrophages. where the degree 01' down-regulation was either greater or lower 
in the C/EBPI1 I- macrophages. Group II genes were up-regulated and group III down-
regulated in lhe C/EBPWI- macro phages during inJection as compared to WT. Group IV genes 
were up-regu lated in both genotypes, bUl the degree of down-regulation was either greater or 
lower in the C/EBPWI- macrophages as compared to WT controls. Ilowever. these simple 
expression patterns still did not help identify genes that were involved in mediating 
listericidal activity. A deeper understanding of the biological functions 01' the DE genes 
during innate immunity and related processes was needed in order to make an educated 
decision of which genes to choose for further analysis. However, since there were 1268 DE 
genes, it would be an overwhelming task to research each individual gene. The reic) re, a new 
strategy, focussing on particular biological functions and characteristics was developed to 
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Figure 21. Hierarchical clustering of differentially expressed based on genes expression 
values. Differentially expressed genes were hierarchically clustered in to four groups (I to IV) 
using Euclidean distance and average linkage. Shown is an Eisen plot where columns 
represent the average of four WT and C/EBPWI- (KO) microarray experiments. Rows 
represent the average expression ratios of individual genes, which is the ratio of the mRNA 
levels for the gene in IFN-y activated macro phages infected with L. monocytogenes as 
compared to untreated macro phages. Genes which have higher levels of their encoding 
mRNA in IFN-y activated macro phages infected with L. monocytogenes than in the untreated 
macro phages are defined as up-regulated and are coloured red. Conversely, genes which have 
lower levels of their encoding mRNA in IFN-y activated macrophages infected with L. 
monocytogenes than in the untreated macro phages are defined as down-regulated and are 
coloured green. The intensity of red or green shading is proportional to the level of gene up-
regulation or down-regulation respectively. During L. monocytogenes infection of IFN-y 
activated macrophages, Group I genes are down-regulated in both WT and C/EBPWI-
macrophages, Group II genes are up-regulated in C/EBPWI- but down-regulated in the WT 
macro phages, Group HI genes are down-regulated in the C/EBPWI- but up-regulated in the 
WT macrophages and Group IV genes are up-regulated in both WT and CIEBPWI-
macrophages. 
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7. Focussed Functional Clustering 
Since the aim of the microarray experiment was to identify listericidal genes downstream of 
C/EBP!i, it was hypothesized that these genes may (i) be transcriptional targets of C/EBPIi 
and may therefore contain C/EBP[3 binding sites in their promoter and/or binding sites for 
other transcription factors that synergize with C/r:Bpr~, (ii) be involved in transcription of 
I"urther downstream effector genes, (iii) be involved in host defense and immunity, (iv) be 
involved in the production of bactericidal ROI and RNI molecules, (v) be involved 111 
promoting phagosome maturation, phago-Iysosome fusion and subsequent lysosome-mediated 
bacterial killing and/or (vi) be involved in signal transduction of extracellular and intracellular 
stimuli. A focussed functional clustering strategy was therefore developed (Fig. 22), in which 
promoter analysis was used to identify potential C/EBPf3 target genes and functional data 
mining orthe gene ontology database extracted l'unctional data for each DE gene, describing 
its cellular localization, biological processes and molecular i'unctions. In addition, the strategy 
included literature mining of the PubMed database to uncover the roles of the DE genes in 
host defense and immunity to intracellular pathogens, phagosome maturation, phago-
lysosome fusion <lnd signal transduction. After extraction and assignment of functional data, 
the DE genes would be clustered into the above six ·'focus" groups based on their gene 
ontology associations, promoter analysis and previously published functional roles. Candidate 
genes belonging to 3 or more of the [()CUS groups would then be selected for further analysis. 
The rationale t()r selecting genes which intersected with 3 or more (i.e. 2'.50%) of the 10cus 
functional groups, was that this strategy may increase the probability of selecting candidate 
genes which have a signil~cant biological impact on the resolution or L monr)(~vtogenes 
infection. For example, the genes that clustered into only one or two of the functional fiJCus 
groups were comprised mostly of putative C/EBPI3 target genes. However, DE genes that 
intersected with 3 or more of the functional focLls groups were found 10 be enriched I'or those 
genes which have already been described in the literature to playa significant role in innate 
immunity to L motlo(J'togetlcs Cfable 5). Moreover, the signi1icant biological impact for 
three of these DE genes during L. mot7ocytogellcs infection has been demonstrated in gene 
deficient mouse models. For example, mice deficient for IL-If3 (21, 43), p47phox (23) and 
TNFRp55 (20) display increased susceptibility to L. mot7ocytogenes. Therefore co-clustering 
of DE genes v"ith these ·'high biologic<ll impact" genes may therefore highlight which or the 












Figure 22. Focussed Functional Clustering Strategy. Promoter analysis is used to identify 
potential C/EBPP target genes and data mining of the Gene Ontology database extracts data 
for each DE gene describing its cellular localization, biological processes and molecular 
functions. In addition, literature mining of the PubMed database is used to uncover the roles 
of the DE genes in host defense and immunity to intracellular pathogens, phagosome 
maturation, phago-Iysosome fusion and signal transduction. After extraction and assignment 
of functional data, the DE genes are clustered into the above six "focus" groups based on their 
functional annotations and genes belonging to 3 or more of the focus groups are selected for 
further analysis. 
195 
Table 5. The intersection of DE genes between one or more of the functional clustering 
focus groups. Listed are the gene accession number, gene symbol, standard deviation (SD) 
for the average gene expression ratio and the number of functional cluster groups that each 
gene belongs to. Shaded in light grey are the genes that would have been exlcuded from the 
candidate DE gene list when using a SD > 0.2 cut ofT for unreliable data. Genes highlighted in 
red are reported in the I iterature to playa role during L. monocytogenes infection. 
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_N_~~33352_____ ~~~!.. _______ ._ ..;1 __ . ____________ .: O~ ____ . __ 
177250 Lrrn6d 3 < 0.2 
I..:c.:.~.~.:_=:-:---------.--------.---- -. --~-.. ---.--.. -.--.-....... --
NM 053251 1\1P4 3 < 0.2 ._----_. __ ._---_ ... _---- ----.------ ---.-.-----.----------- -----._-_._--
. _t!~._H1Q7l_____ _Myo !£. __ . ____ .___ _.:~ ___________ .~().~ _____ .. _ .... ____ . 
NM 080849 Nek8 3 '- 0.2 
NM 183248 Nkx6-2 1 < 0.2 
--' .--------.-- ... __ ._------- ------_._---------- -.---------~-------.... - ----------------.--.-.-... ------~ 
NM 146391 01frl058 3 .: 0.2 
-----'-------_ .. _--------_._-- -----------.-------.- --.----.-----~--~-- ------.---~---~-----
NM 146396 Olfi'1277 3 .: 0.2 -_. __ ._----_._----_._ .. _._ ... _ .. _------- .. _------- .. _ ...... -._ .. _. _._--_ .. _---_._-----+-....::.:.::::..... __ ._-----------
_N_~'Ui70(>.8. __________ 01 Ii- 166 _. _____ . __ . __ .~. __ ._._ ...... _ .. _. ____ ... ....... <.Q:~__________ ___ _ 
NM 146749 Olfr875 3 0.2 
NM 175094 
"~~~~18.:.c2~9~3~0-----_----.-.---I-~P.~le.~k~h,·cl.6.~---.--... ---------i 3 
XM 487324 PolrJa 3 
< 0.2 ------.---_._._----------,,"-
<- 0.2 
-----_._- .... - ----~.-----.---
NM 007453 Prdx6 3 , 0.2 ---_._-'--_ .... __ ._-- -----_ ... _. __ ._._-- ---_._----_._._-_._---_._-- --.----.. ---~--. --_._-_._----
NM 198703 Prkwll~1 3 -: 0.2 •• ~c.. ___ • ____ • _____ •• ______ ~ •• __ .. ____ • ___ "_. ___ •• __ • _______ • __ • ____ ._ •• _________ • _______ ._______ _ ___ ~ _____ •• _._._. __ _ 
NM 11220 Pts 1 < 0.2 
-----~-----~--- _. ,--> ---.-~------~- ---.-------.---






134078 .. ---.-------~.~----....... --
1980:~3.~5 _____ · ____ 4-·:-~~~:~·~~~·~:::-···--·-4-=-----. ___ . __ . __ . ____ + __ ~~~. ______ ._ .... ___ .I 
198 
NM 178927 AV344025 2 " 0.2 
NM 178(l38 B 1300 17P luRik 2 < 0.2 
NM 173427 B230308G 19Rik 2 <: D.2 ... ---
NM .178766 .... ---. B23D315Fli Rik 2 ',0.2 
NM .172742 [lB 128963 2 < 0.2 
NM 199222 Be02D 188 2 < 0.2 
,-,' ------------.~~~""- ..... ,-- . ---. 
N~ 201.352 B('024955 2 < 0.2 -_. _._--_._------_. 
NM 177601 BC027828 2 0.2 
-~--~,--.. -.-. ... 
NM OOIOOI32() BC032266 2 < 0.2 
NM()09ZE Beat2 2 -o:i 
XM 128275 Brdl 2 <O~2 
NM 172757 COJ0036P 15Rik 2 <()i 
NM 177842 C 130021120 2 < 0.2 
l\,M 145540 ('77668 2 ..;: 0.2 .-.-
l\,M 009783 Cacnalg 2 0.2 
l\,M D09792 Camk2a 2 -:-' 0.2 
l\,M 00<)835 ecr6 2 < 0.2 
.-~--. 
l\,M IS3()98 CdlO9 2 0.2 ----
l\,M 007688 ('112 2 ' 0.2 
' .... 
NI\il 009891 Chat 2 <0.2 
.~--. 
l\,M 007691 Chekl 2 <0.2 . __ .-
1~~Jm~ 
('hem 2 < 0.2 
elen2 } - .:: 0.2 
NM033444 Clicl 2 < 0.2 
NM 009932 Col4a2 2 < 0.2 
NM .. OO77,!~ COIl1l 2 < 0.2 
N~ 011991 Cops) 2 < 0.2 
~-NM () 13 71.5. I CopsS 2 < 0.2 
NM _012003 Cops7a .. _- 2 0.2 
NMOl3767 Csnkle 2 n.2 
_~~ 016716 CuD 2 0.2 
~NM 010010 Cyp46al 2 <0.2 
NM 138.'i96 I D13WsuSOe 2 < 0.2 ._----
1_l\!M 0237)1 [) 19Eatd678e 12 < 0.2 ._--
l\M 172490 D5Ertd 1)5e 2 '- 0.2 
l\,M 012008 Ddx3y 2 < 0.2 
XM 135485 Dhrsx ") • 0.2 , .. :: .. -- ._---_. __ . 
NM 023.114 Eif4cl3 :. <. 0.2 
NM .178736 [lmod2 2 <-6:2' 
Fb.-.d7 ENDASDF 2 0.2 
._---
IX730002C09Ri k ENDASDF 2 0.2 
Drld ENDASDF 2 '- 0.2 
D9J0040F2JRik ENDASDF 2 0.2 .-
1)()30016D06 ENDASDF 2 0.2 
IW10006Kl5Rik ENDASDF 2 0.2 
D7]004 7E02Ri k ENDASDF :'l. 0.2 
f_~'6JO() 16117~i_,_.~. f~F.Ti)ASbF 
1-.2"-- ~o:2 






~----'-- ---- --- -_ .. _,,-
B2J014JA IORik ENDASDF 2. < 0.2 
AK079817 ENDASDF 2 0.2 
;\K045323 E"JDASDF :2 0.2 
c- ---.--~-,,-~-,~~-
AK034422 El\[)ASDF :2 < 0.2 
-"~-' .---
AK030927 El\OASDF :2 0.2 
AK0081S!! El\DASDF :2 0.2 
A9J0033M 14Kik EN D!\.-S[)f: i <,0.2 
--.... -
A 9300070 J8Rik ENDASDF :2 .0.2 
A 130079P 1 (lKik ENDASDF .. ". .,,2. <: 0.2 
98301 IA06Rik ENDASDF .:.. <0.2 
199 
9430022A06Rik ENDASDF 2 < 0.2 
8430436014Rik ENDASDF 2 < 0.2 
7330412AI3Rik ENDASDF 2 < 0.2 
5830411007Rik ENDASDF 2 < 0.2 
4930405G09Rik ENDASDF 2 < 0.2 
NM 007991 FbI 2 < 0.2 
NM 013911 Fbxl12 2 <0.2 
NM 028841 Fbxo23 2 < 0.2 
NM 010192 FemIa 2 < 0.2 
NM 011711 Fmnl3 2 < 0.2 
NM 183358 Gadd45gipl 2 < 0.2 
NM 011819 Gdfl5 2 < 0.2 
NM 013529 Gfpt2 2 < 0.2 
NM 145929 GgaJ 2 < 0.2 
NM 177756 Glt25d2 2 < 0.2 
NM 020273 Gmebl 2 < 0.2 
NM 010325 Got2 2 < 0.2 
NM 008175 Gm 2 < 0.2 
NM 146120 Gan (45, 46) 2 < 0.2 
NM 010388 H2-DMb2 2 < 0.2 
NM 008205 H2-M9 2 < 0.2 
XM 131076 Hbxip 2 < 0.2 
NM 008227 Hen3 2 <0.2 
NM 133849 Hrh3 2 < 0.2 
NM OJ8741 Igfbpll 2 < 0.2 
AJ235934 IGKYI2-66 2 < 0.2 
XM 134910 Ireb2 2 < 0.2 
NM 010596 Kena7 2 < 0.2 
NM 020574 Kene3 2 < 0.2 
NM 177715 KetdJ2 2 < 0.2 
NM 146188 Ketdl5 2 < 0.2 
NM 183390 Klhl6 2 < 0.2 
NM 008465 Kpnal 2 < 0.2 
NM 010686 Laptm5 2 < 0.2 
NM 010689 Lat 2 < 0.2 
NM 198646 LOC381062 2 < 0.2 
NM 011843 Mbe2 2 < 0.2 
NM 013595 Mbd3 2 < 0.2 
NM 008564 Mem2 2 < 0.2 
NM 011844 MglI 2 < 0.2 
NM 008598 Mgmt 2 < 0.2 
NM 133761 Mitel 2 < 0.2 
NM 008615 ModI 2 < 0.2 
NC 004279 MoY3sS2gpl 2 < 0.2 
NM 008209 Mrl 2 < 0.2 
NM 021718 Ms4a4b 2 < 0.2 
NM 144843 Mtmr6 2 < 0.2 
NM 008098. Mtpn 2 < 0.2 
XM 485520 Myom3 2 <0.2 
NM 007501 Neurod4 2 < 0.2 
NM 182716 Nfase 2 < 0.2 
S81451 NFI-X3 2 < 0.2 
NM 008706 Nqol 2 < 0.2 
NM 146818 0lfrl218 2 < 0.2 
NM 207157 0lfrl333 2 < 0.2 
NM 207573 0lfrl380 2 < 0.2 
NM 147082 0lfr609 2 < 0.2 
NM 146665 0lfr732 2 < 0.2 
NM 146419 0lfr883 2 < 0.2 
NM 147105 0lfr978 2 < 0.2 
200 
201 
NM 024246 2310042N02Rik 1 < 0.2 
XM 131053 2410015C20Rik 1 < 0.2 
XM 128698 2610024N24Rik I < 0.2 
XM 128768 4921517J08Rik I < 0.2 
NM 177570 4933406A 14Rik I < 0.2 
XM 130851 4933421 B21 Rik 1 < 0.2 
XM 127023 4933437F05Rik 1 < 0.2 
XM 134954 5430433E21 Rik I < 0.2 
XM 132538 583041 I G 16Rik I < 0.2 
NM 146104 6530402N02Rik 1 < 0.2 
NM 177802 9030221 C07Rik 1 < 0.2 
NM 033145 9230106L18Rik 1 < 0.2 
NM 172524 9530066K23Rik 1 < 0.2 
NM 146105 9630058J23Rik I < 0.2 
NM 178165 A230020G22Rik 1 < 0.2 
XM 132396 A 930033CO 1 Rik 1 < 0.2 
NM 013455 Acr 1 < 0.2 I 
NM 021895 Actn4 I < 0.2 
NM 175501 Adamtsl2 I < 0.2 
NM 009624 Adcy9 1 < 0.2 
NM 001005847 Aga I < 0.2 
NM 172754 AI449175 I < 0.2 
NM 021473 Akrl a4 I < 0.2 
NM 054080 Akrl c20 I < 0.2 
NM 175007 Amph I < 0.2 
NM 007385 Apoc4 I < 0.2 
NM 029277 Arhgapl2 I < 0.2 
NM 172751 ArhgefJ 0 1 < 0.2 
NM 017402 Arhgef7 I < 0.2 
NM 026369 ArpcS (47) 1 < 0.2 
NM 080857 Asbl3 I < 0.2 
NM 007517 Aupl I < 0.2 
XM 489070 AWOl1738 1 < 0.2 
NM 021345 AW742319 I < 0.2 
NM 177280 B230206H07Rik I < 0.2 
XM 131619 BC022150 I < 0.2 
NM 172148 BC028440 I < 0.2 
XM 147687 BC042761 I < 0.2 
NM 174848 BC043118 I < 0.2 
NM 172928 BC056929 I < 0.2 
NM 172502 BC057552 I < 0.2 
NM 172872 BC060737 I < 0.2 
NM 025392 Bccip I < 0.2 
NM 009754 Bcl2111 I < 0.2 
NM 172616 C330027C09Rik 1 < 0.2 
NM 019704 C78915 I < 0.2 
NM 007625 Cbx4 1 < 0.2 
NM 019937 Ccnll I < 0.2 
NM 009603 Chrne 1 < 0.2 
XM 356089 Cib3 I < 0.2 
NM 009905 Clkl I < 0.2 
NM 007715 Clock 1 < 0.2 
NM 009933 Col6al I < 0.2 
NM 198408 Crhbp I < 0.2 
XM 139502 Csmd3 I < 0.2 
XM 488510 Cspg2 1 < 0.2 
XM 111693 0130003 B22Rik I < 0.2 
BC046250 014Wsu8ge I < 0.2 
XM 128587 017Wsu92e I < 0.2 
NM 008650 02300 I OK02Rik I < 0.2 
202 
--
XM 286688 D6300 'OB 17Rik 1 < 0,2 
-'J~:rl72689 Ddx58 I < 0.2 
.~ 
NM 026172 [Jeer I I 0.2 
-------
NM 010046 Dgatl 1 < 0,2 
XM 134573 Dndi2 J 0,2 --
NM 145919 Dorzl 1 < 0,2 
NM 019466 Dscrl I <0.2 
--------
NM 007886 Dtnb I < 0.2 
--~- -
NM 026017 Dullard I < 0.2 
---~~--~- -.~--------'---. 
NM 198093 <0,2 Elmol 1 
----.--~---.~ . 
Tas2rl16 ENDASDF I 0.2 
----------~~~ .. -.. -.. -. 
~~2 
I <0.2 ---_. -.---- ... ~ .. ~. 
ap27 - "----, .•. NDASDF I 0,2 
fj~L)-ASD F-------- --------D930015'vlO. --- ._ ....... , I < 0.2 .... --.----.--~-~--.----------~~~~~~-----
[) 1 JOO58E05Rik ENDASDF I <0.2 ,--,,-,- ·~·,, ____ .·_r ___ ._·_~ __ ~~~_~~_. __ ~~._ 
C 130031 E09Rik ENDASDF 1 < 0.2 
B(,060255 ENDASDF 1 < 0.2 
.. ,,----, 
A"-07632 1 ENDASDF 1 < 0.2 ,--,,-,-
A"-028313 ENDASDF 1 < 0.2 ------,---
AK007522 ENDASDF I <0.2 
A 730046J 19Rik ENDASDF , < 0.2 
"--- f-----
A·UO I 08G06R ik ENDASDF I < 0.2 
9530036MIIRik ENDASDF , < 0.2 
91300151021 Rik ENDASDF 1 <: 0,2 
- ----------
4930532G 15Rik ENDASDF I < 0,2 
... - ........ _----_.-
, 4930503007Rik ENDASDF I < 0.2 
"~~ ... ~---~------- .......... __ ..... ...... _-
4930448K 12Rik ENDASDF I < 0.2 
~ --_._---_._._-----
_~_930445N06Rik ENDASDF , <: 0.2 
''''''''''''~-
J II0038A09Rik E)\J[),'\S DF 1 <: 0.2 - "~,~,~~,,,--
_ 1 700029B22Rik ENDASDF , -: 0.2 
XM 484488 Ep300 1 -c.: 0.2 
XM 110248 Fbxoll 1 <: 0.2 
f-NM.OI0205 Fgffl I r-~" 0.2 
NM 199068 Foxkl I <0.2 
NM008021 Foxml I <0.2 
NM 133837 043 100 I [()9Rik 1 <: 0.2 
NM 010255 Gam! I < 0.2 
NM 173048 Gga3 I <0.2 
------'''-----~. 
NM 027544 Ggnbpl 1 <0.2 
N M -0 13531·~--~--- Gnb4 I < 0.2 
NM025331 ,---- Gng!! 1 <0.2 
NM 029791 
---.. - =~i91~1 i <0.2 
NMI45132 Gpr24 1 < 0.2 
NM 022427 GprS8 1 <: 0.2 
c--N~T 02622? Gpr89 I .~ 0.2 
NM 010398 H2-T23 1 0.2 
NMOI1817 liest _I 0.2 
NM 153505 Hempl 1 <: 0.2 
NM 008236 Hes2 1 <: 0.2 -----_. 
f-~M 133550 Homer2 I < 0,,2 
NM 026820 I titllll 1 1 < 0.2 
1-- .-,~---
1.33944 IGHVlSI05 , < 0.2 
1- " .. -----
JOO:;30 IGUY'S2. , < 0.2 
NM 170599 19sfll I <: 0.2 
NM 008370 115ra I <0.2 
NM 008376 Imap38 , /0.2 
NM 023626 Ing3 , < 0.2 
NMOO8387 Ins2 ! <0.2 
XM 192925 Itch 1 <0.2 
NM 010655 Kpna2 I < 0.2 
203 
-N-M---O I 5741 Krtap9-1 
--
I 0.2 
NM 008562 Mell I 0.2 
NM 0lJ597 ~el2a _L 0.2 
NM 01J599 Mmp9 1- <0.2 ---_._._-
NC 00150J rtvt~IJ:\'j Jl. I <: 0.2 
_NM 010814 Mog I " 0.2 
I--NM 016791 Nfate I I < 0.2 
0086<>2 N(ye 1 <: 0.2 _. 
NM 027280 Nkdl 1 -< 0.2 
NM 172478 Oatil I < 0.2 
-----
NM 14659J Olfrllll 1 < 0.2 
NM 146926 01tr477 1 < 0.2 
NM 147089 Olfr572 I < 0.2 
NM 011001 ... - f_Q!fr58 1 0.2 
NM 011112 Papola 1 0.2 
NM 018878 Paxipl I <0.2 
------
NM 008783 Pbxl 1 <" 0.2 -- ----
NM 011042 PebJJ2 ----- I .-: 0.2 ----
NM 016688 Pded7 I < 0.2 
NM 008849 Pitl I < 0.2 
-----
XM 126961 I>kkhhl 1 < 0.2 
NM 011122 Plodl I : 0.2 
XM 133979 Ppfia 1 1 . 0.2 
XM 131309 Prdm 13 1 0.2 
XM 13<>298 Prkaal I < 0.2 
""-'--
NM 024448 Rabl2 1 < 0.2 .----
t-iM 024456 Rab5e 1 < 0.2 
-NM 173781 Rab6b 1 < 0.2 
NM 023126 Rab8a 1 < 0.2 
XM 1J2051 Rhoh I 0.2 ._----
___ l'i~_ 172716 RIlt] I Q.2 
M 023372 RpU8 I <. 0.2 --c- --------------
XM 485277 Senml 1 < 0.2 
-NM 009147 See2Ja I " 0.2 
NM Sema6d 
._-- -1- < 0.2 199241 




NM 080559 ShJbgrl3 I < 0.2 
NM 01140J ~~1c4al I < 0.2 -------
:NM 009320 SIc6a6 I < 0.2 
NM 030687 Sleo I a4 1 < 0.2 
NM 009213 Smpd2 1 < 0.2 
NM 009225 Snrpb I < 0.2 ---_. 
NM 021790 Solt I < 0.2 
_l"J_~~~Q 1680~_ Stx I a I < 0.2 .. _--.- ---_._-- -------
NM 011512 Surt4 1 < 0.2 
NMOl8802 _l)'t8 J < 0.2 ------- --- - - -------------------
N-~1 177089 Tace I I .; 0.2 
----
NMOl1552 Tcofl 1 <: 0.2 





Tes I <: 0.2 
---r------- -----
NM 019725 Tle2 I <0.2 
-" ---~-.-.------~--~-----.- ----
NM 153417 Trpm6 I < 0.2 --.--------
NM 009449 Tuba7 1 < 0.2 
" .. --- .---
NM 199477 Ubie 1 < 0.2 
--.--~----. 
NM 201643 LJgtl a5 I < 0.2 
XM 356061 upn~~------- 1 <: 0.2 
~M 172465 Zdhhe9 1 . 0.2 
c-,c:-- 008825 Ptkfb2 7 < 0.3 
1-:--",-- :----
5 < 0.3 NM 013543 H2-Ke6 
NM 080729 1I17e 5 <: 0.3 
204 
NM 013563 I12rg 5 <0.3 
NM 146221 Zfp426 4 <0.3 
NM 011609 TNFRp55 (20) 4 <0.3 
NM 146946 Olfr50 4 <0.3 
NM 008575 Mdm4 4 < 0.3 
NM 007656 Kai1 4 <0.3 
NM 008361 IL-11l (21, 22) 4 <0.3 
AF304545 IGHV1S126 4 <0.3 
NM 010441 Hmga2 4 <0.3 
NM 008091 Gala3 4 <0.3 I 
D730047P14Rik ENDASOF 4 < 0.3 I 
A 730006G06Rik ENDASOF 4 <0.3 
NM 144884 Oyt1 ' 4 <0.3 
NM 016779 Omp1 ' 4 <0.3 
NM 133238 Cd209a 4 <0.3 
NM 144835 B130016L12Rik 4 <0.3 I 
NM 007504 Atp2a1 4 <0.3 
NM 146119 9 1 304040 14Rik 4 <0.3 
NM 133983 6030411F23Rik 4 <03 I 
NM 177607 4933430117Rik 4 <0.3 
NM 144801 2310076021Rik 4 <0.3 
NM 144953 17000 1 9003 Rik 4 <0.3 
NM 145492 Zfp521 3 <03 
NM 029498 Zfp198 (26, 27) 3 <0.3 
NM 173399 Zbtb5 3 <0.3 
NM 024189 Yat2 3 <0.3 1 
XM 135805 Wdr44 3 <0.3 
NM 053254 Tle6 3 <0.3 
NM 011490 Stau1 3 <0.3 
NM 020495 Slco1 b2 3 <0.3 
NM 144856 Slc22a7 3 < 0.3 I 
NM 011891 Sgcd 3 < 0.3 
NM 025436 Sc4mol 3 < 0.3 
NM 009057 Rga 3 <0.3 
NM 024457 Rap1b 3 < 0.3 
NM 133249 Ppargc1b 3 <0.3 
NM 133167 Parvb 3 <0.3 
NM 023824 Paar4 3 <0.3 
NM 008876 PId2 (24) 3 <0.3 
NM 146418 01fr881 3 < 0.3 
NM 146548 0lfr800 3 <0.3 
. NM 130866 01fr78 3 <0.3 
NM 146353 0lfr706 ' 3 1<0.3 
NM 147073 01fr33 3 1 <0.3 
NM 207576 01frl514 3 <0.3 
NM 207132 0lfr1471 3 <0.3 
NM 146334 0lfr1330 3 <0.3 
NM 147062 OIfr124 , 3 <0.3 
NM 146630 0lfr123 3 1<0.3 
NM 146921 0lfr1 3 <0.3 
NM 145209 Oas11 3 <0.3 
XM 128696 Ndufall 3 <0.3 
NM 181729 Muc6 3 <0.3 
NM 181852 Mrpp1f4 3 <0.3 
NM 145442 Mbip 3 < 0.3 
NM 134152 Lpxn 3 <0.3 
NM 001002011 Lmna 3 1<0.3 
AJ23 1204 1GKV1-108 3 < 0.3 
AF304548 IGHV1S129 3 <0.3 
NM 183174 Homez 3 <0.3 
205 
-_._._--_... -----.--.---- ~--------.. ------. 
NM 010239 Fthl 3 < 0.3 1 
I--N_M~0.0_8_0_4_4 _____ +-Fr-d:_a--.--------.~.-------.--__I__<..:::0~.3:...._.. _______ ~ 
NM 008010 Fgfr3 3 _______ -+_<_ 0.3 __ 
~M 00799~ ___ . ___ r!:'bl! I ._. __ --1....::3~ __ . _____ __I-'-·· 2::0.~3 _____ . __ _ 
~930046M 13Rik ENDASDF ______ +-}:.. _________ -+_<.:::.0.:.:.3:~ __ . ___ _., 
P630030B08,!{ik ENDASDF ____ ,.l ______________ +--<.:::.0.::::.3~ _______ _ 
DOKistJ ENOASOF 3 < 0.3 
rC030003 H22 Rik ENOASDF ------t--=:--:c.-3_--_~~.~~~~_~~~~~~~~-·,,--·~0=-.::::3-----=========--~ 
B230206L02Rik ENDASDF . ..::3.'--______ --..+_<_" 0:.:..3=--______ _ 
'AU0445~-·----· ENDASDF 3 < 0.3=__ _______ -1 
AKOl4142 ENDASDF 3 < 0.3 
f-_AC--13_0_0_22_J_21:_R_ik_-___ ---+_E_N_D_A_S.,--D_F_·' _. ______ ~_-============~=<=0~.~3====-=~====--= 
9830 127L 17Rik ENDASDF 3 < 0 3 
4930471 C06Rik ENDASOF -- ...::·-3:-_-_ -__ -._-____ -_-+~_·~O.:::.:t~:3~-__ -____ . ___ ~ 
NM 010133 Enl 3 < 0.3 
r- -------~-~~----------
NM 029001 Elovl7 .~-=-3 __ _ < 0.3 
NM 153403 Eit2cl 3 < 0.3 
i--~~----,---------+--'::==-=---------r------'------+---"::':::---------'----
~M 175540 Eda2r ----2--... ------+-<.....:: 0:.:;.3=--________ _1 
NM 139293 Ece2 ___ +-=3 ________ -+_<.....:0:.:;.3=--______ ~ 
NM 175355 E330013P04Rik 1--_.::.3 __________ -+-_<..::.0=_.3 ______ ~ 
NM 032418 Oml5 3 <0.3 
i-NM 007760 Crat -------+-"3-----------+-<-: 0:.:.3=------------
~M . 053165 Clrf 3 .' 0 ~ JiMJ81fs8----- Cd59b _____ j_-;3:_~_-_~_-_ -_ -_--__ -. ___ -t-:._O:::~~:=_ _______ -:-_________ -_______________________ ~ 
J~M 007643 _ Cd36 _______ 3 __________ +-<-=.0:::.3 ________ _ 
NM 153545 BC023296 3 < 0.3 
r-NMl-4s~S97 BC02J1§_7 _______ . .+-:::3_-_ -_ -__ ~_~_--_ -_-_ -_-_ -_ -_ -~_--+-1- _<"...:-...:0~.3~-_-----··- --
..!:J.M 144847 BC011468 ________ 3 _____ . ___ +-<...::0~.3~=--________ _I 
~
NM 007472 Aqpl __ ._..:;3=---____ .. ______ ----+_,_0:::.:.;;:,3 ____ _ 
N M 130863 Adrbk 1 _----jf..;3=---__ . _____ --I-_<_...::0-=.3~ _______ ~ 
""NMli19~-----AA960436 ------ 3 < 0.3 _ .. ____ ~ 
NM 1776::..:7..:.1 ______ .+'-A::.::.3.'-30--=-0_9-'-0~H..:..18=_. ____ ~.2.._ < 0.3 _______ _ 
NM 177003 9630033F20Rlk 3 < 0.3 ---- .. -- --_._---------_.- -.-------------+-...::..:::'---------~ 
NM 182995 6330503K22Rik 3 <0.3 
I---~'. --'-.-.. _--.. ---- .--. .-
XM 141565 5530400B04Rik __ 2 _________ <_.::0~.3:.. ________ -1 
NM 182991 5330410GI6Rik 3 < 0.3 
-NMl76829 4931440F15Rik - -3 <0.3 
.. _-----1 
-
NM 178802 4732463GI2Rik 3 _<_..::0::::.3 _______ -1 
NM 181589 "2610318C08Rik 3 <0.3 --------
NM 133722 2210412DOIRik 3 < 0.3 
<0.3 ._!;~?52J 1810022010Rik ___ ~-_ .. ----_-+_-=-::'---_----
NM 183249 1100001G20Rik 3 
r-NM 011769 Zim 1 --- -·2-'------·-·-----+--=:.::=------·-----
< 0.3 
<0.3 
.NM 011766 ______ +-=Z.:J:fp:.::m.:::2:..._ 2 __ 
~09558 Zfp51 ___ j_=2. _____________ I-....:::..:.:=--__ . ______ _ 
NM 019747 Zfpl q------J:-----------+---..::.:.::..-------





NM 00c-::9-=52=-:4=----_____ """I-W.:.:::.::.:.nt:..:.5.::...a ______ ~.-2---.------__+-::.:::..---. __ _ 
NM 011718 WntlOb ') 
-- 2-
NM 011915 Wifl 
<0.3 
-- < 0.3 1-----
<0.3 
NM 011693 Vcaml 2 -----------1---------_._--------\-'=-------------1-----'==----_._._-
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NM 011906 Tpra40 2 <0.3 
NM 177296 Tnpo3 2 <0.3 
NM 013694 Tnp~ 2 <0.3 
NM 134131 Tnfaip8 2 <0.3 
NM 009388 Tkt 2 <0.3 
NM 199154 Tas2r1 07 2 <0.3 
NM 011896 Spry 1 2 <0.3 I 
XM 129130 Spnb3 2 <0.3 
NM_194355 Spirel 2 < 0.3 
XM 129018 
XM 132597 Smarcadl 2 <0.3 
NM 016769 Smad3 2 <0.3 
NM 177084 SIe9a4 2 <0.3 
NM 144852 SIe7a4 2 <0.3 
NM 078484 Slc35a2 2 < 0.3 
NM 011978 Slc27a2 2 < 0.3 i 
NM 015747 SIc20al 2 <0.3 I 
NM 013787 Skp2 2 <0.3 I 
NM 011377 Sim2 2 <0.3 
NM 001001144 Seap 2 <0.3 
XM 354544 Rtdrl 2 <0.3 
NM 145495 Rin1 2 <0.3 
-
XM 355286 , Rimsl 2 <0.3 
NM 175389 Rg9mtd2 2 <0.3 
NM 021525 RelI 2 <0.3 
NM 011240 Ranbp2 2 <0.3 
NM 012025 Raegapl 2 <0.3 
NM 011969 Psma7 2 <0.3 
NM 011183 Psen2 2 <0.3 
NM 008941 Prss7 2 <0.3 
NM 033573 Prcc 2 <0.3 
NM 178250 Pramel7 2 <0.3 
NM 008014 Ppmlg 2 I < 0.3 
XM 129443 Ppfia4 2 <0.3 
NMOll136 Pou2afl 2 <0.3 
NM 011636 Piserl ' 2 <0.3 
NM 145629 PIs3 2 < 0.3 
NM 008841 Pik3r2 2 <0.3 
NM 011082 PigI' 2 < 0.3 
XM 203853 Php!1 2 <0.3 
NM 008787 Pent2 2 <0.3 
I NM 172709 Otopl 2 <0.3 
NM 146546 Olfr775 12 <0.3 
NM 147115 Olfr578 12 < 0.3 
NM 146755 01fr55 1 12 <0.3 
NM 146576 Olfr459 2 <0.3 
. NM 146707 Olfr410 2 <0.3 
NM 146713 Olfr1342 2 <0.3 
NM 146900 Olfrl220 2 <0.3 
NM 146772 Olfrl189 2 <0.3 
NM 146650 Olfrl166 2 <0.3 
NM 207632 Olfrll18 2 <0.3 
NM 001003914 Obsen 2 <0.3 
NM 130858 Nxph3 2 <0.3 
NM 008726 Nppb 2 <0.3 
I NM 130456 Nphs2 2 <0.3 
NM 029561 Ndfip2 2 <0.3 
NM 010876 p47phox (23) 2 <0.3 
NM 008676 Nbrl 2 <0.3 
XM 355634 Myol8b 2 <0.3 
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0 __ ,--0 _________________ 
-~~-.--.. --~ 
<0.3 NM 008648 Mu~4 2 
~M 138~ ____ Mthfdl 2 <0.3 -
NM 019880 Mtchl 2 < 0.3 -- - -- -------
NM 008629 Msilh 2 < 0.3 --
Mgstl ~19946 2 < 0.3 
NM 008594 f--Mfge8 ____ . ___ ~ < 0.3 ~M l39295 --- Mcfd2 2 <0.3 --
NM 145569 Mat2a 2 <0.3 --1--- - -
NM 133653 Matla 2 < 0.3 -- -
NM 008928 Map2k3 2 < 0.3 --I-----
010728 -. I-? NM -- Lox -- < 0.3 
NM 153404 Liph 2 <0.3 
NM 010700 Ldlr 2 < 0.3 
~. 175349 Ldhal6b ') <0.3 
Klk27 
--~ 
NM 020268 2 < 0.3 -
NM 130867 Kirrell 2 < 0.3 -
NM 010612 Kdr ') <0.3 --1-----------~- --
NM 010578 Itgb1 2 <0.3 
NM 133748 Jnsig2 __ . __________ 2 <0.3 -----
NM 133193 III rl2 2 < 0.3 
AJ231229 IGKV4-91 2 <0.3 
0_ ---.----
AJ231222 1GKV4-68 2 <0.3 -_._---------- - ---
M34983 IGHVIS53 ') <0.3 
M 17575$X06866 
--~. --
lGHV1S40 2 <.0.3 1-_______ 
0 
_____ --
~-53088 Ifitm5 -- 2 <0.3 
NM 008327 1fi202b 2 <0.3 --f------ -------------- ---
NM 015765 Hspal4 2 <0.3 r- .-
2 NM 010450 Hoxall <0.3 ------ --
2 _~_~_l9.i~~ ____ Hmoxl < 0.3 - --
NM 010412 Hdac5 2 <0.3 ----- --
NM 010401 Hal 2 <0.3 
--~------ --
NM 133994 Gstt3 2 < 0.3 
~-------- --
NM 010351 Gsc 2 < 0.3 
rytt - -----
2-NM --019518 Grasp < 0.3 ---
NM 013527 Gdt7 ') < 0.3 _~ ____ .o=.. _________ • -----------e---=----
XM ~~ 15? ______ Gal3st4 2 < 0.3 
G630039H03Ri-k-----
~------- --
NM 172824 :2 < 0.3 _____ 0 --
NM 013716 G3bp 2 <0.3 ---
NM 177798 Frs2 2 <0.3 -
NM 053242 Foxp2 2 < 0.3 
r NM 12Jj_48 Fez2 2 < 0.3 .------.-
NM 010191 Fdftl 2 < 0.3 
~M 144960 Fcamr ') < 0.3 




NM 175399 Exosc4 2 <0.3 r--:--
175443 Etnk2 2 < 0.3 NM .. - --j--
U12914 ENDASDF 2 <0.3 0 ______ -
E430002N23Rik ENDASDF 2 < 0.3 
~017H14Ri~ __ ENDASDF 2 <0.3 
END AS[)F------1-='---D930036K23 Rik 2 < 0.3 
D330050G23 Rik ENDASDF ') < 0.3 
D030022P07Rik ENDASDF 
t-=:-. 
') < 0.3 . f-------------.-~ . 
(,C799012 ENDASDF 2 < D.3 
C130D36KD2 ENDASDF 2 < D.3 -------- ---
CD3DDI2D19Rik ENDASDF 2 < D.3 
rsc;051572 ENDASDF 2 < 0.3 
.. - --
BCD25031 ENDASDF :2 < 0.3 -- -
13830D32F12 ENDASDF :2 I~OJ f--- ------AK029D47 ENDASDF 2 ----- '.0.3 
AK028167 ENDASDF 2 <0.3 '--------------------- ------------------- -----_. __ ._- ._-------
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AK019732 ENDASDF 2 1<0.3 
AK014782 ENDASDF ') <0.3 .. 
AK009804 ENDASDF 2 <0.3 
~K005257 ENDASDF 2 <-0:3 
~'-------~--r-'-----------
2 <0.3 I-A~IOO17J23Rik ____ r-g_~I?ASDF 
A7JOOl4G21Rik ENDASDF 2 <-0:3 -_.- ~ 
"-.~O:3 AJJ0041B 18Rik • ENDASDF 2 -,--_. 
• ENDASDF A~30061 C 15Rik 2 < 0.3 
1-:--- ' - ~--."-------
9530034E 1 ORik ENDASDF 2 <-, 0.3 ---------- --------- - <0.3 9330180LJORik ENDASDF 2 
2~Q.408~?Rik . ENDASDF 
-- -, 
<oj 2 ,-
49J0547E14Rik ENDASDF 2 <oj 
~0540M03Rik ENDASDF 2 <0.3 
49J0506A 18Rik ENDASDF 2 <0.3 -
12 49J0463\t105Rik E1\[)ASDF <0.3 
!--49J0455M05Rik E1\DASDF 2 <0.3 
-----
NM 019398 Ear5 2 <0.3 
-
1\M 011816 E430034L04Rik 2 <()3 
-.~-----. --
1\M 177310 E4JOOl2M05Rik 2 • <().3 




! NMI75647 Dmrtal "2 <0.3 
NM 144553 DIg7 2 <o:.f 
NM 207274 ()(,10ll04N 19Rik 2 <oj 
NM 177657 D6JOO03M21 2 <oj 
NM .175514 D430039N05Rik 2 <oj 
NMI72485 D 130067103Rik 2 <0,3 
\Lvl . 138601 DIOJhu81e 2 <oj 
\JM 152809 
-~-----,--
CsnklgJ 2 <0.3 
NM 007755 
~---------~--
Cpebl 2 <0.3 
NM )77751 Cnksr2 2 < 0.3 
-.~.~-.---.---------
NM 00815J Cmklrl 2 < 0.3 
~------_#. 
NM 01956J Cited 4 2 < 0.3 
.. --. .. --
Cilp2 2 ~_~ ",14639J <0.3 -------
_l'J_~.!2}3 85 Cilp 2 <0.3 --
N ~.Jl.? 1528 ~~hst 12 2 <0-:-3 
NM 139134 Chodl 2 <-03 -
Cgrefl .2 .Ji~.J.~ 1420 < 0.3 
12 
-
NM 05j200 Ces3 <0.3 
7675 CeacamlO 2---. < 0.3 _.-
~153785 Cdkl3 2 < 0.3 
NM 110904 I Cd209d 2 <0.3 
NM 007617 • Cav3 2 < 0.3 
NM 007609 Casp4 2 <0.3 
~ '177759 C\30098D09 2 < 0.3 -
<0.3 ~;~!~~ C130026L21 Rik 2 Btbd9 2 <0.3 
NM 009768 Bsg 2 <0.3 -- Bmp2 --. < 0.3 NM 00755J 2 
Beat I :: < 0.3 
NM 198667 BC061212 2 <0.3 
BC038156 
-
:2 < 0.3 \JM 177768 
XM 131888 BC034507 2 <0.3 -
<(j,] NM 146256 BC034099 2 -
\JM 173862 BC030396 2 <(j,] 
NM 145987 BC025833 2 <oj 
NM 001004156 BC023181 2 <oj 
NM 198609 BC003885 2 <()j 
NM 177083 R410106N03Rik 2 <0.3 
NM 020025 B3galii 2 <0.3 
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----~ -~----- _.- ---~-.------- ------------- . - ---------_ .. __ .. _------
XM 130148 B2302081-117Rik 2 <:: 0.3 
NM 174989 AW046014 2 < 0.3 -- --- --
NM 007505 --r-!'-tp5a_I~ _______ 2 < 0.3 _¥-- --------
NM 023472 Ankra2 2 < 0.3 --- ------ --_._"---_._-_. 
NM 011786 Aloxe3 2 < 0.3 
---::----~-------- A L024210--------1-,.-- < 0.3 NM 134052 2 
NM 178898 A1894139 2 <0.3 
I--:-:c~--- ----'---
NM 033526 AI663987 2 <0.3 
--~------------'-------------
NM 145505 AI450540 2 <0.3 
NM 007426 ,~pt2 2 < 0.3 
----~----- -
NM J45146 A fin 2 <0.3 
NM 007414 Adprh ~2 < 0.3 --- --
NM 007399 AdamlO 2 <0.3 
-~---------
NM 011994 Abed2 2 < 0.3 
NM 133349 AA407930 r-~----- <0.3 
NM 177578 A430090E 18Rik 2 <0.3 -----------1--- ----- 1-----
NM 207279 A330045HI2Rik 2 <0.3 
~----------
963004 I N07Rik 2 NM 173387 < 0.3 
f-- --'--
NM 175651 9630008KI5Rik 2 <0.3 ---------
NM 177074 9330158FI4Rik 2 <0.3 -------- ------- '--'-"-c ____________ -----------
XM 127434 9030624013Rik 2 < 0.3 -----
NM 172302 5730453116Rik 2 <0.3 
1---
XM 484382 4930563i02Rik---- 2 <0.3 
----~- ---
<0.3 NM 152825 4930550B20Rik 2 
-XM -~0488N24Rik .------ --142616 2 <0.3 
--~--.-- ----------- ------------
XM 127899 4930403J22Rik 2 <0.3 
-+-4921517L 17Rik 
----- - .--------
XM 130609 2 <0.3 ----'-:-::-::-: --- _._- ----~-NM 133797 4833439L 19Rik 2 < .~, 
~------~---------- ------------ -------
XM 132137 23 1001 1 G06Rik 2 < 0.3 --~-700058C 13Rik--------
-----_._.- -~~-.-------
XM 130597 2 < 0.3 ---------------'------------------------- ---------
NM 173182 1600019004Rik 2 <0.3 
I--NM ----------------176843 1110055N21Rik '1 < 0.3 ------------------------1--::"""'- -----------
NM 025402 I 11003 1102Rik 2 <0.3 --- -
NM 029508 0610009F02Rik 2 < 0.3 
1-----"-- --- --------~ ----------------------
NM 009550 Zf 2 1 -< 0.3 
--NM- 172120 ----- {':""~~---==~-f--------~ <03 ---~-~---- .. --J'lrvl 001001327 ___ Ykorelll I < 0.3 ------------ -----------1---------------
NM 009492 V2a 1 < 0.3 _._---- ---- - --
NM 134218 Ylrh9 1 < 0.3 ----------------
NM 009470 Umod I < 0.3 -------------- -------- --
NM 020285 Tsse4 I < 0.3 
---~------------------------------ -------
< 0.3 XM 127444 ;!~rip 13 _______ 1 
r---~-------
NM 009413 ~ __ II _ - I < 0.3 ---------- -1'----------- --
NM 133683 Tmernl9 < 0.3 
NM -- 144543 Thy28 1 <0.3 ---~-~-
NM 009369 Igfbi I -< 0.3 
".----~--.. ~------ ------- --
M62838 M32485 tea 1 < 0.3 --------
Tdg NM 011561 1 < 0.3 - . .;..;:;...- -
_ NM 207_027 Tas2rl25 I < 0.3 
NM 025303 Stau2 1 < 0.3 ----
NM 020493 Srf 1 < 0.3 
NM 146043 Spin 1 < 0.3 
NM 009242 Spare I < 0.3 
NM 172339 Snape4 1 <0.3 
~-009222 Snap23 I < 0.3 r-
NM 011375 Siat9 1 < 0.3 ------
NM 177386 Sfmbt2 I < 0.3 
NM 013658 Sema4a 1 <0.3 -------------
NM 009086 Rpo 1-2 1 < 0.3 --
NM 013646 Rora I < 0.3 
---~-~ ------"----------
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NM 026014 Ris2 1 <0.3 --
NM 177740 Rgma 1 <0.3 
NM 177721 Ranb06 1 <0.3 
NM 175211 Rahwsl 1 <0.3 
NM 026297 Rabl3 1 <0.3 
NM 019983 Rabgert (25). 1 <0.3 
NM 153559 Qscn61l 1 <0.3 
NM 008976 Ptonl4 1 <0.3 
XM 357441 Plafr 1 <0.3 
XM 284491 Ppp2rlb I 1 <0.3 
XM 358127 Pirall . 1 <0.3 
NM 019781 Pexl4 1 <0.3 
NM 011868 Peci 1 <0.3 
NMOl1865 Pcbpl I < 0.3 
NM 022321 Parv.e; I <0.3 
NM. 177161 P4ha3 1 <0.3 
NM 146430 0lfr742 1 < 0.3 
NM 146600 0lfr7oo I 1 <0.3 -
NM 147109 01fr577 I <0.3 
NM 146374 0lfr368 I <0.3 
NM 146290 0lfrl25 1 <0.3 
NM 153157 0lfin3 1 <0.3 
XM 129809 Ogfrll 1 <0.3 
NM 020610 Nrio3 1 <0.3 
l NM 018787 Noff 1 <0.3 
I NM 008693 Ngfg 1 <0.3 
I NM 008675 Nbll 1 <0.3 
NM 024174 Mros23 I <0.3 
NM 205795 Mrgprb4 I <0.3 
XM 484710 Mocos I <0.3 
BC057926 Mmol6 ·1 <0.3 
NM 008606 Mmpll I <0.3 
NM 145543 Mclc 1 <0.3 
NM 008538 Marcks 1 <0.3 
NM 008519 Ltb4rl 1 <0.3 
XM 128064 LOC223672 1 < 0.3 
NM 199146 LOC209387 1 <0.3 
NM 008501 Lif 1 <0.3 
NM 010662 Krtl-13 1 <0.3 
NM 008450 Kns2 1 < 0.3 
NM 010636 Klfl2 
, 
I < 0.3 
NM 177748 Kirl2 I 1 <0.3 
I NM 033134 Inop5e 1 <0.3 
NM 011829 Impdhl 1 <0.3 
NM 008362 III rl 1 <0.3 
NM 008355 IL-13 (48. 49) 1 <0.3 
NM 027320 Ifi35 i <0.3 
NM 178610 , Hrb2 1 <0.3 
NM 013820 Hk2 I < 0.3 
NM 016956 Hbb-b2 I <0.3 
NM 008206 HZ-Oa 1 <0.3 
NM 023168 Grina 1 <0.3 
NM 018882 Gpr56 I <0.3 
NM 008130 GIi3 1 <0.3 
NM 008080 Gal.e;tl 1 <0.3 
NM 172475 Frmd4a I <0.3 
NM 175473 Frasl I <0.3 
NM 008239 Foxql 1 <0.3 
NM 008260 Foxa3 I <0.3 
NM 145927 Fntb 1 <0.3 
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NM 013710 Fgd2 I <0.3 
, 
NM 010634 Fabp5 I <0.3 
NM 012051 Etv3 I <0.3 
Zfp29 I ENDASDF I <0.3 
Srcasm ENDASDF I <0.3 
MI1859 ENDASDF I <0.3 
Etohd2 ENDASDF I <0.3 
E330029EI2Rik ENDASDF ,I <0.3 
E030024I16Rik ENDASDF I <0.3 
C030014CI2Rik ENDASDF I <0.3 
B230218PI2Rik ENDASDF 1 <0.3 
AK080717 ENDASDF I <0.3 
AK008452 ENDASDF I <0.3 
A430042F24Rik ENDASDF I <0.3 
953OO59014Rik ENDASDF I <0.3 
9030024J 15Rik ENDASDF I <0.3 
8430426J06Rik ENDASDF I <0.3 
84304030 17Rik ENDASDF I <0.3 
5930409G06Rik ENDASDF 1 <0.3 
4930563Il5Rik ENDASDF 1 < 0.3 
4930551013Rik ENDASDF I < 0.3 
4930535Ll5Rik ENDASDF I < 0.3 
4930533K 18Rik ENDASDF I < 0.3 
4930520A20Rik ENDASDF I < 0.3 
4930511E03Rik ENDASDF I < 0.3 
I 4930453H23Rik ENDASDF I <0.3 
2300oo4MII Rik ENDASDF I I < 0.3 
1700021 F07Rik ENDASDF I I <0.3 
1700003G 13Rik ENDASDF I <0.3 
I 1600019K03Rik ENDASDF 1 < 0.3 
NM 139138 Emr4 I <0.3 I 
NM 172760 Elmo3 I <0.3 I 
NM 022980 DserlJ2 I <0.3 
NM 023646 Dnaja3 I < 0.3 I 
NM 010047 Dgcr6 I < 0.3 
NM 172464 Daaml J < 0.3 
XM 284236 D630042F21 Rik I <0.3 
NM 010000 Cyp2bll (28) , I < 0.3 
NM 007764 CrkJ I <0.3 
NM 019877 Copz2 I <0.3 
NM 017477 COOl!. I I < 0.3 
NM 178599 Commd8 I < 0.3 
NM 017393 Clpp I < 0.3 
NM 019701 Clcnkb I < 0.3 
NM 007390 Chrna7 I <0.3 
NM 007693 Chga I < 0.3 
NM 020006 Cde42ep4 I < 0.3 
XM 132882 Cd69 I <0.3 
NM 139301 Catsoerl I <0.3 
NM 009791 Calmbpl I <0.3 
NM 177259 C630028C02Rik I <0.3 
NM 173775 C230069K22Rik I <0.3 
NM 178692 C 130074G 19Rik I <0.3 
NM 172142 AY078069 I < 0.3 
BC025029 Axot I <0.3 
NM 152801 Arhgef6 I < 0.3 
NM 019504 I A04bl I <0.3 
, NM 009663 Alox5ap I <0.3 
NM 053156 Aile I < 0.3 
I XM 127049 I Alkbh I <0.3 
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NM _133884 A183866\ I <0.3 
NM J33770 Adck4 I < 0.3 
NM __ 00961I Actl7a I <0.3 
NM_080633 Aco2 1 <0.3 
NM. ,198661 A630005A06Rik 1 <0.3 
NM 175256 9530025 L 16Rik 1 <0.3 
XM 109819 9330151EI6Rik e-l- < 0.3 ---
<0.3 .NM 177242 9130017A15Rik I 
l]M .175209 i 8430417A20Rik 1 <0.3 
NM 207583 6430517E21 Rik I· < 0.3 
! NM 024282 5830417COIRik I <0.3 
! XM ·134422 • 5730445MJ6Rik I <0.3 
_. --"""-------------
NM 172654 5330401P04Rik ___ 1 __ <0.3 
~NM 172939 4921515A04Rlk * <0.3 ~--
<0:3 . NM 177062 4833444GI9Rik 1 
r-NMI72415 -,---~----~~- <0.3 2810441 C07Rik 1 
N~12}59 2410166105Rik . I <0.3 
'NM 172521 __ 2410080H04Rik I . <0.3 
XM 355182 20 I 0002M 12Rik 1 <0.3 
-XM 110690 1810033BI7Rik I <0.3 
~XM -133915 _ - ~OO()3J15Rik 
~----
I <0.3 
NM 025427 =11190002H23Rik 1 <0.3 
tX~128291____ 06L9005KQl!~jk 
.~----
I <0.3 - '---
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7.1. Promoter Analysis 
It was hypothesized that listericidal genes downstream of CIEBP[3 may themselves be 
transcriptionally regulated by CfEBP[3. This transcriptional regulation may be mediated via 
the direct binding of C/EBP[3 of to its consensus binding site in the promoter of the target 
gene, or via interactions with other transcription factors (TFinteracting) known to interact with 
C/EBP[3 (Fig. 23) According to the TRANSFAC, BIND, HPRD and Entrez Gene databases, 
CIEBP[3 interacts with 46 other transcription factors and has been has been 
experimentally proven to bind directly to the promoter sequences of 54 genes ~. These 
direct C/EBP[3 target genes play important roles in signalling via the cytokine, JAK-STAT, 
TLR, T cell Receptor (TCR), B cell Receptor (BCR), MAPK and ABC transporter pathways, 
and are important for several biological pathways including the complement and coagulation 
cascades, cell cycle, insulin and apoptosis. Moreover, these CfEBP[3 target genes also are 
involved in the biosynthesis and metabolism of glucose, pyruvate, prostaglandins, 
leukotrienes, glutathione, propanoate, tryptophan, arginine, proline, tyrosine, urea, amino 
groups, glycerolipid, fatty acids and bi Ie acids. The promoter sequences of the DE genes were 
therefore searched for potential binding sites for C/EBP[3 and for transcription factors that 
interacted with CfEBP[3. Promoter analysis revealed that only IL-18bp and IL-I[3 genes 
contained experimentally proven C/EBP[3 binding sites, whereas 18% of the DE genes 
contained putative C/EBP[3 binding sites. Similarly, the promoter sequences for IL-18 binding 
protein (IL-18bp), Solute carrier family 25, member 36 (Slc25a3), Amyloid beta precursor 
protein (App), Bone gamma carboxyglutamate protein I (Bglap I), Cysteine and glycine-rich 
protein 2 (Csrp2), IL-I [3, Insulin II (lns2), NADPH dehydrogenase, quinone I (Nqo 1), 
Transcription factor AP-2 gamma (Tcfap2c), Choline acetyltransferase (Chat), Alpha-2 type 
IV collagen (CoI4a2), Ferritin heavy chain I (Fth I), Heme oxygenase 1 (Hmox 1), Vascular 
cell adhesion molecule I (Vcaml), Hemoglobin beta adult major chain (Hbb-bl) and Serum 
response factor (Srf) contained experimentally proven binding sites for transcription factors 
that bind C/EBP[3. Moreover, promoter sequences for 47.3% of the DE genes contained 
putative binding sites for transcription factors known to interact with CfEBP[3 e.g. E I A 
binding protein p300 (Ep300), C/EBP[3, CfEBPu, NF-KB(p50), NF-KB(p65), member of ETS 
oncogene family I (Elk-I), Trans-acting transcription factor 1 (Sp I), runt related transcription 
factor I (Runx I), STATs and the CHOP:C/EBPu dimer. Literature profiling revealed that 
these interacting transcription factors were found to be involved in biological processes and 
signalling pathways that were highly relevant in the context of L. monocytogenes infection. 
For example, L. monocytogenes has been shown to manipulate the host's actin cytoskeleton, 
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gap junctions, adherens junction and focal adhesion complexes in order to facilitate its 
movement through the cytoplasm and cell-cell spread (50, 51). Furthennore, activation of host 
defense and immunity against L. monocytogenes infection requires signalling via lAK-STAT, 
TLR, MAPK, transforming growth factor beta (TGF~), TCR, BCR and calcium mediated 
pathways (44, 52-57). Based on the results of the promoter analysis, DE genes whose 
promoters' contained putative C/EBPP binding sites were clustered into the focus group for 










46 TF interact with C/EBP~ 
Gene 
Gene 
Figure 23. Direct and indirect transcriptional regu lation of CIEBPI3 target genes. 
Shown is a simplified representation of how CIEBP~ directly or indirectly regulates 
transcription of its target genes. (A) Direct transcriptional occurs by the binding of CIEBP~ to 
its consensus binding site in the promoter of the target gene. (B) Indirect transcriptional 
regulation by C/EBPP occurs via protein-protein interactions with other transcription factors 
(TF) that are bound to their consensus binding site in the promoter (TFinleracling). According the 
TRANSFAC, BIND, HPRD and Entrez Gene databases, C/EBP~ interacts with 46 other 
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Figure 24. CIEBPJ3 interacts with 46 other transcription factors. (A) Highlighted in red 
are TF which bind to the promoters of some of the differentially expressed (DE) genes. 
Putative TF binding sites were identified by P-MATCH analysis. (B) Percentage of DE genes 
that have putative binding sites in their promoter for the TF highlighted in red. (C) Pathways 























Figure 25. Fifty-four genes with experimentally proven CfEBPI3 binding sites in their 
promoters. (A) Direct C/EBPI3 target genes listed in the TRANSFAC database as having 
experimentally proven binding site for C/EBPI3 in their promoters. Highlighted in red are DE 
genes (B) The signalling pathways and (C) metabolic processes regulated by the direct 
C/EBPI3 target genes. 
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7.2. Gene ontology mining and literature profiling 
Since 35% of the DE genes were unknown and consequently did not have any gene ontology 
or published litcmture, they could not be included in the functional clustering analysis. For 
those genes with annotation and literature, the gene ontology associations describing their 
cellular localization, biological processes and molecular functions were downloaded from the 
Gene Ontology Database Llsing the FatiGOplus program (58). Similarly, literature mining of 
the PubMed database uncovered roles for the DE genes during host defense and immunity to 
intracellular pathogens, phagosome maturation, phago-lysosome fusion and signal 
transduction. The inclusion of genes into each f~)cus group category based on their gene 
ontology associations was carefully considered (Fig. 26 A, Gene Ontology panel). For 
example, genes with ontology terms such as immune response, immune pathway signalling, 
cellular defense, humoral defense and defense response to bacteria were included in the 
"defense and immunity" tocus group. Included in this group, were genes encoding cytokines, 
chemokines, their cognate receptors, as well as genes involved in the production of nitric 
oxide, superoxide and reported in literature to play a role in defense against L. 
II/OllO(ytogenes. Genes in the "RNI and ROI production" focus group included those which 
had oxidoreductase activity, such as NADPH oxidase, the major enzyme responsible jor 
generating superoxide. In addition, genes involved in binding or transporting potassium, iron 
and/or chloride and regulation of pI-! were also included in this focus group. Recently, 
NADPII oxidase was shown to be involved in a novel bacterial killing mechanism mediated 
by potassium ion influx in a pH-dependent manner (59-62). Furthermore, potassium, iron and 
chloride ions have been shown to be elevated in phagosomes containing tvlycobacteriuln or 
Listeria and may be important in the restricting the survival of these bacteria (62, 63). 
Furthermore, DE genes involved in signalling pathways mediated by GPCRs, GTPases, 
cytokines, mitogen activated protein kinases (MAPKs), Wnt, insulin, hedgehog, growth 
factors, phosphatidylinositol, neuropeptides, B cell receptor (HCR), T cell receptor (TeR), 
TLR. notch, integrins, cAMP and calcium were included into the "signaI1ransductioll" focLis 
group. Since phagosome maturation and phago-Iysosome fusion involved the synergistic 
interaction of several biological processes, signalling pathways and intracellular organelles 
(64, 65), DI~ genes were grouped into the "phagosome maturation and phago-lysosollle 
fusion" focus group if' their encoded proteins were (i) reported in literature to playa role in 
phagosome maturation, (ii) were located wiLhin the cytoskeleton or organelles such as the 
endoplasmic reticulum (l:::R). Golgi apparatlls, endosomes, phagosomes, Iysosomes and/or 
intracellular vesicles, (iii) were involved in the regulation of endOl:ytosis, phagocytosis and/or 
organization and biogenesis of the actin cytoskeleton, (iv) transported proteins to and/or from 
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the FR, Golgi apparatus, endosomes, phagosol1les, Iysosomes and/or intracellu lar vesicles, 
and (v) regulated the activity of Rab proteins, especially Rab5a e.g. GTPases, (;r'Ts, GDTs, 
GAPs, vATPases and PlJkinases. 
A comparison ofthe functional clusters generated for DE genes that had SD<O.2 or SD<O.J. 
showed that although the number of genes within each cluster was much lower in the SD<O.2 
data set as compared to the S[)<O.3 set the overall propol1ional sizes of' the clusters did not 
differ between the two analyses (Fig.26 A, B). Functional clustering of DE genes with 
SD<O.J showed that 4.6% of the annotated DE genes were described as having transcription 
ractor activity or were involved in the regulation of transcription. Similarly, promoter analysis 
identi ned that 18% of the annotated DE genes had proven/putative binding sites ft)r C/EBP~ 
and 47.36% had binding sites ror transcription factors that interacted with C/EI3P~. 
Furthermore, 2'()% of the annotated DE genes were involved in host immunity and defense, 
J.I'YrJ in the production or ROl, 16.1% in signalling and 8.9% were involved in phagosome 
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Figure 26. Clustering of genes into the functional "focus groups". (A) Promoter analysis, 
literature and gene ontology mining was used to identify potential C/EBP[3 target genes and to 
extract functional data describing the cellular localization, biological processes and molecular 
functions for each gene. Shown are the gene ontology terms used to define each category. 
Genes were then clustered into the "focus groups" based on their functional annotation. (B) 
Functional clusters for OE genes that have a standard deviation (SO) less than 0.2 and (C) SD 
less than 0.3. Shown are the percentages of annotated genes belonging to each " focus group". 
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After clustering the DE genes into the Cunctional "focus groups", genes that clustered into 
-,-,50%) of the functional foclls groups were selected for further analysis. Within the set of DF~ 
genes that had SD<0.2, only 115 genes clustered into >50% of the functional focus groups. 
Ilowever, key immunological genes which have been shown to playa significant role during 
defense against L. l11ot/()cytogenes, were excluded due to the S D>0.2 cut ofr criteria. Since the 
microarray was an exploratory study, elimination of known and other, as yet, unidentified 
biologically relevant genes would decrease the probability of fulfilling the aims of the study, 
which were to identify genes involved in mediating listericidal activity. Therefore, DE genes 
with SD<O.3 and that clustered into >50% of the Cunctional fi.,cuS groups were selected for 
further analysis. Although this strategy increased the number of candidate genes to 220, as 
compared to the 115 j~)r the SD<().2 set, it at least did not exclude potentially biologically 
significant listericidal genes. 
Further literature profiling of these genes revealed that several had already been published as 
playing a role during L. l11onocytogencs infCctions. For example the C/EBPrrl macrophages 
had down-regulation of IL-I r~, RAB guanine nucleotide exchange factor I (RabgefJ) and 
Cielsolin (Gsn) but had higher levels of' Phospholipase D2 (Pld2) and p47phox. I L-I [3, which 
was expressed 2-j~)ld lower in the C/EBPP macrophages, is a potent inllammatory cytokine 
that is important Cor early resistance against I. 1nOl1ocytogenes infection. Injection of mice 
with [L-I P prior to intravenous infection with L. l11ot/o(ytogenes, resulted in accelerated 
recovery from infection (66) and studies using monoclonal anti-IL-l p antibodies 
demonstrated that 110-1 f\ was essential Cor L. mot/o(vtogenes-dependent induction macrophage 
activation (67). Although IL-I P ddicientmice showed equivalent resistance as WT mice to L. 
mono(')'togenes infection (68), obstruction or I L-l [3 signalling via the blocking of the IL-I R 
by antibodies or by gene targeting, resulted in highly increased susceptibility to L 
l11ono(ytogenes (21, 43). Moreover, IL-J P has been shown to be important 1~)r innale 
immunity against M tuherculosis (69). (jsn is Ca2+ sensitive protein that plays an important 
role in L. mOl1ocytogenes actin-based motility and consequent cell-cell spread. At normal 
resting intracellular free Ca2+ levels, (isn is concentrated directly behind motile L. 
mOI1()(ytogmes at the junction between the actin filament rocket tail and the bacteriul1l, where 
it was shown to enhance L. l11onocy/ogenes actin tail disassembly resulting in impaired 
motility. Ilowevcr, at lowered intracellular free Ca2+ levels, (Jsn dissociated from the actin 
rocket tails and its severing activity was blocked, resulting in lengthening of the L 
mOtlocytogmes tail lengths and enhanced motility (45). PLD2 is a phosphatidylcholine (PC)-
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speci ric phospholi pase that catalyzes the hydrolysis of PC to phosphatidic acid and choline, 
which arc important molecules For cellular processes such as signal transduction, membrane 
trall1cking, secretion, cytoskeletal reorganization. transcriptional regulation. and cell cycle 
control. During L. mOllocytogenes infection, host polyphosphoinositide-specitic 
phospholipase C (PI-PLC) and PLD2 arc induced and activated by bacterial PI-PLe and LLO 
(24). Moreover, PLD2 has been shown to bcilitate that escape of L. monocytogel1cs from 
macrophage phagosomes (24). Furthermore, p47phox, the cytosol ic component of NADPH 
oxidase. was shown to be important for killing L. monocytogenes (23, 70-72). Rabger forms a 
complex with Rabep I. which has been shown to be essential for mediating Rab5a functions 
(25). Rab5a is an IFN-y effector protein thal is important for promoting phagosome 
maturation, fusion with the lysosome and su bsequent bacteria] ki /I ing (73, 74). L. 
IIIOlw(ytogenes has been shown to delay phagosome maturation by impairing the activity or 
Rab5a. It does so by preventing the exchange of inactive GDP-bound Rab5a for active GTP-
bound Rab5u (75), possibly via manipulation of Rab5a regulating proteins such as guanine 
nucleotide exchange i'actors (ClEFs). Indeed, Rabgefl, a Rab5a GEF, was down-regulated 0.8 
fold in the ClEBPjr/- l11acrophages. 
PKC8 was selected for further study since it was j()und to belong to each of the "focus 
groups" (transcription, direct or indirect C/EBpr~ target gene, signal transduction, deICnse and 
immunity, produclion or ROI and RNI and phagosome maturation and pbago-Iysosome 
fusion) in both the SD<O.2 and SJ)<O.3 data set analyses (Fig. 27). For example, promoter 
unalysis of the first 1000bp upstream of the transcriptional start site revealed several putative 
C/EIWp-f and a NF-KB binding sites, suggesting that PKC8 may be transcriptionally 
regulated by CIEBP[3. Gene ontology assignments to PKCo showed that it was involved 111 
humoral defense and intracellular signalling. Literature profiling revealed that PKC8 IS 
involved in several key immune signalling pathways such as NF-KB (76-78), TNF (79, 80), 
I L-6 (81, 82), I FN-(1 and I FN-P (83), I FN-y (84). PKC8 has also been shown to regulate the 
production of superoxide by phagocyte oxidase (85-87) and to playa role in transcription by 
phosphorylating the transcription factors STAT'], STAT3 and p300 (88). Furthermore, studies 
by Wadsworth and Gnldline using rottlerin, a putative specitic PKC6 inhibitor, indirectly 
suggested that PKC6 may playa role in phagosomal escape (24, 44). The role of PKC8 during 
L. /J1onocytogenes infection was thereftwe fI.ll1her fUllctionally characterized by in vitro und in 
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Figure 27. PKCI) belongs to each functional clustering "focus group". Promoter analysis 
revealed that the PKCI) may be a CIEBP~ target gene since its promoter contains a NF-KB and 
several putative C/EBPW'- binding sites. Gene ontology assignments and literature profiling 
showed that PKCI) was involved in humoral defense and may promote escape of L. 
monocylogenes from the phagosome. PKC8 is involved in regulating key immune signalling 
pathways such as NF-KB, TNF, IL-6, -cr, IFN-~ and IFN-y, regulates the production of 
superoxide and plays a role in transcription by phosphorylating the transcription factors 
STATI, STAT3 and p300. 
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DISClJSSION 
The anti-listerial transcriptional response of IFN-y-activated macro phages from WT and 
C/EBPrr/- mice WaS profiled at 4 hours p.i., since this was the earliest time point at which 
impaired bactericidal activity was observed in the ClEBPI3-1- macrophages. The execution of 
the rnicroarray experiments went smoothly, with the exception for the hybridization step in 
which several problems were experienced. The preparation of the high quality cDNA or 
aRNA with a frequency of incorporation (FOI) of at least 20 dye molecules per 1000 
nucleotides is crucial to the success or any microarray experiment. Since the yield aRNA was 
outstanding (> I OO~lg fix each sample) and the FOI was 39-57 dye molecules per 1000 
nuclcotides of aRNA, the microarray hybridization step was proceeded to with eonfidencc. 
However, technical variation may have been introduced during the hybridization reaction due 
to the unintentional incubation of tht~ arrays at 35"C instead of at 42°C. Although no 
observable non-specific hybridization was detected by eye, unequal hybridization kinetics 
across the array can not be discountcd. Morl'l)Vcr, image analysis of the arrays showed that 
there were several quality and printing defects resulting in technical systematic variation 
within and between the arrays. In order [0 accurately mcasure differential gene expression, 
these systematic variations wcrc rcmoved by a sequential normalization procedure 
recommcnded by Wit and McClure (7). Probabilistic background correction, print-group 
LOWESS and slide-scale normalization were used to correct for the high background, spatial 
hybridization effects and intensity-dependent dye biases within and between arrays. However, 
despite these eff()l'ts to remove as much systematic variation as possible, statistical evaluation 
of the arrays showed the technical reproducibility within each array was poor as shown by 
>50% of the replicate spots having SD>O.2. Similarly, the reproducibility between the 
biological rcplicate experiments was poor and only 51 (Yo ot'the microarray dala was reliable 
(SD<0.3), In order to improve the reliability and eontidence oflhe microarray data, unreliable 
or questionable data was removed. However, since the S[»0.2 cut off critcria for reliability, 
as defined by many researchers (18), removed >60% of the genes from the data set, it was 
considered too stringent since several known biologically relevant genes werc excluded from 
the data set. Since the microarrays were an exploratory study, it was considered more 
important to include hiologically significant genes for future analyses, Climination of known 
and other, as yet, unidentified biologically relevant genes, would decrease the probability of 
f'ulfi Iling the aims of the study. which were to identify genes involved in mediating I isterieidal 
activity. 'fherefore a less conserVative value of SD>O.3 was used to remove unreliable data. 
Although this strategy removed 49%, it did result in better correlation and reproducibility 
between the biological replicates. Moreover, the olllcome of PKC8 being selected as the 
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prime candidate gene would have been the same, regardless if either the SD<O.2 or SD<O.3 
cut olT criteria was used, since the Sf) 01' the average gene expression ratio for PKCi) in both 
the WT' and KO arrays was less than 0.2. Ideally, the microarray experiments should have 
been repeated using high quality arrays, however budget limitations did not allow for this. 
The systematic variation 111 the mlcroarray data could have been introduced by several 
possible SlHm:es. For example, technical variation could have been introduced by 
unintentional differences in conditions during the infection experiment or RI\JA purification 
procedures. In addition, slight differences in the mRNA amplification procedure and 
enicicncies of dye labelling may have added to the variation. RNA amplification was 
originally developed as a method to expand very small RNA samples to produce enough 
material for hybridization to micruarrays (89). A major concern when deciding to use the 
mRNA amplification procedure. was that not all mRNAs may amplify equally, which could 
introduce variation and bias within and between samples. llowever, studies by several groups 
have shown that any bias introduced by RNA ampliJication was minimal (4-6). Moreover, 
RNA amplification was reported to be actually improve the reliability of array results (5,6). A 
major source of technical variation was the printed arrays themselves. Image analysis and 
visual inspection of the fluorescent array images revealed that there were several printing 
anomalies. Considerable variation in spot quality and morphology within and between arrays 
was observed. Nut all the spots on printed DNA arrays are perfect and many microarray 
printing facilities routinely find that 2%) of the spots on an array are defective. Unfortunately, 
in the current study 10% or the spots un the arrays were found to be either printed on top of 
each other or had merged into each other. resulting in a significant portion of the data 
hecoming unreliable and questionable. Another potential source of variation within and 
between arrays was the hybridization procedure. The microarray arrays were processed in 
batches of 2 on different days over a 6 week period during spring. Several problems were 
experienced with Lhe hybridization process: when adding the denatured labeled aRNA probes 
to the microarray array, some probes took longer to load than others due to uneven capillary 
action between the array slide and the coverslip. This diJrerence in loading time could have 
resulted in some probes cooling and re-annealing. Therefore the degree or denaturation and 
temperature of the probes may not have been equal for all arrays. In some cases. bubbles 
formed when the probe was being added due to uneven capillary action and needed to be 
eased out from under the hybridization coverslip. which may have created unequal 
hybridization conditions. Moreover, the hybridization apparatus did not hold the hybridization 
temperature at 42°(', but instead cooled to 35°C over the incubation period. This temperature 
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fluctuation may have caused unequal hybridization kinetics within and between the arrays. 
Although sequential normalization of the microarray data removcd as much technical 
variation and systematic biases as possible. there was still considerable "non-biological" 
variability due to the inclusion of questionable or inconsistent data. In order to reduce the 
complexity of ,md variance in the microarray data, the M values for the replicate spots were 
merged and averaged over all rour biological replicate experiments 
Even though there were several quality isslles. the arrays still contained biologically 
meaningful data. As reported in literature. genes for several pro-inflammatory cytokines, 
cheillokines and iNOS were significantly up-regulated in both the WT and C/EBPrrJ 
activated macro phages during L. 11I0YIO(ytogcncs infection. Moreover. genes involved in 
macrophage activation. MHC class II presentation and in mediating signalling stimulated by 
IFN-y and TNF, were also were significantly up-regulated in macrophages {"rom both 
genotypes. More significantly, the induction of C/E8P~\ was observed only in Ihe WT 
manophages and the up-regulation of ClEBPP target genes such as G-CSF, CLECSFl), lL-
12p35 and ISGF3y was impaired in the C/EBPrrJ- macrophages. c/EBP~~ was shown to be 
essential for the induction of G-CSF during innate immunity against L. monocv/ogenes (29), 
/v/yco/Jacterillll1 tuherCII/()sis (30) and Brucella abortus (31). Similarly, C/EBPl3 was found to 
be necessary for the induction of CLU_:SI·'9 in response to LPS, TNF, 11,-6, and IFN-y 
stimulation. (32) and IL-12p35 Juring Calldida a/bicans infection (33). In addition, C/ELWr~ 
was shown to play an important rok in IFN-y signaling transduction via its transcriptional 
control of p48, a component of the ISGDy protein complex which is essential for IFN 
signaling (34). Since biologically relevant data could be extracted from the microarray dat(l. 
despite the poor performance on a statistical level, the deeision was made to go ahead with the 
data analysis. 
Differentially expressed (DE) genes were identified by a paired T-'Test where p values were 
calculated based on permutation and Bonferroni correction rather than distribution, in order to 
account f(lr Type I Family Wise Error Rate encountered during multiple testing. The Type I 
error rate in the context of the current study is the probability of identifying genes as being 
differentially expressed between the WT and ClEBPrrJ- maerophages, when in fact they are 
not. Differentially expressed genes were defined as those genes whose expression was 
significantly higher or lower in the C/l~nprr! macrophages as compared to the WT in all 4 
biological experiments. Five percent (1268 genes) of the mOLlse genome was identij'jed as 
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being differentially expressed beLween the WT and C/ERPWI- aclivated macrophages infeeted 
with L. monocytogenes. Furthermore, 55%) of the DE genes were up-regulated, -18% were 
down-regulated. The dilTerential expression of these genes may have been be due to either (i) 
the deletion of C/EBP~ and consequent loss of transcriptional regulation, (ii) IFN-y 
stimulation, (iii) infection by L. fI1onocytogenes or (iv) a combination of all these parameters. 
Ideally. microarray experiments using RNA representing each of these individual parameters 
should have becn dOllC, but unfortunately a limited budget did not allow this. Instead, the 
dependence or independence of candidate DE genes would be determined by quantitative RT-
PCR using RNA isolated from these experimental controls e.g. RNA isolated rrom 
maerophages treated only with IFN-y or infected only with L. tnollocytogcnl's. 
Several methods were considered on how to best to choose candidate genes that were 
potentially involved in mediating listerieidal activity. The natural intuitive approach selecting 
the most highly up- or down-regulated genes. only enriched for genes that acted upstream in 
immune response signalling pathways rather than downstream, where listericidal activity is 
mediated. Moreover, this method made the assumption that large di rferences in gene 
expression were more biologically signilicant than small changes, which may not necessarily 
be true. Furthermore, since the microarray data lacked dimension, genes could not be selected 
based on interesting expression pattern observed during the time-course or the injection 
experiment; nor could any functional information be inferred upon the unknown genes based 
on their co-clustering with known genes. Moreover. the DE genes clustered into f()ur simple 
patterns of expression only, which still did not help identify potential candidak genes. In 
depth knowledge of' the biological functions of the DE genes during innak immunity was 
required in order to make an educated decision of which genes to choose. Theref()re, a 
focussed functional clustering strategy was developed, where genes were selected based on 
particular biological functions and characteristics, rather than gene expression values. Since 
35% or the DE genes were unknown and did not have any gene ontology or published 
literature they could not be included in the functional clustering analysis. Functional 
clustering oj' genes with functional information, showed that 4,6li';) of the annotated DE genes 
were involved in the regulation oftranseription. 2.0% in host immunity and dciense, 3.1% in 
the production of ROI, 16.1 % in signalling and 8.9% in phagosome maturation and phago-
lysosome fusion. Similarly, promoter analysis revealed that 18.0% of the annotated DE genes 
were possible direct transcriptional targets or (,/1':13pr3, while 47.3% or the annotated DE 
genes had binding sites for transcription factors that interacted with C/EBPft The f()cusscd 
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functional clustering strategy reduced the number of candidate genes ['rom 1268 down to 220 
genes. Literature profiling of these 220 candidate genes revealed that several were already 
published in the literature as playing a role in defense against L. IJIOJlOcrtogel1(,s. 
With hindsight, excluding the "unknown" genes from further analyses was limiting, since 
some or these genes may have provided novel insight into the RN IIROI-independent killing 
pathway <lgainst L. mOJl()(ytogenes. The "unknown" genes could have been co-clustered along 
with the known candidate genes based on the occurrence of functional protein motifs/domains 
within their encoded proteins. For example, genes encoding proteins that contain GTPase or 
VPS domains would be of interest since these domains occur within the Rab family of 
proteins, which are responsible for regulating endocytosis, phagosome maturation and phago-
lysosome fusion. Similarly, the "unknown" genes could have been clustered according to the 
various response elements occurring within their regulatory promoter regions. For example, 
"unknown" genes that contained an IFN-y response element within their promoters would 
most likely be involved in the pro-inflammatory immune response. These putative IFN-y 
responsive genes could be grouped with other known IFN-y response genes into the "Defense 
and Immunity" cluster. Had these analyses been done, the inclusion of the "unknown" genes 
in the foclIsed clustering strategy would most likely have changed the percentages of the 
genes within each cluster. In addition, this mure comprehensive analysis may have resulted in 
a significant enrichmenl for a pi.ll1icular CUllctional group or activity as compared to the 
functional groups f(Jr thc entire gene set. Furthermore, some of these "unknown" genes may 
have encoded key 1 isteric ida! prote ins. Therefore, due to the Ii 111 itat ions or the original 
strategy, the above proposed analyses will be done in the near future to address these issues. 
PKC6 was selected from all the candidate genes for further study since it was found to belong 
to each of the ['unclional clustering "focus groups". Promoter analysis suggested that PKCo 
may be a transcriptionally regulated by C/EBPlt Gene ontology and literature data mining 
showed Ihat PKCo was involved in humoral defense and several key immune signalling 
pathways such as NF-KB (76-78), TNF (79,80), IL-6 (81. 82), IFN-a and IFN-I~ (83), IFN-y 
(84). PKCo has also been shown to regulate the production of superoxide by phagocyte 
oxidase (85-87) and to playa role in transcription by phosphorylating the transcription factors 
STATl, STAT3 and p300. In addition, in B cells stimulated with LPS, PKCo was shown to 
negatively regulate C/EBPf3 transcriptional activity by phosphorylating C/EBPP at a serine 
residue within the DNA binding domain that results in decreased DNA binding activity (90). 
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Furthermore. studies by Wadswol1h and Goldfine Llsing rottlerin, a putative specific PKC8 
inhibitor, indirectly suggested [hat PKC8 may playa role in phagosomal escape by pnssibly 
activating pun (24, ·-\,4). However, no direct evidence showing a correlation between 1he 
listerial phagosomal escape and PKC8 activity was presented. Moreover, the role 01" PKCo in 
innate iml11unity to intracellular pathogens has not been directly investigated to date. Since the 
up-regulation PKCo in the C/EBPrr/- macrophages was validated by quantitative R.T-PCR 
(discussed in Chapter 5), the role or PKC8 during L. 1I10l1o(ytogenes infection was therefore 
further rum:tionally characterized using a PKCo gene deficient mouse model, rather than 
rottlerin. since this putative PKC8 specific inhibitor has been reported to non-speciJically 
inhibit several other kinases and non-kinase cn/ymes (1,2). 
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FUNCTIONAL INFECTION STUDIES IN TI-IE PKCo-l - MOUSE MODEL 
SUMMARY 
PKC8 was found by microarray and confirmed by quantitative RT-PCR to be expressed at 
1.77 fold higher levels in activated C/EBPW1- macrophages infected with L. monocytof,';f!lles as 
compared to W'L Functional clustering and literature profiling revealed PKC8 10 be the most 
promising candidate gene since it has been shown to be involved in (I) several critical 
immune signalling pathways, (2) regulation of superoxide production by phagocyte oxidase, 
(3) regulation of transcription, (4) may be transcriptionally regulated by C/EBP[3 and (5) may 
be involved promoting listerial escape from the phagosome. In addition, PKC8 was shown to 
negatively regulate C/EBP~ transcription. Furthermore, since PKCo was up-regulated in the 
highly susceptible C/EBP[r- macrophages infected with L. monocytogenes. as shown by 
microarray and conJinned by RT-PCR, it was postulated that PKCo was detrimental to the 
host during L tr/OIlOcY/()f,';l'nes. However, since this premise has never been directly 
investigated, the role of PKCo in innate immunity to intracellular pathogens was investigated 
using the PKCi)+ mouse model, rather than rotilerin, since this putative PKCo specific 
inhibitor has been reported to non-specifically inhibit several other kinases and non-kinase 
cnzymes (1, 2). PKGr/- macrophages infected with L. monocY/()f,';eYteS displayed increased 
bacterial escape from phagosomes and uncontrolled bacterial growth. Despite increased 
production of iNOS, pro-inllammatory mediators and enhanced neutrophil recruitment, 
PKCo-irnicc were highly susceptible to L monocytof,';enes and displayeu impaired bactericiual 
killing, enhanced histopathology and decreased activated macrophage recruitment. PKC8 is 
therefore critical for confinement of L l11onocytof,';enes within phagosomes during innate 
immunity against L mOllOcytogcl1l's. [n contrast, PKC8-1 - mice were able to control M. 
tuberculosis infection as well as WT mice, suggesting that PKCo is targeted by L. 
1170nocytof,';cnes in order to facilitate its escape from the phagosome. PKCo may be pm1 oj' an 
unknown listericidal mechanism that is independent of iNOS and pro-int1ammatory cytokines 
that was previously observed in IFN-ii -, TNFRp5Y-, ICSBP-- and C/EBPW1- mice. Using a 
systems biology approach, a putative role of PKC8 in the unknown listcricidal mechanism 
was uncovercd, where PKC8 may function to promote and/or enhance Rab5a activity leading 
to phagosome maturation, phago-lysosome rusion and bacilli killing. 
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I~ESULTS 
1. Identification of PKCo by microarray 
The expression levels of PKC8 were found by mlcroarray to be 1.13 fold higher in the 
C/I ~Bprr - macrophages as compared to WT, which was confirmed by real-time ljuantitati ve 
RT-PCR to he even higher at 1.77 fold (Fig. 1 A). Quantitative RT-PCR of macro phages 
infected with L monocyto;:;cnes stimulated with or without IFN-y, showed significant 
induction of PKC8 in the C/EBPWI- macrophages as compared to the media control at 4 hours 
p.i. (Fig. I B). The induction of PKC8 by 1,. fIlollocylo;:;enes in the absence IFN-y stimulation 
may be due to L monocylo;:;enes-induced transcription of TNF via TLR2 (3) and '1'1,R5 
signalling (4). TNF has been shown to induce the expression of PKC8 in a NF-KB dependent 
manner (5). Moreover, PKC8 itself promotes the nuclear translocation of NF-KB and 
consequent NF-KB-mediated transcription. Since the transcription of G-CSF is mediated by 
N F-KB (6), it may he possible that G-CS F acts in a negative feedback regulatory loop to 
prevcnt its over-expression by NF-KB. The suppression of NF-KB transcriptional activity hy 
(i-CSF may occur via an, as yet unknown mechanism, whereby genes encoding proteins that 
promote the activation and nuclear translocation or NF-KG e.g. PKC8, are transcriptionally 
repressed. Consistent with this hypothesis is the observation that the induction of PKC8 by L 
monocyto;:;cnes alone in infected C/mWrr/- macrophages was signilicantly higher as 
comparcd to WI control macrophagcs (Fig.I.B). The impaired production of G-CSF in the 
C'/EBP[ri macrophages, due to the absence C/EBPf3 (7), may have resulted in the alleviation 
of the transcriptional repression or PKC8 by the G-CSF regulatory negative iCedback loop. 
The effect of G-CSF and other C/EBpr~ target genes such as IL-12p35, ClecsC9 and ISCiF3y 
on the transcription of of PKC8 will be further investigated by real-time quantitative RT-PCR 
in WT and C/E13Plri - macrophages. Similarly, the expression levels of PKC8 were higher 
afler IFN-y stimulation as compared to media controls, hut the observed increase was not 
significant (I·'ig. I C). The apparent decreased levels of PKC8 ill untreated CIEBPW-
macrophages, although not significant as compared to WT, suggested that PKC8 may be a 
target gene of C/EBPI-L Gene Ontology (00) assignments to PKC8 showed that it was 
involved in humoral defense and intracellular signalling. Ijterature rrofiling revealed that 
PKC8 is involved in several key immune signalling pathways such as NF-KB (8-10), TNF 
(11, 12), lL-6 (13,14), IFN-a and IFN-[) (15), IFN-y (16). PKC8 has also been shown to 
rcgulate the production of superoxide by phagocyte oxidase (/7-19) and to playa role 111 
transcriptinn by phosphorylating the transcription factors STAT I (16,20,21), STA T3 (13,22, 
21) and p300 (24). Furthermore, studies hy Wadsworth and (}oldfine using rottlerin, a 
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putative specific PKCo inhibitor, indirectly suggested that PKCi') may play a role in 
phagosomal escape (25, 26). However, no direct evidence showing a correlation between the 
listerial phagosomal escape and PKCi') activity has been reported. In addition, PKCo was 
shown to negatively regulate C/FBP[) transcriptional activity by phosphorylating C/EBP~ at a 
serine residue within the DNA binding domain that results in decreased DNA binding activity 
(27). Furthermore, since PKC8 was up-regulated in the highly susceptible C/EBPP-' 
macrophages infected with L. 11IOnocylogene,'I', sbown by microan'ay and continned by [{T-
PCR, it was postulated that PKCo was detrimental to the host during L. mmlOLylogenes. 
I [owever, since the role of PKC8 in innate immunity to intracellular pathogens has not been 
directly investigated to dat, the PKCo·l. mouse model was used to investigate this premise. 
'rhe PKCo·l. mOllse model was used, rather than rottlerin, since this putative PKCli specific 
inhibitor has been reported to non-specilicallyinhibit several other kinases and non-kinase 















































Figure I. U (l-regulation of PKC6 in activated C/EBPp-/- macrophagcs during L. 
mono(vtogenes infection. Differential up-regulation of PKC8 in C/EBPW1- macrophages 
(empty bars) as compared to WI' (filled bars) as discovered by (A) microarray analysis and 
(B) confirmed by quantitative RT-PCR. Shown are the averages and SEM of 4 independent 
biological experiments at 4 hours p.i .. Microarray data is relative to WT and RT-PCR data 
was normalized to the B2MG housekeeping gene and is relative to the WT average. (C) 
Quantitative RT-PCR of PKC8 in WT and C/EBP[r- macrophages with or without IFN-y 
stimulation and infected with /" monocytogenes (denoted by LM), Data is relative to the 
B2MO housekeeping gene and represents the averages and SEM or 4 independent biological 
experiments at 4 hours p.i. (* p <. 0.5). 
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2. PKCo-1- macrophages have enhanced bacterial growth and increased bacterial escape 
from phagosomes 
Since Wadsworth and Goldtine (25) did not diredly show a correlalion bctween PKC8 and 
phagosornal escape nor listericidal activity, I FN-y-activatcd PKGY- BMDMs were inkcted 
with L. monocylogenes and bacilli growth measured at 2.4, 8 and 12 hours p.i. (Fig. 2 A). 
Macrophages thml WT control mice were able to restrict bacterial growth and reached a 
steady stak plateau at 8 and 12 hours p.i .. Similarly. even though the bacterial load in the 
PKC8 1 /- control rnacrophages was 4 times significantly higher than in the WT. the PKC8 f/-
macrophages were sti II able to restrict bacterial growth. In contrast, PKC&-I- macrophages had 
significantly increased bacterial growth at all time points. with uncontrolled bacilli growth 8 
and 12 hours p.i .. To determine if the increased bacterial growth was due to enhanced 
bacterial escape from phagosomes. BMDMs were infected with L. mono(y/ogenes and 
baclerial escape measured by /1uorcscent microscopy (Fig. 2 C, D, E. F). WT. PKC&'/- and 
PKO( macro phages contained an equal number of bacteria at 90 minutes, indicating no 
significant defect with respect to phagocytosis in any of the groups. The number of bacteria 
associated with actin (red. escaped bacteria) and number of bacteria trapped in the phagosome 
(greeu) were scored and the percentage of escape calculated as described in the methods. 
PKC&- macrophages had 6.5 times greater bac1erial escape than the WT and PKC&l/- controls 
(Fig. 2 [~. 90 minutes p.i.; Fig. 2 C, E). At later time points, significantly more bacteria were 
associated with actin (Fig. 2 13, 180 and 270 minutes; Fig. 2 D, F) and were in motion (inset, 
Fig. 2 D) in the PKC8-
i
. macrophages as compared 10 the controls. Taken together these 
results shuwed that PKC8-- macro phages had impaired listericidal activity due to their 
inability to contine L. 1nOl1ocylogenes within the phagosome, which resulted in enhanced 
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Figure 2. Enhanced bacterial growth and increased bacterial escape from PKCo·l . 
phagosomes. BMDMs from WT (filled squares), PKC8~/. (fiJled circles) and PKC1)·I. (open 
circles) were infected with L monocylogenes. (A) Bacterial load was detennined at 2, 4, 8 and 
12 hours p.i .. Results are representative of three independent experiments (B) Quantification 
of L monocylogenes escape from phagosomes at 90, 180 and 270 minutes p.i. The number of 
bacteria associated with actin (red) and trapped in the phagosome (green) was scored. Data 
are averages ± SEM of the means for three independent experiments. Deconvoluting 
fluorescent microscopy of BMDMs infected with L monocytogenes at 90 minutes (C, E) and 
270 minutes (D, F) Escaped bacteria (red) are indicated by arrows. Magnification: X I 00. 
Results are representative of three independent experiments (*p<0.05 ; **p<O.OOO 1). 
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3. Efficient induction of pro-inflammatory mediators and nitric oxide in L. 
mOl1ocytogel1es-infected PKCi)-I- macrophag(~s 
To determine if the enhanced phagosomal escape and impaired bacterial killing in PKC6-1 -
macrophage was a consequence of impaired macrophage activation, the levels of pro-
inflammatory cytokines, chemokine MCP-l and nitric oxide in the supernatant from L. 
fJ/ono(.'}'/oKenes-infected macrophages were quantified (Fig. 3). Control PKC8+1- macrophages 
produced peak levels of cytokines IL-6, TNF, IL-12p40, IL-12p70 and the chemokine MCP-l 
at 8 hours p.i., followed by down-regulation at 12 hours p.i.. In contrast, secretion of 
cytokines and chemokines from PKC8- macrophagcs reached peak levels at 12 hours p.i. 
which were significantly higher as compared to PKC&,I- controls. FLl11hennore, nitrite 
production, representative of nitric oxide, was significantly increased in the PKC&-I-
l1lacrophages at 8 and 12 hours p.i .. In addition, the levels of GM-CSF were found to be 
similar among the PKCir/- and control macrophages, indicating that enh::mced cytokine 
production was not due to enhanced macrophage proliferation. Furthermore, the levels of 
IFN-y were t()Ltnd to be similar for PKC6- and control macrophagcs, indicating comparable 
levels of activation among all samples. These results demonstrated that in the absence of 
PKC8, macrophages were still able to be activated and etriciently produced pro-inflammatory 
and killing etTector molecules such as iNOS in response to the increased bacterial burden, 
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Figure 3. Efficient induction of pro-inflammatory mediators and iNOS in PKCo·l -
macrophages. Secretion or cytokine~. chcmokine MCP-l and nitrite into culture supernatants 
by BMDN1s from WT (n01 shown), PKC15+1• (tilled circles), PKCo" (open circles) mice 
infected with L rnomnylogene,,,-. Data are represented as means ± SEM of triplicate samples. 
Results are representative of two independent experiments (* p<0.05; ** p<0.005). 
4. Increased mortality in L. mOl1ocyt(}gel1e.'i-infech~d PKCcY/- mice 
Ilaving shown in viTro that PKCiS is involved in controlling L. mOl7ocyloRcncs inrection in 
macrophagcs, the role of PKC8 in vivo was investigated. PKC8-1- mice and their control 
littermaLes were injected i.p. with titrated doses or L mOI7()cyloRenes and mortality was 
measured (Fig.4). WT mice were ahle to survive L monocylogenes inCection at all doses and 
had a LD:;o _c 2 x 105 eFU. Furthermore, control PKC8 1-/- mice controlled the infection to the 
~ame degree as WT, although one out of five mice died at the highest inoculum (1 x 104 
('FlJ). In contrast, PK(W- mice were highly susceptihle to L. mOl1oc),logenes injection and 
had a LDs!) of 2 x 103 CFU. Even at a very low dose or 200 CFU, two out or nine PKC8--
mice died. IFN-yR-· mice were included in the 1110l1ality study, in order to assess degree of 
suseeptihi lity of PKC8- - mice to L monocyloRenes infection. IFI\J-yR- - mice have heen shown 
to he extremely susceptible to L monocyloRenes and arc unable to resist even less than 70 
CFU (28). As expected, all the IFN-yR-- mice died within 5-6 days after infected with 200 
CFU, whereas only 22(Yo or the PKC(,;- - mice died within the same period. These results 
demonstrated that the PKC6-- mice had dcCective innate immune responses and were highly 
susceptihle to L monocyloRcnes iniCction, alheit not to the same degree as the IFN-yR- -- mice. 
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Figure 4. Enhanced mortality after L. n1onocytogelles infection in the absence of PKC(). 
Mice were inlected with either (A) :2 x 102 eFlJ, (B) 2 x 103 CFU or (C) 2 x 104 eFU of L. 
mono(ytogenes and mortality measured. Results are representative of 2 independent 
experiments For (A) n= 7 - 10 mice per group; (B) n='12 mice per group; (C) n=oc5 mice per 
group. For (C) 2 PKC8- -were moribund and 3 PKC8-
i
. mice had died 2 days aner infection. 
Moribund mice were sacrificed and used to determine the bacterial burden in liver and spleen. 
Shown are p values comparing the survival curves of WT and PKC(3"/- mice. Survival data 
was analyzed by Kaplan-Meier using the log-rank test lo compare survival data. 
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5. Enhanced bacterial burden and increased histopathology in L. monocytogenes-
infected PKC6-1- mice 
L. t/1onocYloxenes-infccted PKCr- mice died early after infection (2 days) with a sub-lethal 
dose fiH WT mice, indicating a defect in their innate immunity. To verify this hypothesis 
PKCir-, WT and PKCo+/- control mice were infeetcd with 2 x 104 L mono(yloxenes and the 
bacterial burden in liver and spleen was mcasured at 2 days p.i. (Fig. 5 A, B). The CFU in 
spleen and liver from PKCo-'- mice was significantly increased over 3-log fold as compared to 
their WT and PKCo 1/- control littermates. This indicated that PKC8"'" mice were detective in 
their innate immunity and were unable to control bacterial growth resulting in early mortality. 
Protective immune responses against L monocylogenes involve the proper formation of 
intiltrating immune cells to form small microabseesscs that coniine the infeclion and control 
bacterial growth. The histopathology of liver (Fig. 5 C, D) was analysed at 2 days p.i .. 
Ilaematoxylin and eosin staining showed signilicantly more abundant microabseesses in 
PKCo-- mice as compared to their littermate controls. The microabscesses from WT mice 
were small. well defined (fig. 5 C. WT) and contained only a few bacilli (Fig. 5 D, WT). In 
contrast, the PKC8-/- microabscesses were very large, unorganized and contained many 
polymorphonuclear cells and zones of hepatocellular necrosis (Fig. 5 C, PKCo--). Many rod-
shaped bacilli were visible in the PKC8-'- microabsccsses (Fig. 5 D, PKCo- -) whcreas the WT 
and PKC;), I- microabsccsses only contained a lew bacteria. Failure to control bacterial growth 
resulted in necrotic lesions and liver dcstruction in the PKC8- - mice. The size or 
microabscesscs was significantly larger in PKC8- - mice as compared to the WT mice (Fig. 5 
E). Taken together, histopathology from L. monocYloxenes-infected PKCo-i - mice showed 
significantly more abundant and larger microabscesses than the WT controls, with extensive 
necrotic lesions, liver parenchyma} destruction and bacterial overgrowth. 
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Figure 5. Increased bacterial burden and histopathology in PKCo-l - mice. WT (filled 
squares), PKC8+1- (filled circles) and PKC8-1- (open circles) mice were infected i.p. with 2 x 
104 L. monocytogenes (n=4 - 5/group). Bacterial load in (A) spleen and (B) liver was 
determined at 2 and 3 days pj. (C) Microabscess liver sections were stained with 
haematoxylinleosin (C, D) and Gram positive stain (D) which colours L. monocytogenes in 
blue (arrow). Magnifications: C X400; 0 XIOOO. All data are representative of two 
independent experiments. (E) Size quantification of liver microabscesses in control PKC8+1-
(filled bars) and PKC8-1- (empty bars) mice (***p<O.OOOl). 
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6. r>ecreased activated macrophages but enhanced neutrophil recruitment in PKCo-l -
mice following L. Inonocytogenes infection. 
Clearance of L. monocylogcne.\· involves the proper recruitment of activated macrophages and 
neutrophils to the site of infection. PKor mice and their WT and PKCo'/- littermate controls 
were infected with 2 x 10-1 L. monocyto}!,enl.'s CFU and the recruitment of inflammatory cells 
at 2 days p.i. was analyzed by FACs. PKCo- - mice had increased numbers of peritoneal 
exudak cells (PEes) as compared to their control littermates, indicating no defect in cellular 
n:cruitment to the site of infection (Fig. 6). However, PKCo-- mice had 10% decreased 
n.:cruitmcnt of activated macrophages than the controls as shown by MIlC class JIlMACl 
(Fig. 7 A) and MIlC class IIIF4/80 (Fig. 7 B) staining. Furthennore, GR lIMACI expression 
was increased in PKCo-'- mice indicating 30% greater neutrophil recruitment as compared to 
the controls (Fig. 7 C). These results showed that the PKCo-i - mice had increased cellular 






Figure 6. Yield of recovered peritoneal exudate cells. Control PKCo l /- liHermates and 
PKC6- - mice was infected with 2 x 104 CFU of L. mOf1ocytogenes. Two days after infection 
peritoneal exudate cells (PEes) were recovered and pooled (n=5/group). Data represent the 





















































Figure 7. Decreased activated macrophage and enhanced neutrophil recruitment in 
PKCo·l - mice. F ACs analysis of L. monocytogenes elicited PECs from PKCS+I- and PKCS-I -
stained for activated macrophages (A) MHC class II and MAC 1, (B) MHC class II and F4/80 
and for neutrophils (C) MAC 1 and GR 1. Nwnbers represent the percentage of cells in that 
particular quadrant. Results represent pooled samples n=5/group. 
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7. Efficient induction of pro-inflammatory mediators and nitric oxide In L. 
monocytogenes-infected PKC()-I- mice. 
Serum levels of pro-intlammatory mediators collected 2 and 3 days after infection showed 
that (he PKC8- mice etliciently produced MCP-1, IL-6, TNF, IL12-p40, 11.-18 and IFN-y at 
levels comparable or significantly higher than the WT (Fig. 8). Similarly, quantitative real-
time RT-PCR of infccted liver and spleen samples at 2 days (Fig. 9) and 3 days (Fig. 10) p.i. 
conlJrmed that the PKc<r"- mice eniciently induced expression of pro-inflammatory mediators 
and iNOS at levels greater than thcir control iitlermates. The increascd MCP-l cxpression in 
PKC8-i - mice might explain the observed increased cellular recruitment to the site of infection 
as shown hy FACs analysis (Fig. 7). Interestingly, C/EBP~ was highly up-regulated in the 
PK(W- mice as compared to WT controls. Induction of hactericidal effector, iNOS, was also 
highly increased in PKC8-'- mice, however this was not suHicient to reduce the bacterial 
burden. I L-1 0, an anti-intlammatory cytokinc, was also increased in the PKCS-l- mice. These 
results showed that the PKGr- mice had efficient or significantly greater induction oC pro-
intlammatory mediators and iNOS due to their increased bacterial burden, but were 
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Figure 8. Efficient production and secretion of pro-inflammatory mediators in PKCo-l -
mice. Pro-intlammatory mediators were 1l1casured by sandwich ELISA in sera or mice at 2 
and 3 days after L. monocyfogenes infection with 2 x 1 O~ eFU. Results are representative of 
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Figure 9. Efficient induction of pro-inflammatory mediators and iNOS in PKC6-/-mice at 
2 days p.i .. Quantitative RT-PCR of pro-int1ammatory mediators in livers and spleens of mice 
at 2 days alter L. monocylogenes infection with 2 x 104 CFU. Results are representative of 
two independent experiments (n"=5/group). RT-peR data was normalized to the B2MCj 



















































Figure to. Efficient induction of llt-o-inflammatol"y mediators and iNOS in PKC6-I-mice 
at 3 days p.i.. Quantitative RT-PCR of pro-inf1ammatory mediators in livers and spleens of 
mice at 3 days aner L l71om)(ytogcnes infection with 2 x 104 CFLJ. Results are representative 
or two independent experiments (n=5/group). RT-PCR data was normalized to the B2MG 
housekeeping gene and to the WT average. Data are represented as means _1:: SEM (* p<0.05; 
** p<O.OI: *** p<O.OOOI). 
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8. Normal memory response in PKCo-l - mice following infection 
Clearance of bacilli during secondary L l11onocylogenes challenge is mediated by protective 
antigen-specific T cell memory. To determine if immunization of PKC8-'- mice conferred 
protection against a subsequent lethal dose of L. monocylogenfs, PKC8-;- mice and their 
control littermates were immunized with a LD50 dose 01'2 x 103 L mOI1()Lytogenes CFlJ. After 
2 months, the surviving mice were re-challenged with a secondary lethul dose of 2 x J 04 L. 
/l/onocylogenes CFU and the memory response measured by means of bacterial burden in 
spleen and liver at 2 days after infection. Non-immunized WT and PKCo+/- control mice 
efficiently controlled bacterial replication and displayed similar bacterial hurden in both 
organs (Fig. 11). In contrast, non-immunized PKCr;- mice displayed uncontrolled bacterial 
growth with 3 log fold significantly higher CFU in liver and spleen as compared to the 
controls. Following secondary infection, the bactcrial burden decreased by 1 -2 log fold in the 
WI' and PKCo i/- immunized control mice. Surprisingly, immunized PKCo-i mice also 
el1iciently cleared this higher dose and the bacterial burden in liver and spleen was reduced to 
the same level as the WT and PKCo 1/- control mice. Taken together, these results 
demonstrated that PKC8 was not required for the generation nor fix the elfector phase of 
adaptive cell-mediated immune responses to L. mOI1()Lylogenes infection. 
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Figure 11. Normal memory response in PKCo-l - mice. Bacterial load in (i\) spleen and (B) 
liver or non-immunized or immunized WT (tilled squares), PKC8+/- (filled circles) and PKC8-
/- (open circles) mice at 2 days p.i. alter re-challenge with a lethal dose of 2 x 104 1.. 
11/0noqlOgenes (n=-=6/ gro up). 
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9. J>KCB-1- <Ire resistant to aerosol M. tuberculosis infection. 
To test susceptibility in the absence of PKC& to another intracellular pathogen, PKC&-i- mice 
were infected with M tuherculosis by inhalation. Since C/EBPW and IFN-yR- - mice are 
highly susceptible to !v!ycohacterium (29, 30) they were included as positive controls and as a 
reference against which to measure the degree of susceptibility in the PKGr- mice. The 
weight of the mice was monitored weekly and mice sacrificed when they were moribund and 
had lost 2': 25°;() of their initial body weight. The weight of the PKC&- mice increased 
following infection as compared to their control mice (Fig. 12). In contrast, the C/EBPW- and 
IFN-yR-i - mice rapidly lost weight ailer 5 weeks and became cachectic and moribund by 6 and 
7 weeks p.i. respectively. The bacterial load in the spleen, liver and lungs of the C/EBPf3+ and 
I FN-yR- - mice was :1 log increased compared to their WT controls (Fig. 1:1). In contrast, 
bacterial burden [rom PKGri - mice were similar to their WT controls at 10 weeks p.i., except 
for a I log increased in the lungs. These data showed that PKC8 was did not playa major role 
in protection against Mycohacterillm, since PKCir - mice efficiently controlled M 
tuherculosis intec/ion as compared to their littennate controls. 
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Figure 12. Percentage body weight loss during M. tuberculosis infection. WT, PKC8-u-, 
PKC;)- -, I FN-yR-- and C/EBPW"- mice (n c4-6/group) were infected with 100 CFU of M 
tuherculosis via aerosol. Body weight was monitored weekly and mice were sacrificed once 
they had lost ~ 251% of their body weight. 
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Figure 13. Resistance to M. tuberculosis infection in PKC8-/- mice. WT, PKCO'/', PKC\Y-, 
[FN-yR" and C/EBPrri, mice (n=4-6/group) were infected with 100 CFU of AI tuherculosis 
via aerosol. Moribund C/EBPrr' and [FN-yR" mice were sacrificed at 6 and 7 weeks post 
infection respectively and their CFUs determined in lung, liver and spleen. WT, PKC(,)+/., 
PKC(')' . were sacri ficed 10 weeks post inrection and their bacterial burden was analysed. 
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] U. Generation and Analysis of a Protein-Protein Interaction Network for PKC8, RabS'l 
and G-CSF. 
A systems biology approach was used in order to determine the mechanism whereby PKCo 
confined L monocylogenes within macrophage phagosomes. Data from Wadsworth and 
Goldfine indirectly suggested that PKCo played a role in promoting listerial escape from the 
phagosome. In their studies, they showed that inhibition of PKCo activity by rottlerin, during 
I,. monocYlog,enes infection, resulted in impaired calcium intlux into the infected 
macrophages, which prevented the translocation of PKqm to early endosomes. Additional 
experiments blocking PKCB translocation with hispidin resulted in decreased escape of L. 
mOl1ocylogenes from phagosomes. Moreover, pre-treatment of macrophages with calcium 
channel inhibitors SK&F 96365 and thapsigargin. which block influx of calcium from the 
extracellular environment or intracellular stores respectively, resulted in 25-30% decreased 
escape of L. monocytogenes from the phagosomes (26). T'hese results therefore indirectly 
sugg,ested that PKCo played a role in promoting listerial escape from the phagosome, by 
racilitating the initial calcium influx into the inJected macrophages. Furthermore. additional 
studies by the same research group showed that LLO and Pi-PLe secreted by L 
11I0l1ocylOgenes during infection induced the activation of host phospholipase C (PLC) and 
phospholipase D (PLD). Using rottlerin, PKCo was shown to be responsible 1'01' activating 
PLD resulting in increased escape of the bacilli from the phagosomes. since pre-treatment of 
the macro phages with the PLD inhibitor, 2, 3-diphosphoglycerate partially inhibited escape 
Crom the phagosome (26). PKCo was therefore considered a detrimental factor during L 
monocytop,enes infections. 
However, results of this dissertation indicated that PKCo played a protective, rather than 
detrimental role during L. monocytogenes in1ection. PKCo - mice were highly susceptible and 
displayed increased escape of L. monocylogenes from the phagosome. Since phagosornal 
escape was shown to be dependent on increased cytosoJic calcium levels (31), these results 
suggested that the calcium intlllx into the infected PKCo- l - macro phages still took place 
despite the lack or PKCo. Other calcium-independent PKC isoforms e.g. PKCf:, PKC'l and 
PKC(), Illay have compensated for the lack PKC6 in the PKCo-- macrophages, and stimulated 
the inllux of calcium required for translocation of PKq:Hl to early endosomes and consequent 
bacterial escape from phagosomes. If PKCo did playa detrimental role during infection, the 
percentage of bacterial escape in the PKCo-- macrophages, resulting from the calcium int1ux 
cOlllpensat(~d 1()r by other PKC isoforms, was cxpected to be equivalent or slightly reduced as 
compared to WT macrophages. However, the PKCo-"- macrophages had 6.5 l()ld greater 
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bacterial escape from the phagosomes as compared to WT, suggesting Lhat PKC8 played an 
additional role otber than stimulating il1\vard calcium inl1uxes. For example, PKCo has been 
shown to regulate the production of superoxide by phagocyte NADPH oxidase by 
phosphorylating the enzymes p47phox and p67phox components (17-19). Moreover, since the 
localized release of superoxide and nitric oxide into the small space of the phagosome was 
shown to redlll:e escape of L. monocytogenes from the phagosome (32), PKCo may also 
function to stimulate the release or superoxide into the phagosome in order to prevent 
bacterial escape. However, the PKCo- - mice displayed higher susceptihility to L. 
monocytogl!nes than mice deficient for p47phox (p47phox-
i
-) (33), gp91 phox (gp91 phox--) 
(14) and doubly deficient fix iNOS and gp91 phox (gp91 phox liNOS 1-) (35). 'rhese results 
suggested that PKCo played an additional protective role during infection other than 
stimulating the production of superoxide (17-19). Experiments by Pizarro-Cerda et al (36) 
using C/EBP/f" mice infected with B abortus, demonstrated that CIEIW~} promoted 
endocytosis and membrane fusion between endosomes and pathogen-containing phagosomes 
in a G-CSF-dependent manner (36). In these studies, C/EBPW'- mice had impaired induction 
ofG-CSF and impaired bacterial killing, however, addition of the G-CSF restored endocytosis 
and bactericidal activity. C/EBPl3 was highly up-regUlated in the PKC8';- macrophages during 
L IIlOrlOcyU)ReneS infection, thereby suggesting that PKC8 may act downstream of C/EBP~ in 
the signaling pathway. It therefore seemed promising that PKC8 may he involved in C/EBP~ 
mediated regulation of endocytosis, phagosome maturation and consequent bacterial killing. 
A protein-protein network was created using protein-protein interaction data of PKC8, G-CSF 
and Rab5a. All protein-protein interaction data was taken trom the BIND, Entrez Gene and 
IlPRD databases which represent experimentally proven interactions. Although no direct 
interaction between Rab5a and PKC8 has been documented in any or the public databases to 
date, this interaction can not he discounted. The Cytoscape software programme was used to 
visualize and analyze the interaction networks (J 7). The complete network showing all first, 
second and third neighhour interactions, was very large and complex and the links between 
PKCo, G-CSF and Rah5a were unclear (Fig. 14). Therefore only the tirst and second 
neighbours and their edges were selected for Rah5a, G-CSF and PKCo proteins (Figure 15). 
Although the network is still complex, it can be seen that all the interactions in the signalling 
network converge on four proteins, RAB GTPase binding effector protein 1 (Rabcp I), 
Angiotensin receptor 1 (Agtrl a), RAS p21 protein activator 1 (Rasa I ) and Tuberous sclerosis 
2 (Tsc2), which interact with Rab5a directly (Figure 15 A, orange circles). Selecting only 
those interactions with the shortest "route" linking PKCo and G-CSF to Rah5a, the 
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relationship between these players became clearer (Fig. 15 B, C). PKC8 was found to interact 
directly with "intermediate" proteins such as protein tyrosine kinase 2 beta (Ptk2b), guanine 
nllcleotide binding protein. bela 2, related sequence 1 (Gnb2rs 1), Insulin-like growth factor I 
receptor (IgfJ r). Insulin receptor (Lnsr), ROllS sarcoma oncogene (Src), Guanine nucleotide 
binding protein alpha 13 (OnaI3) or 14-3-3 gamma (Ywhag), which themselves interacted 
with the proteins (Rabep]. Agtrla, Rasa I and 1's(2) that bound to directly Rab5a. G-CSF 
interacted only \vith its receptor, G-CSFR which itself signalled via an additional "layer" of 
intermediate proteins to Rasa I and Agtr I a in order to signal to Rab5a. G-CSFR interacted 
with Spleen tyrosine kinase (Syk), Yamaguchi sarcoma viral oncogene (Lyn), Protein tyrosine 
phosphatase. non-receptor lype 11 (Ptpn 11) and JAK l, which in turn interacted with either 
Hemopoietic cell kinase (lick), Growth tactor receptor bound protein 2 (Grh2). Ptk2b, Src, 
InsL Gnb2rs I or 19f1 r to signal to Rasa L which in turn bound directly to Rab5a, The most 
direct route II)r G-CSFR to Rab5n was via JAK2 which interacted with Agtrla. No direct 
interaction was found between PKC8 and G-CSF or G-CSFR. However, PKC8 was found to 
interact with Src homology 2 domain-containing transforming protein C I (Shc I) which binds 
(J-CSI:R (Fig. 15 A). Moreover, PKC8 interacted with several of the ""intermediate" proteins 
involved in (i-CSFR interactions e.g. Ptpn 11, Insulin receptor substrate 1 (lrsl), Interleukin 6 
signal transducer (IL6st), STAn and Mucin I (Muc1). In order to obtain a clearer picture of 
which protein interactions were important during L. monocytogenes infection, the literature 
for each interaction was profiled. 
Rabep 1 has been shown to hind directly to Rab5a Via protein-protein interactions with 
Rahgefl and the resulting Rabepl : Rabgefl complex shown to be essential for mediating 
Rab5a functions (38). Rabep! is essential fiX membrane docking and fusion (39). whereas 
Rahgcfl functions as a specific guanine nucleotide exchange tactor 1()r Rab5 and exchanges 
GDP for GTP (38). Furthermore, Rabgefl was shown to interact with Ywhag, a 14-3-3 
protein which is phosphorylated by PKC8 (40). Ywhag is the gamma isot(mn or the] 4-3-3 
family or proteins which are involved in the regulation of most cellular processes. including 
several metabolic pathways, redox-regulation, transcription, RNA processing, protein 
synthesis, protein i()lding and degradation, cell cycle, cytoskeletal organization and cellular 
traFncking (41). Since 14-3-3 proteins have heen shown to acts as "scaffolds" for multi-
protein complexes, Ywhag may function to stabilize the Rabep1 :Rabgefl complex, (42). 
Furthermore, the activity of 14-3-3 proleins is controlled by phosphorylation, which promotes 
binding to their protein partners (41), Since PKC8 has been shown to phosphorylate Ywhag 
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(40), i I may function to promote the formation the Rabep 1: Rabgefl complex. thereby 
enhancing RabSa activity and consequent phagosome maturation, phago-Iysosome fusion and 
bacterial killing. Similarly. the interaction between agonist-activated Agtrl and RabSa was 
shown to promote RabSa GTP binding and vesicular Cusion (43). P KCi5 was f()Und to 
phosphorylate and activate Gna 13 (44), an Agtr 1 agonist (45). PKC8 may therefore promote 
RabSa activity, by driving Agtrl activation via phosphorylation ofGnal3. In conl.rClst, PKC8 
may down-regulate the activities of Rasa! and Tsc2, as both these proteins have been shown 
to inhibit RabSa activity. Rasal was shown to suppress RAS signalling by stimulating its 
intrinsic GTPase activity resulting in the inactive GDP-bound {(mn of RAS. The suppressing 
activity of Rasa 1 was controlled by tyrosine phosphorylation or association with tyrosine 
phosphorylated proteins (46). Since Rab5a is a Ras related protein, its interaction with Rasal 
may promote GTP hydrolysis resulting in suppression of Rab5a activity. To counteract this 
Rab5a suppressive action, PKCi5 may phosphorylate Rasa! interacting proteins such as Ptk2b, 
Gnbrs 1, 19f1 r, [nsr, Src, Hck and Grb2, which once phosphorylated may bind to Rasa 1 and 
inhibit its activity. Similarly, Tsc2 has been shown to function as a RabS GAP in vivo to 
negatively regulate Rab5-GTP activity in endocytosis (47). Tsc2 interacted with Rab5a via 
Rabep 1 and specifically stimulated the built-in GTPase acti vity of Rab5a resulting in inactive 
GDP-bound RabSa (47). The suppressive activity of Tse2 was controlled by the binding of 
14-3-3 proteins (48) including Ywhag (49). r;urthennore, PKC8 has been shown to 
phosphorylate Ywhag (40), which promoted its binding to its target proteins e.g. Tsc2 (41). 
PKC8 may therefore down-regulate the RabSa suppressive function of Tsc2 by 
phosphorylating Ywhag and thereby promote its binding to Tsc2. 
260 
Figure 14. Protein-Protein Interactions between PKCo, G-CSF and Rab5a. Shown are 
protein-protein interactions between Rab5a (yellow), PKC8 (red), G-CSF (pink), G-CSFR 
(Pink) and their first, second and third neighbour interacting proteins (blue). Proteins are 
displayed as coloured circles and protein-protein interactions as black lines. Proteins in orange 
interact directly with Rab5a. 
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Figure 15. Putative mechanism of PKC/5 and G-CSF regulation of Rab5a activity. Shown 
are protein-protein interaction networks of (A) Rab5a, PKC8, G-CSF and their first and 
second neighbour interacting proteins. (8) Putative pathway whereby PKC8 (red) signals to 
RabSa (yellow) via Rasal, Agtrla, Tsc2 and Rabepl (orange). (C) Putative pathway whereby 
G-CSF (Pink) signals through its receptor, G-CSFR (Pink) to Rab5a (yellow) via protein-
protein interactions through Rasal and Agtrla (orange circles). Proteins are displayed as 
coloured circles and interactions as lines. Red lines indicate the direct interactions with RabSa 
that either activate (+) or suppress (-) Rab5a activity. 
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] 1. I)utative Mechanism whereby PKC3 confines L. mOllOcytogelles within phagosomes 
Based on the above protein interactions, literature and hypotheses, PKC8 may therefore 
indirectly promote Rab5a activity, phagosome maturation, phago-Iysosome fusion and 
subsequent bacterial killing, by promoting the Rab5a-activating functions of Agtrl a and 
Rabgefl and by inhibiting the Rab5a-sllpressing functions of Tsc2 and Rasa!. The following 
mechanism whereby PKCo confines L. monocytogenes with the phagosome is therefore 
proposed (Fig. 16 A). During L. monocytogenes infection, the secretion of pro-inflammatory 
mediators slleh as IFN-y, IL-l and lL-6 induces the expression of C/EBP~ (SO). Moreover, 
stimuli such as pro-inflammatory cytokines and LPS activate CIEBPI) by promoting 
phosphorylation of its transactivation domain (SI). Once activated C/EBPr3, translocates to 
the nucleus where it stimulates the expression of genes involved in oxidative bacterial killing 
(e.g. iN OS or PKC8) and/or genes involved in phago-lysosome mediated bactericidal activity 
e.g. Rab5a, Agtrla and Rabgefl. Promoter analysis of Agtrla, G-CSF, iNOS, PKC8, RabSa, 
Rabep I, Rabgefl, Rasal and Tsc2 genes revealed that they all contained putative binding 
sites for C/EBPr) or transcription factors that interacled with C/EBPr1 c.g. NF-KB (Fig. 16 B). 
In this hypothesis, PKC8 is involved mediating bacterial killing via both the oxidative and 
phago-lysosomc pathways. PKC8 has been previously shown to regulate the activation of 
phagocyte NADPH oxidase, the multi-protein enzyme complex that generates superoxide (17, 
18). However, its hypothesized role in tht~ phago-lysosome pathway is based on (l) the results 
01' this thesis where it was shown to playa crucial role in contining the L. monocytogenes 
within the phagosome, and (2) the hypotheses generated from analysis of the above protein-
protein interaction network. In the proposed mechanism, PKC8 indirectly promotes the 
activation of RabSa activity by regulating two opposite pathways (Fig. 16 A). 'rhe first 
pathway involves PKC8 phosphorylating the Gna 13 and Ywhag proteins, which in turn 
enhance and activate Agtrla and Rabgefl. Once activated, Agtrla and RabgeJl subsequently 
interact direclly with Rab5a bound at the phagosome membrane and promote the exchange of 
Rab5a-CiDP for GTP. Upon binding GTP, RabSa becomes activated and is thcn able to 
promote the rccruitment iNOS and phagocyte NAPDH oxidase resulting in the localized 
production of nitric oxide and superoxide into the phagosome (32). Moreover, activated 
Rab5a promotes phagosome maturation, phago-lysosome fusion and subsequent bacterial 
ki Iling. The second pathway involves PKC8 indirectly inhibiting the RabSa-supressing 
activities of Tsc2 and Rasal via its phosphory lation of Ywhag, Ptk2b, Gnb2rs I, 19f1 r. Insr, 
and Src. The binding of phosphorylated Ywhag to Tsc2 and phosphorylated Ptk2b, (Jnb2rs 1, 
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IgfJ r, Insr, and Src to Rasa!, inhibits their Rab5a suppressing activities. PKC8 therefore plays 
a central role in synergizing both these pathways in order to promote Rab5a activity and 
consequent phago-Iysosome fusion and bacterial killing. 
The gene expression data [rom the infected WT C/EBPW- macrophages was compared to the 
proposed mechanism to determine if there was any correlation. Since promoter analysis 
showed that Agtr1a. Rabgefl, G-CSF, Rasal, PKC8, Rab5a, Tsc2 and Rabepl contained 
putative C/EI~PP binding sites in their promoters (Fig. 16 B), it was natural to expect that 
induction of these putative C/EBPP target genes would be decreased in the infected C/EBPP--
macro phages as compared to WI. This was indeed observed for several of the target genes 
e.g. Rabgefl, Agtrla, G-CSF, however, Rasa!, Tsc2, PKC8, Rab5a and Rabepl were up-
regulated (Fig. 16 C). The up-regulation of these genes in the absence of C/EBPP may be due 
to compensation by other C/EBP transcription factor family members e.g. CIEBPa, C/EBP8, 
C/EI3P£ or due to alleviation of transcriptional repression by C/EBPfL Alternative splicing of 
C/EBP~) mRNA was found to generate long and short forms of the C/EBPI~ protein, which 
had opposile functions: the longer form activated transcription whereas the shorter lorm, 
which lacked a trans-activating domain, repressed transcription (52). An example of 
compensation by other C/ERP family members is demonstrated by the efficient induction of 
iNOS in the infected C/EBP[r macrophages, even though iNOS has an experimentally 
proven CIEBPP binding site in its promoter. Furthermore, the up-regulation of protective 
f~lctorS such as Rab5a, Rabep! and PKC8 may have been stimulated by the significantly 
higher bacterial load in the CIEBP~-I- macrophages. In addition. the up-regulation or the 
Rasa! and Tsc2 may have been induced by L monocytogenes itself in order to prevent 
phagosome maturation. 
According to the proposed mechanism (Fig !6 A), despite the enhanced induction or Rab5a, 
Rabepl and PKC8 in the C/L,:BPp-/- macrophages, PKC8 could not promote the exchange of 
inactive Rab5a-ClDP for active Rab5a-OTP at the phagosome membrane because of the 
impaired production Agtrla and Rabgcfl proteins due to the absence of C/EBP[t In the 
inkcted C/EBPP- - macrophages, Rabgefl was significantly down-regulated by 0.76 fold and 
Agtr!a by 0.71 fold. Moreover, Tsc2 and Rasal were up-regulated 1.24 and 1.1 fold 
respectively in the C/EBP~-/- macrophages. The consequent increased Rab5a-supressing 
activity or Tsc2 and Rasa 1 may have been be inhibited by PKC8, which was also up-regulated 
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by 1.13 f()ld in the C/E[3P[r- macrophages. However, although PKC8 could block the Rab5a 
suppressing activity of'rsc2 and Rasa!, it still could not promote activation of Rab5a via 
exchangc of GDP for GTP. The phagosome maturation and phago-Iysosome fusion pathway 
therefore came to a halt at the ·'activation or Rab-GDP" step and consequently resulted in 
increased escape of bacilli from the phagosome anu consequent bacterial overgrowth. 
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Figure 16. (A) Proposed mechanism whereby PKC8 confines L. monocylogenes with the 
macrophage phagosome. (8) Promoters of Rab5a regulating proteins containing putative 
C!EBP~ ( I ) and/or NF -KB (.) binding sites; A TO denotes the transcriptional start site. (C) 
Differential regulation of putative Rab5a regulatory proteins in C/EBP~·I. macrophages 
infected with L. monocylogenes. Data is relative to WT controls and are the averages and 
SEM of 4 independent biological experiments at 4 hours p.i. (* p<O.05 based on permutation 
and Bonferroni Correction). 
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DISCUSSION 
Early control of L monocy/ogenes infection requires the innate immune response dominated 
by neutrophils and macrophages, which are the major cells responsible for killing of L. 
monocylogenes (53-55), IFN-y and TNF arc essential for full macrophage activation (56, 57), 
resulting in enhanced production of cytokines, chcmokines and bactericidal molecules such as 
ROI and RNI. Several in vivo infection studies using mice iNOS--, gp47phox-/-, gp91 phox--
J 1\ 1 phox anu gp7 liNOS mice showed that bacterial killing took place despite the lack of ROI 
and RNI (33-35, 58, 59), suggesting that macrophages have an alternative ki Iling mechanism 
independent of ROI and RNI. This hypothesis was underscored by studies using mice 
deficient for genes such as IFN-y (60, 61), IFN-yR (28, 60), ICSBP (62), IRF2 (62). RelB 
(63), TNFRp55 (64, 65), and C/EBP~ (7), Allor these mice were highly susceptible to L. 
monocylOgenes despite full macrophage activation and production of pro-inllammatory 
mediators, ROI and RNI. This hypothetical unknown killing pathway is most likely driven by 
l[:N-y and TNF, with the most downstream effector being C/EBPf3, since C/EBP[r-
macrophages expressed normal levels of I FN-y and TNF (7), Since the etTector genes 
involved in this unknown mechanism would most likely be downstream of C/EBP~3, the 
transcriptional responses of L. monocylogenes-infected WT' and C/EBPW - macrophages were 
compared in order to identify the eITector genes, 
The transcriptional response of IFN-y-activated macrophages from WT and C/EBPW
I
- mice 
infected with L monocylogenes was profiled at 4 hours p.i,. PKC8 was selected as the prime 
candidate gene because it has been shown to be involved in several critical immune signalling 
pathways (8-10, 12-19) and may be transcriptionally regulated by C!EBPI) as revealed by 
promoter analysis. Moreover, studies by Wadsworth and Goldfine indirectly suggested that 
PKC8 played a role in promoting listerial escape from the phagosome by facilitating the initial 
calcium influx into the cell required for translocation to early endosomes (25) and by 
activating host phospholipase 0 (26). In addition, they showed that bacterial escape from the 
phagosomes was dependent on increased cytosolic calcium levels (26). T'hese results therefore 
suggested that PKC8 played a role in promoting listerial escape from the phagosome, by 
I~lcilitating the initial calcium inllux into the infected macrophages. In addition, B cells from 
PKCi')' - mice stimulated with LPS showed increased binding of C/EBPf1 to DNA due to 
alleviation or PKC8 phosphorylation of C/EBPI3 at a serine residue within the DNA binding 
domain that results in decreased DNA binding activity (27), Furthermore. PKC8 was up-
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regulated in L monocyto~-erles-inrected C/EBPfr- macrophages as compared to WT, as shown 
by microarray and confirmed by RT-PCR. It was therd/xe postulated that PKCo was 
detrimental to the host during L monocylo?;enes intCctions since in addition to promoting 
phagosomal escape of L monocylogenes (25, 26) it also inhibited the transcriptional activity 
of C/EBPf) (27), which may also result in increased phagosomal escape and impaired 
listericidal activity as observed in C/EBPW' mice (7). 
To lest this hypothesis, activated PKCo- - macrophages were infected with L. monocytogenes 
and bacterial growth and phagosomal escape measured. From the hypothesis, it was expected 
that PKCo- - macro phages should have decreased levels of phagosomal escape and bacterial 
load due to enhanced C/EBP~ transcription of effector genes in the absence or PKCo (27). 
Surprisingly, PKC8-- macrophages had increased bacterial escape from phagosome and 
uncontrolled bacterial growth, despite enhanced production of iNOS and pro-inflammatory 
cytokines in response to the high bacterial load. This was unexpected since it opposed in vitro 
data by Wadsworth and Goldfine (25) which indirectly suggested that PKC8 promoted 
phagosomal escape. This divergence may have resulted from their use or rottlerin at a 
concentration (25IlM) which has been shown to non-specifically inhibit several other kinases 
(I, 2}. Their observations may have been compounded by the non-specific inhibition or other 
kinases by rottlerin. In this thesis. using PKC8-i - macrophages, it has been clearly 
demonstrated that PKC8 is critical for confining L. mon()(;yto?;cnes within the phagosome. 
Moreover, despite having significantly higher expression of C/[';Bpr~ and its expected 
enhanced transcriptional activity in the absence of PKC8 (27), the PKCo-! macrophages were 
unable to control the growth of L. monocy/ogenes. Data from this thesis clearly shows that 
PKC8 is protective rather than detrimental during innate immunity to L. monocyfogenes. 
Furlhermore, PKCo did not appear to playa critical role in innate immune responses against 
AI. tuhercuiosis, an intracellular bacterium that preierentially resides within the phagosome. 
PKCo may therefore be a target that is negatively modulated by L. monocytogenes to facilitate 
its own escape and survival. 
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The most important finding of this dissertation was that PKCo was indispensable for 
confinement of L. mono(J'/ogenes within the phagosome, sll1ce no other PKC isoform 
compensated for it in the PKCo·· maerophages. The enhanced listerial escape and impaired 
listericidal activity resulted in uncontrolled bacterial growth and dissemination of L. 
lI1onocy/ogenes, which ultimately led to early death of the PKCO'- mice. 'The increased 
susceptibility of the PKCir/-mice was not due to defective induction of pro-inflammatory 
mediators, since in vilro and ex vivo quanlilation showed that they produced significantly 
higher levels of nitrite, MCP-l, IFN-y, TNf', IL-12 and IL-6 than the WT mice in response to 
the high bacterial load. As expected, the inflammatory response was counter-balanced by the 
production of IL-I 0 by the activated macrophages with kinetics similar to that f(w the pro-
inflammatory mediators (66, 67). Furthermore, the massive recruitment of intlammatory cells 
into the peritoneal cavity and abundant granulomas of PKOr-miee indicated that impaired 
resistance to L. Jnonocylogenes was not due to defects in chemokine attraction. I fowever, the 
number of recruited activated macrophages was 10% lower in the PKC;S- -mice. Furthermore, 
despite having recruited 30% more neutrophils, which are essential for killing L 
JIIonocylogenes (53-55), the PKCo--mice were still unable to kill and clear the 1.. 
lI1ol1ocylogenes bacill i, as shown by the signi ticantly increased bacterial burden and 
histopathology in their spleens and livers. In addition, PKC8 was not required fix the 
generation or for the effector phase of adaptive cell-mediated immune responses to 1.. 
monocyloRenes infection, since immunized PKCo·- were able to kill and clear a lethal dose of 
L monocylogenes as dliciently as the WT controls. PKCo is therefore a critical component of 
the innate immune response and is critical for confinement of L. 11lonocylogenes within the 
phagosome. Furthermore, data from this disserwtion suggests that PKC8 is involved in similar 
unknown listericidal mechanism that is independent or iNOS and pro-inflammatory cytokines, 
that was lirst observed in [FN-y-;-, TNFRp5S-;-, ICSBlr - and C/EBPW- mice. 
The key questions arising from this study include (i) what is the mechanism whereby PKC8 
confines L. monocy{ogenes within phagosomes, (ii) is PKCo part of the unknown listericidal 
mechanism that is independent of' RNI and ROI, and if so (iii) where docs it fit in this yet 
undc1ined pathway? Since phagosomal escape was shown to be dependent 011 increased 
cytosolic calcium levels (31) and the PKGr- macropbages had 6.5 fold increased bacterial 
escape from lhe phagosome, this indicated that calcium influx into the PKCo-- macrophages 
occurred independently of PKCo. Moreover, the significantly increased rate of bacterial 
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escape from the phagosome and higher bacterial load in the PKC8-/- macro phages, suggested 
that PKC8 played an additional role other than stimulating inward calcium inl1uxes. Therefore 
investigation into the interaction between PKC8 and calcium channels was not pursued. 
Instead, the role of PKC8 within the milieu 0[' the phagosome was t()cussed upon, since this 
was the "site or action" where its function to conIine the bacilli was etTected. 
ConJinement of bacteria within the phagosome has been shown to be dependent on active 
CiTP-bound Rab5a (68) and the localized release of nitric oxide and superoxidc into the 
phagosomal space (32, 69). However, the actual mechanisms of how this is achieved are not 
fully elucidated. Active Rab5a promotes phagosome maturation, phago-Iysosome fusion and 
consequent bacterial killing by digestion with lytic enzymes, whereas the release of nitric 
oxide and superoxide into the small space of the phagosome results in ratal oxidative damage 
to the bacilli (53-55). Several studies have shown that IfNI and ROI are important but not 
essential t()r hacterial killing (33-35). Data in this dissertation corroborate these studies, since 
PKC6-/ mice were unable to kill and clear the L tnono(vtoRenes infection, despite enhanced 
iNOS production. Since PKC8 has been shown to be important i{))" superoxide production by 
phagocyte oxidase (17-19), it can he argued that the increased susceptihility of PKC8-1- mice 
to L nwnocyloRenes may he due to decreased production of superoxide. Ilowever, several 
lines of evidence suggest that this is not the case. PKC8-- mice had a much higher degree of 
susceptibility to L fJJonocylogenes than p47phox'- and gp91 phox-- miee: The LDso dose t(X 
p47phox-- mice was only 1 log fold lower than their WT controls (33), whereas for the PKC8-
- mice it was 2 log j()ld lower. Similarly, at 2 days p.i., the bacterial burden in the liver and 
splcen of gp91 phox- - mice were only 1 log 1{)ld higher than in the WT. In contrast, the PKC8-
- mice had 3 log f()ld higher CFU in the liver and spleen compared to WT controls. In 
addition, gp91 phox-- mice displayed heightened susceptibility only during the first 2 days of 
L fJ}OIwLylogenes infection and recovered hy day 6. PKC8-'- mice, on the other han(t, were 
highly sLlsceptible and died by day 3 p.i. (34). These data theret()re suggested that PKC8 plays 
an additional role during L tnonocylogenes infection, other than stimulating the production of 
superoxidc. 
The PKC8-- mice were highly susceptihle to L monocytogenes, but not to the same extent as 
ohserved j()r extremely susceptihle IFN-yR"-, C/rmpp--, TNI·'Rp5y i- and ICSBP mice which 
had LD50 doses greater tban 3 log fold lower than their WT controls (7, 28,33, (2). However, 
tbe phenotype of PKC8- - mice was similar to that observed in C/E':BP[r- mice, with respect to 
enhanced bacterial growth and escape despite efJlcient induction or IFN-y , TNF and iNOS 
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(7). It was therefore tempting to speculate that PKC8 may be directly or indirectly involved in 
the unknown RNIIROI-independent killing mechanism that was first observed in the IFN-yR--
, TNFRpS5" -, ICSBP-- and C/EBPW
i
- mice (7, 28, 33, 62). Levels of PKC8 were decreased in 
resting CIEBP[r - macrophages as compared to WT, which suggested that it may require 
C/FBpr~ for its expression. Indeed, promoter analyses identilied a putative NF-KB and several 
C/EBPB binding sites in the promoter of the PKC8 gene. PKCo may therefore be a direct 
transcriptional target of CIEBP[~ through its CIl'lWr3 binding sites or an indirect target via its 
NF-KB binding site, since C/E\3P~ interacts with Nl"-KB subunits p50 (70) and p65 (71). 
However, PKC8 was efficiently induced by L monocytogenes in activated and non-activated 
C/EBPW - macrophages. This may be due to the alleviation of transcriptional repression by 
C/EBP[), which has been shown to either induce or repress transcription (72, 73) of its target 
genes. However, since both PKC8 and C/EBPfi are essential for innate immunity to L. 
mOf1ocy/ogenes, it is more likely that other related C/EBP family members transcriptionally 
cumpensated ll.)r the lack of C/EBPB during L mOl1ocy/ogenes infection in the CIEBP~--
macrophages. 
A systems biology approach was used to investigate the mechanism whereby PKC8 conlined 
1.. m0l1ocytog!'17eS within macrophage phagosomcs. It was hypothesized that PKC8 may 
achieve this acting in synergy with G-CSF to promote C/EBPr3 mediated regulation of 
phagosome maturation and phago-Iysosome fusion (36). Analysis of the protein-protein 
interaction network generated the hypothesis lhat PKCo indirectly promoted Rab5a activity. 
phagosome maturation, phago-lysosome fusion and subsequent bacterial killing, by promoting 
the Rab5a-activating functions of Agtrla and Rabgefl and by inhibiting the Rab5a-supressing 
functions of Tsc2 and Rasal. Moreover, the microarray gene expression data correlated with 
the proposed mechanism, since the Rab5a-activating Agtrl a and Rabgefl were down-
regulated in the c/rmpw macrophages as compared to WT, whereas the Rab5a-supressing 
Tsc2 and Rasa I proteins were up-regu lated. Although the increased levels of PKCo may have 
compensated and repressed the enhanced Rab5a-supressing activities of Rasa I and 1'sc2, it 
was not able to promote Rab5a activation due to impaired production Agtrl a and Rabgefl 
proteins. ThereJ()fe phagosome maturation, phago-Iysosome fusion and bacterial killing could 
not take place due the inability to activate Rab5a. Consequently the L. tr/onocytogel1cs bacilli 
could escape more efficiently from the phagosol1lcs of C/EBPrr/- macrophages resulting in 
bacterial overgrowth. Taken altogether, the i()llowing hypothetical killing pathway is 
proposed (Fig. 17): 
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Since 1 FN-y activates the cytocidal or cytostatic potential of macrophages (28, 74) and TNF 
has phagocytic and bactericidal/bacteriostatic functions (74), both these cytokines would drive 
the hypothetical killing pathway. IFN-y would be the first component in the pathway, since 
IFN-i i - (60, 61) and IFN-yR-- (28, 60) mice had impaired induction of TNF. Downstream of 
lFN-yR would be RelB, a transcription factor belonging to the NF-Kf3 family, since RelB--
mice eiIiciently produced JFN-y but had impaired macrophage activation due to defective 
induction of TNF (75). Consequently TNF would be downstream of lFN-y and RelB. 'rhe 
most downstream molecule in this hypothetical pathway would be C/EBPr-~, since L. 
monocytogenes-intected macrophages from C/EBPW1 - mice expressed normal levels of fFN-y 
and TNF (7). PKC8 would most likely to be downstream of C/EBPr3 in this pathway, since 
C/EBP[3 mRNA was highly up-regulated in the PKC8-1- mice during the early phase of L. 
fJ/onocytogenes infection. This suggested that PKC8 may activate or synergize with, as yet, 
unknown proteins which are transcriptionally induced by C/EBPB. 'fherefore in the PKGY/-
mice, even though C/EBPl3 target gencs were expressed, they could not fu1111 their function to 
confine lhe L monocylogenes within phagosomes due to the absence of PKC8. Similarly, the 
C/EBPrr- macrophages were unable to prevent listerial escape from the phagosomes despite 
up-regulation of PKC8, due to the absence of C/EBPB target genes in the C/EBPW-
macrophages. The proposed hypothetical killing pathway may be initiated by an "IFN-y 
module" where IFN-y binds [0 the IFN-yR, which in turn activates IFN-y responsive 
transcription factors such as S'1'ATI, JCSBP and IRF2. RelB would transcribe TNF, which 
enters the pathway downstream of the "J FN-y module" and signals via the TNFRp55 and not 
TNFRp75, since TNFRp7Y- mice did not exhibit any defects in host defense and 
inllammatory responses to L monocytogenes (76). Secretion of pro-intlammatory cytokines 
such as IFN-y, 11,-1 and IL-6 inducc expression and activation ofC/EBPB (50, 77). Moreover, 
IFN-y activation of mixed-lineage kinases of the mitogen-activated protein kinase (MAPK) 
l~lmily (MLKs), mitogen-activated protein kinase kinase/extracellular signal-regulated protein 
kinase (MEKs) and extracellular signal-regulated protein kinases (ERKs) phosphorylate and 
thereby activate C/EBPB transcription activity (78, 79). 'The "C/EBP[) module" enters 
downstream of the "TNF module", where activated C/EBP~) transcribes its target genes which 
are needed for confinement of bacteria within phagosome e.g. G-CSF, Agtrla, RAB GTPase 
binding efTector protein I (Rabep 1) and Rabgefl. Furthermore, transcription oJ~ as yet, 
unidentified C/EBPI) target genes may themselves be bactericidal or act in concert with other 
proteins to generate bactericidal molecules. For example, iNOS which generates nitric oxide 
during pro-inflammatory innate immune response and PKC8 which stimulates production of 
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superoxide by phagocyte NADPH oxidase (17-19). Downstream of the "C/EBP[3 module" is 
P1(C8 which may act in synergy with G-CSF to augment RabSa activity by promoting the 
activity of Agtrl and Rabepl : Rabgefl, while suppressing the activity of Rasal and Tse2. 
Thercailer phagosome maturation and phago-Iysosome fusion occurs resulting in bacterial 
killing, antigen presentation and clearance by the adaptive immune response. The role of 
PKC8 in promoting phagosome maturation and phago-Iysosome fusion is not implausible, 
since PKCa has recently been shown to be important for phagosome maturation (80). In 
addition, activated RabSa and PKCi5 act in concert to recruit phagocyte NADPH oxidase to 
tile phagosome membrane and stimulate the production of superoxide into the phagosome(l7, 
18, (9). Furthermore, PKCo may have an additional role in the proposed pathway where it 
may directly or indirectly modulate the activation of C/EBPP through phosphorylation of the 
trans-activation domain. The activity of PKC6 is regulated by phosphorylation of its tyrosine 
residues in response to different stimuli, and the effect of tyrosine phosphorylation can have 
many different effects on PKC8, depending on the biological context e.g. the cell type and 
nature of the stimulus (81, 82). In 13 cells stimulated with LPS, PKC8-i - was shown to inhibit 
C/EBPI1 transcriptional activity by phosphorylating C/EBPP at a serine residue within the 
DNA binding domain, resulting in decreased DNA binding activity (27). However, the 
biological context of B cells stimulated with LPS is very different from IFN-y activated 
macrophages infected with L IllOnocytoRcnes, where PKC8 appears to be a downstream 
elkctor of IFN-y in mediating listericidal activity. Indeed, fL-l r~ and TNF secreted by IFN-y 
activated macrophages induces the transcription of PKC8 (5, 16). Moreover, IFN-y stimulates 
the activation of PKC8, which in turn mediates serine phosphorylation of STATl and thereby 
facilitates transcription of I FN-y stimulated genes (16). It Illay there1()fe be possi ble that in 
activated Inacrophages, PKC6 may activate CIEBP[3 through phosphorylation of its 
transcriptional activation domain; however, this premise would have to be investigated 
further. Based on this speculation, the higher levels of PKC8 in the C/EBP[r/- intCcted 
macrophages may have lunctioned to promote C/EBPI3 activity and therefore enhance tile, as 
yet, unknown bacterial killing mechanism. It is also possible that PKCo Illay indirectly 
activate C/EBP[3 via phosphorylation of other kinases lhat bind to and activate C/EBpr~. For 
example, activated [>KC6 phosphorylales MEK 1 leading to the activation of ERK1I2 (83), 
which is involved in the activation of C/EBPP in response to JFN-y (78). 
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However, since the PKC8-1 mice were not as susceptible as IFN-yR-1-, STATI-I-, ICSBP-I-, 
IRFT1-, ReJB-1-, TNFRp55-1- or C/EBPWI- mice, it can be argucd that PKC8 may not in I~lct be 
part of the hypothetical RNIIRO-independent killing pathway. It could be possible that the 
increased expression of PKC6 in the C/EBPW- during infection by L. monocytogel1es 
functioned to enhance the assembly or the phagocyte NADPI f oxidase. However, since the 
PKCo-- mice were more susceptible than p47phox-- or p67phox-/- mice, this suggested that 
PKC6 played an additional role other than regulating the production of superoxide by 
phagocyte NADPH oxidase. Alternatively, PKCi') may be involved in a totally separate 
pathway that functions to contine the hacilli within the phagosome. It can be speculated that 
PKC(') may activate and/or synergize with, as yet, unidentitied proteins to neutralize that 
activity of listerial LtO and PI-PLC activities, thereby preventing the escape or L. 
rrtol1ocylogel1cs from the phagosome. These unknown proteins may themselves be 
transcriptional targets of CIE13P[t since the high levels of PKC8 in the infected C/EBPW'-
macrophages still could not control listerial escape ii"om the phagosome, due to the absence of 
the unknown proteins. Clearly further studies are required in order to test the above 
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Figure 17. Role of PKCo in the hypothetical L. monocytogenes killing pathway mediated 
by IFN-y, TNF and CfEBPI3 that is independent of ROI and RNI. Solid lines with arrows 
represent positive (+) regulation; solid lines with blunted ends represent negative (-) 
regulation; dashed lines represent phosphorylation and activation. 
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III the current study, L. lI/ol/ocy/ogencs was used as a model intracellular pathogen to 
invl~stigate :lIld identify the genes involved in Illcdiating macroph;)ge hactcricidal elTeclor 
activity. Early control of L lJ}onocy/ogencs infection requires the innate immune rcsponsc, the 
prilllary goal of which is to restrict the proliferation of L. monocytogcnes, thercby preventing 
bacterial dissemination into the blood stream, infection of othcr vital organs and 
overwhelming sepsis. Activated neutrophiJs and macrophages arc the major cell types 
respunsible fl)r killing ofL. I//OI/ocytogenes (1-3). IFN-y alld n'-iF are key cytokines essential 
It)!' I 'til I macrophage activation (4, 5), resulting in enhanced production of cytnkines, 
chell1ukincs and bactericidal molecules such as inducible nitric oxide and superoxide. Several 
ill l'il'O infection sludies using iNOS·1., gp47phox·I., gp9Iphox·l. and gp91 phox I liNOSI 
Illice showed that bacterial killing took place despite the lack of nitric oxide and superoxide 
(6-10), suggesting that lllacrophages have an alternative killing mechanism independcnt or 
these reacti ve n itrogen- and oxygen- interlllcd iates. This hypothesis was further underscored 
by stud ies using mice deficient for genes such as I FN-l' (II, 12), IFN-yR·1- (II, 13), Rem 
(14), TNI7Rp55·1. (15, In) and C/EBPWI . (17). All of'these mice were highly susceptible to L. 
1II0I/ocv/o,!!,efles despite full macrophage acti vation and production of pro-inflammatory 
Illediators, superoxide and nitric oxide. Since IFN-y activates the cytocidal or cytostatic 
potentia I or macrophages (13, 18) and TN F has phagocytic and bactericida I/bacteriustatic 
('ullctions (I S), this hypothetical killing pathway is most likely activated by these cytokines. 
il"N-y would be the first component in 1he rathway, since IFN-l- (11,12) and IFN-yR·1- (II, 
13) mice had impaired induction onNF. Similarly, RelB would be downstream of IFN-y, 
since mice deficient in this transcription factor efficiently produced IFN-y but had defective 
indllction of TNF (14). Consequently TNT-' would be downstream of IFN-y and Relf3. The 
Illost downstream mulecule in this hypothetical pathway would be c/EBP~, since the 
C/E lW[r/. 111 ice expressed normal levels of I FN -y and TNt' (17). Since I FN-y stimulation 
resliits in the enhanced expression (19, 20) and activatioll of C/EBPP (21, 22), and TNF 
prunlulcs 111C (ra nslocat inn () I' C/UWfl to the nucleus in response to pro- i nllallllllatmy 
,:yl()killc signalling (23), it can therefore be envisaged that IFN-y and TNF signalling 
uJIl\'erge l1l1 C/EBPP In transcribe genes required for confinement of L. mOl/ocy/ogenes 
\\' itl! i n the phagosome, lead ing to rhago-lysosome fusion and consequent bacterial ki II ing. 
Macruphage e!'lector genes involved in this unknown mechanism would therclore most likely 
he duwnstrealll ol'C/EBI)II. C/I~Bprl is a transcription factor that is important for macrophage-
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mediated antibacterial de lenses. Th 1 immune responses, anti-tumour defenses., dillerentiation 
or variuus cell types and storage and metabolism of carbohydrates and lipids (22), 
l'urLhcrlllore. C/[IWrl/'l11icc are highly susceptible to intracellular pathogens slich as Listeria 
(I S'u/mone//a (I 7). Brllcella (24). MycobacteriulII (25) and Candida (26) due to thci r 
inabiiity to coniine the pathogen within phagosomes, resulting in impaired listericidal activity, 
11 was therefore postulated that the comparison between the gene expression profiles of WT 
alld ell ',BPrrl. macrophages inkcted with L. IJ/Ol1ocvtogenes would increase the probability of 
identifying these effector genes, which would be differentially expressed between these two. 
gell,)1 ypes. 
The Ilrst part or this study established and optimized the in vitro infection of WT and 
C/EBPfr/. bone marrow derived macrophage:; with L. fIIonocytogenes, Contrary to most il1 
\'ifm protocols published in literature, the macrophages were simultalleously stimulated with 
IFN-y alld inlected with L. tnOJlocylogenes, and not pre-activated prior to infection. This 
particular ill vitro infection protocol was fl)llowed in order to authentically reproduce the 
biology 0 I' the in vivo infection experiments, since macrophage:; do not naturally exist in a 
pre-activated state. Both WT and C/EBPWI- infected macrophages were rully activated and 
_",ccrcled equivalent amounts or pro-inflammatory mediators such as I L-6, IL-l2, fL-lS, TN F, 
l'v1CP-1 and nitric oxide, llowever, despite full macrophage activation C/EBP~.f· macrophages 
had 30% more escaped L lJIoriocytogenes bacilli in the cytoplasm and uncontrolled bacilli 
growth as compared to WT. Furthermore, the induction of C/EBpr~ target genes G-CSF, 
CLl'CSF9, IL-!2p35 and lSGF3y was impaired in lhe C/E8prr!' macrophages (17, 27-29). 
(\lInparison of tbe in vitro infection data to that published in the literature cunfirmed that the 
ill villO infection experiments had sLlccessfully mimicked the biology of in vivo infections (17, 
and provided a solid foundation on which to base the gene expression prol1ling 
experiments. 
The sl'C'ond part of the study used comparative DNA microarray analysis to identify genes 
Inv\)\vcd in mediating macrophage listerial activity, which were postulated to be diflerentially 
l'xpressed bct ween the infected WT and C/EBPrrl . macrophages. The transcriptional response 
ul'L IllOllOcrlogell(!s infected macrophage:; from WT and C/EBPrr' mice was compared at 4 
IltHirs p,i. for all t(H1l' biological experiments. This particular time point was chosen, since it 
was the l'arliesl instance where a significant difference between WT and C/EBPrr/. 
maLTophage listerkidal activity was observed, due to differential expression of Iistericidal 
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gcne" hetvvceil the WT and C/EBPpie macrophagcs. AltllOUgh the execution ofthe microarray 
c\rll>rimt~nh went smoothly. image analysis revealed that there was significant systematic 
variatiull within and between the arrays. This may have been caused by variability in the 
hybridization proccJurc as well as by the mieroarray slides themselves. which had several 
quality and printing defects. Although sequential normalization within and between arrays 
removed as much systematic variation as possible from the data, statistical evaluation of the 
normalized microarray data showed that the technical reproducibility within each array and 
hdwt'en replicate cxperiments was poor. Within each array, more than 50% of the replicated 
genes had standard deviations (SD) greater than 0.2, which was considered not reproducible 
(30). Moreover, reproducibility between arrays (biological replicates) was poor since 49% of 
the genes had SD>O.3 resulting in low correlation coefficients (Rl = 0.00000 I - 0.13), which 
accord i ng to Churchi II et al indicates that the biological replicates are not rep rod ucible (31). 
'rril11J1ling the unreliable data from the microarray data set improved the reproducibility as 
shown by the correlation coefficients that were between R2 = 0.2 and R2 = 0.4. llowever, 
despite the disappointing performance on statistical level, the microarray data still contained 
biologically meaningful data. Genes encoding pro-inflammatory cytokines, chemokines, 
iNOS and genes important fiJr macrophage activatiun and MHC class 11 presentatiun were -
significantly up-regulated in both the WT and C/EBPWI- activated mHcrophages during L. 
monncytogcnes infection. Moreover, the expected impaired induction of C/EI3P~) and its 
target genes, G-CSF, CLECSF9, lL-12p35 and ISGF3y. was observed in the C/EBPWI. 
Il\acrophages (17, 28, 32). Since the microarray data neld biologically relevant 
inrunnatiull, it was therci'ore used to search for di1H:!rentially expressed genes which were 
postulated to be involved in macrophage effector functions against L. monocytogenes. Five 
percent (1268 out of25000 genes) oCthe mouse genome was differentially expressed between 
lhe WI and C/t~13 Pfr"- activated macrophages in feCled with L. monocyJogenes. Functional 
cluslering ule the DE genes revealed that 2.0% of the DE genes were involved in host 
immunity and delcnse, 3.1 % in the production or ROI, 4.6(% in the regulation of transcription, 
16.1 % in signalling and 8.9% in phagosome maturation and phago-Iysosome fusion. 
Mon:uver. 18.0% of the DE genes had putative binding sites for C/EBPP and 47.3% had 
binding sites fiJr transcription 1actors that interacted with ClEBPfl A jc)cussed functional 
e IlIslcring strategy was used to reduce the number uf candidate genes from 1268 dowll to 220 
genes. PKCi5 was sdected for further study since it possessed all the postuJatetl criteria of a 
macrophage etTeclor gene: ontology and literature data mining showed that PKCo was 
involved in humoral defense. immune signalling (33-43), production of superoxide by 
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phag()cyte oxidase (-+1-43) and regulation 01' transcription via its phosphorylation of Statl, 
SlaU ~lJld p3()() (4-~). Moreover, promoter analysis revealed that it may be directly or 
illdireclly regulated by C/E13prt Furthermore, the role of PKC8 in innate immunity to 
illlrau:lllIl,lr pathogens has not been investigated to date, except for studies by Wadsworth and 
(inldlinc. Using roiJ.lerin, a putative speciJic PKCo inhihitor, data by Wadsworth and 
(Ioldline indirectly suggested that PKC(i played a role in promoting phagosomal escape ofL 
1IIIJIlIlcv/ogenl'.I' by initiating calcium influx into infected macrophages and by activating 
IlLD2 (45, 46). However, no evidence showing a direct correlation between PKC8 activity 
,mel listeri,ti plwgosomal escape was reported. In addition, 13 cells from PKC8/ . mice 
.\til11l1iated with LPS showed that PKC8 phosphorylation of C/EBPP negatively regulated its 
lrililscriptional activity (47). Furthermore, PKC8 was up-regUlated in L. lIIonocytogenes-
inlected UEH prf' macrophages as compared to WT, as shown by microarray and con iirmed 
by In-I)CR. Jt was therefore postulated that up-regulation of PKC8 may be detrimental 
durillg L II/lill(J(y/ogenes infections since it may promote phagosomal escape of 1.. 
IllOlIocvtogene.l' (45, 46) by an unknown mechanism that may involve the inhibition of 
('/LBPI3 transcriptional activity (47), which in C/EBPp-/' mice resulted in increased listerial 
escape frul11 the phagosomal (17). 
TIll' third part of' the current study functionally characterized the role of PKC8 in L. 
IIwllocytOg!'IICS inCcction and addressed the hypothesis that PKC8 played a detrimental role by 
prol11oting phagosomal escape. The fUl1ctional ill vitro and in vivo studies were done using the 
I'KC(S·I mOLise model rather than rottlerin, since this putative PKC8-specific inhibitor has 
been sliown to nOll-specifically inhibit several other kinases and non-kinase enzymes (48, 49). 
I)KC() was found to be important flJr preventing, rather then promoting, phagosomal escape of 
L IlIIJIIOn'tof!,cIICS. PKC6-1- macrophages had a 6.S fold increased bacterial escape from 
phagosome and uncontrolled bacterial growth, despite enhanced production of iNOS and pro-
in llammatory cytokines. Furthermore, the PKCo·l . mice were highly susceptible and uied 2 
clays ;i1ler infection with a sub-lethal dose for WT mice, Although the recruitment of activated 
macrophages to the site 01- infection was 10% lower ill the PKCo·l . mice, their susceptibility 
\Vas 110t due to impaired macrophage activation, since in vitro and ex vivo quantitation showed 
Ihal they produced significantly higher levels ol'nitric oxide and pro-inflammatory mediators 
in response to the high bacterial load than did WT mice. Furthermore, their impaired 
resistance to L IllOlj()C1'togencs was not due to defects in chemokine attraction, since the 
[)J(C,') I III icc displayed massive recruitment or inllammatory cells to the site of infection and 
abundant granulumas in their livers and spleens. In addition, the PKCo·I'micc were still unable 
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(0 kill and clear the L IIlOtlOcy/ogenes despite having recruited 30(% more ncutrophils, which 
an.: essential rilr ki Iling L flI01}()(yloJ,!;enes (I ). The current study has therc1<m: clearly 
demonstraled that PKCo was indispensable for confinement of L. monocyfogenes within the 
pilagosol11c, since 110 other PKC iSO(()J'Jll compensated for it during infection. As a result. the 
PKc\~ mice suffered significantly increased escape of L. m()nocylogenes from the 
macrophage phagosomcs, resulting in bacterial overgrowth, dissemination and early death. 
I'inally, the l.jLlcstion or how PKCo COli fined the bacilli within the phagosome was addressed 
and a hypothesis generated and tested against the microarray gene expression data. Studies by 
Wadsvvorth and Goldfine, using rottlerin and calcium channel inhibitors, showed that listerial 
escapc li'om macrophagc phagosomes was dependent on elevated cytosolic calcium levels 
(50) and that PKC15 was responsible for initiating the lirst calcium innux into macrophages 
UpOIl infection with L llIonocyfogenes (45). However, the results from this dissertation clearly 
showed [hat PKCo· l - macrophages had 6.5 f()ld more escaped L. n1of10cylogenes than WT, 
suggesting that the initial calcium influx into the macrophages upon infection occurred 
independently of PKCo. Moreover, the high susceptibility of the PKCO,I- mice to L 
JIIolloClJ/ogenes suggested that PKCo played an additional role other than phosphorylating and 
activating l..'alciull1 channels. 
PKC6 has been shown to be important for stlperoxide production by phagocyte oxidase (41 
through its phosphorylation of the enzyme's p47phox and p67phox components. In these 
studies, lack of phosphorylation by PKC8 resulted in the impaired recruitment of the cytosolic 
p47phox and p67phox components to the phagosome membrane, where they were to be 
asscmbled with other components to form functional phagocyte NADPlI oxidase enzyme. 
1\1\1fcovcr, the localized release of nitric oxide and sllpcroxide into the phagosomal space has 
b,;en shown to decrease bacterial escape (51). Therefore thc increased phagosomal escape and 
high susceptibility of the PKC8-1- mice may be due to impaired slIpcroxide production. 
Ilowcver, since the PKCo+ mice displayed a mllch higher degree of susceptibility to L. 
IlIIIIIOC)J/O,I!,CIlCS than p47pho:.;+ and gp91 phox-i - mice, it suggested that PKC8 may play an 
ndditiollal role other than stimulating the production or supcroxide into the phagosome. 
It can be cnvisaged that the RN IIROT pathway and the phago-lysosome fusion pathway act in 
concert to confine bacteria within the phagosome and to mediate killing by fusion with the 
IYSOSUlllC, which contains bactericidal enzymes that kill and degrade the bacilli. Confinement 
of hacteria within the phagosome has been shown to be dependent on the rccruitment and 
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assembly or l'unctional NAPDH phagocyte oxidase and nitric oxide synthase at the 
phagosome membrane and the localized release of nitric oxide and superoxide into the 
phagosumal space (51, Recruitment of these enzymes is effected by active GTP-bouncl 
R"h5~1, which lranslocates Rac::! to the phagosome membrane and regulates its activity. 
J\cliva1cd Rac2 in turn governs the assembly and activity of phagocyte NADPH oxidase at the 
phagosome rncl11hrane (52). The process or phagosome maturation, phago-Iysosome fusion 
alld subsequent [wcterial killing is also regulated by active Rab5a in an IFN-y dependent 
manner (52, 53). Active Rah5a causes remodeling of the phagosomal environment and 
pnmlllles phagosome maturation by enhancing membrane fusion between the pathogcn-
containing phagosome and endosomes (53). Similarly, experiments by Pizarro-Ct:rda et al 
del110nstrated thm C/EI3P[} promoted t:ndocytosis and membrane fusion bt:tween 
enLiosnmes <lnd pathogen-containing phagosomes in a G-CSF -dependent manner (24). 
Ilowever the actual mechanisms of these patll\vays are not fully elucidated. Since several 
studies have shown that RNI and ROl are important, but not essential f{Jr bacterial killing (6, 
8, () and that macro phages have an altcrnatiw killing mechanism dependent on IFN-y 01-
TNF (15,16) and C/EBPWI - (17), it ~vas therefore postulated that this unknown killing 
pathway may involve the phago-lysosome fusion pathway. In addition, since PKCo-!- mice 
were unable to connnc and ki II the 1,. monocytoJ!,enes bact Iii, despite fuJI macrophage 
activation and enhanced production of pro-inl1ammatory mediators and nitric oxide, it was 
further postulated that PKCo may be involved in a similar RNl/ROf-independent unknown 
listericidalmechanisll1 that was fIrst observed in IFN-il-, TNFRp5 ,rCSIlP+ and C/EBPI~r!· 
lJ1ic~~. More[)ver, since PKC8 appeared to act downstream of C/EBPB, this indicated that 
PKC6 may be involved in C/EI3PP mediated regulation of endocytosis, phagosome 
maluration and consequent bacterial killing. 
!\ systems biology approach was lIscd to investigate the mechanism whereby PKCo conllned 
I.. III(Jfloc),/ogellcs withinll1acrophage phagosomes. Analysis of the protein-protein interaction 
nelwork generated the hypothesis that PKC8 acted in synergy with G-CSF to promote Rab5a 
activilY, phagosome maturation, rllago-Iysosomc fusion and subsequent bacterial killing, by 
prol1111ting the Rab5a-activating functions of Agtrla and Rabgefl and by inhibiting the 
Rab5a-suprcssing fllllctions of TSc2 and Rasa I. Moreover, the microarray gene expression 
daw correlated with the proposed mechanism, since the Rab5a-activating proteins Agtrl a and 
Raht;efl were down-regulated, whereas the Rab5a-supressing and Rasa I proteins were 
lip-regulated in the C/FIWrrJ- macro phages as compared to WT. Although the inen.:ased levels 
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nf' PI(CS may have adequately repressed the increased Rab5a-supressing activities of Rasa I 
and Tsc2, it was not able to promote Rab5a activation due to impaired production Agtr I a and 
Ibhgen proteins due to the lack of ClEBPfl Therefore phagosome maturation, phago-
Iy~u"ollle rLlStOn and bacterial killing could not take place due the inability lo activate Rab5a. 
III addition, since transcription or G-CSF was impaired in the C/EBPWI. macrophages, 
activatiul\ uf Rab5a activity by G-CSF could not take place. Consequently the L. 
11I0/l0CV(OgCIIL'.1 bacilli could escape more efficiently from the phagosomes of C/EfWp-/. 
l11<1crophagt's resulting in bacterial overgrowth. This hypothesis could also be extended to the 
PKCi)'/' III ice, where G-CSF may activate Rab5a and inhibit Tsc2 and Rasa! activities, but not 
to the .same exlent as when in synergy with PKCo. 
III addition to prol11oting Rab5a activity, PKC8 may also act upstream of C/EBPP in the 
Ilypothetical killing where it augmenls IF1\I-y signalling by activating STATI (38, 54). In 
addition, PKCo may augment the activation of C/EBPP via phosphorylation or its trans-
aclivation domain, rather than phosphorylation of the DNA binding domain resulting in 
inhibition of C/EBPP activity (47). This is not implausible since the activity of PKC8 can 
vary according to the activation stimulus and cell type (44,55). tor example, in norma] cells 
IlKCiS 1'I'OI110tes apoptosis and generally suppresses normal cell prol ifcration, however, in 
cancer cells, activation of PKC8 inhibits apoptosis and promotes tUlllour growth (44, 55, 56). 
Moreover, both PKC8 and C/EBPP arc involved in IFN-y induced signalling: PKC8 itse! f is 
aLIi va!ed by I FN-y (38) and in turn activates STAT I by phosphorylation of its serine residue 
Ilumber 727 (38), Similarly, IFN-y induces the expression and activation of ClEBPr3 (19,20) 
vi:1 Ivll.KJ ,mellor a MEKKI/MEKI/ERKII2 signalling cascade to induce transcription of 
I FN-y responsive genes (21, 22). Therefore, in the context of IFN-y activated macrophages 
infected with L mot7ocylogcn£'s, PKC8 may augment the activation of C/EBPP via 
phosphorylation of othcr kinases that bind to and activate C/EBPp. For example, activated 
IlKCl1 phosphorylate'S MEK I leading to the activation of ERK 112 (57), wI! ich is also involved 
in the activation of' ClE13PP in response to IFN-y (58). 'rhererore, the higher levels of PKC8 in 
the IFN-y activated ClEBPp-/. infected macrophages may have functioned to promote C/EBP~) 
activity in order to enhance macrophage listericidal activity via the alternative RNIIROI-
independent pathway. The concerted action of PKC8 in promoting the localized release of" 
Slll1l'roxide into the phagosome, the activation C/EBPP transcriptional activity and the 
activa1 ion uf Rab5a activity may therefore augment macrophage Iistericidal activity via the 
hypothesized altal1ativc killil1g pathway. Alternatively, PKC8 may not be involved in 
287 
regulating Rab5a activity, and may only serve to activate C/EBPP transcriptional actIvIty. 
I'vlorenver, sincL' the PKC8,I, mice were not as susceptible as lPN-yR,I" RelB, TNFRp5y/' or 
c/l~l3prrl mice, it could be possible that PKCi5 may not in fact be part of the hypothetical 
RNIIROI-independent alternative killing rathway. In this context, PKC8 may confine the L. 
IIlo/JOey/ogenes within phagosomes by activating and/or synergizing with, as yet, unidentified 
proteins to neutralize that activity of listerial LID and PI-PLC. 
Currently further studies are being implemented in order to determine the mechanism 
whereby PKCiS conlines L. monocy(ogcnes within phagosomes. Key questions being 
addressed in the current investigations include (i) if PKC8 phosphorylation of C/f~Bpr3 can 
activate its transcriptional activity in IFN-y activated macrophages infected with L. 
1I1(}II(}Cl'/ogene,\, (ii) if L. monocy(ogenes can negatively modulate the activity of PKCi) in 
urder to I;lcilitate its escape frorn the phagosome, and (iii) if PKC8 can promote activation of 
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The cllrrent study addressed the hypothesis that macrophages have an alternative killing 
mechanism that is independent of superoxide and nitric oxide (1-3) but depemknl on IFN-y 
(4-6), TNF (7, 8) and C/EBPW'- (9). Since the mechanism and the genes involved in this 
alternative pathway arc largely unknown, the aim or this dissertation was to identify these 
macrophage efiector genes and to functionally characterize their role during infection by 
lIti I i/.ing gene de1icient mOLise models. 
In the current study, L lIIonocy/ogellfs was used as a model intracellular pathogen fix in vitro 
infection of I FN-y activated bone marrow derived macrophagcs in order to identily the genes 
involved in mediating macrophage bactericidal ellcctor activity. In IFN-y activated 
Illacrophages infected with L. fIIonocytogCI1l!S, IFN-y and TNF signalling converge nil 
C/EBP~~ promoting its transcription, activation and translocation to the nucleus resulting in 
the transcription of genes required for con1inement of L. monocy/ogenes within the 
phagosome (10-14). Since C/EBPrrl- mice expressed normal levels of IFN-y and TNF (9) 
during L nlOf1ocytogcrles in Icction, the macrophage effector genes involved in COll flnemenl 
and killing of L. II/oflocytogenes were postulated to be downstream ot' C/[~Bpr1. Furthermore, 
comparison between the gene expression profiles of WT and ClEBPWI- macrophages in1ected 
with L. 1l/()//OL:v/ogenes was hypothesized to increase the probability of identifying Ihese 
cffector gencs, which would be differentially expressed hetween the two groups. Comparative 
gene expression profiling by DNA microarrays between L monocytogcnes infected WT and 
ClFn PWi- macro phages, sllccessfully identified 1268 genes to be d i fferenlially expressed 
lx·tween the two groups. A focllssed Cunctional clustering strategy reduced the number of 
candidate genes to 220, which were enriched 1()1' genes already published to playa protective 
Ilr detrimental role during role 1,. lfIonoc}'togcm's infections, thereby validating the success of 
the microarray and data mining strategy. 
PKCo was selected as the prime candidate gene far further study since it possessed all the 
postulated criteria or a macrophage e!'lector gene. To date, the role of PKCo in innate 
immunity to intracellular pathogens hilS only been investigated by one group, which indirectly 
demonstrated that PKCo promoted phagosol1lal escape (15, 16). llowever, no evidence 
showing a direct correlation between PKC6 activity and I isterial phagosomal escape was 
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reported. Moreover, PKC8 phosphorylation or ClEBPf3 was shown to negatively rcgulate the 
transcription factor's transcriptional activity (17). Furthermore, since PKC8 was up-regulated 
in L mO}1Oc)'togf'nes-infecled CIEBPW- macro phages as compared to WT, as shown by 
microurray and confirmed by RT-PCR, it was thercfc)re postulated that up-regulation PKC8 
may be detrimental during L. mmlOcv/ogcncs infection. 
This dissertation provides novel insight into role of PKC8 during innate immunity against L. 
flI0110cy/ogt'JlL's. Functional studies using thc PKCiS-I - mouse model uncovcred a novel 
protective role, rather than a detrimental role, f()r PKC8 in innate immunity against L 
/J/olloc),/ogeflcs. Data in the current study clearly showed that PKCo was indispensahlc for 
confincment of L. JlI0floc)//ogenes within thc phagosome, since no other PKC isnll)I'Jll 
compcnsated /01' it in the PKC8-!- macrophagcs, The enhanccd listerial escapc and impaired 
listericidal activity, despite full macrophage activation and production or nitric oxidc, resulted 
in uncontrolled bacterial growth and dissemination of L nJOJlocyiogenes, which ultimately led 
to early dcath of the PKO;-I- mice. Furthermore, a systems biology approach was lIsed to 
investigate the mechanism whereby PKCB collfll\ed L. lI1onocy/ogefles within macrophage 
phagosome,,,;. It was hypothesized that PKC'o may playa role in the altcrnative killing 
mechanism that is independent of superoxide and nitric oxide (1-3) that was lirst observed in 
the I FN-y/- (4, 5), JFN-yR-1- (5, 6), TNf'Rp5yl (7, 8), and C/I~lH)lrl' (9) mice. It was 
envisaged that PKC8 may syncrgize with G-CSF to activate Rab5a, by promoting the activity 
01' )\gtJ" a and the Rabep I : Rubgefl protein complex, and by inhibiting the Rab5a-supressing 
activity of Tsc2 and Rasa I, Once activated, Rab5a was then able to promotc phagosome 
maturation, phago-Iysosome rusion and consequent bacterial killing_ Morcover, activatcd 
Rab5a has heen shown to stimulate Rac2-mediatcd recruitment, assembly and activation of 
phagocyte NADPII oxidase at the phagosome mcmbrane, resulting in localized release of 
sllpcroxidc into the phagosome. The concerted action of PKC6 in promoting the localized 
release of sllperoxidt.! into the phagosome coupled together with ib activation of C/EllPf3 and 
Rab5a, may thcrd'orc augmcnt the confinement of the L. I1lOnocp/ogt'fll's bacilli within the 
phagosome and consequent phago-Iysosomc mcdiated listerieidal activity. Altcrnatively, 
I'KC6 may runctioll only to activate ClEBJ>[) transcriptional activity, thereby augmenting 
C/EBPli mediated endocytosis and phago-[ysosoll1t.! fusion (18). Ilowevcr, since the PKCo-l -
mice were not as sllsccptible as IFN-yR-1-, RelB, TNFRp5S-I- or C/EBPrr/- mice, PKCB may 
not in 1~lct bt.! part of thc hypothctical RNI/ROI-independcnt alternative killing pathway. 
Instead PKC6 may act in parallel with the hypothetical RNI/ROI-indepcndt.!nt altcrnativc 
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killing pathway to cnhance confinement or the bacilli within the phagosolllc. For example, 
PKC8 Illay con rine the L. lIIof1ocyfogenes within phagosomes by activating and/or synergize 
with, as yet. unidentified proteins to neutralize that activity of listerial LLO and P[-PLC. 
The research undertaken in this dissertation has successfully fulfilled thc aims set out at the 
heginning of the study. Comparative DNA Illicroarray gene expression proliling between 
inICcted WT and C/EBPrr/. macrophages, integrated with a focussed functional clustering 
strategy. successfully identilied candidate genes involved in macrophage effector activity 
against L J1Iono(ytogenes. Furthermore, functional characterization 01' one of thcse candidate 
genes, PKC8, validated and uncovered a novel protcctivc role for PKC8 during L. 
lIIonocy/ogene.I' infcction, thereby adding ncw insight into the role of PKG5 during innate 
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Currently, thc mechanism wherehy PI<.C8 confines L tnOll(xytoKenes within phagosolllcs is 
bcing investigated. In addition, the putative positivc regulation of C/EI3P[3 by PI<.C8 and the 
negative regulation of PKC8 activation by L. 1I/1i/lOcytogenes are also being explorcd. In 
addition to PKCo, several other gencs were idcntificd by the microarray and data mining 
strategy as putative macrophage eflcctor genes. Among these, Rabgefl, pl<.qm and the very 
low density lipoprotein receptor (VLDLR) were selected for further study. Ragben was 
down-regulatcd 0.76 fold in the ClEBP[r/- rnacrophages as comparcd to WT. III vitro infection 
studies reported that L. fflonocvtoKcnes suppressed Rab5a function by preventing the 
exchange of GOP fix GTP and that this inhibition by most likely mediated through 
I\llldu lation 0 r Rab5a G EFs (1). Ilowcvcr, til is prcl1l ise has never becn tcsted in vivo using thc 
Rabgc 1"1 gene de1icient mouse model. Si III i larly, al though PKC[1 r I was not d iDercntially 
expressed bctween I.he inlCctcd WT and C/lmpwl-, its putativc role in promoting L 
IllOfJO(ytoKerles phagosomal cscapc (2) has never been v,llilbkd in vivo using the PKCPIr/-
IllOllse model. The very low density lipoprotein receptor (VLDLR), which is important for 
uptake and metabolism of cholesterol, was down-regulated 0.89 fold respectively in the 
C/r~J3prr!' macrophages as cOlllpared to WT. VLDL binds cholesterol and thc uptakc or 
VLDL-bounc! cholesterol into cells occLirs via VUJLR-I\lediated endocytosis which tranicks 
thc VLDL-bound cholesterol to Iysosollll:s. F::nzymatic degradation of the lipoprotein within 
thc Iysosomc rcleases the cholesterol, which then represses the activity or microsomal ellzyme 
3-hydroxy-3-I11e!ilylglutaryl coenzyme A (lIMG eoA) reductase, the major enzyme involved 
in cllOlestl:rol synthesis (3,4). Although no role was found in the literature 1'01' VLDLR during 
L lJI()nocytoKenes in Icction, it can be ellvisaged that the pathogen may down-regulate the 
VLDLR gene, since its survival depends on phagosomal escape mediated predominantly by 
U.o, the activity of which is dependent on cholesterol. r~L1nctional studies uncovering and 
validating thl: roles of thesc additional genes in L. lJIonocvtogencs infections will be 
implemented utilizing their respective gene deficient mouse models. 
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